id	sid	tid	token	lemma	pos
dpc-1936	1	1	dermatology	dermatology	NOUN
dpc-1936	1	2	:	:	PUNCT
dpc-1936	1	3	practical	practical	ADJ
dpc-1936	1	4	and	and	CCONJ
dpc-1936	1	5	conceptual	conceptual	ADJ
dpc-1936	1	6	original	original	ADJ
dpc-1936	1	7	article	article	NOUN
dpc-1936	1	8	|	|	ADV
dpc-1936	1	9	dermatol	dermatol	ADJ
dpc-1936	1	10	pract	pract	NOUN
dpc-1936	1	11	concept	concept	NOUN
dpc-1936	1	12	.	.	PUNCT
dpc-1936	2	1	2022;12(2):e2022104	2022;12(2):e2022104	PROPN
dpc-1936	2	2	1	1	NUM
dpc-1936	2	3	efficacy	efficacy	NOUN
dpc-1936	2	4	and	and	CCONJ
dpc-1936	2	5	safety	safety	NOUN
dpc-1936	2	6	of	of	ADP
dpc-1936	2	7	ixekizumab	ixekizumab	NOUN
dpc-1936	2	8	versus	versus	ADP
dpc-1936	2	9	adalimumab	adalimumab	NOUN
dpc-1936	2	10	in	in	ADP
dpc-1936	2	11	biologic	biologic	ADJ
dpc-1936	2	12	-	-	PUNCT
dpc-1936	2	13	naïve	naïve	ADJ
dpc-1936	2	14	patients	patient	NOUN
dpc-1936	2	15	with	with	ADP
dpc-1936	2	16	active	active	ADJ
dpc-1936	2	17	psoriatic	psoriatic	ADJ
dpc-1936	2	18	arthritis	arthritis	NOUN
dpc-1936	2	19	and	and	CCONJ
dpc-1936	2	20	moderate	moderate	ADJ
dpc-1936	2	21	-	-	PUNCT
dpc-1936	2	22	to	to	ADP
dpc-1936	2	23	-	-	PUNCT
dpc-1936	2	24	severe	severe	ADJ
dpc-1936	2	25	psoriasis	psoriasis	NOUN
dpc-1936	2	26	:	:	PUNCT
dpc-1936	2	27	52	52	NUM
dpc-1936	2	28	-	-	PUNCT
dpc-1936	2	29	week	week	NOUN
dpc-1936	2	30	results	result	NOUN
dpc-1936	2	31	from	from	ADP
dpc-1936	2	32	the	the	DET
dpc-1936	2	33	randomized	randomized	ADJ
dpc-1936	2	34	spirit	spirit	NOUN
dpc-1936	2	35	-	-	PUNCT
dpc-1936	2	36	h2h	h2h	PROPN
dpc-1936	2	37	trial	trial	NOUN
dpc-1936	2	38	kristian	kristian	PROPN
dpc-1936	2	39	reich1	reich1	PROPN
dpc-1936	2	40	,	,	PUNCT
dpc-1936	2	41	lars	lars	PROPN
dpc-1936	2	42	erik	erik	PROPN
dpc-1936	2	43	kristensen2	kristensen2	PROPN
dpc-1936	2	44	,	,	PUNCT
dpc-1936	2	45	saxon	saxon	PROPN
dpc-1936	2	46	d.	d.	PROPN
dpc-1936	2	47	smith3	smith3	PROPN
dpc-1936	2	48	,	,	PUNCT
dpc-1936	2	49	phoebe	phoebe	PROPN
dpc-1936	2	50	rich4	rich4	PROPN
dpc-1936	2	51	,	,	PUNCT
dpc-1936	2	52	christophe	christophe	PROPN
dpc-1936	2	53	sapin5	sapin5	PROPN
dpc-1936	2	54	,	,	PUNCT
dpc-1936	2	55	soyi	soyi	PROPN
dpc-1936	2	56	liu	liu	PROPN
dpc-1936	2	57	leage5	leage5	PROPN
dpc-1936	2	58	,	,	PUNCT
dpc-1936	2	59	robert	robert	PROPN
dpc-1936	2	60	mckenzie5	mckenzie5	PROPN
dpc-1936	2	61	,	,	PUNCT
dpc-1936	2	62	christopher	christopher	PROPN
dpc-1936	2	63	schuster5,6	schuster5,6	PROPN
dpc-1936	2	64	,	,	PUNCT
dpc-1936	2	65	elisabeth	elisabeth	PROPN
dpc-1936	2	66	riedl5,6	riedl5,6	PROPN
dpc-1936	2	67	,	,	PUNCT
dpc-1936	2	68	melinda	melinda	PROPN
dpc-1936	2	69	gooderham7	gooderham7	PROPN
dpc-1936	2	70	1	1	NUM
dpc-1936	2	71	center	center	NOUN
dpc-1936	2	72	for	for	ADP
dpc-1936	2	73	translational	translational	ADJ
dpc-1936	2	74	research	research	NOUN
dpc-1936	2	75	in	in	ADP
dpc-1936	2	76	inflammatory	inflammatory	ADJ
dpc-1936	2	77	skin	skin	NOUN
dpc-1936	2	78	diseases	disease	NOUN
dpc-1936	2	79	,	,	PUNCT
dpc-1936	2	80	institute	institute	NOUN
dpc-1936	2	81	for	for	ADP
dpc-1936	2	82	health	health	NOUN
dpc-1936	2	83	services	service	NOUN
dpc-1936	2	84	research	research	NOUN
dpc-1936	2	85	in	in	ADP
dpc-1936	2	86	dermatology	dermatology	NOUN
dpc-1936	2	87	and	and	CCONJ
dpc-1936	2	88	nursing	nursing	NOUN
dpc-1936	2	89	,	,	PUNCT
dpc-1936	2	90	university	university	NOUN
dpc-1936	2	91	medical	medical	ADJ
dpc-1936	2	92	center	center	PROPN
dpc-1936	2	93	hamburg	hamburg	PROPN
dpc-1936	2	94	-	-	PUNCT
dpc-1936	2	95	eppendorf	eppendorf	PROPN
dpc-1936	2	96	,	,	PUNCT
dpc-1936	2	97	hamburg	hamburg	PROPN
dpc-1936	2	98	,	,	PUNCT
dpc-1936	2	99	germany	germany	PROPN
dpc-1936	2	100	;	;	PUNCT
dpc-1936	2	101	2	2	NUM
dpc-1936	2	102	musculoskeletal	musculoskeletal	ADJ
dpc-1936	2	103	statistics	statistic	NOUN
dpc-1936	2	104	unit	unit	NOUN
dpc-1936	2	105	,	,	PUNCT
dpc-1936	2	106	the	the	DET
dpc-1936	2	107	parker	parker	PROPN
dpc-1936	2	108	institute	institute	PROPN
dpc-1936	2	109	,	,	PUNCT
dpc-1936	2	110	copenhagen	copenhagen	PROPN
dpc-1936	2	111	university	university	PROPN
dpc-1936	2	112	hospital	hospital	NOUN
dpc-1936	2	113	,	,	PUNCT
dpc-1936	2	114	bispebjerg	bispebjerg	PROPN
dpc-1936	2	115	and	and	CCONJ
dpc-1936	2	116	frederiksberg	frederiksberg	PROPN
dpc-1936	2	117	hospital	hospital	PROPN
dpc-1936	2	118	,	,	PUNCT
dpc-1936	2	119	copenhagen	copenhagen	PROPN
dpc-1936	2	120	,	,	PUNCT
dpc-1936	2	121	denmark	denmark	PROPN
dpc-1936	2	122	;	;	PUNCT
dpc-1936	2	123	3	3	NUM
dpc-1936	2	124	the	the	DET
dpc-1936	2	125	dermatology	dermatology	NOUN
dpc-1936	2	126	and	and	CCONJ
dpc-1936	2	127	skin	skin	NOUN
dpc-1936	2	128	cancer	cancer	NOUN
dpc-1936	2	129	centre	centre	NOUN
dpc-1936	2	130	,	,	PUNCT
dpc-1936	2	131	st	st	PROPN
dpc-1936	2	132	leonards	leonards	PROPN
dpc-1936	2	133	,	,	PUNCT
dpc-1936	2	134	and	and	CCONJ
dpc-1936	2	135	discipline	discipline	NOUN
dpc-1936	2	136	of	of	ADP
dpc-1936	2	137	dermatology	dermatology	NOUN
dpc-1936	2	138	,	,	PUNCT
dpc-1936	2	139	sydney	sydney	PROPN
dpc-1936	2	140	medical	medical	PROPN
dpc-1936	2	141	school	school	PROPN
dpc-1936	2	142	,	,	PUNCT
dpc-1936	2	143	university	university	PROPN
dpc-1936	2	144	of	of	ADP
dpc-1936	2	145	sydney	sydney	PROPN
dpc-1936	2	146	,	,	PUNCT
dpc-1936	2	147	sydney	sydney	PROPN
dpc-1936	2	148	,	,	PUNCT
dpc-1936	2	149	australia	australia	PROPN
dpc-1936	2	150	;	;	PUNCT
dpc-1936	2	151	4	4	NUM
dpc-1936	2	152	oregon	oregon	NOUN
dpc-1936	2	153	dermatology	dermatology	NOUN
dpc-1936	2	154	and	and	CCONJ
dpc-1936	2	155	research	research	NOUN
dpc-1936	2	156	,	,	PUNCT
dpc-1936	2	157	portland	portland	PROPN
dpc-1936	2	158	,	,	PUNCT
dpc-1936	2	159	oregon	oregon	PROPN
dpc-1936	2	160	,	,	PUNCT
dpc-1936	2	161	usa	usa	PROPN
dpc-1936	2	162	;	;	PUNCT
dpc-1936	2	163	5	5	NUM
dpc-1936	2	164	eli	eli	PROPN
dpc-1936	2	165	lilly	lilly	PROPN
dpc-1936	2	166	and	and	CCONJ
dpc-1936	2	167	company	company	NOUN
dpc-1936	2	168	,	,	PUNCT
dpc-1936	2	169	indianapolis	indianapolis	PROPN
dpc-1936	2	170	,	,	PUNCT
dpc-1936	2	171	indiana	indiana	PROPN
dpc-1936	2	172	,	,	PUNCT
dpc-1936	2	173	usa	usa	PROPN
dpc-1936	2	174	;	;	PUNCT
dpc-1936	2	175	6	6	NUM
dpc-1936	2	176	department	department	NOUN
dpc-1936	2	177	of	of	ADP
dpc-1936	2	178	dermatology	dermatology	NOUN
dpc-1936	2	179	,	,	PUNCT
dpc-1936	2	180	medical	medical	ADJ
dpc-1936	2	181	university	university	PROPN
dpc-1936	2	182	of	of	ADP
dpc-1936	2	183	vienna	vienna	PROPN
dpc-1936	2	184	,	,	PUNCT
dpc-1936	2	185	vienna	vienna	PROPN
dpc-1936	2	186	,	,	PUNCT
dpc-1936	2	187	austria	austria	PROPN
dpc-1936	2	188	;	;	PUNCT
dpc-1936	2	189	7	7	NUM
dpc-1936	2	190	skin	skin	NOUN
dpc-1936	2	191	centre	centre	NOUN
dpc-1936	2	192	for	for	ADP
dpc-1936	2	193	dermatology	dermatology	NOUN
dpc-1936	2	194	,	,	PUNCT
dpc-1936	2	195	probity	probity	NOUN
dpc-1936	2	196	medical	medical	ADJ
dpc-1936	2	197	research	research	PROPN
dpc-1936	2	198	and	and	CCONJ
dpc-1936	2	199	queen	queen	PROPN
dpc-1936	2	200	’s	’s	PART
dpc-1936	2	201	university	university	PROPN
dpc-1936	2	202	,	,	PUNCT
dpc-1936	2	203	peterborough	peterborough	PROPN
dpc-1936	2	204	,	,	PUNCT
dpc-1936	2	205	ontario	ontario	PROPN
dpc-1936	2	206	,	,	PUNCT
dpc-1936	2	207	canada	canada	PROPN
dpc-1936	2	208	.	.	PUNCT
dpc-1936	3	1	key	key	ADJ
dpc-1936	3	2	words	word	NOUN
dpc-1936	3	3	:	:	PUNCT
dpc-1936	3	4	ixekizumab	ixekizumab	NOUN
dpc-1936	3	5	,	,	PUNCT
dpc-1936	3	6	adalimumab	adalimumab	NOUN
dpc-1936	3	7	,	,	PUNCT
dpc-1936	3	8	spirit	spirit	PROPN
dpc-1936	3	9	-	-	PUNCT
dpc-1936	3	10	h2h	h2h	PROPN
dpc-1936	3	11	,	,	PUNCT
dpc-1936	3	12	nail	nail	NOUN
dpc-1936	3	13	psoriasis	psoriasis	NOUN
dpc-1936	3	14	,	,	PUNCT
dpc-1936	3	15	psoriasis	psoriasis	NOUN
dpc-1936	3	16	,	,	PUNCT
dpc-1936	3	17	citation	citation	NOUN
dpc-1936	3	18	:	:	PUNCT
dpc-1936	3	19	reich	reich	PROPN
dpc-1936	3	20	k	k	PROPN
dpc-1936	3	21	,	,	PUNCT
dpc-1936	3	22	kristensen	kristensen	PROPN
dpc-1936	3	23	le	le	PROPN
dpc-1936	3	24	,	,	PUNCT
dpc-1936	3	25	smith	smith	PROPN
dpc-1936	3	26	sd	sd	PROPN
dpc-1936	3	27	et	et	PROPN
dpc-1936	3	28	al	al	PROPN
dpc-1936	3	29	.	.	PROPN
dpc-1936	3	30	efficacy	efficacy	NOUN
dpc-1936	3	31	and	and	CCONJ
dpc-1936	3	32	safety	safety	NOUN
dpc-1936	3	33	of	of	ADP
dpc-1936	3	34	ixekizumab	ixekizumab	NOUN
dpc-1936	3	35	versus	versus	ADP
dpc-1936	3	36	adalimumab	adalimumab	NOUN
dpc-1936	3	37	in	in	ADP
dpc-1936	3	38	biologic	biologic	ADJ
dpc-1936	3	39	-	-	PUNCT
dpc-1936	3	40	naïve	naïve	ADJ
dpc-1936	3	41	patients	patient	NOUN
dpc-1936	3	42	with	with	ADP
dpc-1936	3	43	active	active	ADJ
dpc-1936	3	44	psoriatic	psoriatic	ADJ
dpc-1936	3	45	arthritis	arthritis	NOUN
dpc-1936	3	46	and	and	CCONJ
dpc-1936	3	47	moderate	moderate	ADJ
dpc-1936	3	48	-	-	PUNCT
dpc-1936	3	49	to	to	ADP
dpc-1936	3	50	-	-	PUNCT
dpc-1936	3	51	severe	severe	ADJ
dpc-1936	3	52	psoriasis	psoriasis	NOUN
dpc-1936	3	53	:	:	PUNCT
dpc-1936	3	54	52	52	NUM
dpc-1936	3	55	-	-	PUNCT
dpc-1936	3	56	week	week	NOUN
dpc-1936	3	57	results	result	NOUN
dpc-1936	3	58	from	from	ADP
dpc-1936	3	59	the	the	DET
dpc-1936	3	60	randomized	randomized	ADJ
dpc-1936	3	61	spirit	spirit	NOUN
dpc-1936	3	62	-	-	PUNCT
dpc-1936	3	63	h2h	h2h	PROPN
dpc-1936	3	64	trial	trial	NOUN
dpc-1936	3	65	.	.	PUNCT
dpc-1936	4	1	dermatol	dermatol	NOUN
dpc-1936	4	2	pract	pract	PROPN
dpc-1936	4	3	concept	concept	NOUN
dpc-1936	4	4	.	.	PUNCT
dpc-1936	5	1	2022;12(2):e2022104	2022;12(2):e2022104	X
dpc-1936	5	2	.	.	PUNCT
dpc-1936	5	3	doi	doi	PROPN
dpc-1936	5	4	:	:	PUNCT
dpc-1936	6	1	https://doi.org/10.5826/dpc.1202a104	https://doi.org/10.5826/dpc.1202a104	PROPN
dpc-1936	6	2	accepted	accept	VERB
dpc-1936	6	3	:	:	PUNCT
dpc-1936	6	4	october	october	PROPN
dpc-1936	6	5	25	25	NUM
dpc-1936	6	6	,	,	PUNCT
dpc-1936	6	7	2021	2021	NUM
dpc-1936	6	8	;	;	PUNCT
dpc-1936	6	9	published	publish	VERB
dpc-1936	6	10	:	:	PUNCT
dpc-1936	6	11	april	april	PROPN
dpc-1936	6	12	2022	2022	NUM
dpc-1936	7	1	copyright	copyright	NOUN
dpc-1936	7	2	:	:	PUNCT
dpc-1936	7	3	©	©	PROPN
dpc-1936	7	4	2022	2022	NUM
dpc-1936	7	5	reich	reich	PROPN
dpc-1936	7	6	et	et	PROPN
dpc-1936	7	7	al	al	PROPN
dpc-1936	7	8	.	.	PUNCT
dpc-1936	8	1	this	this	PRON
dpc-1936	8	2	is	be	AUX
dpc-1936	8	3	an	an	DET
dpc-1936	8	4	open	open	ADJ
dpc-1936	8	5	-	-	PUNCT
dpc-1936	8	6	access	access	NOUN
dpc-1936	8	7	article	article	NOUN
dpc-1936	8	8	distributed	distribute	VERB
dpc-1936	8	9	under	under	ADP
dpc-1936	8	10	the	the	DET
dpc-1936	8	11	terms	term	NOUN
dpc-1936	8	12	of	of	ADP
dpc-1936	8	13	the	the	DET
dpc-1936	8	14	creative	creative	ADJ
dpc-1936	8	15	commons	common	NOUN
dpc-1936	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-1936	8	17	license	license	NOUN
dpc-1936	8	18	(	(	PUNCT
dpc-1936	8	19	by	by	ADP
dpc-1936	8	20	-	-	PUNCT
dpc-1936	8	21	nc-4.0	nc-4.0	NOUN
dpc-1936	8	22	)	)	PUNCT
dpc-1936	8	23	,	,	PUNCT
dpc-1936	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-1936	8	25	,	,	PUNCT
dpc-1936	8	26	which	which	PRON
dpc-1936	8	27	permits	permit	VERB
dpc-1936	8	28	unrestricted	unrestricted	ADJ
dpc-1936	8	29	noncommercial	noncommercial	ADJ
dpc-1936	8	30	use	use	NOUN
dpc-1936	8	31	,	,	PUNCT
dpc-1936	8	32	distribution	distribution	NOUN
dpc-1936	8	33	,	,	PUNCT
dpc-1936	8	34	and	and	CCONJ
dpc-1936	8	35	reproduction	reproduction	NOUN
dpc-1936	8	36	in	in	ADP
dpc-1936	8	37	any	any	DET
dpc-1936	8	38	medium	medium	NOUN
dpc-1936	8	39	,	,	PUNCT
dpc-1936	8	40	provided	provide	VERB
dpc-1936	8	41	the	the	DET
dpc-1936	8	42	original	original	ADJ
dpc-1936	8	43	authors	author	NOUN
dpc-1936	8	44	and	and	CCONJ
dpc-1936	8	45	source	source	NOUN
dpc-1936	8	46	are	be	AUX
dpc-1936	8	47	credited	credit	VERB
dpc-1936	8	48	.	.	PUNCT
dpc-1936	9	1	funding	funding	NOUN
dpc-1936	9	2	:	:	PUNCT
dpc-1936	9	3	this	this	DET
dpc-1936	9	4	work	work	NOUN
dpc-1936	9	5	was	be	AUX
dpc-1936	9	6	supported	support	VERB
dpc-1936	9	7	by	by	ADP
dpc-1936	9	8	eli	eli	PROPN
dpc-1936	9	9	lilly	lilly	PROPN
dpc-1936	9	10	and	and	CCONJ
dpc-1936	9	11	company	company	NOUN
dpc-1936	9	12	,	,	PUNCT
dpc-1936	9	13	which	which	PRON
dpc-1936	9	14	contributed	contribute	VERB
dpc-1936	9	15	to	to	PART
dpc-1936	9	16	study	study	VERB
dpc-1936	9	17	design	design	NOUN
dpc-1936	9	18	,	,	PUNCT
dpc-1936	9	19	data	data	NOUN
dpc-1936	9	20	collection	collection	NOUN
dpc-1936	9	21	,	,	PUNCT
dpc-1936	9	22	data	datum	NOUN
dpc-1936	9	23	analysis	analysis	NOUN
dpc-1936	9	24	,	,	PUNCT
dpc-1936	9	25	data	datum	NOUN
dpc-1936	9	26	interpretation	interpretation	NOUN
dpc-1936	9	27	,	,	PUNCT
dpc-1936	9	28	manuscript	manuscript	NOUN
dpc-1936	9	29	preparation	preparation	NOUN
dpc-1936	9	30	,	,	PUNCT
dpc-1936	9	31	and	and	CCONJ
dpc-1936	9	32	publication	publication	NOUN
dpc-1936	9	33	decisions	decision	NOUN
dpc-1936	9	34	.	.	PUNCT
dpc-1936	10	1	competing	compete	VERB
dpc-1936	10	2	interests	interest	NOUN
dpc-1936	10	3	:	:	PUNCT
dpc-1936	10	4	k.	k.	PROPN
dpc-1936	10	5	reich	reich	PROPN
dpc-1936	10	6	reports	report	VERB
dpc-1936	10	7	conflicts	conflict	NOUN
dpc-1936	10	8	of	of	ADP
dpc-1936	10	9	interest	interest	NOUN
dpc-1936	10	10	from	from	ADP
dpc-1936	10	11	abbvie	abbvie	PROPN
dpc-1936	10	12	,	,	PUNCT
dpc-1936	10	13	affibody	affibody	NOUN
dpc-1936	10	14	,	,	PUNCT
dpc-1936	10	15	amgen	amgen	PROPN
dpc-1936	10	16	,	,	PUNCT
dpc-1936	10	17	boehringer	boehringer	PROPN
dpc-1936	10	18	ingelheim	ingelheim	PROPN
dpc-1936	10	19	,	,	PUNCT
dpc-1936	10	20	bristol	bristol	PROPN
dpc-1936	10	21	-	-	PUNCT
dpc-1936	10	22	myers	myers	PROPN
dpc-1936	10	23	squibb	squibb	PROPN
dpc-1936	10	24	,	,	PUNCT
dpc-1936	10	25	eli	eli	PROPN
dpc-1936	10	26	lilly	lilly	PROPN
dpc-1936	10	27	and	and	CCONJ
dpc-1936	10	28	company	company	NOUN
dpc-1936	10	29	,	,	PUNCT
dpc-1936	10	30	forward	forward	ADJ
dpc-1936	10	31	pharma	pharma	PROPN
dpc-1936	10	32	,	,	PUNCT
dpc-1936	10	33	janssen	janssen	PROPN
dpc-1936	10	34	,	,	PUNCT
dpc-1936	10	35	kyowa	kyowa	PROPN
dpc-1936	10	36	kirin	kirin	PROPN
dpc-1936	10	37	,	,	PUNCT
dpc-1936	10	38	leo	leo	PROPN
dpc-1936	10	39	,	,	PUNCT
dpc-1936	10	40	and	and	CCONJ
dpc-1936	10	41	ucb	ucb	PROPN
dpc-1936	10	42	.	.	PUNCT
dpc-1936	11	1	l.e	l.e	PROPN
dpc-1936	11	2	.	.	PUNCT
dpc-1936	11	3	kristensen	kristensen	PROPN
dpc-1936	11	4	reports	report	VERB
dpc-1936	11	5	conflicts	conflict	NOUN
dpc-1936	11	6	of	of	ADP
dpc-1936	11	7	interest	interest	NOUN
dpc-1936	11	8	from	from	ADP
dpc-1936	11	9	abbvie	abbvie	PROPN
dpc-1936	11	10	,	,	PUNCT
dpc-1936	11	11	amgen	amgen	PROPN
dpc-1936	11	12	,	,	PUNCT
dpc-1936	11	13	biogen	biogen	PROPN
dpc-1936	11	14	,	,	PUNCT
dpc-1936	11	15	bristol	bristol	PROPN
dpc-1936	11	16	-	-	PUNCT
dpc-1936	11	17	myers	myers	PROPN
dpc-1936	11	18	squibb	squibb	PROPN
dpc-1936	11	19	,	,	PUNCT
dpc-1936	11	20	celgene	celgene	PROPN
dpc-1936	11	21	,	,	PUNCT
dpc-1936	11	22	eli	eli	PROPN
dpc-1936	11	23	lilly	lilly	PROPN
dpc-1936	11	24	and	and	CCONJ
dpc-1936	11	25	company	company	NOUN
dpc-1936	11	26	,	,	PUNCT
dpc-1936	11	27	forward	forward	ADJ
dpc-1936	11	28	pharma	pharma	PROPN
dpc-1936	11	29	,	,	PUNCT
dpc-1936	11	30	janssen	janssen	PROPN
dpc-1936	11	31	,	,	PUNCT
dpc-1936	11	32	merck	merck	PROPN
dpc-1936	11	33	,	,	PUNCT
dpc-1936	11	34	and	and	CCONJ
dpc-1936	11	35	co.	co.	PROPN
dpc-1936	11	36	,	,	PUNCT
dpc-1936	11	37	novartis	novartis	NOUN
dpc-1936	11	38	,	,	PUNCT
dpc-1936	11	39	pfizer	pfizer	NOUN
dpc-1936	11	40	,	,	PUNCT
dpc-1936	11	41	and	and	CCONJ
dpc-1936	11	42	ucb	ucb	PROPN
dpc-1936	11	43	.	.	PROPN
dpc-1936	12	1	s.d	s.d	PROPN
dpc-1936	12	2	.	.	PROPN
dpc-1936	12	3	smith	smith	PROPN
dpc-1936	12	4	has	have	AUX
dpc-1936	12	5	been	be	AUX
dpc-1936	12	6	an	an	DET
dpc-1936	12	7	advisor	advisor	NOUN
dpc-1936	12	8	for	for	ADP
dpc-1936	12	9	and/or	and/or	CCONJ
dpc-1936	12	10	received	receive	VERB
dpc-1936	12	11	speaking	speaking	NOUN
dpc-1936	12	12	fees	fee	NOUN
dpc-1936	12	13	and/or	and/or	CCONJ
dpc-1936	12	14	served	serve	VERB
dpc-1936	12	15	as	as	ADP
dpc-1936	12	16	an	an	DET
dpc-1936	12	17	investigator	investigator	NOUN
dpc-1936	12	18	in	in	ADP
dpc-1936	12	19	clinical	clinical	ADJ
dpc-1936	12	20	trials	trial	NOUN
dpc-1936	12	21	for	for	ADP
dpc-1936	12	22	abbvie	abbvie	PROPN
dpc-1936	12	23	,	,	PUNCT
dpc-1936	12	24	amgen	amgen	PROPN
dpc-1936	12	25	,	,	PUNCT
dpc-1936	12	26	biogen	biogen	PROPN
dpc-1936	12	27	,	,	PUNCT
dpc-1936	12	28	bristol	bristol	PROPN
dpc-1936	12	29	myers	myers	PROPN
dpc-1936	12	30	squibb	squibb	PROPN
dpc-1936	12	31	,	,	PUNCT
dpc-1936	12	32	eli	eli	PROPN
dpc-1936	12	33	lilly	lilly	PROPN
dpc-1936	12	34	and	and	CCONJ
dpc-1936	12	35	company	company	NOUN
dpc-1936	12	36	,	,	PUNCT
dpc-1936	12	37	janssen	janssen	PROPN
dpc-1936	12	38	cilag	cilag	PROPN
dpc-1936	12	39	,	,	PUNCT
dpc-1936	12	40	leo	leo	PROPN
dpc-1936	12	41	pharma	pharma	PROPN
dpc-1936	12	42	,	,	PUNCT
dpc-1936	12	43	novartis	novartis	NOUN
dpc-1936	12	44	,	,	PUNCT
dpc-1936	12	45	pfizer	pfizer	NOUN
dpc-1936	12	46	,	,	PUNCT
dpc-1936	12	47	sanofi	sanofi	PROPN
dpc-1936	12	48	genzyme	genzyme	PROPN
dpc-1936	12	49	,	,	PUNCT
dpc-1936	12	50	and	and	CCONJ
dpc-1936	12	51	ucb	ucb	PROPN
dpc-1936	12	52	.	.	PUNCT
dpc-1936	13	1	p.	p.	PROPN
dpc-1936	13	2	rich	rich	ADJ
dpc-1936	13	3	has	have	AUX
dpc-1936	13	4	been	be	AUX
dpc-1936	13	5	a	a	DET
dpc-1936	13	6	principal	principal	ADJ
dpc-1936	13	7	investigator	investigator	NOUN
dpc-1936	13	8	for	for	ADP
dpc-1936	13	9	abbvie	abbvie	PROPN
dpc-1936	13	10	,	,	PUNCT
dpc-1936	13	11	amgen	amgen	PROPN
dpc-1936	13	12	,	,	PUNCT
dpc-1936	13	13	arcutis	arcutis	PROPN
dpc-1936	13	14	,	,	PUNCT
dpc-1936	13	15	boehringer	boehringer	PROPN
dpc-1936	13	16	ingelheim	ingelheim	PROPN
dpc-1936	13	17	,	,	PUNCT
dpc-1936	13	18	bristol	bristol	PROPN
dpc-1936	13	19	-	-	PUNCT
dpc-1936	13	20	myers	myers	PROPN
dpc-1936	13	21	squibb	squibb	PROPN
dpc-1936	13	22	,	,	PUNCT
dpc-1936	13	23	celgene	celgene	NOUN
dpc-1936	13	24	,	,	PUNCT
dpc-1936	13	25	dermavant	dermavant	PROPN
dpc-1936	13	26	,	,	PUNCT
dpc-1936	13	27	eli	eli	PROPN
dpc-1936	13	28	lilly	lilly	PROPN
dpc-1936	13	29	and	and	CCONJ
dpc-1936	13	30	company	company	NOUN
dpc-1936	13	31	,	,	PUNCT
dpc-1936	13	32	merck	merck	PROPN
dpc-1936	13	33	,	,	PUNCT
dpc-1936	13	34	novartis	novartis	PROPN
dpc-1936	13	35	,	,	PUNCT
dpc-1936	13	36	pfizer	pfizer	NOUN
dpc-1936	13	37	and	and	CCONJ
dpc-1936	13	38	sandoz	sandoz	PROPN
dpc-1936	13	39	,	,	PUNCT
dpc-1936	13	40	sun	sun	NOUN
dpc-1936	13	41	pharma	pharma	PROPN
dpc-1936	13	42	,	,	PUNCT
dpc-1936	13	43	and	and	CCONJ
dpc-1936	13	44	ucb	ucb	PROPN
dpc-1936	13	45	;	;	PUNCT
dpc-1936	13	46	a	a	DET
dpc-1936	13	47	consultant	consultant	NOUN
dpc-1936	13	48	for	for	ADP
dpc-1936	13	49	abbvie	abbvie	PROPN
dpc-1936	13	50	,	,	PUNCT
dpc-1936	13	51	novartis	novartis	PROPN
dpc-1936	13	52	and	and	CCONJ
dpc-1936	13	53	polichem	polichem	NOUN
dpc-1936	13	54	;	;	PUNCT
dpc-1936	13	55	and	and	CCONJ
dpc-1936	13	56	an	an	DET
dpc-1936	13	57	advisory	advisory	ADJ
dpc-1936	13	58	board	board	NOUN
dpc-1936	13	59	participant	participant	NOUN
dpc-1936	13	60	for	for	ADP
dpc-1936	13	61	abbvie	abbvie	PROPN
dpc-1936	13	62	,	,	PUNCT
dpc-1936	13	63	eli	eli	PROPN
dpc-1936	13	64	lilly	lilly	PROPN
dpc-1936	13	65	and	and	CCONJ
dpc-1936	13	66	company	company	NOUN
dpc-1936	13	67	,	,	PUNCT
dpc-1936	13	68	leo	leo	PROPN
dpc-1936	13	69	,	,	PUNCT
dpc-1936	13	70	novartis	novartis	PROPN
dpc-1936	13	71	,	,	PUNCT
dpc-1936	13	72	and	and	CCONJ
dpc-1936	13	73	sandoz	sandoz	PROPN
dpc-1936	13	74	.	.	PUNCT
dpc-1936	14	1	c.	c.	PROPN
dpc-1936	14	2	sapin	sapin	PROPN
dpc-1936	14	3	,	,	PUNCT
dpc-1936	14	4	s.	s.	PROPN
dpc-1936	14	5	liu	liu	PROPN
dpc-1936	14	6	leage	leage	PROPN
dpc-1936	14	7	,	,	PUNCT
dpc-1936	14	8	r.	r.	PROPN
dpc-1936	14	9	mckenzie	mckenzie	PROPN
dpc-1936	14	10	,	,	PUNCT
dpc-1936	14	11	c.	c.	PROPN
dpc-1936	14	12	schuster	schuster	PROPN
dpc-1936	14	13	,	,	PUNCT
dpc-1936	14	14	and	and	CCONJ
dpc-1936	14	15	e.	e.	PROPN
dpc-1936	14	16	riedl	riedl	PROPN
dpc-1936	14	17	are	be	AUX
dpc-1936	14	18	employees	employee	NOUN
dpc-1936	14	19	and	and	CCONJ
dpc-1936	14	20	minor	minor	ADJ
dpc-1936	14	21	shareholders	shareholder	NOUN
dpc-1936	14	22	of	of	ADP
dpc-1936	14	23	eli	eli	PROPN
dpc-1936	14	24	lilly	lilly	PROPN
dpc-1936	14	25	and	and	CCONJ
dpc-1936	14	26	company	company	NOUN
dpc-1936	14	27	.	.	PUNCT
dpc-1936	15	1	m.	m.	NOUN
dpc-1936	15	2	gooderham	gooderham	PROPN
dpc-1936	15	3	has	have	AUX
dpc-1936	15	4	received	receive	VERB
dpc-1936	15	5	grant	grant	NOUN
dpc-1936	15	6	/	/	SYM
dpc-1936	15	7	research	research	NOUN
dpc-1936	15	8	support	support	NOUN
dpc-1936	15	9	from	from	ADP
dpc-1936	15	10	:	:	PUNCT
dpc-1936	15	11	abbvie	abbvie	PROPN
dpc-1936	15	12	,	,	PUNCT
dpc-1936	15	13	actelion	actelion	NOUN
dpc-1936	15	14	pharmaceuticals	pharmaceutical	NOUN
dpc-1936	15	15	,	,	PUNCT
dpc-1936	15	16	akros	akro	NOUN
dpc-1936	15	17	pharma	pharma	PROPN
dpc-1936	15	18	,	,	PUNCT
dpc-1936	15	19	amgen	amgen	PROPN
dpc-1936	15	20	,	,	PUNCT
dpc-1936	15	21	arcutis	arcutis	NOUN
dpc-1936	15	22	pharmaceuticals	pharmaceutical	NOUN
dpc-1936	15	23	,	,	PUNCT
dpc-1936	15	24	boehringer	boehringer	PROPN
dpc-1936	15	25	ingelheim	ingelheim	PROPN
dpc-1936	15	26	,	,	PUNCT
dpc-1936	15	27	bristol	bristol	PROPN
dpc-1936	15	28	-	-	PUNCT
dpc-1936	15	29	myers	myers	PROPN
dpc-1936	15	30	squibb	squibb	PROPN
dpc-1936	15	31	,	,	PUNCT
dpc-1936	15	32	celgene	celgene	NOUN
dpc-1936	15	33	,	,	PUNCT
dpc-1936	15	34	dermira	dermira	NOUN
dpc-1936	15	35	,	,	PUNCT
dpc-1936	15	36	dermavant	dermavant	PROPN
dpc-1936	15	37	,	,	PUNCT
dpc-1936	15	38	eli	eli	PROPN
dpc-1936	15	39	lilly	lilly	PROPN
dpc-1936	15	40	and	and	CCONJ
dpc-1936	15	41	company	company	NOUN
dpc-1936	15	42	,	,	PUNCT
dpc-1936	15	43	galderma	galderma	PROPN
dpc-1936	15	44	sa	sa	PROPN
dpc-1936	15	45	,	,	PUNCT
dpc-1936	15	46	incyte	incyte	PROPN
dpc-1936	15	47	,	,	PUNCT
dpc-1936	15	48	kyowa	kyowa	PROPN
dpc-1936	15	49	kirin	kirin	PROPN
dpc-1936	15	50	,	,	PUNCT
dpc-1936	15	51	janssen	janssen	PROPN
dpc-1936	15	52	,	,	PUNCT
dpc-1936	15	53	leo	leo	PROPN
dpc-1936	15	54	pharma	pharma	PROPN
dpc-1936	15	55	,	,	PUNCT
dpc-1936	15	56	medimmune	medimmune	PROPN
dpc-1936	15	57	,	,	PUNCT
dpc-1936	15	58	merck	merck	PROPN
dpc-1936	15	59	and	and	CCONJ
dpc-1936	15	60	co.	co.	PROPN
dpc-1936	15	61	,	,	PUNCT
dpc-1936	15	62	novartis	novartis	PROPN
dpc-1936	15	63	,	,	PUNCT
dpc-1936	15	64	pfizer	pfizer	NOUN
dpc-1936	15	65	,	,	PUNCT
dpc-1936	15	66	regeneron	regeneron	NOUN
dpc-1936	15	67	pharmaceuticals	pharmaceutical	NOUN
dpc-1936	15	68	,	,	PUNCT
dpc-1936	15	69	roche	roche	PROPN
dpc-1936	15	70	laboratories	laboratory	NOUN
dpc-1936	15	71	,	,	PUNCT
dpc-1936	15	72	sanofi	sanofi	PROPN
dpc-1936	15	73	genzyme	genzyme	PROPN
dpc-1936	15	74	,	,	PUNCT
dpc-1936	15	75	ucb	ucb	PROPN
dpc-1936	15	76	,	,	PUNCT
dpc-1936	15	77	and	and	CCONJ
dpc-1936	15	78	bausch	bausch	PROPN
dpc-1936	15	79	/	/	SYM
dpc-1936	15	80	valeant	valeant	PROPN
dpc-1936	15	81	pharmaceuticals	pharmaceutical	NOUN
dpc-1936	15	82	.	.	PUNCT
dpc-1936	16	1	consultant	consultant	NOUN
dpc-1936	16	2	for	for	ADP
dpc-1936	16	3	:	:	PUNCT
dpc-1936	16	4	akros	akros	PROPN
dpc-1936	16	5	pharma	pharma	PROPN
dpc-1936	16	6	,	,	PUNCT
dpc-1936	16	7	amgen	amgen	PROPN
dpc-1936	16	8	,	,	PUNCT
dpc-1936	16	9	boehringer	boehringer	PROPN
dpc-1936	16	10	ingelheim	ingelheim	PROPN
dpc-1936	16	11	,	,	PUNCT
dpc-1936	16	12	celgene	celgene	PROPN
dpc-1936	16	13	,	,	PUNCT
dpc-1936	16	14	eli	eli	PROPN
dpc-1936	16	15	lilly	lilly	PROPN
dpc-1936	16	16	and	and	CCONJ
dpc-1936	16	17	company	company	NOUN
dpc-1936	16	18	,	,	PUNCT
dpc-1936	16	19	janssen	janssen	PROPN
dpc-1936	16	20	,	,	PUNCT
dpc-1936	16	21	novartis	novartis	PROPN
dpc-1936	16	22	,	,	PUNCT
dpc-1936	16	23	sanofi	sanofi	PROPN
dpc-1936	16	24	genzyme	genzyme	PROPN
dpc-1936	16	25	,	,	PUNCT
dpc-1936	16	26	valeant	valeant	NOUN
dpc-1936	16	27	pharmaceuticals	pharmaceutical	NOUN
dpc-1936	16	28	.	.	PUNCT
dpc-1936	17	1	speakers	speaker	NOUN
dpc-1936	17	2	bureau	bureau	PROPN
dpc-1936	17	3	for	for	ADP
dpc-1936	17	4	:	:	PUNCT
dpc-1936	17	5	abbvie	abbvie	PROPN
dpc-1936	17	6	,	,	PUNCT
dpc-1936	17	7	amgen	amgen	PROPN
dpc-1936	17	8	,	,	PUNCT
dpc-1936	17	9	arcutis	arcutis	PROPN
dpc-1936	17	10	,	,	PUNCT
dpc-1936	17	11	boehringer	boehringer	PROPN
dpc-1936	17	12	ingelheim	ingelheim	PROPN
dpc-1936	17	13	international	international	PROPN
dpc-1936	17	14	gmbh	gmbh	PROPN
dpc-1936	17	15	,	,	PUNCT
dpc-1936	17	16	celgene	celgene	NOUN
dpc-1936	17	17	,	,	PUNCT
dpc-1936	17	18	eli	eli	PROPN
dpc-1936	17	19	lilly	lilly	PROPN
dpc-1936	17	20	and	and	CCONJ
dpc-1936	17	21	company	company	NOUN
dpc-1936	17	22	,	,	PUNCT
dpc-1936	17	23	galderma	galderma	PROPN
dpc-1936	17	24	sa	sa	PROPN
dpc-1936	17	25	,	,	PUNCT
dpc-1936	17	26	janssen	janssen	PROPN
dpc-1936	17	27	,	,	PUNCT
dpc-1936	17	28	leo	leo	PROPN
dpc-1936	17	29	pharma	pharma	PROPN
dpc-1936	17	30	,	,	PUNCT
dpc-1936	17	31	novartis	novartis	NOUN
dpc-1936	17	32	,	,	PUNCT
dpc-1936	17	33	pfizer	pfizer	NOUN
dpc-1936	17	34	,	,	PUNCT
dpc-1936	17	35	regeneron	regeneron	NOUN
dpc-1936	17	36	pharmaceuticals	pharmaceutical	NOUN
dpc-1936	17	37	,	,	PUNCT
dpc-1936	17	38	sanofi	sanofi	PROPN
dpc-1936	17	39	genzyme	genzyme	PROPN
dpc-1936	17	40	,	,	PUNCT
dpc-1936	17	41	and	and	CCONJ
dpc-1936	17	42	ucb	ucb	PROPN
dpc-1936	17	43	.	.	PROPN
dpc-1936	17	44	authorship	authorship	PROPN
dpc-1936	17	45	:	:	PUNCT
dpc-1936	17	46	all	all	DET
dpc-1936	17	47	authors	author	NOUN
dpc-1936	17	48	have	have	AUX
dpc-1936	17	49	contributed	contribute	VERB
dpc-1936	17	50	significantly	significantly	ADV
dpc-1936	17	51	to	to	ADP
dpc-1936	17	52	this	this	DET
dpc-1936	17	53	publication	publication	NOUN
dpc-1936	17	54	corresponding	correspond	VERB
dpc-1936	17	55	author	author	NOUN
dpc-1936	17	56	:	:	PUNCT
dpc-1936	17	57	elisabeth	elisabeth	PROPN
dpc-1936	17	58	riedl	riedl	PROPN
dpc-1936	17	59	,	,	PUNCT
dpc-1936	17	60	md	md	PROPN
dpc-1936	17	61	,	,	PUNCT
dpc-1936	17	62	eli	eli	PROPN
dpc-1936	17	63	lilly	lilly	PROPN
dpc-1936	17	64	regional	regional	ADJ
dpc-1936	17	65	operations	operation	NOUN
dpc-1936	17	66	gmbh	gmbh	NOUN
dpc-1936	17	67	,	,	PUNCT
dpc-1936	17	68	erdberger	erdberger	NOUN
dpc-1936	17	69	lände	lände	NOUN
dpc-1936	17	70	26	26	NUM
dpc-1936	17	71	,	,	PUNCT
dpc-1936	17	72	1030	1030	NUM
dpc-1936	17	73	vienna	vienna	PROPN
dpc-1936	17	74	,	,	PUNCT
dpc-1936	17	75	austria	austria	PROPN
dpc-1936	17	76	.	.	PUNCT
dpc-1936	18	1	e	e	X
dpc-1936	18	2	-	-	NOUN
dpc-1936	18	3	mail	mail	NOUN
dpc-1936	18	4	:	:	PUNCT
dpc-1936	18	5	riedl_elisabeth@lilly.com	riedl_elisabeth@lilly.com	X
dpc-1936	18	6	2	2	NUM
dpc-1936	18	7	original	original	ADJ
dpc-1936	18	8	article	article	NOUN
dpc-1936	18	9	|	|	ADV
dpc-1936	18	10	dermatol	dermatol	ADJ
dpc-1936	18	11	pract	pract	NOUN
dpc-1936	18	12	concept	concept	NOUN
dpc-1936	18	13	.	.	PUNCT
dpc-1936	19	1	2022;12(2):e2022104	2022;12(2):e2022104	X
dpc-1936	19	2	introduction	introduction	NOUN
dpc-1936	19	3	:	:	PUNCT
dpc-1936	19	4	the	the	DET
dpc-1936	19	5	randomized	randomized	ADJ
dpc-1936	19	6	,	,	PUNCT
dpc-1936	19	7	open	open	ADJ
dpc-1936	19	8	-	-	PUNCT
dpc-1936	19	9	label	label	NOUN
dpc-1936	19	10	,	,	PUNCT
dpc-1936	19	11	assessor	assessor	NOUN
dpc-1936	19	12	-	-	PUNCT
dpc-1936	19	13	blinded	blind	VERB
dpc-1936	19	14	,	,	PUNCT
dpc-1936	19	15	parallel	parallel	ADJ
dpc-1936	19	16	-	-	PUNCT
dpc-1936	19	17	group	group	NOUN
dpc-1936	19	18	spirit	spirit	PROPN
dpc-1936	19	19	-	-	PUNCT
dpc-1936	19	20	h2h	h2h	PROPN
dpc-1936	19	21	trial	trial	NOUN
dpc-1936	19	22	(	(	PUNCT
dpc-1936	19	23	nct03151551	nct03151551	NOUN
dpc-1936	19	24	)	)	PUNCT
dpc-1936	19	25	demonstrated	demonstrate	VERB
dpc-1936	19	26	superiority	superiority	NOUN
dpc-1936	19	27	of	of	ADP
dpc-1936	19	28	ixekizumab	ixekizumab	NOUN
dpc-1936	19	29	over	over	ADP
dpc-1936	19	30	adalimumab	adalimumab	NOUN
dpc-1936	19	31	in	in	ADP
dpc-1936	19	32	simultaneously	simultaneously	ADV
dpc-1936	19	33	achieving	achieve	VERB
dpc-1936	19	34	improvement	improvement	NOUN
dpc-1936	19	35	in	in	ADP
dpc-1936	19	36	joint	joint	ADJ
dpc-1936	19	37	symptoms	symptom	NOUN
dpc-1936	19	38	(	(	PUNCT
dpc-1936	19	39	american	american	PROPN
dpc-1936	19	40	college	college	PROPN
dpc-1936	19	41	of	of	ADP
dpc-1936	19	42	rheumatology	rheumatology	NOUN
dpc-1936	19	43	[	[	X
dpc-1936	19	44	acr]50	acr]50	X
dpc-1936	19	45	)	)	PUNCT
dpc-1936	19	46	and	and	CCONJ
dpc-1936	19	47	skin	skin	NOUN
dpc-1936	19	48	clearance	clearance	NOUN
dpc-1936	19	49	(	(	PUNCT
dpc-1936	19	50	psoriasis	psoriasis	NOUN
dpc-1936	19	51	area	area	NOUN
dpc-1936	19	52	and	and	CCONJ
dpc-1936	19	53	severity	severity	NOUN
dpc-1936	19	54	index	index	NOUN
dpc-1936	19	55	[	[	X
dpc-1936	19	56	pasi]100	pasi]100	PROPN
dpc-1936	19	57	)	)	PUNCT
dpc-1936	19	58	in	in	ADP
dpc-1936	19	59	biologic	biologic	ADJ
dpc-1936	19	60	-	-	PUNCT
dpc-1936	19	61	naïve	naïve	ADJ
dpc-1936	19	62	patients	patient	NOUN
dpc-1936	19	63	with	with	ADP
dpc-1936	19	64	active	active	ADJ
dpc-1936	19	65	psoriatic	psoriatic	ADJ
dpc-1936	19	66	arthritis	arthritis	NOUN
dpc-1936	19	67	(	(	PUNCT
dpc-1936	19	68	psa	psa	NOUN
dpc-1936	19	69	)	)	PUNCT
dpc-1936	19	70	and	and	CCONJ
dpc-1936	19	71	plaque	plaque	NOUN
dpc-1936	19	72	psoriasis	psoriasis	NOUN
dpc-1936	19	73	(	(	PUNCT
dpc-1936	19	74	pso	pso	NOUN
dpc-1936	19	75	)	)	PUNCT
dpc-1936	19	76	at	at	ADP
dpc-1936	19	77	week	week	NOUN
dpc-1936	19	78	(	(	PUNCT
dpc-1936	19	79	w	w	NOUN
dpc-1936	19	80	)	)	PUNCT
dpc-1936	19	81	24	24	NUM
dpc-1936	19	82	.	.	PUNCT
dpc-1936	19	83	higher	high	ADJ
dpc-1936	19	84	efficacy	efficacy	NOUN
dpc-1936	19	85	of	of	ADP
dpc-1936	19	86	ixekizumab	ixekizumab	NOUN
dpc-1936	19	87	versus	versus	ADP
dpc-1936	19	88	adalimumab	adalimumab	NOUN
dpc-1936	19	89	was	be	AUX
dpc-1936	19	90	maintained	maintain	VERB
dpc-1936	19	91	through	through	ADP
dpc-1936	19	92	w52	w52	PROPN
dpc-1936	19	93	.	.	PUNCT
dpc-1936	20	1	objectives	objective	NOUN
dpc-1936	20	2	:	:	PUNCT
dpc-1936	20	3	this	this	DET
dpc-1936	20	4	analysis	analysis	NOUN
dpc-1936	20	5	investigated	investigate	VERB
dpc-1936	20	6	efficacy	efficacy	NOUN
dpc-1936	20	7	and	and	CCONJ
dpc-1936	20	8	safety	safety	NOUN
dpc-1936	20	9	of	of	ADP
dpc-1936	20	10	ixekizumab	ixekizumab	NOUN
dpc-1936	20	11	and	and	CCONJ
dpc-1936	20	12	adalimumab	adalimumab	NOUN
dpc-1936	20	13	in	in	ADP
dpc-1936	20	14	the	the	DET
dpc-1936	20	15	subgroup	subgroup	NOUN
dpc-1936	20	16	of	of	ADP
dpc-1936	20	17	patients	patient	NOUN
dpc-1936	20	18	with	with	ADP
dpc-1936	20	19	psa	psa	NOUN
dpc-1936	20	20	and	and	CCONJ
dpc-1936	20	21	moderate	moderate	ADJ
dpc-1936	20	22	-	-	PUNCT
dpc-1936	20	23	to	to	ADP
dpc-1936	20	24	-	-	PUNCT
dpc-1936	20	25	severe	severe	ADJ
dpc-1936	20	26	pso	pso	NOUN
dpc-1936	20	27	through	through	ADP
dpc-1936	20	28	w52	w52	PROPN
dpc-1936	20	29	.	.	PUNCT
dpc-1936	21	1	methods	method	NOUN
dpc-1936	21	2	:	:	PUNCT
dpc-1936	21	3	efficacy	efficacy	NOUN
dpc-1936	21	4	and	and	CCONJ
dpc-1936	21	5	safety	safety	NOUN
dpc-1936	21	6	outcomes	outcome	NOUN
dpc-1936	21	7	were	be	AUX
dpc-1936	21	8	analyzed	analyze	VERB
dpc-1936	21	9	in	in	ADP
dpc-1936	21	10	patients	patient	NOUN
dpc-1936	21	11	with	with	ADP
dpc-1936	21	12	psa	psa	NOUN
dpc-1936	21	13	and	and	CCONJ
dpc-1936	21	14	moderate	moderate	ADJ
dpc-1936	21	15	-	-	PUNCT
dpc-1936	21	16	to	to	ADP
dpc-1936	21	17	-	-	PUNCT
dpc-1936	21	18	severe	severe	ADJ
dpc-1936	21	19	pso	pso	NOUN
dpc-1936	21	20	(	(	PUNCT
dpc-1936	21	21	pasi	pasi	NOUN
dpc-1936	21	22	≥	≥	NUM
dpc-1936	21	23	12	12	NUM
dpc-1936	21	24	,	,	PUNCT
dpc-1936	21	25	body	body	NOUN
dpc-1936	21	26	surface	surface	NOUN
dpc-1936	21	27	area	area	NOUN
dpc-1936	21	28	≥	≥	NUM
dpc-1936	21	29	10	10	NUM
dpc-1936	21	30	%	%	NOUN
dpc-1936	21	31	,	,	PUNCT
dpc-1936	21	32	static	static	ADJ
dpc-1936	21	33	physician	physician	NOUN
dpc-1936	21	34	global	global	ADJ
dpc-1936	21	35	assessment	assessment	NOUN
dpc-1936	21	36	≥	≥	NOUN
dpc-1936	21	37	3	3	NUM
dpc-1936	21	38	)	)	PUNCT
dpc-1936	21	39	through	through	ADP
dpc-1936	21	40	w52	w52	PROPN
dpc-1936	21	41	.	.	PUNCT
dpc-1936	22	1	categorical	categorical	ADJ
dpc-1936	22	2	and	and	CCONJ
dpc-1936	22	3	continuous	continuous	ADJ
dpc-1936	22	4	outcomes	outcome	NOUN
dpc-1936	22	5	were	be	AUX
dpc-1936	22	6	analyzed	analyze	VERB
dpc-1936	22	7	using	use	VERB
dpc-1936	22	8	logistic	logistic	ADJ
dpc-1936	22	9	regression	regression	NOUN
dpc-1936	22	10	models	model	NOUN
dpc-1936	22	11	and	and	CCONJ
dpc-1936	22	12	mixed	mixed	ADJ
dpc-1936	22	13	model	model	NOUN
dpc-1936	22	14	for	for	ADP
dpc-1936	22	15	repeated	repeat	VERB
dpc-1936	22	16	measures	measure	NOUN
dpc-1936	22	17	,	,	PUNCT
dpc-1936	22	18	respectively	respectively	ADV
dpc-1936	22	19	.	.	PUNCT
dpc-1936	23	1	results	result	NOUN
dpc-1936	23	2	:	:	PUNCT
dpc-1936	23	3	more	more	ADJ
dpc-1936	23	4	ixekizumabversus	ixekizumabversus	VERB
dpc-1936	23	5	adalimumab	adalimumab	NOUN
dpc-1936	23	6	-	-	PUNCT
dpc-1936	23	7	treated	treat	VERB
dpc-1936	23	8	patients	patient	NOUN
dpc-1936	23	9	simultaneously	simultaneously	ADV
dpc-1936	23	10	achieved	achieve	VERB
dpc-1936	23	11	pasi100	pasi100	PROPN
dpc-1936	23	12	and	and	CCONJ
dpc-1936	23	13	acr50	acr50	VERB
dpc-1936	23	14	at	at	ADP
dpc-1936	23	15	w24	w24	PROPN
dpc-1936	23	16	(	(	PUNCT
dpc-1936	23	17	40.8	40.8	NUM
dpc-1936	23	18	%	%	NOUN
dpc-1936	23	19	versus	versus	ADP
dpc-1936	23	20	17.6	17.6	NUM
dpc-1936	23	21	%	%	NOUN
dpc-1936	23	22	,	,	PUNCT
dpc-1936	23	23	p	p	X
dpc-1936	23	24	=	=	NOUN
dpc-1936	23	25	0.015	0.015	NUM
dpc-1936	23	26	)	)	PUNCT
dpc-1936	23	27	and	and	CCONJ
dpc-1936	23	28	w52	w52	ADJ
dpc-1936	23	29	(	(	PUNCT
dpc-1936	23	30	38.8	38.8	NUM
dpc-1936	23	31	%	%	NOUN
dpc-1936	23	32	versus	versus	ADP
dpc-1936	23	33	17.6	17.6	NUM
dpc-1936	23	34	%	%	NOUN
dpc-1936	23	35	,	,	PUNCT
dpc-1936	23	36	p	p	X
dpc-1936	23	37	=	=	NOUN
dpc-1936	23	38	0.026	0.026	NUM
dpc-1936	23	39	)	)	PUNCT
dpc-1936	23	40	.	.	PUNCT
dpc-1936	24	1	likewise	likewise	ADV
dpc-1936	24	2	,	,	PUNCT
dpc-1936	24	3	more	more	ADV
dpc-1936	24	4	ixekizumabversus	ixekizumabversus	VERB
dpc-1936	24	5	adalimumab	adalimumab	NOUN
dpc-1936	24	6	-	-	PUNCT
dpc-1936	24	7	treated	treat	VERB
dpc-1936	24	8	patients	patient	NOUN
dpc-1936	24	9	achieved	achieve	VERB
dpc-1936	24	10	pasi100	pasi100	PROPN
dpc-1936	24	11	(	(	PUNCT
dpc-1936	24	12	59.2	59.2	NUM
dpc-1936	24	13	%	%	NOUN
dpc-1936	24	14	versus	versus	ADP
dpc-1936	24	15	25.5	25.5	NUM
dpc-1936	24	16	%	%	NOUN
dpc-1936	24	17	,	,	PUNCT
dpc-1936	24	18	p	p	NOUN
dpc-1936	24	19	=	=	NOUN
dpc-1936	24	20	0.001	0.001	NUM
dpc-1936	24	21	)	)	PUNCT
dpc-1936	24	22	and	and	CCONJ
dpc-1936	24	23	pasi90	pasi90	NOUN
dpc-1936	24	24	(	(	PUNCT
dpc-1936	24	25	81.6	81.6	NUM
dpc-1936	24	26	%	%	NOUN
dpc-1936	24	27	versus	versus	ADP
dpc-1936	24	28	60.8	60.8	NUM
dpc-1936	24	29	%	%	NOUN
dpc-1936	24	30	,	,	PUNCT
dpc-1936	24	31	p	p	X
dpc-1936	24	32	=	=	NOUN
dpc-1936	24	33	0.028	0.028	NUM
dpc-1936	24	34	)	)	PUNCT
dpc-1936	24	35	through	through	ADP
dpc-1936	24	36	w52	w52	NOUN
dpc-1936	24	37	,	,	PUNCT
dpc-1936	24	38	and	and	CCONJ
dpc-1936	24	39	nail	nail	NOUN
dpc-1936	24	40	pso	pso	NOUN
dpc-1936	24	41	clearance	clearance	NOUN
dpc-1936	24	42	at	at	ADP
dpc-1936	24	43	w24	w24	PROPN
dpc-1936	24	44	.	.	PUNCT
dpc-1936	25	1	joint	joint	ADJ
dpc-1936	25	2	symptom	symptom	NOUN
dpc-1936	25	3	improvements	improvement	NOUN
dpc-1936	25	4	were	be	AUX
dpc-1936	25	5	comparable	comparable	ADJ
dpc-1936	25	6	between	between	ADP
dpc-1936	25	7	groups	group	NOUN
dpc-1936	25	8	.	.	PUNCT
dpc-1936	26	1	no	no	DET
dpc-1936	26	2	new	new	ADJ
dpc-1936	26	3	safety	safety	NOUN
dpc-1936	26	4	findings	finding	NOUN
dpc-1936	26	5	were	be	AUX
dpc-1936	26	6	reported	report	VERB
dpc-1936	26	7	.	.	PUNCT
dpc-1936	27	1	conclusions	conclusion	NOUN
dpc-1936	27	2	:	:	PUNCT
dpc-1936	27	3	ixekizumab	ixekizumab	NOUN
dpc-1936	27	4	had	have	VERB
dpc-1936	27	5	higher	high	ADJ
dpc-1936	27	6	efficacy	efficacy	NOUN
dpc-1936	27	7	than	than	ADP
dpc-1936	27	8	adalimumab	adalimumab	NOUN
dpc-1936	27	9	in	in	ADP
dpc-1936	27	10	simultaneous	simultaneous	ADJ
dpc-1936	27	11	achievement	achievement	NOUN
dpc-1936	27	12	of	of	ADP
dpc-1936	27	13	acr50	acr50	ADJ
dpc-1936	27	14	and	and	CCONJ
dpc-1936	27	15	pasi100	pasi100	PROPN
dpc-1936	27	16	at	at	ADP
dpc-1936	27	17	w24	w24	PROPN
dpc-1936	27	18	and	and	CCONJ
dpc-1936	27	19	w52	w52	NOUN
dpc-1936	27	20	in	in	ADP
dpc-1936	27	21	patients	patient	NOUN
dpc-1936	27	22	with	with	ADP
dpc-1936	27	23	psa	psa	NOUN
dpc-1936	27	24	and	and	CCONJ
dpc-1936	27	25	moderate	moderate	ADJ
dpc-1936	27	26	-	-	PUNCT
dpc-1936	27	27	to	to	ADP
dpc-1936	27	28	-	-	PUNCT
dpc-1936	27	29	severe	severe	ADJ
dpc-1936	27	30	pso	pso	NOUN
dpc-1936	27	31	.	.	PUNCT
dpc-1936	27	32	ixekizumab	ixekizumab	NOUN
dpc-1936	27	33	-	-	PUNCT
dpc-1936	27	34	treated	treat	VERB
dpc-1936	27	35	patients	patient	NOUN
dpc-1936	27	36	showed	show	VERB
dpc-1936	27	37	higher	high	ADJ
dpc-1936	27	38	response	response	NOUN
dpc-1936	27	39	rates	rate	NOUN
dpc-1936	27	40	for	for	ADP
dpc-1936	27	41	nail	nail	NOUN
dpc-1936	27	42	pso	pso	NOUN
dpc-1936	27	43	clearance	clearance	NOUN
dpc-1936	27	44	and	and	CCONJ
dpc-1936	27	45	for	for	ADP
dpc-1936	27	46	reporting	report	VERB
dpc-1936	27	47	minimal	minimal	ADJ
dpc-1936	27	48	or	or	CCONJ
dpc-1936	27	49	no	no	DET
dpc-1936	27	50	impact	impact	NOUN
dpc-1936	27	51	on	on	ADP
dpc-1936	27	52	quality	quality	NOUN
dpc-1936	27	53	of	of	ADP
dpc-1936	27	54	life	life	NOUN
dpc-1936	27	55	at	at	ADP
dpc-1936	27	56	w24	w24	PROPN
dpc-1936	27	57	.	.	PUNCT
dpc-1936	28	1	abstract	abstract	ADJ
dpc-1936	28	2	introduction	introduction	NOUN
dpc-1936	28	3	plaque	plaque	NOUN
dpc-1936	28	4	psoriasis	psoriasis	NOUN
dpc-1936	28	5	(	(	PUNCT
dpc-1936	28	6	pso	pso	NOUN
dpc-1936	28	7	)	)	PUNCT
dpc-1936	28	8	is	be	AUX
dpc-1936	28	9	a	a	DET
dpc-1936	28	10	chronic	chronic	NOUN
dpc-1936	28	11	,	,	PUNCT
dpc-1936	28	12	inflammatory	inflammatory	ADJ
dpc-1936	28	13	skin	skin	NOUN
dpc-1936	28	14	condition	condition	NOUN
dpc-1936	28	15	that	that	PRON
dpc-1936	28	16	has	have	VERB
dpc-1936	28	17	a	a	DET
dpc-1936	28	18	high	high	ADJ
dpc-1936	28	19	disease	disease	NOUN
dpc-1936	28	20	burden	burden	NOUN
dpc-1936	28	21	and	and	CCONJ
dpc-1936	28	22	significantly	significantly	ADV
dpc-1936	28	23	impacts	impact	VERB
dpc-1936	28	24	patients	patient	NOUN
dpc-1936	28	25	’	'	PUNCT
dpc-1936	28	26	quality	quality	NOUN
dpc-1936	28	27	of	of	ADP
dpc-1936	28	28	life	life	NOUN
dpc-1936	28	29	(	(	PUNCT
dpc-1936	28	30	qol	qol	NOUN
dpc-1936	28	31	)	)	PUNCT
dpc-1936	28	32	,	,	PUNCT
dpc-1936	28	33	especially	especially	ADV
dpc-1936	28	34	in	in	ADP
dpc-1936	28	35	those	those	PRON
dpc-1936	28	36	with	with	ADP
dpc-1936	28	37	moderate	moderate	ADJ
dpc-1936	28	38	-	-	PUNCT
dpc-1936	28	39	to	to	ADP
dpc-1936	28	40	-	-	PUNCT
dpc-1936	28	41	severe	severe	ADJ
dpc-1936	28	42	disease	disease	NOUN
dpc-1936	28	43	and	and	CCONJ
dpc-1936	28	44	involvement	involvement	NOUN
dpc-1936	28	45	of	of	ADP
dpc-1936	28	46	difficult	difficult	ADJ
dpc-1936	28	47	to	to	PART
dpc-1936	28	48	treat	treat	VERB
dpc-1936	28	49	areas	area	NOUN
dpc-1936	28	50	,	,	PUNCT
dpc-1936	28	51	such	such	ADJ
dpc-1936	28	52	as	as	ADP
dpc-1936	28	53	the	the	DET
dpc-1936	28	54	nails	nail	NOUN
dpc-1936	28	55	.	.	PUNCT
dpc-1936	29	1	psoriatic	psoriatic	ADJ
dpc-1936	29	2	arthritis	arthritis	NOUN
dpc-1936	29	3	(	(	PUNCT
dpc-1936	29	4	psa	psa	NOUN
dpc-1936	29	5	)	)	PUNCT
dpc-1936	29	6	is	be	AUX
dpc-1936	29	7	a	a	DET
dpc-1936	29	8	chronic	chronic	NOUN
dpc-1936	29	9	,	,	PUNCT
dpc-1936	29	10	immune	immune	NOUN
dpc-1936	29	11	-	-	PUNCT
dpc-1936	29	12	mediated	mediate	VERB
dpc-1936	29	13	,	,	PUNCT
dpc-1936	29	14	seronegative	seronegative	ADJ
dpc-1936	29	15	spondylarthritis	spondylarthritis	NOUN
dpc-1936	29	16	associated	associate	VERB
dpc-1936	29	17	with	with	ADP
dpc-1936	29	18	musculoskeletal	musculoskeletal	ADJ
dpc-1936	29	19	and	and	CCONJ
dpc-1936	29	20	non	non	ADJ
dpc-1936	29	21	-	-	ADJ
dpc-1936	29	22	skeletal	skeletal	ADJ
dpc-1936	29	23	manifestations	manifestation	NOUN
dpc-1936	29	24	.	.	PUNCT
dpc-1936	30	1	a	a	DET
dpc-1936	30	2	personal	personal	ADJ
dpc-1936	30	3	or	or	CCONJ
dpc-1936	30	4	familial	familial	ADJ
dpc-1936	30	5	history	history	NOUN
dpc-1936	30	6	of	of	ADP
dpc-1936	30	7	pso	pso	NOUN
dpc-1936	30	8	is	be	AUX
dpc-1936	30	9	one	one	NUM
dpc-1936	30	10	of	of	ADP
dpc-1936	30	11	the	the	DET
dpc-1936	30	12	diagnostic	diagnostic	ADJ
dpc-1936	30	13	criteria	criterion	NOUN
dpc-1936	30	14	for	for	ADP
dpc-1936	30	15	psa	psa	NOUN
dpc-1936	30	16	,	,	PUNCT
dpc-1936	30	17	as	as	SCONJ
dpc-1936	30	18	pso	pso	NOUN
dpc-1936	30	19	commonly	commonly	ADV
dpc-1936	30	20	precedes	precede	VERB
dpc-1936	30	21	the	the	DET
dpc-1936	30	22	development	development	NOUN
dpc-1936	30	23	of	of	ADP
dpc-1936	30	24	psa	psa	NOUN
dpc-1936	30	25	[	[	X
dpc-1936	30	26	1	1	NUM
dpc-1936	30	27	]	]	PUNCT
dpc-1936	30	28	.	.	PUNCT
dpc-1936	31	1	up	up	ADP
dpc-1936	31	2	to	to	PART
dpc-1936	31	3	30	30	NUM
dpc-1936	31	4	%	%	NOUN
dpc-1936	31	5	of	of	ADP
dpc-1936	31	6	patients	patient	NOUN
dpc-1936	31	7	with	with	ADP
dpc-1936	31	8	pso	pso	NOUN
dpc-1936	31	9	will	will	AUX
dpc-1936	31	10	develop	develop	VERB
dpc-1936	31	11	psa	psa	VERB
dpc-1936	31	12	,	,	PUNCT
dpc-1936	31	13	in	in	ADP
dpc-1936	31	14	particular	particular	ADJ
dpc-1936	31	15	those	those	PRON
dpc-1936	31	16	with	with	ADP
dpc-1936	31	17	scalp	scalp	NOUN
dpc-1936	31	18	,	,	PUNCT
dpc-1936	31	19	intergluteal/	intergluteal/	NUM
dpc-1936	31	20	perianal	perianal	ADJ
dpc-1936	31	21	and	and	CCONJ
dpc-1936	31	22	nail	nail	NOUN
dpc-1936	31	23	involvement	involvement	NOUN
dpc-1936	31	24	,	,	PUNCT
dpc-1936	31	25	further	far	ADV
dpc-1936	31	26	increasing	increase	VERB
dpc-1936	31	27	the	the	DET
dpc-1936	31	28	disease	disease	NOUN
dpc-1936	31	29	burden	burden	NOUN
dpc-1936	31	30	and	and	CCONJ
dpc-1936	31	31	reducing	reduce	VERB
dpc-1936	31	32	qol	qol	NOUN
dpc-1936	32	1	[	[	X
dpc-1936	32	2	1	1	NUM
dpc-1936	32	3	-	-	SYM
dpc-1936	32	4	4	4	NUM
dpc-1936	32	5	]	]	PUNCT
dpc-1936	32	6	.	.	PUNCT
dpc-1936	33	1	the	the	DET
dpc-1936	33	2	prevalence	prevalence	NOUN
dpc-1936	33	3	of	of	ADP
dpc-1936	33	4	nail	nail	NOUN
dpc-1936	33	5	pso	pso	NOUN
dpc-1936	33	6	,	,	PUNCT
dpc-1936	33	7	a	a	DET
dpc-1936	33	8	painful	painful	ADJ
dpc-1936	33	9	and	and	CCONJ
dpc-1936	33	10	burdensome	burdensome	ADJ
dpc-1936	33	11	manifestation	manifestation	NOUN
dpc-1936	33	12	,	,	PUNCT
dpc-1936	33	13	is	be	AUX
dpc-1936	33	14	higher	high	ADJ
dpc-1936	33	15	in	in	ADP
dpc-1936	33	16	psa	psa	NOUN
dpc-1936	33	17	than	than	ADP
dpc-1936	33	18	pso	pso	NOUN
dpc-1936	33	19	[	[	X
dpc-1936	33	20	5,6	5,6	NUM
dpc-1936	33	21	]	]	X
dpc-1936	33	22	.	.	PUNCT
dpc-1936	34	1	one	one	NUM
dpc-1936	34	2	possible	possible	ADJ
dpc-1936	34	3	explanation	explanation	NOUN
dpc-1936	34	4	of	of	ADP
dpc-1936	34	5	this	this	PRON
dpc-1936	34	6	is	be	AUX
dpc-1936	34	7	the	the	DET
dpc-1936	34	8	anatomical	anatomical	ADJ
dpc-1936	34	9	connection	connection	NOUN
dpc-1936	34	10	between	between	ADP
dpc-1936	34	11	the	the	DET
dpc-1936	34	12	nail	nail	NOUN
dpc-1936	34	13	matrix	matrix	NOUN
dpc-1936	34	14	and	and	CCONJ
dpc-1936	34	15	structures	structure	NOUN
dpc-1936	34	16	of	of	ADP
dpc-1936	34	17	the	the	DET
dpc-1936	34	18	distal	distal	ADJ
dpc-1936	34	19	interphalangeal	interphalangeal	ADJ
dpc-1936	34	20	joint	joint	NOUN
dpc-1936	34	21	[	[	X
dpc-1936	34	22	7	7	NUM
dpc-1936	34	23	]	]	PUNCT
dpc-1936	34	24	.	.	PUNCT
dpc-1936	35	1	therefore	therefore	ADV
dpc-1936	35	2	,	,	PUNCT
dpc-1936	35	3	successful	successful	ADJ
dpc-1936	35	4	treatment	treatment	NOUN
dpc-1936	35	5	of	of	ADP
dpc-1936	35	6	both	both	CCONJ
dpc-1936	35	7	joint	joint	ADJ
dpc-1936	35	8	and	and	CCONJ
dpc-1936	35	9	skin	skin	NOUN
dpc-1936	35	10	symptoms	symptom	NOUN
dpc-1936	35	11	is	be	AUX
dpc-1936	35	12	important	important	ADJ
dpc-1936	35	13	in	in	ADP
dpc-1936	35	14	achieving	achieve	VERB
dpc-1936	35	15	optimal	optimal	ADJ
dpc-1936	35	16	improvements	improvement	NOUN
dpc-1936	35	17	to	to	ADP
dpc-1936	35	18	health	health	NOUN
dpc-1936	35	19	-	-	PUNCT
dpc-1936	35	20	related	relate	VERB
dpc-1936	35	21	qol	qol	NOUN
dpc-1936	35	22	in	in	ADP
dpc-1936	35	23	patients	patient	NOUN
dpc-1936	35	24	with	with	ADP
dpc-1936	35	25	pso	pso	NOUN
dpc-1936	35	26	and	and	CCONJ
dpc-1936	35	27	psa	psa	VERB
dpc-1936	35	28	,	,	PUNCT
dpc-1936	35	29	with	with	ADP
dpc-1936	35	30	clearance	clearance	NOUN
dpc-1936	35	31	of	of	ADP
dpc-1936	35	32	co	co	ADJ
dpc-1936	35	33	-	-	ADJ
dpc-1936	35	34	existing	exist	VERB
dpc-1936	35	35	nail	nail	NOUN
dpc-1936	35	36	pso	pso	NOUN
dpc-1936	35	37	providing	provide	VERB
dpc-1936	35	38	additional	additional	ADJ
dpc-1936	35	39	benefits	benefit	NOUN
dpc-1936	35	40	[	[	X
dpc-1936	35	41	8	8	NUM
dpc-1936	35	42	]	]	PUNCT
dpc-1936	35	43	.	.	PUNCT
dpc-1936	36	1	first	first	ADJ
dpc-1936	36	2	-	-	PUNCT
dpc-1936	36	3	line	line	NOUN
dpc-1936	36	4	treatments	treatment	NOUN
dpc-1936	36	5	for	for	ADP
dpc-1936	36	6	pso	pso	NOUN
dpc-1936	36	7	and	and	CCONJ
dpc-1936	36	8	psa	psa	NOUN
dpc-1936	36	9	include	include	VERB
dpc-1936	36	10	conventional	conventional	ADJ
dpc-1936	36	11	systemic	systemic	ADJ
dpc-1936	36	12	therapies	therapy	NOUN
dpc-1936	36	13	and	and	CCONJ
dpc-1936	36	14	conventional	conventional	ADJ
dpc-1936	36	15	systemic	systemic	ADJ
dpc-1936	36	16	disease	disease	NOUN
dpc-1936	36	17	modifying	modify	VERB
dpc-1936	36	18	anti	anti	ADJ
dpc-1936	36	19	-	-	ADJ
dpc-1936	36	20	rheumatic	rheumatic	ADJ
dpc-1936	36	21	drugs	drug	NOUN
dpc-1936	36	22	(	(	PUNCT
dpc-1936	36	23	csdmards	csdmard	NOUN
dpc-1936	36	24	)	)	PUNCT
dpc-1936	36	25	,	,	PUNCT
dpc-1936	36	26	respectively	respectively	ADV
dpc-1936	36	27	.	.	PUNCT
dpc-1936	37	1	for	for	ADP
dpc-1936	37	2	patients	patient	NOUN
dpc-1936	37	3	with	with	ADP
dpc-1936	37	4	inadequate	inadequate	ADJ
dpc-1936	37	5	responses	response	NOUN
dpc-1936	37	6	to	to	ADP
dpc-1936	37	7	these	these	PRON
dpc-1936	37	8	,	,	PUNCT
dpc-1936	37	9	the	the	DET
dpc-1936	37	10	european	european	ADJ
dpc-1936	37	11	dermatology	dermatology	PROPN
dpc-1936	37	12	forum	forum	PROPN
dpc-1936	37	13	and	and	CCONJ
dpc-1936	37	14	european	european	PROPN
dpc-1936	37	15	league	league	PROPN
dpc-1936	37	16	against	against	ADP
dpc-1936	37	17	rheumatism	rheumatism	NOUN
dpc-1936	37	18	recommend	recommend	VERB
dpc-1936	37	19	the	the	DET
dpc-1936	37	20	use	use	NOUN
dpc-1936	37	21	of	of	ADP
dpc-1936	37	22	biologics	biologic	NOUN
dpc-1936	37	23	targeting	target	VERB
dpc-1936	37	24	inflammatory	inflammatory	ADJ
dpc-1936	37	25	cytokines	cytokine	NOUN
dpc-1936	37	26	,	,	PUNCT
dpc-1936	37	27	such	such	ADJ
dpc-1936	37	28	as	as	ADP
dpc-1936	37	29	interleukin	interleukin	NOUN
dpc-1936	37	30	(	(	PUNCT
dpc-1936	37	31	il)-17a	il)-17a	X
dpc-1936	37	32	and	and	CCONJ
dpc-1936	37	33	tumor	tumor	NOUN
dpc-1936	37	34	necrosis	necrosis	NOUN
dpc-1936	37	35	factor	factor	NOUN
dpc-1936	37	36	(	(	PUNCT
dpc-1936	37	37	tnf	tnf	PROPN
dpc-1936	37	38	)	)	PUNCT
dpc-1936	38	1	[	[	X
dpc-1936	38	2	9,10	9,10	NUM
dpc-1936	38	3	]	]	X
dpc-1936	38	4	.	.	PUNCT
dpc-1936	39	1	biologics	biologic	NOUN
dpc-1936	39	2	inhibiting	inhibit	VERB
dpc-1936	39	3	either	either	CCONJ
dpc-1936	39	4	il-17	il-17	ADV
dpc-1936	39	5	or	or	CCONJ
dpc-1936	39	6	tnf	tnf	PROPN
dpc-1936	39	7	(	(	PUNCT
dpc-1936	39	8	such	such	ADJ
dpc-1936	39	9	as	as	ADP
dpc-1936	39	10	adalimumab	adalimumab	NOUN
dpc-1936	39	11	[	[	X
dpc-1936	39	12	ada	ada	NOUN
dpc-1936	39	13	]	]	X
dpc-1936	39	14	)	)	PUNCT
dpc-1936	39	15	signaling	signal	VERB
dpc-1936	39	16	pathways	pathway	NOUN
dpc-1936	39	17	have	have	AUX
dpc-1936	39	18	demonstrated	demonstrate	VERB
dpc-1936	39	19	high	high	ADJ
dpc-1936	39	20	efficacy	efficacy	NOUN
dpc-1936	39	21	in	in	ADP
dpc-1936	39	22	improving	improve	VERB
dpc-1936	39	23	joint	joint	ADJ
dpc-1936	39	24	symptoms	symptom	NOUN
dpc-1936	39	25	in	in	ADP
dpc-1936	39	26	patients	patient	NOUN
dpc-1936	39	27	with	with	ADP
dpc-1936	39	28	psa	psa	NOUN
dpc-1936	39	29	in	in	ADP
dpc-1936	39	30	randomized	randomized	ADJ
dpc-1936	39	31	clinical	clinical	ADJ
dpc-1936	39	32	trials	trial	NOUN
dpc-1936	39	33	[	[	X
dpc-1936	39	34	11–19	11–19	NUM
dpc-1936	39	35	]	]	PUNCT
dpc-1936	39	36	.	.	PUNCT
dpc-1936	40	1	as	as	SCONJ
dpc-1936	40	2	higher	high	ADJ
dpc-1936	40	3	rates	rate	NOUN
dpc-1936	40	4	of	of	ADP
dpc-1936	40	5	skin	skin	NOUN
dpc-1936	40	6	clearance	clearance	NOUN
dpc-1936	40	7	have	have	AUX
dpc-1936	40	8	been	be	AUX
dpc-1936	40	9	observed	observe	VERB
dpc-1936	40	10	for	for	ADP
dpc-1936	40	11	anti	anti	ADJ
dpc-1936	40	12	-	-	ADJ
dpc-1936	40	13	il-17	il-17	ADJ
dpc-1936	40	14	versus	versus	ADP
dpc-1936	40	15	anti	anti	ADJ
dpc-1936	40	16	-	-	ADJ
dpc-1936	40	17	tnf	tnf	ADJ
dpc-1936	40	18	biologics	biologic	NOUN
dpc-1936	40	19	,	,	PUNCT
dpc-1936	40	20	the	the	DET
dpc-1936	40	21	comparative	comparative	ADJ
dpc-1936	40	22	efficacy	efficacy	NOUN
dpc-1936	40	23	of	of	ADP
dpc-1936	40	24	these	these	DET
dpc-1936	40	25	biologics	biologic	NOUN
dpc-1936	40	26	in	in	ADP
dpc-1936	40	27	patients	patient	NOUN
dpc-1936	40	28	with	with	ADP
dpc-1936	40	29	concurrent	concurrent	ADJ
dpc-1936	40	30	psa	psa	NOUN
dpc-1936	40	31	and	and	CCONJ
dpc-1936	40	32	moderate	moderate	ADJ
dpc-1936	40	33	-	-	PUNCT
dpc-1936	40	34	to	to	ADP
dpc-1936	40	35	-	-	PUNCT
dpc-1936	40	36	severe	severe	ADJ
dpc-1936	40	37	pso	pso	NOUN
dpc-1936	40	38	should	should	AUX
dpc-1936	40	39	be	be	AUX
dpc-1936	40	40	investigated	investigate	VERB
dpc-1936	40	41	[	[	PUNCT
dpc-1936	40	42	15,18–22	15,18–22	NUM
dpc-1936	40	43	]	]	PUNCT
dpc-1936	40	44	.	.	PUNCT
dpc-1936	41	1	objectives	objective	NOUN
dpc-1936	41	2	ixekizumab	ixekizumab	NOUN
dpc-1936	41	3	(	(	PUNCT
dpc-1936	41	4	ixe	ixe	NOUN
dpc-1936	41	5	)	)	PUNCT
dpc-1936	41	6	,	,	PUNCT
dpc-1936	41	7	a	a	DET
dpc-1936	41	8	high	high	ADJ
dpc-1936	41	9	-	-	PUNCT
dpc-1936	41	10	affinity	affinity	NOUN
dpc-1936	41	11	monoclonal	monoclonal	NOUN
dpc-1936	41	12	antibody	antibody	NOUN
dpc-1936	41	13	that	that	PRON
dpc-1936	41	14	selectively	selectively	ADV
dpc-1936	41	15	targets	target	VERB
dpc-1936	41	16	il-17a	il-17a	PROPN
dpc-1936	41	17	,	,	PUNCT
dpc-1936	41	18	is	be	AUX
dpc-1936	41	19	efficacious	efficacious	ADJ
dpc-1936	41	20	in	in	ADP
dpc-1936	41	21	patients	patient	NOUN
dpc-1936	41	22	with	with	ADP
dpc-1936	41	23	pso	pso	NOUN
dpc-1936	41	24	and/or	and/or	CCONJ
dpc-1936	41	25	psa	psa	VERB
dpc-1936	41	26	[	[	X
dpc-1936	41	27	15,17,21,23	15,17,21,23	NUM
dpc-1936	41	28	]	]	PUNCT
dpc-1936	41	29	.	.	PUNCT
dpc-1936	42	1	the	the	DET
dpc-1936	42	2	spirit	spirit	PROPN
dpc-1936	42	3	-	-	PUNCT
dpc-1936	42	4	h2h	h2h	PROPN
dpc-1936	42	5	trial	trial	NOUN
dpc-1936	42	6	,	,	PUNCT
dpc-1936	42	7	the	the	DET
dpc-1936	42	8	first	first	ADJ
dpc-1936	42	9	direct	direct	ADJ
dpc-1936	42	10	comparison	comparison	NOUN
dpc-1936	42	11	of	of	ADP
dpc-1936	42	12	ixe	ixe	PROPN
dpc-1936	42	13	and	and	CCONJ
dpc-1936	42	14	ada	ada	PROPN
dpc-1936	42	15	in	in	ADP
dpc-1936	42	16	biologic	biologic	ADJ
dpc-1936	42	17	-	-	PUNCT
dpc-1936	42	18	naïve	naïve	ADJ
dpc-1936	42	19	patients	patient	NOUN
dpc-1936	42	20	with	with	ADP
dpc-1936	42	21	active	active	ADJ
dpc-1936	42	22	psa	psa	NOUN
dpc-1936	42	23	and	and	CCONJ
dpc-1936	42	24	pso	pso	NOUN
dpc-1936	42	25	,	,	PUNCT
dpc-1936	42	26	reported	report	VERB
dpc-1936	42	27	that	that	SCONJ
dpc-1936	42	28	significantly	significantly	ADV
dpc-1936	42	29	more	more	ADV
dpc-1936	42	30	ixeversus	ixeversus	PROPN
dpc-1936	42	31	ada	ada	PROPN
dpc-1936	42	32	-	-	PUNCT
dpc-1936	42	33	treated	treat	VERB
dpc-1936	42	34	patients	patient	NOUN
dpc-1936	42	35	simultaneously	simultaneously	ADV
dpc-1936	42	36	achieved	achieve	VERB
dpc-1936	42	37	american	american	ADJ
dpc-1936	42	38	college	college	PROPN
dpc-1936	42	39	of	of	ADP
dpc-1936	42	40	rheumatology	rheumatology	NOUN
dpc-1936	42	41	(	(	PUNCT
dpc-1936	42	42	acr)50	acr)50	NOUN
dpc-1936	42	43	and	and	CCONJ
dpc-1936	42	44	complete	complete	ADJ
dpc-1936	42	45	clearance	clearance	NOUN
dpc-1936	42	46	of	of	ADP
dpc-1936	42	47	pso	pso	NOUN
dpc-1936	42	48	at	at	ADP
dpc-1936	42	49	week	week	NOUN
dpc-1936	42	50	(	(	PUNCT
dpc-1936	42	51	w	w	NOUN
dpc-1936	42	52	)	)	PUNCT
dpc-1936	42	53	24	24	NUM
dpc-1936	42	54	and	and	CCONJ
dpc-1936	42	55	w52	w52	ADJ
dpc-1936	43	1	[	[	X
dpc-1936	43	2	18,19	18,19	NUM
dpc-1936	43	3	]	]	X
dpc-1936	43	4	.	.	PUNCT
dpc-1936	44	1	this	this	DET
dpc-1936	44	2	analysis	analysis	NOUN
dpc-1936	44	3	aims	aim	VERB
dpc-1936	44	4	to	to	PART
dpc-1936	44	5	compare	compare	VERB
dpc-1936	44	6	the	the	DET
dpc-1936	44	7	efficacy	efficacy	NOUN
dpc-1936	44	8	of	of	ADP
dpc-1936	44	9	ixe	ixe	PROPN
dpc-1936	44	10	versus	versus	ADP
dpc-1936	44	11	ada	ada	PROPN
dpc-1936	44	12	through	through	ADP
dpc-1936	44	13	w52	w52	NOUN
dpc-1936	44	14	in	in	ADP
dpc-1936	44	15	the	the	DET
dpc-1936	44	16	subgroup	subgroup	NOUN
dpc-1936	44	17	of	of	ADP
dpc-1936	44	18	patients	patient	NOUN
dpc-1936	44	19	with	with	ADP
dpc-1936	44	20	active	active	ADJ
dpc-1936	44	21	psa	psa	NOUN
dpc-1936	44	22	and	and	CCONJ
dpc-1936	44	23	moderate	moderate	ADJ
dpc-1936	44	24	-	-	PUNCT
dpc-1936	44	25	to	to	ADP
dpc-1936	44	26	-	-	PUNCT
dpc-1936	44	27	severe	severe	ADJ
dpc-1936	44	28	pso	pso	NOUN
dpc-1936	44	29	in	in	ADP
dpc-1936	44	30	the	the	DET
dpc-1936	44	31	spirit	spirit	PROPN
dpc-1936	44	32	-	-	PUNCT
dpc-1936	44	33	h2h	h2h	PROPN
dpc-1936	44	34	trial	trial	NOUN
dpc-1936	44	35	,	,	PUNCT
dpc-1936	44	36	who	who	PRON
dpc-1936	44	37	received	receive	VERB
dpc-1936	44	38	dosage	dosage	NOUN
dpc-1936	44	39	regimens	regimen	NOUN
dpc-1936	44	40	per	per	ADP
dpc-1936	44	41	approved	approve	VERB
dpc-1936	44	42	label	label	NOUN
dpc-1936	44	43	for	for	ADP
dpc-1936	44	44	moderate	moderate	ADJ
dpc-1936	44	45	-	-	PUNCT
dpc-1936	44	46	to	to	ADP
dpc-1936	44	47	-	-	PUNCT
dpc-1936	44	48	severe	severe	ADJ
dpc-1936	44	49	pso	pso	NOUN
dpc-1936	44	50	.	.	PUNCT
dpc-1936	45	1	as	as	SCONJ
dpc-1936	45	2	this	this	DET
dpc-1936	45	3	subgroup	subgroup	NOUN
dpc-1936	45	4	is	be	AUX
dpc-1936	45	5	reflective	reflective	ADJ
dpc-1936	45	6	of	of	ADP
dpc-1936	45	7	the	the	DET
dpc-1936	45	8	patients	patient	NOUN
dpc-1936	45	9	eligible	eligible	ADJ
dpc-1936	45	10	for	for	ADP
dpc-1936	45	11	biologic	biologic	ADJ
dpc-1936	45	12	treatment	treatment	NOUN
dpc-1936	45	13	in	in	ADP
dpc-1936	45	14	routine	routine	ADJ
dpc-1936	45	15	dermatological	dermatological	ADJ
dpc-1936	45	16	clinical	clinical	ADJ
dpc-1936	45	17	practice	practice	NOUN
dpc-1936	45	18	,	,	PUNCT
dpc-1936	45	19	this	this	DET
dpc-1936	45	20	analysis	analysis	NOUN
dpc-1936	45	21	will	will	AUX
dpc-1936	45	22	inform	inform	VERB
dpc-1936	45	23	treatment	treatment	NOUN
dpc-1936	45	24	decisions	decision	NOUN
dpc-1936	45	25	in	in	ADP
dpc-1936	45	26	these	these	DET
dpc-1936	45	27	settings	setting	NOUN
dpc-1936	45	28	.	.	PUNCT
dpc-1936	46	1	original	original	ADJ
dpc-1936	46	2	article	article	NOUN
dpc-1936	46	3	|	|	ADV
dpc-1936	46	4	dermatol	dermatol	ADJ
dpc-1936	46	5	pract	pract	NOUN
dpc-1936	46	6	concept	concept	NOUN
dpc-1936	46	7	.	.	PUNCT
dpc-1936	47	1	2022;12(2):e2022104	2022;12(2):e2022104	PROPN
dpc-1936	47	2	3	3	NUM
dpc-1936	47	3	fingernails	fingernail	VERB
dpc-1936	47	4	score	score	NOUN
dpc-1936	47	5	and	and	CCONJ
dpc-1936	47	6	proportion	proportion	NOUN
dpc-1936	47	7	of	of	ADP
dpc-1936	47	8	patients	patient	NOUN
dpc-1936	47	9	achieving	achieve	VERB
dpc-1936	47	10	complete	complete	ADJ
dpc-1936	47	11	clearance	clearance	NOUN
dpc-1936	47	12	of	of	ADP
dpc-1936	47	13	nail	nail	NOUN
dpc-1936	47	14	psoriasis	psoriasis	NOUN
dpc-1936	47	15	(	(	PUNCT
dpc-1936	47	16	napsi	napsi	NOUN
dpc-1936	47	17	=	=	SYM
dpc-1936	47	18	0	0	NUM
dpc-1936	47	19	)	)	PUNCT
dpc-1936	47	20	in	in	ADP
dpc-1936	47	21	the	the	DET
dpc-1936	47	22	subgroup	subgroup	NOUN
dpc-1936	47	23	of	of	ADP
dpc-1936	47	24	patients	patient	NOUN
dpc-1936	47	25	with	with	ADP
dpc-1936	47	26	napsi	napsi	PROPN
dpc-1936	47	27	≥	≥	NUM
dpc-1936	47	28	1	1	NUM
dpc-1936	47	29	at	at	ADP
dpc-1936	47	30	baseline	baseline	NOUN
dpc-1936	47	31	.	.	PUNCT
dpc-1936	48	1	safety	safety	NOUN
dpc-1936	48	2	treatment	treatment	NOUN
dpc-1936	48	3	-	-	PUNCT
dpc-1936	48	4	emergent	emergent	ADJ
dpc-1936	48	5	adverse	adverse	ADJ
dpc-1936	48	6	events	event	NOUN
dpc-1936	48	7	(	(	PUNCT
dpc-1936	48	8	teaes	teaes	ADV
dpc-1936	48	9	)	)	PUNCT
dpc-1936	48	10	were	be	AUX
dpc-1936	48	11	defined	define	VERB
dpc-1936	48	12	as	as	ADP
dpc-1936	48	13	events	event	NOUN
dpc-1936	48	14	that	that	PRON
dpc-1936	48	15	initially	initially	ADV
dpc-1936	48	16	occurred	occur	VERB
dpc-1936	48	17	or	or	CCONJ
dpc-1936	48	18	worsened	worsen	VERB
dpc-1936	48	19	in	in	ADP
dpc-1936	48	20	severity	severity	NOUN
dpc-1936	48	21	after	after	ADP
dpc-1936	48	22	the	the	DET
dpc-1936	48	23	first	first	ADJ
dpc-1936	48	24	dose	dose	NOUN
dpc-1936	48	25	of	of	ADP
dpc-1936	48	26	the	the	DET
dpc-1936	48	27	study	study	NOUN
dpc-1936	48	28	treatment	treatment	NOUN
dpc-1936	48	29	and	and	CCONJ
dpc-1936	48	30	on	on	ADV
dpc-1936	48	31	or	or	CCONJ
dpc-1936	48	32	before	before	ADP
dpc-1936	48	33	the	the	DET
dpc-1936	48	34	date	date	NOUN
dpc-1936	48	35	of	of	ADP
dpc-1936	48	36	the	the	DET
dpc-1936	48	37	final	final	ADJ
dpc-1936	48	38	visit	visit	NOUN
dpc-1936	48	39	within	within	ADP
dpc-1936	48	40	the	the	DET
dpc-1936	48	41	treatment	treatment	NOUN
dpc-1936	48	42	period	period	NOUN
dpc-1936	48	43	.	.	PUNCT
dpc-1936	49	1	adverse	adverse	ADJ
dpc-1936	49	2	events	event	NOUN
dpc-1936	49	3	(	(	PUNCT
dpc-1936	49	4	aes	aes	NOUN
dpc-1936	49	5	)	)	PUNCT
dpc-1936	49	6	of	of	ADP
dpc-1936	49	7	special	special	ADJ
dpc-1936	49	8	interest	interest	NOUN
dpc-1936	49	9	included	include	VERB
dpc-1936	49	10	infections	infection	NOUN
dpc-1936	49	11	,	,	PUNCT
dpc-1936	49	12	injection	injection	NOUN
dpc-1936	49	13	site	site	NOUN
dpc-1936	49	14	reactions	reaction	NOUN
dpc-1936	49	15	,	,	PUNCT
dpc-1936	49	16	malignancies	malignancy	NOUN
dpc-1936	49	17	,	,	PUNCT
dpc-1936	49	18	major	major	ADJ
dpc-1936	49	19	adverse	adverse	ADJ
dpc-1936	49	20	cardiovascular	cardiovascular	ADJ
dpc-1936	49	21	events	event	NOUN
dpc-1936	49	22	,	,	PUNCT
dpc-1936	49	23	allergic	allergic	ADJ
dpc-1936	49	24	reactions	reaction	NOUN
dpc-1936	49	25	/	/	SYM
dpc-1936	49	26	hypersensitivity	hypersensitivity	NOUN
dpc-1936	49	27	,	,	PUNCT
dpc-1936	49	28	inflammatory	inflammatory	ADJ
dpc-1936	49	29	bowel	bowel	NOUN
dpc-1936	49	30	disease	disease	NOUN
dpc-1936	49	31	,	,	PUNCT
dpc-1936	49	32	depression	depression	NOUN
dpc-1936	49	33	,	,	PUNCT
dpc-1936	49	34	hepatic	hepatic	ADJ
dpc-1936	49	35	laboratory	laboratory	NOUN
dpc-1936	49	36	changes	change	NOUN
dpc-1936	49	37	,	,	PUNCT
dpc-1936	49	38	cytopenia	cytopenia	NOUN
dpc-1936	49	39	,	,	PUNCT
dpc-1936	49	40	and	and	CCONJ
dpc-1936	49	41	neutropenia	neutropenia	NOUN
dpc-1936	49	42	.	.	PUNCT
dpc-1936	50	1	cerebrocardiovascular	cerebrocardiovascular	ADJ
dpc-1936	50	2	events	event	NOUN
dpc-1936	50	3	were	be	AUX
dpc-1936	50	4	adjudicated	adjudicate	VERB
dpc-1936	50	5	by	by	ADP
dpc-1936	50	6	external	external	ADJ
dpc-1936	50	7	clinical	clinical	ADJ
dpc-1936	50	8	events	event	NOUN
dpc-1936	50	9	committees	committee	NOUN
dpc-1936	50	10	.	.	PUNCT
dpc-1936	51	1	safety	safety	NOUN
dpc-1936	51	2	results	result	NOUN
dpc-1936	51	3	for	for	ADP
dpc-1936	51	4	the	the	DET
dpc-1936	51	5	total	total	ADJ
dpc-1936	51	6	study	study	NOUN
dpc-1936	51	7	population	population	NOUN
dpc-1936	51	8	have	have	AUX
dpc-1936	51	9	been	be	AUX
dpc-1936	51	10	published	publish	VERB
dpc-1936	51	11	previously	previously	ADV
dpc-1936	51	12	[	[	X
dpc-1936	51	13	18,19	18,19	NUM
dpc-1936	51	14	]	]	PUNCT
dpc-1936	51	15	.	.	PUNCT
dpc-1936	52	1	statistical	statistical	ADJ
dpc-1936	52	2	analysis	analysis	NOUN
dpc-1936	52	3	efficacy	efficacy	NOUN
dpc-1936	52	4	in	in	ADP
dpc-1936	52	5	this	this	DET
dpc-1936	52	6	post	post	ADJ
dpc-1936	52	7	hoc	hoc	X
dpc-1936	52	8	analysis	analysis	NOUN
dpc-1936	52	9	,	,	PUNCT
dpc-1936	52	10	efficacy	efficacy	NOUN
dpc-1936	52	11	analyses	analysis	NOUN
dpc-1936	52	12	were	be	AUX
dpc-1936	52	13	performed	perform	VERB
dpc-1936	52	14	on	on	ADP
dpc-1936	52	15	the	the	DET
dpc-1936	52	16	intent	intent	NOUN
dpc-1936	52	17	-	-	PUNCT
dpc-1936	52	18	to	to	ADP
dpc-1936	52	19	-	-	PUNCT
dpc-1936	52	20	treat	treat	VERB
dpc-1936	52	21	population	population	NOUN
dpc-1936	52	22	,	,	PUNCT
dpc-1936	52	23	consisting	consist	VERB
dpc-1936	52	24	of	of	ADP
dpc-1936	52	25	all	all	DET
dpc-1936	52	26	randomized	randomized	ADJ
dpc-1936	52	27	patients	patient	NOUN
dpc-1936	52	28	according	accord	VERB
dpc-1936	52	29	to	to	ADP
dpc-1936	52	30	the	the	DET
dpc-1936	52	31	treatment	treatment	NOUN
dpc-1936	52	32	assigned	assign	VERB
dpc-1936	52	33	at	at	ADP
dpc-1936	52	34	w0	w0	PROPN
dpc-1936	52	35	.	.	PUNCT
dpc-1936	53	1	categorical	categorical	ADJ
dpc-1936	53	2	variables	variable	NOUN
dpc-1936	53	3	were	be	AUX
dpc-1936	53	4	assessed	assess	VERB
dpc-1936	53	5	using	use	VERB
dpc-1936	53	6	logistic	logistic	ADJ
dpc-1936	53	7	regression	regression	NOUN
dpc-1936	53	8	models	model	NOUN
dpc-1936	53	9	with	with	ADP
dpc-1936	53	10	treatment	treatment	NOUN
dpc-1936	53	11	and	and	CCONJ
dpc-1936	53	12	concomitant	concomitant	ADJ
dpc-1936	53	13	csdmard	csdmard	NOUN
dpc-1936	53	14	use	use	NOUN
dpc-1936	53	15	at	at	ADP
dpc-1936	53	16	baseline	baseline	NOUN
dpc-1936	53	17	as	as	ADP
dpc-1936	53	18	factors	factor	NOUN
dpc-1936	53	19	,	,	PUNCT
dpc-1936	53	20	as	as	ADV
dpc-1936	53	21	well	well	ADV
dpc-1936	53	22	as	as	ADP
dpc-1936	53	23	fisher	fisher	PROPN
dpc-1936	53	24	’s	’s	PART
dpc-1936	53	25	exact	exact	ADJ
dpc-1936	53	26	tests	test	NOUN
dpc-1936	53	27	whenever	whenever	SCONJ
dpc-1936	53	28	relevant	relevant	ADJ
dpc-1936	53	29	.	.	PUNCT
dpc-1936	54	1	the	the	DET
dpc-1936	54	2	non	non	ADJ
dpc-1936	54	3	-	-	ADJ
dpc-1936	54	4	responder	responder	ADJ
dpc-1936	54	5	imputation	imputation	NOUN
dpc-1936	54	6	(	(	PUNCT
dpc-1936	54	7	nri	nri	PROPN
dpc-1936	54	8	)	)	PUNCT
dpc-1936	54	9	method	method	NOUN
dpc-1936	54	10	was	be	AUX
dpc-1936	54	11	used	use	VERB
dpc-1936	54	12	in	in	ADP
dpc-1936	54	13	case	case	NOUN
dpc-1936	54	14	of	of	ADP
dpc-1936	54	15	missing	miss	VERB
dpc-1936	54	16	data	datum	NOUN
dpc-1936	54	17	:	:	PUNCT
dpc-1936	54	18	patients	patient	NOUN
dpc-1936	54	19	were	be	AUX
dpc-1936	54	20	considered	consider	VERB
dpc-1936	54	21	non	non	NOUN
dpc-1936	54	22	-	-	NOUN
dpc-1936	54	23	responders	responder	NOUN
dpc-1936	54	24	if	if	SCONJ
dpc-1936	54	25	they	they	PRON
dpc-1936	54	26	did	do	AUX
dpc-1936	54	27	not	not	PART
dpc-1936	54	28	meet	meet	VERB
dpc-1936	54	29	the	the	DET
dpc-1936	54	30	clinical	clinical	ADJ
dpc-1936	54	31	response	response	NOUN
dpc-1936	54	32	criteria	criterion	NOUN
dpc-1936	54	33	or	or	CCONJ
dpc-1936	54	34	had	have	AUX
dpc-1936	54	35	missing	miss	VERB
dpc-1936	54	36	clinical	clinical	ADJ
dpc-1936	54	37	response	response	NOUN
dpc-1936	54	38	data	datum	NOUN
dpc-1936	54	39	at	at	ADP
dpc-1936	54	40	a	a	DET
dpc-1936	54	41	particular	particular	ADJ
dpc-1936	54	42	time	time	NOUN
dpc-1936	54	43	point	point	NOUN
dpc-1936	54	44	of	of	ADP
dpc-1936	54	45	analysis	analysis	NOUN
dpc-1936	54	46	.	.	PUNCT
dpc-1936	55	1	continuous	continuous	ADJ
dpc-1936	55	2	variables	variable	NOUN
dpc-1936	55	3	were	be	AUX
dpc-1936	55	4	analyzed	analyze	VERB
dpc-1936	55	5	using	use	VERB
dpc-1936	55	6	a	a	DET
dpc-1936	55	7	mixed	mixed	ADJ
dpc-1936	55	8	effects	effect	NOUN
dpc-1936	55	9	model	model	NOUN
dpc-1936	55	10	of	of	ADP
dpc-1936	55	11	repeated	repeat	VERB
dpc-1936	55	12	measures	measure	NOUN
dpc-1936	55	13	analysis	analysis	NOUN
dpc-1936	55	14	,	,	PUNCT
dpc-1936	55	15	which	which	PRON
dpc-1936	55	16	included	include	VERB
dpc-1936	55	17	treatment	treatment	NOUN
dpc-1936	55	18	group	group	NOUN
dpc-1936	55	19	,	,	PUNCT
dpc-1936	55	20	concomitant	concomitant	ADJ
dpc-1936	55	21	csdmard	csdmard	NOUN
dpc-1936	55	22	use	use	NOUN
dpc-1936	55	23	at	at	ADP
dpc-1936	55	24	baseline	baseline	NOUN
dpc-1936	55	25	,	,	PUNCT
dpc-1936	55	26	and	and	CCONJ
dpc-1936	55	27	visit	visit	VERB
dpc-1936	55	28	as	as	ADP
dpc-1936	55	29	fixed	fix	VERB
dpc-1936	55	30	factors	factor	NOUN
dpc-1936	55	31	,	,	PUNCT
dpc-1936	55	32	baseline	baseline	NOUN
dpc-1936	55	33	value	value	NOUN
dpc-1936	55	34	as	as	ADP
dpc-1936	55	35	a	a	DET
dpc-1936	55	36	covariate	covariate	NOUN
dpc-1936	55	37	,	,	PUNCT
dpc-1936	55	38	and	and	CCONJ
dpc-1936	55	39	baseline	baseline	NOUN
dpc-1936	55	40	-	-	PUNCT
dpc-1936	55	41	by	by	ADP
dpc-1936	55	42	-	-	PUNCT
dpc-1936	55	43	visit	visit	NOUN
dpc-1936	55	44	and	and	CCONJ
dpc-1936	55	45	treatment	treatment	NOUN
dpc-1936	55	46	-	-	PUNCT
dpc-1936	55	47	by	by	ADP
dpc-1936	55	48	-	-	PUNCT
dpc-1936	55	49	visit	visit	NOUN
dpc-1936	55	50	interaction	interaction	NOUN
dpc-1936	55	51	terms	term	NOUN
dpc-1936	55	52	.	.	PUNCT
dpc-1936	56	1	safety	safety	NOUN
dpc-1936	56	2	descriptive	descriptive	ADJ
dpc-1936	56	3	statistics	statistic	NOUN
dpc-1936	56	4	were	be	AUX
dpc-1936	56	5	performed	perform	VERB
dpc-1936	56	6	on	on	ADP
dpc-1936	56	7	the	the	DET
dpc-1936	56	8	safety	safety	NOUN
dpc-1936	56	9	population	population	NOUN
dpc-1936	56	10	,	,	PUNCT
dpc-1936	56	11	defined	define	VERB
dpc-1936	56	12	as	as	ADP
dpc-1936	56	13	all	all	DET
dpc-1936	56	14	randomized	randomize	VERB
dpc-1936	56	15	patients	patient	NOUN
dpc-1936	56	16	who	who	PRON
dpc-1936	56	17	received	receive	VERB
dpc-1936	56	18	≥	≥	NOUN
dpc-1936	56	19	1	1	NUM
dpc-1936	56	20	 	 	SPACE
dpc-1936	56	21	dose	dose	NOUN
dpc-1936	56	22	of	of	ADP
dpc-1936	56	23	the	the	DET
dpc-1936	56	24	study	study	NOUN
dpc-1936	56	25	treatment	treatment	NOUN
dpc-1936	56	26	.	.	PUNCT
dpc-1936	57	1	results	result	NOUN
dpc-1936	57	2	baseline	baseline	VERB
dpc-1936	57	3	characteristics	characteristic	NOUN
dpc-1936	57	4	of	of	ADP
dpc-1936	57	5	the	the	DET
dpc-1936	57	6	566	566	NUM
dpc-1936	57	7	biologic	biologic	NOUN
dpc-1936	57	8	-	-	PUNCT
dpc-1936	57	9	naïve	naïve	ADJ
dpc-1936	57	10	patients	patient	NOUN
dpc-1936	57	11	included	include	VERB
dpc-1936	57	12	in	in	ADP
dpc-1936	57	13	the	the	DET
dpc-1936	57	14	spirit	spirit	PROPN
dpc-1936	57	15	-	-	PUNCT
dpc-1936	57	16	h2h	h2h	PROPN
dpc-1936	57	17	study	study	NOUN
dpc-1936	57	18	,	,	PUNCT
dpc-1936	57	19	49	49	NUM
dpc-1936	57	20	(	(	PUNCT
dpc-1936	57	21	17.3	17.3	NUM
dpc-1936	57	22	%	%	NOUN
dpc-1936	57	23	)	)	PUNCT
dpc-1936	57	24	of	of	ADP
dpc-1936	57	25	the	the	DET
dpc-1936	57	26	ixe	ixe	ADV
dpc-1936	57	27	-	-	PUNCT
dpc-1936	57	28	treated	treat	VERB
dpc-1936	57	29	patients	patient	NOUN
dpc-1936	57	30	and	and	CCONJ
dpc-1936	57	31	51	51	NUM
dpc-1936	57	32	(	(	PUNCT
dpc-1936	57	33	18.0	18.0	NUM
dpc-1936	57	34	%	%	NOUN
dpc-1936	57	35	)	)	PUNCT
dpc-1936	57	36	of	of	ADP
dpc-1936	57	37	the	the	DET
dpc-1936	57	38	ada	ada	PROPN
dpc-1936	57	39	-	-	PUNCT
dpc-1936	57	40	treated	treat	VERB
dpc-1936	57	41	patients	patient	NOUN
dpc-1936	57	42	had	have	VERB
dpc-1936	57	43	moderatetosevere	moderatetosevere	ADV
dpc-1936	57	44	pso	pso	NOUN
dpc-1936	57	45	(	(	PUNCT
dpc-1936	57	46	pasi	pasi	NOUN
dpc-1936	57	47	≥	≥	NUM
dpc-1936	57	48	12	12	NUM
dpc-1936	57	49	,	,	PUNCT
dpc-1936	57	50	spga	spga	NOUN
dpc-1936	57	51	≥	≥	NOUN
dpc-1936	57	52	3	3	NUM
dpc-1936	57	53	,	,	PUNCT
dpc-1936	57	54	and	and	CCONJ
dpc-1936	57	55	bsa	bsa	PROPN
dpc-1936	57	56	≥	≥	NUM
dpc-1936	57	57	10	10	NUM
dpc-1936	57	58	%	%	NOUN
dpc-1936	57	59	)	)	PUNCT
dpc-1936	57	60	at	at	ADP
dpc-1936	57	61	baseline	baseline	NOUN
dpc-1936	57	62	.	.	PUNCT
dpc-1936	58	1	the	the	DET
dpc-1936	58	2	frequency	frequency	NOUN
dpc-1936	58	3	of	of	ADP
dpc-1936	58	4	moderate	moderate	ADJ
dpc-1936	58	5	-	-	PUNCT
dpc-1936	58	6	to	to	ADP
dpc-1936	58	7	-	-	PUNCT
dpc-1936	58	8	severe	severe	ADJ
dpc-1936	58	9	pso	pso	NOUN
dpc-1936	58	10	and	and	CCONJ
dpc-1936	58	11	nail	nail	NOUN
dpc-1936	58	12	pso	pso	NOUN
dpc-1936	58	13	in	in	ADP
dpc-1936	58	14	the	the	DET
dpc-1936	58	15	overall	overall	ADJ
dpc-1936	58	16	spirit	spirit	PROPN
dpc-1936	58	17	-	-	PUNCT
dpc-1936	58	18	h2h	h2h	PROPN
dpc-1936	58	19	population	population	NOUN
dpc-1936	58	20	is	be	AUX
dpc-1936	58	21	visually	visually	ADV
dpc-1936	58	22	methods	method	NOUN
dpc-1936	58	23	participants	participant	NOUN
dpc-1936	58	24	and	and	CCONJ
dpc-1936	58	25	study	study	NOUN
dpc-1936	58	26	design	design	NOUN
dpc-1936	58	27	spirit	spirit	PROPN
dpc-1936	58	28	-	-	PUNCT
dpc-1936	58	29	h2h	h2h	PROPN
dpc-1936	58	30	(	(	PUNCT
dpc-1936	58	31	clinicaltrials.gov	clinicaltrials.gov	NOUN
dpc-1936	58	32	:	:	PUNCT
dpc-1936	58	33	nct03151551	nct03151551	NOUN
dpc-1936	58	34	)	)	PUNCT
dpc-1936	58	35	is	be	AUX
dpc-1936	58	36	a	a	DET
dpc-1936	58	37	52week	52week	NUM
dpc-1936	58	38	,	,	PUNCT
dpc-1936	58	39	multicenter	multicenter	NOUN
dpc-1936	58	40	,	,	PUNCT
dpc-1936	58	41	randomized	randomize	VERB
dpc-1936	58	42	,	,	PUNCT
dpc-1936	58	43	open	open	ADJ
dpc-1936	58	44	-	-	PUNCT
dpc-1936	58	45	label	label	NOUN
dpc-1936	58	46	,	,	PUNCT
dpc-1936	58	47	assessor	assessor	NOUN
dpc-1936	58	48	-	-	PUNCT
dpc-1936	58	49	blinded	blind	VERB
dpc-1936	58	50	,	,	PUNCT
dpc-1936	58	51	parallel	parallel	ADJ
dpc-1936	58	52	-	-	PUNCT
dpc-1936	58	53	group	group	NOUN
dpc-1936	58	54	study	study	NOUN
dpc-1936	58	55	evaluating	evaluate	VERB
dpc-1936	58	56	the	the	DET
dpc-1936	58	57	efficacy	efficacy	NOUN
dpc-1936	58	58	and	and	CCONJ
dpc-1936	58	59	safety	safety	NOUN
dpc-1936	58	60	of	of	ADP
dpc-1936	58	61	ixe	ixe	PROPN
dpc-1936	58	62	versus	versus	ADP
dpc-1936	58	63	ada	ada	PROPN
dpc-1936	58	64	in	in	ADP
dpc-1936	58	65	biologic	biologic	NOUN
dpc-1936	58	66	-	-	PUNCT
dpc-1936	58	67	naïve	naïve	ADJ
dpc-1936	58	68	,	,	PUNCT
dpc-1936	58	69	csdmard	csdmard	NOUN
dpc-1936	58	70	-	-	PUNCT
dpc-1936	58	71	inadequate	inadequate	ADJ
dpc-1936	58	72	-	-	PUNCT
dpc-1936	58	73	responder	responder	NOUN
dpc-1936	58	74	patients	patient	NOUN
dpc-1936	58	75	with	with	ADP
dpc-1936	58	76	active	active	ADJ
dpc-1936	58	77	psa	psa	NOUN
dpc-1936	58	78	and	and	CCONJ
dpc-1936	58	79	pso	pso	NOUN
dpc-1936	58	80	.	.	PUNCT
dpc-1936	59	1	the	the	DET
dpc-1936	59	2	study	study	NOUN
dpc-1936	59	3	population	population	NOUN
dpc-1936	59	4	and	and	CCONJ
dpc-1936	59	5	study	study	NOUN
dpc-1936	59	6	design	design	NOUN
dpc-1936	59	7	have	have	AUX
dpc-1936	59	8	been	be	AUX
dpc-1936	59	9	previously	previously	ADV
dpc-1936	59	10	published	publish	VERB
dpc-1936	59	11	[	[	PUNCT
dpc-1936	59	12	18	18	NUM
dpc-1936	59	13	]	]	PUNCT
dpc-1936	59	14	.	.	PUNCT
dpc-1936	60	1	briefly	briefly	NOUN
dpc-1936	60	2	,	,	PUNCT
dpc-1936	60	3	patients	patient	NOUN
dpc-1936	60	4	were	be	AUX
dpc-1936	60	5	aged	age	VERB
dpc-1936	60	6	≥	≥	NUM
dpc-1936	60	7	18	18	NUM
dpc-1936	60	8	years	year	NOUN
dpc-1936	60	9	,	,	PUNCT
dpc-1936	60	10	had	have	VERB
dpc-1936	60	11	a	a	DET
dpc-1936	60	12	confirmed	confirm	VERB
dpc-1936	60	13	diagnosis	diagnosis	NOUN
dpc-1936	60	14	of	of	ADP
dpc-1936	60	15	psa	psa	NOUN
dpc-1936	60	16	of	of	ADP
dpc-1936	60	17	≥	≥	NUM
dpc-1936	60	18	6	6	NUM
dpc-1936	60	19	months	month	NOUN
dpc-1936	60	20	,	,	PUNCT
dpc-1936	60	21	had	have	VERB
dpc-1936	60	22	active	active	ADJ
dpc-1936	60	23	psa	psa	NOUN
dpc-1936	60	24	(	(	PUNCT
dpc-1936	60	25	≥	≥	NUM
dpc-1936	60	26	3/66	3/66	NUM
dpc-1936	60	27	swollen	swollen	ADJ
dpc-1936	60	28	joints	joint	NOUN
dpc-1936	60	29	and	and	CCONJ
dpc-1936	60	30	≥	≥	NUM
dpc-1936	60	31	3/68	3/68	NUM
dpc-1936	60	32	tender	tender	NOUN
dpc-1936	60	33	joints	joint	NOUN
dpc-1936	60	34	)	)	PUNCT
dpc-1936	60	35	and	and	CCONJ
dpc-1936	60	36	pso	pso	NOUN
dpc-1936	60	37	(	(	PUNCT
dpc-1936	60	38	≥	≥	NOUN
dpc-1936	60	39	3	3	NUM
dpc-1936	60	40	%	%	NOUN
dpc-1936	60	41	of	of	ADP
dpc-1936	60	42	the	the	DET
dpc-1936	60	43	body	body	NOUN
dpc-1936	60	44	surface	surface	NOUN
dpc-1936	60	45	area	area	NOUN
dpc-1936	61	1	[	[	X
dpc-1936	61	2	bsa	bsa	X
dpc-1936	61	3	]	]	X
dpc-1936	61	4	affected	affect	VERB
dpc-1936	61	5	)	)	PUNCT
dpc-1936	61	6	,	,	PUNCT
dpc-1936	61	7	fulfilled	fulfil	VERB
dpc-1936	61	8	the	the	DET
dpc-1936	61	9	classification	classification	NOUN
dpc-1936	61	10	for	for	ADP
dpc-1936	61	11	psoriatic	psoriatic	ADJ
dpc-1936	61	12	arthritis	arthritis	NOUN
dpc-1936	61	13	(	(	PUNCT
dpc-1936	61	14	caspar	caspar	PROPN
dpc-1936	61	15	)	)	PUNCT
dpc-1936	61	16	criteria	criterion	NOUN
dpc-1936	61	17	and	and	CCONJ
dpc-1936	61	18	were	be	AUX
dpc-1936	61	19	not	not	PART
dpc-1936	61	20	previously	previously	ADV
dpc-1936	61	21	treated	treat	VERB
dpc-1936	61	22	with	with	ADP
dpc-1936	61	23	biologics	biologic	NOUN
dpc-1936	61	24	or	or	CCONJ
dpc-1936	61	25	janus	janus	PROPN
dpc-1936	61	26	kinase	kinase	PROPN
dpc-1936	61	27	inhibitors	inhibitor	NOUN
dpc-1936	61	28	.	.	PUNCT
dpc-1936	62	1	patients	patient	NOUN
dpc-1936	62	2	on	on	ADP
dpc-1936	62	3	csdmards	csdmard	NOUN
dpc-1936	62	4	at	at	ADP
dpc-1936	62	5	screening	screening	NOUN
dpc-1936	62	6	were	be	AUX
dpc-1936	62	7	permitted	permit	VERB
dpc-1936	62	8	to	to	PART
dpc-1936	62	9	continue	continue	VERB
dpc-1936	62	10	at	at	ADP
dpc-1936	62	11	a	a	DET
dpc-1936	62	12	stable	stable	ADJ
dpc-1936	62	13	dose	dose	NOUN
dpc-1936	62	14	.	.	PUNCT
dpc-1936	63	1	randomization	randomization	NOUN
dpc-1936	63	2	was	be	AUX
dpc-1936	63	3	stratified	stratify	VERB
dpc-1936	63	4	by	by	ADP
dpc-1936	63	5	concomitant	concomitant	ADJ
dpc-1936	63	6	csdmard	csdmard	NOUN
dpc-1936	63	7	use	use	NOUN
dpc-1936	63	8	and	and	CCONJ
dpc-1936	63	9	moderate	moderate	ADJ
dpc-1936	63	10	-	-	PUNCT
dpc-1936	63	11	to	to	ADP
dpc-1936	63	12	-	-	PUNCT
dpc-1936	63	13	severe	severe	ADJ
dpc-1936	63	14	pso	pso	NOUN
dpc-1936	63	15	involvement	involvement	NOUN
dpc-1936	63	16	(	(	PUNCT
dpc-1936	63	17	pasi	pasi	NOUN
dpc-1936	63	18	≥	≥	NUM
dpc-1936	63	19	12	12	NUM
dpc-1936	63	20	,	,	PUNCT
dpc-1936	63	21	bsa	bsa	PROPN
dpc-1936	63	22	≥	≥	NUM
dpc-1936	63	23	10	10	NUM
dpc-1936	63	24	%	%	NOUN
dpc-1936	63	25	,	,	PUNCT
dpc-1936	63	26	and	and	CCONJ
dpc-1936	63	27	static	static	ADJ
dpc-1936	63	28	physician	physician	NOUN
dpc-1936	63	29	global	global	ADJ
dpc-1936	63	30	assessment	assessment	NOUN
dpc-1936	63	31	[	[	X
dpc-1936	63	32	spga	spga	NOUN
dpc-1936	63	33	]	]	PUNCT
dpc-1936	63	34	≥	≥	NUM
dpc-1936	63	35	3	3	NUM
dpc-1936	63	36	)	)	PUNCT
dpc-1936	63	37	at	at	ADP
dpc-1936	63	38	baseline	baseline	NOUN
dpc-1936	63	39	.	.	PUNCT
dpc-1936	64	1	patients	patient	NOUN
dpc-1936	64	2	were	be	AUX
dpc-1936	64	3	randomized	randomize	VERB
dpc-1936	64	4	at	at	ADP
dpc-1936	64	5	a	a	DET
dpc-1936	64	6	1:1	1:1	NUM
dpc-1936	64	7	ratio	ratio	NOUN
dpc-1936	64	8	to	to	PART
dpc-1936	64	9	receive	receive	VERB
dpc-1936	64	10	ixe	ixe	NOUN
dpc-1936	64	11	or	or	CCONJ
dpc-1936	64	12	ada	ada	PROPN
dpc-1936	64	13	.	.	PUNCT
dpc-1936	65	1	patients	patient	NOUN
dpc-1936	65	2	with	with	ADP
dpc-1936	65	3	active	active	ADJ
dpc-1936	65	4	psa	psa	NOUN
dpc-1936	65	5	and	and	CCONJ
dpc-1936	65	6	moderate	moderate	ADJ
dpc-1936	65	7	-	-	PUNCT
dpc-1936	65	8	to	to	ADP
dpc-1936	65	9	-	-	PUNCT
dpc-1936	65	10	severe	severe	ADJ
dpc-1936	65	11	pso	pso	NOUN
dpc-1936	65	12	were	be	AUX
dpc-1936	65	13	treated	treat	VERB
dpc-1936	65	14	as	as	ADP
dpc-1936	65	15	per	per	ADP
dpc-1936	65	16	approved	approve	VERB
dpc-1936	65	17	label	label	NOUN
dpc-1936	65	18	for	for	ADP
dpc-1936	65	19	moderate	moderate	ADJ
dpc-1936	65	20	-	-	PUNCT
dpc-1936	65	21	to	to	ADP
dpc-1936	65	22	-	-	PUNCT
dpc-1936	65	23	severe	severe	ADJ
dpc-1936	65	24	pso	pso	NOUN
dpc-1936	65	25	and	and	CCONJ
dpc-1936	65	26	received	receive	VERB
dpc-1936	65	27	a	a	DET
dpc-1936	65	28	160	160	NUM
dpc-1936	65	29	mg	mg	NOUN
dpc-1936	65	30	ixe	ixe	NOUN
dpc-1936	65	31	starting	starting	AUX
dpc-1936	65	32	dose	dose	VERB
dpc-1936	65	33	at	at	ADP
dpc-1936	65	34	w0	w0	PROPN
dpc-1936	65	35	,	,	PUNCT
dpc-1936	65	36	followed	follow	VERB
dpc-1936	65	37	by	by	ADP
dpc-1936	65	38	80	80	NUM
dpc-1936	65	39	mg	mg	NOUN
dpc-1936	65	40	ixe	ixe	NOUN
dpc-1936	65	41	every	every	DET
dpc-1936	65	42	2	2	NUM
dpc-1936	65	43	weeks	week	NOUN
dpc-1936	65	44	(	(	PUNCT
dpc-1936	65	45	q2w	q2w	NOUN
dpc-1936	65	46	)	)	PUNCT
dpc-1936	65	47	from	from	ADP
dpc-1936	65	48	w2	w2	PROPN
dpc-1936	65	49	to	to	ADP
dpc-1936	65	50	w12	w12	PROPN
dpc-1936	65	51	and	and	CCONJ
dpc-1936	65	52	every	every	DET
dpc-1936	65	53	4	4	NUM
dpc-1936	65	54	weeks	week	NOUN
dpc-1936	65	55	thereafter	thereafter	ADV
dpc-1936	65	56	,	,	PUNCT
dpc-1936	65	57	or	or	CCONJ
dpc-1936	65	58	an	an	DET
dpc-1936	65	59	80	80	NUM
dpc-1936	65	60	mg	mg	PROPN
dpc-1936	65	61	ada	ada	PROPN
dpc-1936	65	62	starting	starting	PROPN
dpc-1936	65	63	dose	dose	PROPN
dpc-1936	65	64	,	,	PUNCT
dpc-1936	65	65	followed	follow	VERB
dpc-1936	65	66	by	by	ADP
dpc-1936	65	67	40	40	NUM
dpc-1936	65	68	mg	mg	PROPN
dpc-1936	65	69	ada	ada	PROPN
dpc-1936	65	70	q2w	q2w	PROPN
dpc-1936	65	71	starting	start	VERB
dpc-1936	65	72	at	at	ADP
dpc-1936	65	73	w1	w1	NOUN
dpc-1936	65	74	.	.	PUNCT
dpc-1936	66	1	in	in	ADP
dpc-1936	66	2	this	this	DET
dpc-1936	66	3	post	post	ADJ
dpc-1936	66	4	hoc	hoc	X
dpc-1936	66	5	analysis	analysis	NOUN
dpc-1936	66	6	,	,	PUNCT
dpc-1936	66	7	only	only	ADV
dpc-1936	66	8	patients	patient	NOUN
dpc-1936	66	9	with	with	ADP
dpc-1936	66	10	active	active	ADJ
dpc-1936	66	11	psa	psa	NOUN
dpc-1936	66	12	and	and	CCONJ
dpc-1936	66	13	moderate	moderate	ADJ
dpc-1936	66	14	-	-	PUNCT
dpc-1936	66	15	to	to	ADP
dpc-1936	66	16	-	-	PUNCT
dpc-1936	66	17	severe	severe	ADJ
dpc-1936	66	18	pso	pso	NOUN
dpc-1936	66	19	at	at	ADP
dpc-1936	66	20	baseline	baseline	PROPN
dpc-1936	66	21	were	be	AUX
dpc-1936	66	22	included	include	VERB
dpc-1936	66	23	.	.	PUNCT
dpc-1936	67	1	spirit	spirit	PROPN
dpc-1936	67	2	-	-	PUNCT
dpc-1936	67	3	h2h	h2h	PROPN
dpc-1936	67	4	was	be	AUX
dpc-1936	67	5	conducted	conduct	VERB
dpc-1936	67	6	in	in	ADP
dpc-1936	67	7	accordance	accordance	NOUN
dpc-1936	67	8	with	with	ADP
dpc-1936	67	9	the	the	DET
dpc-1936	67	10	ethical	ethical	ADJ
dpc-1936	67	11	principles	principle	NOUN
dpc-1936	67	12	of	of	ADP
dpc-1936	67	13	the	the	DET
dpc-1936	67	14	declaration	declaration	NOUN
dpc-1936	67	15	of	of	ADP
dpc-1936	67	16	helsinki	helsinki	PROPN
dpc-1936	67	17	.	.	PUNCT
dpc-1936	68	1	the	the	DET
dpc-1936	68	2	study	study	NOUN
dpc-1936	68	3	protocol	protocol	NOUN
dpc-1936	68	4	was	be	AUX
dpc-1936	68	5	approved	approve	VERB
dpc-1936	68	6	by	by	ADP
dpc-1936	68	7	the	the	DET
dpc-1936	68	8	ethical	ethical	ADJ
dpc-1936	68	9	review	review	NOUN
dpc-1936	68	10	boards	board	NOUN
dpc-1936	68	11	of	of	ADP
dpc-1936	68	12	all	all	DET
dpc-1936	68	13	participating	participate	VERB
dpc-1936	68	14	sites	site	NOUN
dpc-1936	68	15	prior	prior	ADV
dpc-1936	68	16	to	to	ADP
dpc-1936	68	17	the	the	DET
dpc-1936	68	18	start	start	NOUN
dpc-1936	68	19	of	of	ADP
dpc-1936	68	20	study	study	NOUN
dpc-1936	68	21	-	-	PUNCT
dpc-1936	68	22	related	relate	VERB
dpc-1936	68	23	procedures	procedure	NOUN
dpc-1936	68	24	.	.	PUNCT
dpc-1936	69	1	informed	informed	ADJ
dpc-1936	69	2	consent	consent	NOUN
dpc-1936	69	3	was	be	AUX
dpc-1936	69	4	obtained	obtain	VERB
dpc-1936	69	5	from	from	ADP
dpc-1936	69	6	all	all	DET
dpc-1936	69	7	participants	participant	NOUN
dpc-1936	69	8	.	.	PUNCT
dpc-1936	70	1	efficacy	efficacy	NOUN
dpc-1936	70	2	endpoints	endpoint	NOUN
dpc-1936	70	3	endpoints	endpoint	NOUN
dpc-1936	70	4	were	be	AUX
dpc-1936	70	5	assessed	assess	VERB
dpc-1936	70	6	in	in	ADP
dpc-1936	70	7	all	all	DET
dpc-1936	70	8	patients	patient	NOUN
dpc-1936	70	9	with	with	ADP
dpc-1936	70	10	active	active	ADJ
dpc-1936	70	11	psa	psa	NOUN
dpc-1936	70	12	and	and	CCONJ
dpc-1936	70	13	moderate	moderate	ADJ
dpc-1936	70	14	-	-	PUNCT
dpc-1936	70	15	to	to	ADP
dpc-1936	70	16	-	-	PUNCT
dpc-1936	70	17	severe	severe	ADJ
dpc-1936	70	18	pso	pso	NOUN
dpc-1936	70	19	at	at	ADP
dpc-1936	70	20	baseline	baseline	NOUN
dpc-1936	70	21	.	.	PUNCT
dpc-1936	71	1	the	the	DET
dpc-1936	71	2	primary	primary	ADJ
dpc-1936	71	3	endpoint	endpoint	NOUN
dpc-1936	71	4	of	of	ADP
dpc-1936	71	5	spirit	spirit	PROPN
dpc-1936	71	6	-	-	PUNCT
dpc-1936	71	7	h2h	h2h	PROPN
dpc-1936	71	8	was	be	AUX
dpc-1936	71	9	the	the	DET
dpc-1936	71	10	proportion	proportion	NOUN
dpc-1936	71	11	of	of	ADP
dpc-1936	71	12	patients	patient	NOUN
dpc-1936	71	13	who	who	PRON
dpc-1936	71	14	simultaneously	simultaneously	ADV
dpc-1936	71	15	achieved	achieve	VERB
dpc-1936	71	16	acr50	acr50	ADJ
dpc-1936	71	17	and	and	CCONJ
dpc-1936	71	18	pasi100	pasi100	PROPN
dpc-1936	71	19	responses	response	NOUN
dpc-1936	71	20	at	at	ADP
dpc-1936	71	21	w24	w24	PROPN
dpc-1936	71	22	.	.	PUNCT
dpc-1936	72	1	major	major	ADJ
dpc-1936	72	2	secondary	secondary	ADJ
dpc-1936	72	3	endpoints	endpoint	NOUN
dpc-1936	72	4	were	be	AUX
dpc-1936	72	5	the	the	DET
dpc-1936	72	6	proportion	proportion	NOUN
dpc-1936	72	7	of	of	ADP
dpc-1936	72	8	patients	patient	NOUN
dpc-1936	72	9	achieving	achieve	VERB
dpc-1936	72	10	acr50	acr50	ADJ
dpc-1936	72	11	and	and	CCONJ
dpc-1936	72	12	the	the	DET
dpc-1936	72	13	proportion	proportion	NOUN
dpc-1936	72	14	of	of	ADP
dpc-1936	72	15	patients	patient	NOUN
dpc-1936	72	16	achieving	achieve	VERB
dpc-1936	72	17	pasi100	pasi100	PROPN
dpc-1936	72	18	at	at	ADP
dpc-1936	72	19	w24	w24	PROPN
dpc-1936	72	20	.	.	PUNCT
dpc-1936	73	1	endpoints	endpoint	NOUN
dpc-1936	73	2	at	at	ADP
dpc-1936	73	3	w52	w52	PROPN
dpc-1936	73	4	included	include	VERB
dpc-1936	73	5	the	the	DET
dpc-1936	73	6	proportion	proportion	NOUN
dpc-1936	73	7	of	of	ADP
dpc-1936	73	8	patients	patient	NOUN
dpc-1936	73	9	simultaneously	simultaneously	ADV
dpc-1936	73	10	achieving	achieve	VERB
dpc-1936	73	11	acr50	acr50	ADJ
dpc-1936	73	12	and	and	CCONJ
dpc-1936	73	13	pasi100	pasi100	PROPN
dpc-1936	73	14	responses	response	NOUN
dpc-1936	73	15	,	,	PUNCT
dpc-1936	73	16	pasi100	pasi100	PROPN
dpc-1936	73	17	,	,	PUNCT
dpc-1936	73	18	pasi90	pasi90	NOUN
dpc-1936	73	19	or	or	CCONJ
dpc-1936	73	20	pasi75	pasi75	NOUN
dpc-1936	73	21	responses	response	NOUN
dpc-1936	73	22	,	,	PUNCT
dpc-1936	73	23	change	change	NOUN
dpc-1936	73	24	from	from	ADP
dpc-1936	73	25	baseline	baseline	NOUN
dpc-1936	73	26	in	in	ADP
dpc-1936	73	27	dermatology	dermatology	NOUN
dpc-1936	73	28	life	life	NOUN
dpc-1936	73	29	quality	quality	NOUN
dpc-1936	73	30	index	index	NOUN
dpc-1936	73	31	(	(	PUNCT
dpc-1936	73	32	dlqi	dlqi	ADJ
dpc-1936	73	33	)	)	PUNCT
dpc-1936	73	34	total	total	ADJ
dpc-1936	73	35	score	score	NOUN
dpc-1936	73	36	,	,	PUNCT
dpc-1936	73	37	proportion	proportion	NOUN
dpc-1936	73	38	of	of	ADP
dpc-1936	73	39	patients	patient	NOUN
dpc-1936	73	40	achieving	achieve	VERB
dpc-1936	73	41	dlqi	dlqi	PROPN
dpc-1936	73	42	(	(	PUNCT
dpc-1936	73	43	0,1	0,1	NUM
dpc-1936	73	44	)	)	PUNCT
dpc-1936	73	45	,	,	PUNCT
dpc-1936	73	46	change	change	NOUN
dpc-1936	73	47	from	from	ADP
dpc-1936	73	48	baseline	baseline	NOUN
dpc-1936	73	49	in	in	ADP
dpc-1936	73	50	the	the	DET
dpc-1936	73	51	itch	itch	NOUN
dpc-1936	73	52	numeric	numeric	ADJ
dpc-1936	73	53	rating	rating	NOUN
dpc-1936	73	54	scale	scale	NOUN
dpc-1936	73	55	(	(	PUNCT
dpc-1936	73	56	nrs	nrs	PROPN
dpc-1936	73	57	)	)	PUNCT
dpc-1936	73	58	score	score	NOUN
dpc-1936	73	59	,	,	PUNCT
dpc-1936	73	60	proportion	proportion	NOUN
dpc-1936	73	61	of	of	ADP
dpc-1936	73	62	patients	patient	NOUN
dpc-1936	73	63	achieving	achieve	VERB
dpc-1936	73	64	itch	itch	NOUN
dpc-1936	73	65	nrs	nrs	NOUN
dpc-1936	73	66	score	score	NOUN
dpc-1936	73	67	=	=	PUNCT
dpc-1936	73	68	0	0	NUM
dpc-1936	73	69	,	,	PUNCT
dpc-1936	73	70	and	and	CCONJ
dpc-1936	73	71	change	change	NOUN
dpc-1936	73	72	from	from	ADP
dpc-1936	73	73	baseline	baseline	NOUN
dpc-1936	73	74	in	in	ADP
dpc-1936	73	75	the	the	DET
dpc-1936	73	76	nail	nail	NOUN
dpc-1936	73	77	psoriasis	psoriasis	NOUN
dpc-1936	73	78	severity	severity	NOUN
dpc-1936	73	79	index	index	NOUN
dpc-1936	73	80	(	(	PUNCT
dpc-1936	73	81	napsi	napsi	NOUN
dpc-1936	73	82	)	)	PUNCT
dpc-1936	73	83	4	4	NUM
dpc-1936	73	84	original	original	ADJ
dpc-1936	73	85	article	article	NOUN
dpc-1936	73	86	|	|	ADV
dpc-1936	73	87	dermatol	dermatol	ADJ
dpc-1936	73	88	pract	pract	NOUN
dpc-1936	73	89	concept	concept	NOUN
dpc-1936	73	90	.	.	PUNCT
dpc-1936	74	1	2022;12(2):e2022104	2022;12(2):e2022104	PROPN
dpc-1936	74	2	ixeand	ixeand	PROPN
dpc-1936	74	3	ada	ada	PROPN
dpc-1936	74	4	-	-	PUNCT
dpc-1936	74	5	treated	treat	VERB
dpc-1936	74	6	patients	patient	NOUN
dpc-1936	74	7	,	,	PUNCT
dpc-1936	74	8	respectively	respectively	ADV
dpc-1936	74	9	,	,	PUNCT
dpc-1936	74	10	had	have	VERB
dpc-1936	74	11	concomitant	concomitant	ADJ
dpc-1936	74	12	methotrexate	methotrexate	NOUN
dpc-1936	74	13	(	(	PUNCT
dpc-1936	74	14	mtx	mtx	NOUN
dpc-1936	74	15	)	)	PUNCT
dpc-1936	74	16	use	use	NOUN
dpc-1936	74	17	at	at	ADP
dpc-1936	74	18	baseline	baseline	NOUN
dpc-1936	74	19	,	,	PUNCT
dpc-1936	74	20	which	which	PRON
dpc-1936	74	21	was	be	AUX
dpc-1936	74	22	permitted	permit	VERB
dpc-1936	74	23	throughout	throughout	ADP
dpc-1936	74	24	the	the	DET
dpc-1936	74	25	study	study	NOUN
dpc-1936	74	26	.	.	PUNCT
dpc-1936	75	1	represented	represent	VERB
dpc-1936	75	2	in	in	ADP
dpc-1936	75	3	figure	figure	NOUN
dpc-1936	75	4	1	1	NUM
dpc-1936	75	5	.	.	PUNCT
dpc-1936	75	6	baseline	baseline	PROPN
dpc-1936	75	7	demographics	demographic	NOUN
dpc-1936	75	8	and	and	CCONJ
dpc-1936	75	9	disease	disease	NOUN
dpc-1936	75	10	characteristics	characteristic	NOUN
dpc-1936	75	11	were	be	AUX
dpc-1936	75	12	mostly	mostly	ADV
dpc-1936	75	13	balanced	balance	VERB
dpc-1936	75	14	between	between	ADP
dpc-1936	75	15	the	the	DET
dpc-1936	75	16	ixe	ixe	PROPN
dpc-1936	75	17	and	and	CCONJ
dpc-1936	75	18	ada	ada	PROPN
dpc-1936	75	19	groups	group	NOUN
dpc-1936	75	20	(	(	PUNCT
dpc-1936	75	21	table	table	NOUN
dpc-1936	75	22	1	1	NUM
dpc-1936	75	23	)	)	PUNCT
dpc-1936	75	24	.	.	PUNCT
dpc-1936	76	1	totals	total	NOUN
dpc-1936	76	2	of	of	ADP
dpc-1936	76	3	51.0	51.0	NUM
dpc-1936	76	4	%	%	NOUN
dpc-1936	76	5	and	and	CCONJ
dpc-1936	76	6	54.9	54.9	NUM
dpc-1936	76	7	%	%	NOUN
dpc-1936	76	8	of	of	ADP
dpc-1936	76	9	figure	figure	NOUN
dpc-1936	76	10	1	1	NUM
dpc-1936	76	11	.	.	PUNCT
dpc-1936	76	12	schematic	schematic	ADJ
dpc-1936	76	13	representation	representation	NOUN
dpc-1936	76	14	of	of	ADP
dpc-1936	76	15	moderate	moderate	ADJ
dpc-1936	76	16	-	-	PUNCT
dpc-1936	76	17	to	to	ADP
dpc-1936	76	18	-	-	PUNCT
dpc-1936	76	19	severe	severe	ADJ
dpc-1936	76	20	psoriasis	psoriasis	NOUN
dpc-1936	76	21	and	and	CCONJ
dpc-1936	76	22	nail	nail	NOUN
dpc-1936	76	23	psoriasis	psoriasis	NOUN
dpc-1936	76	24	frequency	frequency	NOUN
dpc-1936	76	25	in	in	ADP
dpc-1936	76	26	the	the	DET
dpc-1936	76	27	spirit	spirit	PROPN
dpc-1936	76	28	-	-	PUNCT
dpc-1936	76	29	h2h	h2h	PROPN
dpc-1936	76	30	patient	patient	ADJ
dpc-1936	76	31	population	population	NOUN
dpc-1936	76	32	.	.	PUNCT
dpc-1936	77	1	venn	venn	PROPN
dpc-1936	77	2	diagrams	diagram	NOUN
dpc-1936	77	3	show	show	VERB
dpc-1936	77	4	the	the	DET
dpc-1936	77	5	proportion	proportion	NOUN
dpc-1936	77	6	of	of	ADP
dpc-1936	77	7	patients	patient	NOUN
dpc-1936	77	8	with	with	ADP
dpc-1936	77	9	moderate	moderate	ADJ
dpc-1936	77	10	-	-	PUNCT
dpc-1936	77	11	to	to	ADP
dpc-1936	77	12	-	-	PUNCT
dpc-1936	77	13	severe	severe	ADJ
dpc-1936	77	14	pso	pso	NOUN
dpc-1936	77	15	and	and	CCONJ
dpc-1936	77	16	nail	nail	NOUN
dpc-1936	77	17	pso	pso	NOUN
dpc-1936	77	18	(	(	PUNCT
dpc-1936	77	19	napsi	napsi	NOUN
dpc-1936	77	20	≥	≥	NUM
dpc-1936	77	21	1	1	NUM
dpc-1936	77	22	)	)	PUNCT
dpc-1936	77	23	in	in	ADP
dpc-1936	77	24	the	the	DET
dpc-1936	77	25	ixe	ixe	NOUN
dpc-1936	77	26	(	(	PUNCT
dpc-1936	77	27	n	n	NOUN
dpc-1936	77	28	=	=	SYM
dpc-1936	77	29	283	283	NUM
dpc-1936	77	30	)	)	PUNCT
dpc-1936	77	31	and	and	CCONJ
dpc-1936	77	32	ada	ada	PROPN
dpc-1936	77	33	(	(	PUNCT
dpc-1936	77	34	n	n	NOUN
dpc-1936	77	35	=	=	SYM
dpc-1936	77	36	283	283	NUM
dpc-1936	77	37	)	)	PUNCT
dpc-1936	77	38	groups	group	NOUN
dpc-1936	77	39	of	of	ADP
dpc-1936	77	40	the	the	DET
dpc-1936	77	41	entire	entire	ADJ
dpc-1936	77	42	spirit	spirit	NOUN
dpc-1936	77	43	-	-	PUNCT
dpc-1936	77	44	h2h	h2h	PROPN
dpc-1936	77	45	population	population	NOUN
dpc-1936	77	46	at	at	ADP
dpc-1936	77	47	baseline	baseline	PROPN
dpc-1936	77	48	.	.	PUNCT
dpc-1936	78	1	ada	ada	PROPN
dpc-1936	78	2	=	=	PUNCT
dpc-1936	78	3	adalimumab	adalimumab	PROPN
dpc-1936	78	4	;	;	PUNCT
dpc-1936	78	5	ixe	ixe	NOUN
dpc-1936	78	6	=	=	SYM
dpc-1936	78	7	ixekizumab	ixekizumab	NOUN
dpc-1936	78	8	;	;	PUNCT
dpc-1936	78	9	mod	mod	ADJ
dpc-1936	78	10	-	-	PUNCT
dpc-1936	78	11	sev	sev	NOUN
dpc-1936	78	12	=	=	SYM
dpc-1936	78	13	moderate	moderate	ADJ
dpc-1936	78	14	-	-	PUNCT
dpc-1936	78	15	to	to	ADP
dpc-1936	78	16	-	-	PUNCT
dpc-1936	78	17	severe	severe	ADJ
dpc-1936	78	18	;	;	PUNCT
dpc-1936	78	19	napsi	napsi	NOUN
dpc-1936	78	20	=	=	SYM
dpc-1936	78	21	nail	nail	NOUN
dpc-1936	78	22	psoriasis	psoriasis	NOUN
dpc-1936	78	23	severity	severity	NOUN
dpc-1936	78	24	index	index	NOUN
dpc-1936	78	25	;	;	PUNCT
dpc-1936	78	26	psa	psa	VERB
dpc-1936	78	27	=	=	SYM
dpc-1936	78	28	psoriatic	psoriatic	ADJ
dpc-1936	78	29	arthritis	arthritis	NOUN
dpc-1936	78	30	;	;	PUNCT
dpc-1936	78	31	pso	pso	NOUN
dpc-1936	78	32	=	=	SYM
dpc-1936	78	33	plaque	plaque	NOUN
dpc-1936	78	34	psoriasis	psoriasis	NOUN
dpc-1936	78	35	.	.	PUNCT
dpc-1936	79	1	table	table	NOUN
dpc-1936	79	2	1	1	NUM
dpc-1936	79	3	.	.	PUNCT
dpc-1936	79	4	baseline	baseline	PROPN
dpc-1936	79	5	demographics	demographic	NOUN
dpc-1936	79	6	and	and	CCONJ
dpc-1936	79	7	disease	disease	NOUN
dpc-1936	79	8	characteristics	characteristic	NOUN
dpc-1936	79	9	of	of	ADP
dpc-1936	79	10	patients	patient	NOUN
dpc-1936	79	11	with	with	ADP
dpc-1936	79	12	psa	psa	NOUN
dpc-1936	79	13	and	and	CCONJ
dpc-1936	79	14	moderate	moderate	ADJ
dpc-1936	79	15	-	-	PUNCT
dpc-1936	79	16	to	to	ADP
dpc-1936	79	17	-	-	PUNCT
dpc-1936	79	18	severe	severe	ADJ
dpc-1936	79	19	pso	pso	NOUN
dpc-1936	79	20	category	category	NOUN
dpc-1936	79	21	ixe	ixe	NOUN
dpc-1936	79	22	(	(	PUNCT
dpc-1936	79	23	n	n	NOUN
dpc-1936	79	24	=	=	SYM
dpc-1936	79	25	49	49	NUM
dpc-1936	79	26	)	)	PUNCT
dpc-1936	79	27	ada	ada	PROPN
dpc-1936	79	28	(	(	PUNCT
dpc-1936	79	29	n	n	NOUN
dpc-1936	79	30	=	=	SYM
dpc-1936	79	31	51	51	NUM
dpc-1936	79	32	)	)	PUNCT
dpc-1936	79	33	age	age	NOUN
dpc-1936	79	34	(	(	PUNCT
dpc-1936	79	35	years	year	NOUN
dpc-1936	79	36	)	)	PUNCT
dpc-1936	79	37	45.3	45.3	NUM
dpc-1936	79	38	±	±	NUM
dpc-1936	79	39	11.5	11.5	NUM
dpc-1936	79	40	46.3	46.3	NUM
dpc-1936	79	41	±	±	NUM
dpc-1936	79	42	11.3	11.3	NUM
dpc-1936	79	43	male	male	NOUN
dpc-1936	79	44	,	,	PUNCT
dpc-1936	79	45	n	n	CCONJ
dpc-1936	79	46	(	(	PUNCT
dpc-1936	79	47	%	%	INTJ
dpc-1936	79	48	)	)	PUNCT
dpc-1936	79	49	30	30	NUM
dpc-1936	79	50	(	(	PUNCT
dpc-1936	79	51	61.2	61.2	NUM
dpc-1936	79	52	)	)	PUNCT
dpc-1936	79	53	33	33	NUM
dpc-1936	79	54	(	(	PUNCT
dpc-1936	79	55	64.7	64.7	NUM
dpc-1936	79	56	)	)	PUNCT
dpc-1936	79	57	bmi	bmi	NOUN
dpc-1936	79	58	(	(	PUNCT
dpc-1936	79	59	kg	kg	NOUN
dpc-1936	79	60	/	/	SYM
dpc-1936	79	61	m2	m2	PROPN
dpc-1936	79	62	)	)	PUNCT
dpc-1936	79	63	29.5	29.5	NUM
dpc-1936	79	64	±	±	NUM
dpc-1936	79	65	7.3	7.3	NUM
dpc-1936	79	66	30.2	30.2	NUM
dpc-1936	79	67	±	±	NUM
dpc-1936	79	68	8.7	8.7	NUM
dpc-1936	79	69	duration	duration	NOUN
dpc-1936	79	70	of	of	ADP
dpc-1936	79	71	symptoms	symptom	NOUN
dpc-1936	79	72	since	since	SCONJ
dpc-1936	79	73	pso	pso	NOUN
dpc-1936	79	74	diagnosis	diagnosis	NOUN
dpc-1936	79	75	(	(	PUNCT
dpc-1936	79	76	years	year	NOUN
dpc-1936	79	77	)	)	PUNCT
dpc-1936	79	78	17.0	17.0	NUM
dpc-1936	79	79	±	±	NUM
dpc-1936	79	80	10.5	10.5	NUM
dpc-1936	79	81	15.0	15.0	NUM
dpc-1936	79	82	±	±	NUM
dpc-1936	79	83	11.3	11.3	NUM
dpc-1936	79	84	duration	duration	NOUN
dpc-1936	79	85	of	of	ADP
dpc-1936	79	86	symptoms	symptom	NOUN
dpc-1936	79	87	since	since	SCONJ
dpc-1936	79	88	psa	psa	VERB
dpc-1936	79	89	diagnosis	diagnosis	NOUN
dpc-1936	79	90	(	(	PUNCT
dpc-1936	79	91	years	year	NOUN
dpc-1936	79	92	)	)	PUNCT
dpc-1936	79	93	7.0	7.0	NUM
dpc-1936	79	94	±	±	NUM
dpc-1936	79	95	7.4	7.4	NUM
dpc-1936	79	96	5.7	5.7	NUM
dpc-1936	79	97	±	±	NUM
dpc-1936	79	98	6.2	6.2	NUM
dpc-1936	79	99	pasi	pasi	NOUN
dpc-1936	79	100	22.9	22.9	NUM
dpc-1936	79	101	±	±	NUM
dpc-1936	79	102	10.5	10.5	NUM
dpc-1936	79	103	20.5	20.5	NUM
dpc-1936	79	104	±	±	NUM
dpc-1936	79	105	7.3	7.3	NUM
dpc-1936	79	106	spga	spga	NOUN
dpc-1936	79	107	3.6	3.6	NUM
dpc-1936	79	108	±	±	NOUN
dpc-1936	79	109	0.7	0.7	NUM
dpc-1936	79	110	3.6	3.6	NUM
dpc-1936	79	111	±	±	NUM
dpc-1936	79	112	0.7	0.7	NUM
dpc-1936	79	113	percentage	percentage	NOUN
dpc-1936	79	114	bsa	bsa	PROPN
dpc-1936	79	115	41.2	41.2	NUM
dpc-1936	79	116	±	±	NUM
dpc-1936	79	117	24.1	24.1	NUM
dpc-1936	79	118	32.5	32.5	NUM
dpc-1936	79	119	±	±	NUM
dpc-1936	79	120	19.3	19.3	NUM
dpc-1936	79	121	fingernail	fingernail	NOUN
dpc-1936	79	122	napsi	napsi	NOUN
dpc-1936	79	123	≥	≥	NUM
dpc-1936	79	124	1	1	NUM
dpc-1936	79	125	,	,	PUNCT
dpc-1936	79	126	n	n	CCONJ
dpc-1936	79	127	(	(	PUNCT
dpc-1936	79	128	%	%	INTJ
dpc-1936	79	129	)	)	PUNCT
dpc-1936	79	130	37	37	NUM
dpc-1936	79	131	(	(	PUNCT
dpc-1936	79	132	75.5	75.5	NUM
dpc-1936	79	133	)	)	PUNCT
dpc-1936	79	134	41	41	NUM
dpc-1936	79	135	(	(	PUNCT
dpc-1936	79	136	80.4	80.4	NUM
dpc-1936	79	137	)	)	PUNCT
dpc-1936	79	138	fingernail	fingernail	NOUN
dpc-1936	79	139	napsi	napsi	NOUN
dpc-1936	79	140	26.1	26.1	NUM
dpc-1936	79	141	±	±	NUM
dpc-1936	79	142	21.6	21.6	NUM
dpc-1936	79	143	23.3	23.3	NUM
dpc-1936	79	144	±	±	NUM
dpc-1936	79	145	18.5	18.5	NUM
dpc-1936	79	146	fingernail	fingernail	NOUN
dpc-1936	79	147	napsi	napsi	NOUN
dpc-1936	79	148	>	>	X
dpc-1936	79	149	16	16	NUM
dpc-1936	79	150	,	,	PUNCT
dpc-1936	79	151	n	n	CCONJ
dpc-1936	79	152	(	(	PUNCT
dpc-1936	79	153	%	%	INTJ
dpc-1936	79	154	)	)	PUNCT
dpc-1936	79	155	21	21	NUM
dpc-1936	79	156	(	(	PUNCT
dpc-1936	79	157	42.9	42.9	NUM
dpc-1936	79	158	)	)	PUNCT
dpc-1936	79	159	24	24	NUM
dpc-1936	79	160	(	(	PUNCT
dpc-1936	79	161	47.1	47.1	NUM
dpc-1936	79	162	)	)	PUNCT
dpc-1936	79	163	fingernail	fingernail	NOUN
dpc-1936	79	164	napsi	napsi	NOUN
dpc-1936	79	165	>	>	X
dpc-1936	79	166	40	40	NUM
dpc-1936	79	167	,	,	PUNCT
dpc-1936	79	168	n	n	CCONJ
dpc-1936	79	169	(	(	PUNCT
dpc-1936	79	170	%	%	INTJ
dpc-1936	79	171	)	)	PUNCT
dpc-1936	79	172	10	10	NUM
dpc-1936	79	173	(	(	PUNCT
dpc-1936	79	174	20.4	20.4	NUM
dpc-1936	79	175	)	)	PUNCT
dpc-1936	79	176	7	7	NUM
dpc-1936	79	177	(	(	PUNCT
dpc-1936	79	178	13.7	13.7	NUM
dpc-1936	79	179	)	)	PUNCT
dpc-1936	79	180	itch	itch	NOUN
dpc-1936	79	181	nrs	nrs	NOUN
dpc-1936	79	182	6.5	6.5	NUM
dpc-1936	79	183	±	±	NUM
dpc-1936	79	184	2.5	2.5	NUM
dpc-1936	79	185	7.6	7.6	NUM
dpc-1936	79	186	±	±	NUM
dpc-1936	79	187	1.8	1.8	NUM
dpc-1936	79	188	dlqi	dlqi	VERB
dpc-1936	79	189	16.9	16.9	NUM
dpc-1936	79	190	±	±	NUM
dpc-1936	79	191	7.3	7.3	NUM
dpc-1936	79	192	16.7	16.7	NUM
dpc-1936	79	193	±	±	NUM
dpc-1936	79	194	6.4	6.4	NUM
dpc-1936	79	195	tender	tender	NOUN
dpc-1936	79	196	joint	joint	ADJ
dpc-1936	79	197	count	count	NOUN
dpc-1936	79	198	24.2	24.2	NUM
dpc-1936	79	199	±	±	NUM
dpc-1936	79	200	15.7	15.7	NUM
dpc-1936	79	201	23.9	23.9	NUM
dpc-1936	79	202	±	±	NUM
dpc-1936	79	203	15.5	15.5	NUM
dpc-1936	79	204	swollen	swollen	ADJ
dpc-1936	79	205	joint	joint	ADJ
dpc-1936	79	206	count	count	NOUN
dpc-1936	79	207	12.4	12.4	NUM
dpc-1936	79	208	±	±	NUM
dpc-1936	79	209	9.7	9.7	NUM
dpc-1936	79	210	13.0	13.0	NUM
dpc-1936	79	211	±	±	NUM
dpc-1936	79	212	11.0	11.0	NUM
dpc-1936	79	213	crp	crp	NOUN
dpc-1936	79	214	level	level	NOUN
dpc-1936	79	215	(	(	PUNCT
dpc-1936	79	216	mg	mg	PROPN
dpc-1936	79	217	/	/	SYM
dpc-1936	79	218	l	l	NOUN
dpc-1936	79	219	)	)	PUNCT
dpc-1936	79	220	14.5	14.5	NUM
dpc-1936	79	221	±	±	NUM
dpc-1936	79	222	21.7	21.7	NUM
dpc-1936	79	223	17.6	17.6	NUM
dpc-1936	79	224	±	±	NUM
dpc-1936	79	225	28.9	28.9	NUM
dpc-1936	79	226	concomitant	concomitant	ADJ
dpc-1936	79	227	mtx	mtx	NOUN
dpc-1936	79	228	use	use	NOUN
dpc-1936	79	229	,	,	PUNCT
dpc-1936	79	230	n	n	CCONJ
dpc-1936	79	231	(	(	PUNCT
dpc-1936	79	232	%	%	INTJ
dpc-1936	79	233	)	)	PUNCT
dpc-1936	79	234	25	25	NUM
dpc-1936	79	235	(	(	PUNCT
dpc-1936	79	236	51.0	51.0	NUM
dpc-1936	79	237	)	)	SYM
dpc-1936	79	238	28	28	NUM
dpc-1936	79	239	(	(	PUNCT
dpc-1936	79	240	54.9	54.9	NUM
dpc-1936	79	241	)	)	PUNCT
dpc-1936	79	242	unless	unless	SCONJ
dpc-1936	79	243	indicated	indicate	VERB
dpc-1936	79	244	otherwise	otherwise	ADV
dpc-1936	79	245	,	,	PUNCT
dpc-1936	79	246	data	datum	NOUN
dpc-1936	79	247	are	be	AUX
dpc-1936	79	248	presented	present	VERB
dpc-1936	79	249	as	as	ADP
dpc-1936	79	250	mean	mean	NOUN
dpc-1936	79	251	±	±	NUM
dpc-1936	79	252	sd	sd	NOUN
dpc-1936	79	253	.	.	PUNCT
dpc-1936	80	1	ada	ada	PROPN
dpc-1936	81	1	=	=	PUNCT
dpc-1936	81	2	adalimumab	adalimumab	PROPN
dpc-1936	81	3	;	;	PUNCT
dpc-1936	81	4	bmi	bmi	NOUN
dpc-1936	81	5	=	=	SYM
dpc-1936	81	6	body	body	PROPN
dpc-1936	81	7	mass	mass	PROPN
dpc-1936	81	8	index	index	NOUN
dpc-1936	81	9	;	;	PUNCT
dpc-1936	81	10	bsa	bsa	PROPN
dpc-1936	81	11	=	=	PROPN
dpc-1936	81	12	body	body	PROPN
dpc-1936	81	13	surface	surface	NOUN
dpc-1936	81	14	area	area	NOUN
dpc-1936	81	15	;	;	PUNCT
dpc-1936	81	16	crp	crp	X
dpc-1936	81	17	=	=	PUNCT
dpc-1936	81	18	c	c	PROPN
dpc-1936	81	19	reactive	reactive	ADJ
dpc-1936	81	20	protein	protein	NOUN
dpc-1936	81	21	;	;	PUNCT
dpc-1936	81	22	dlqi	dlqi	ADJ
dpc-1936	81	23	=	=	PUNCT
dpc-1936	81	24	dermatology	dermatology	NOUN
dpc-1936	81	25	life	life	NOUN
dpc-1936	81	26	quality	quality	NOUN
dpc-1936	81	27	index	index	NOUN
dpc-1936	81	28	;	;	PUNCT
dpc-1936	81	29	mtx	mtx	NOUN
dpc-1936	81	30	=	=	PUNCT
dpc-1936	81	31	methotrexate	methotrexate	NOUN
dpc-1936	81	32	;	;	PUNCT
dpc-1936	81	33	napsi	napsi	NOUN
dpc-1936	81	34	=	=	SYM
dpc-1936	81	35	nail	nail	NOUN
dpc-1936	81	36	psoriasis	psoriasis	NOUN
dpc-1936	81	37	severity	severity	NOUN
dpc-1936	81	38	index	index	NOUN
dpc-1936	81	39	;	;	PUNCT
dpc-1936	81	40	nrs	nrs	PROPN
dpc-1936	81	41	=	=	PUNCT
dpc-1936	81	42	numeric	numeric	ADJ
dpc-1936	81	43	rating	rating	NOUN
dpc-1936	81	44	scale	scale	NOUN
dpc-1936	81	45	;	;	PUNCT
dpc-1936	81	46	pasi	pasi	NOUN
dpc-1936	81	47	=	=	SYM
dpc-1936	81	48	psoriasis	psoriasis	NOUN
dpc-1936	81	49	area	area	NOUN
dpc-1936	81	50	and	and	CCONJ
dpc-1936	81	51	severity	severity	NOUN
dpc-1936	81	52	index	index	NOUN
dpc-1936	81	53	;	;	PUNCT
dpc-1936	81	54	psa	psa	VERB
dpc-1936	81	55	=	=	SYM
dpc-1936	81	56	psoriatic	psoriatic	ADJ
dpc-1936	81	57	arthritis	arthritis	NOUN
dpc-1936	81	58	;	;	PUNCT
dpc-1936	81	59	pso	pso	NOUN
dpc-1936	81	60	=	=	SYM
dpc-1936	81	61	plaque	plaque	NOUN
dpc-1936	81	62	psoriasis	psoriasis	NOUN
dpc-1936	81	63	;	;	PUNCT
dpc-1936	81	64	sd	sd	NOUN
dpc-1936	81	65	=	=	SYM
dpc-1936	81	66	standard	standard	ADJ
dpc-1936	81	67	deviation	deviation	NOUN
dpc-1936	81	68	;	;	PUNCT
dpc-1936	81	69	spga	spga	NOUN
dpc-1936	81	70	=	=	SYM
dpc-1936	81	71	static	static	ADJ
dpc-1936	81	72	physician	physician	NOUN
dpc-1936	81	73	global	global	ADJ
dpc-1936	81	74	assessment	assessment	NOUN
dpc-1936	81	75	.	.	PUNCT
dpc-1936	82	1	original	original	ADJ
dpc-1936	82	2	article	article	NOUN
dpc-1936	82	3	|	|	ADV
dpc-1936	82	4	dermatol	dermatol	ADJ
dpc-1936	82	5	pract	pract	NOUN
dpc-1936	82	6	concept	concept	NOUN
dpc-1936	82	7	.	.	PUNCT
dpc-1936	83	1	2022;12(2):e2022104	2022;12(2):e2022104	PROPN
dpc-1936	83	2	5	5	NUM
dpc-1936	83	3	ixeversus	ixeversus	PROPN
dpc-1936	83	4	ada	ada	PROPN
dpc-1936	83	5	-	-	PUNCT
dpc-1936	83	6	treated	treat	VERB
dpc-1936	83	7	patients	patient	NOUN
dpc-1936	83	8	had	have	VERB
dpc-1936	83	9	a	a	DET
dpc-1936	83	10	napsi	napsi	NOUN
dpc-1936	83	11	=	=	SYM
dpc-1936	83	12	0	0	NUM
dpc-1936	83	13	response	response	NOUN
dpc-1936	83	14	at	at	ADP
dpc-1936	83	15	all	all	DET
dpc-1936	83	16	time	time	NOUN
dpc-1936	83	17	points	point	NOUN
dpc-1936	83	18	through	through	ADP
dpc-1936	83	19	w52	w52	ADJ
dpc-1936	83	20	(	(	PUNCT
dpc-1936	83	21	figure	figure	NOUN
dpc-1936	83	22	4a	4a	NUM
dpc-1936	83	23	)	)	PUNCT
dpc-1936	83	24	.	.	PUNCT
dpc-1936	84	1	the	the	DET
dpc-1936	84	2	mean	mean	ADJ
dpc-1936	84	3	change	change	NOUN
dpc-1936	84	4	from	from	ADP
dpc-1936	84	5	baseline	baseline	NOUN
dpc-1936	84	6	in	in	ADP
dpc-1936	84	7	fingernail	fingernail	NOUN
dpc-1936	84	8	napsi	napsi	NOUN
dpc-1936	84	9	score	score	NOUN
dpc-1936	84	10	indicated	indicate	VERB
dpc-1936	84	11	a	a	DET
dpc-1936	84	12	more	more	ADV
dpc-1936	84	13	rapid	rapid	ADJ
dpc-1936	84	14	decrease	decrease	NOUN
dpc-1936	84	15	overall	overall	ADV
dpc-1936	84	16	and	and	CCONJ
dpc-1936	84	17	a	a	DET
dpc-1936	84	18	statistically	statistically	ADV
dpc-1936	84	19	larger	large	ADJ
dpc-1936	84	20	difference	difference	NOUN
dpc-1936	84	21	for	for	ADP
dpc-1936	84	22	ixeversus	ixeversus	PROPN
dpc-1936	84	23	ada	ada	PROPN
dpc-1936	84	24	-	-	PUNCT
dpc-1936	84	25	treated	treat	VERB
dpc-1936	84	26	patients	patient	NOUN
dpc-1936	84	27	at	at	ADP
dpc-1936	84	28	w40	w40	NUM
dpc-1936	84	29	,	,	PUNCT
dpc-1936	84	30	and	and	CCONJ
dpc-1936	84	31	numerically	numerically	ADV
dpc-1936	84	32	greater	great	ADJ
dpc-1936	84	33	for	for	ADP
dpc-1936	84	34	all	all	DET
dpc-1936	84	35	other	other	ADJ
dpc-1936	84	36	time	time	NOUN
dpc-1936	84	37	points	point	NOUN
dpc-1936	84	38	through	through	ADP
dpc-1936	84	39	w52	w52	ADJ
dpc-1936	84	40	(	(	PUNCT
dpc-1936	84	41	-21.9	-21.9	ADJ
dpc-1936	84	42	versus	versus	ADP
dpc-1936	84	43	-20.9	-20.9	NOUN
dpc-1936	84	44	,	,	PUNCT
dpc-1936	84	45	p	p	X
dpc-1936	84	46	 	 	SPACE
dpc-1936	84	47	=	=	NOUN
dpc-1936	84	48	0.583	0.583	NUM
dpc-1936	84	49	)	)	PUNCT
dpc-1936	84	50	(	(	PUNCT
dpc-1936	84	51	figure	figure	VERB
dpc-1936	84	52	4b	4b	PROPN
dpc-1936	84	53	)	)	PUNCT
dpc-1936	84	54	.	.	PUNCT
dpc-1936	85	1	patient	patient	NOUN
dpc-1936	85	2	-	-	PUNCT
dpc-1936	85	3	reported	report	VERB
dpc-1936	85	4	outcomes	outcome	NOUN
dpc-1936	85	5	the	the	DET
dpc-1936	85	6	baseline	baseline	PROPN
dpc-1936	85	7	dlqi	dlqi	VERB
dpc-1936	85	8	scores	score	NOUN
dpc-1936	85	9	for	for	ADP
dpc-1936	85	10	the	the	DET
dpc-1936	85	11	subgroup	subgroup	NOUN
dpc-1936	85	12	of	of	ADP
dpc-1936	85	13	patients	patient	NOUN
dpc-1936	85	14	with	with	ADP
dpc-1936	85	15	active	active	ADJ
dpc-1936	85	16	psa	psa	NOUN
dpc-1936	85	17	and	and	CCONJ
dpc-1936	85	18	moderate	moderate	ADJ
dpc-1936	85	19	-	-	PUNCT
dpc-1936	85	20	to	to	ADP
dpc-1936	85	21	-	-	PUNCT
dpc-1936	85	22	severe	severe	ADJ
dpc-1936	85	23	pso	pso	NOUN
dpc-1936	85	24	were	be	AUX
dpc-1936	85	25	16.9	16.9	NUM
dpc-1936	85	26	(	(	PUNCT
dpc-1936	85	27	standard	standard	ADJ
dpc-1936	85	28	deviation	deviation	NOUN
dpc-1936	86	1	[	[	X
dpc-1936	86	2	sd	sd	X
dpc-1936	86	3	]	]	PUNCT
dpc-1936	86	4	±	±	NUM
dpc-1936	86	5	7.3	7.3	NUM
dpc-1936	86	6	)	)	PUNCT
dpc-1936	86	7	and	and	CCONJ
dpc-1936	86	8	16.7	16.7	NUM
dpc-1936	86	9	(	(	PUNCT
dpc-1936	86	10	sd	sd	ADP
dpc-1936	86	11	±	±	NUM
dpc-1936	86	12	6.4	6.4	NUM
dpc-1936	86	13	)	)	PUNCT
dpc-1936	86	14	for	for	ADP
dpc-1936	86	15	ixeand	ixeand	ADJ
dpc-1936	86	16	adatreated	adatreate	VERB
dpc-1936	86	17	patients	patient	NOUN
dpc-1936	86	18	,	,	PUNCT
dpc-1936	86	19	respectively	respectively	ADV
dpc-1936	86	20	,	,	PUNCT
dpc-1936	86	21	which	which	PRON
dpc-1936	86	22	was	be	AUX
dpc-1936	86	23	reflective	reflective	ADJ
dpc-1936	86	24	of	of	ADP
dpc-1936	86	25	the	the	DET
dpc-1936	86	26	high	high	ADJ
dpc-1936	86	27	disease	disease	NOUN
dpc-1936	86	28	burden	burden	NOUN
dpc-1936	86	29	of	of	ADP
dpc-1936	86	30	this	this	DET
dpc-1936	86	31	subgroup	subgroup	NOUN
dpc-1936	86	32	(	(	PUNCT
dpc-1936	86	33	table	table	NOUN
dpc-1936	86	34	1	1	NUM
dpc-1936	86	35	)	)	PUNCT
dpc-1936	86	36	.	.	PUNCT
dpc-1936	87	1	in	in	ADP
dpc-1936	87	2	the	the	DET
dpc-1936	87	3	ixe	ixe	PROPN
dpc-1936	87	4	versus	versus	ADP
dpc-1936	87	5	ada	ada	PROPN
dpc-1936	87	6	group	group	PROPN
dpc-1936	87	7	,	,	PUNCT
dpc-1936	87	8	significantly	significantly	ADV
dpc-1936	87	9	more	more	ADJ
dpc-1936	87	10	patients	patient	NOUN
dpc-1936	87	11	reported	report	VERB
dpc-1936	87	12	no	no	PRON
dpc-1936	87	13	or	or	CCONJ
dpc-1936	87	14	only	only	ADV
dpc-1936	87	15	minimal	minimal	ADJ
dpc-1936	87	16	impact	impact	NOUN
dpc-1936	87	17	of	of	ADP
dpc-1936	87	18	skin	skin	NOUN
dpc-1936	87	19	disease	disease	NOUN
dpc-1936	87	20	on	on	ADP
dpc-1936	87	21	their	their	PRON
dpc-1936	87	22	qol	qol	NOUN
dpc-1936	87	23	(	(	PUNCT
dpc-1936	87	24	dlqi	dlqi	NOUN
dpc-1936	87	25	0,1	0,1	NUM
dpc-1936	87	26	)	)	PUNCT
dpc-1936	87	27	at	at	ADP
dpc-1936	87	28	w24	w24	PROPN
dpc-1936	87	29	(	(	PUNCT
dpc-1936	87	30	59.2	59.2	NUM
dpc-1936	87	31	%	%	NOUN
dpc-1936	87	32	versus	versus	ADP
dpc-1936	87	33	33.3	33.3	NUM
dpc-1936	87	34	%	%	NOUN
dpc-1936	87	35	,	,	PUNCT
dpc-1936	87	36	p	p	X
dpc-1936	87	37	=	=	NOUN
dpc-1936	87	38	0.016	0.016	NUM
dpc-1936	87	39	)	)	PUNCT
dpc-1936	87	40	and	and	CCONJ
dpc-1936	87	41	numerically	numerically	ADV
dpc-1936	87	42	more	more	ADV
dpc-1936	87	43	at	at	ADP
dpc-1936	87	44	w52	w52	NOUN
dpc-1936	87	45	(	(	PUNCT
dpc-1936	87	46	55.1	55.1	NUM
dpc-1936	87	47	%	%	NOUN
dpc-1936	87	48	versus	versus	ADP
dpc-1936	87	49	37.3	37.3	NUM
dpc-1936	87	50	%	%	NOUN
dpc-1936	87	51	,	,	PUNCT
dpc-1936	87	52	p	p	NOUN
dpc-1936	87	53	=	=	NOUN
dpc-1936	87	54	0.108	0.108	NUM
dpc-1936	87	55	)	)	PUNCT
dpc-1936	87	56	(	(	PUNCT
dpc-1936	87	57	figure	figure	NOUN
dpc-1936	87	58	5a	5a	NUM
dpc-1936	87	59	)	)	PUNCT
dpc-1936	87	60	.	.	PUNCT
dpc-1936	88	1	ixe	ixe	PROPN
dpc-1936	88	2	versus	versus	ADP
dpc-1936	88	3	ada	ada	PROPN
dpc-1936	88	4	-	-	PUNCT
dpc-1936	88	5	treated	treat	VERB
dpc-1936	88	6	patients	patient	NOUN
dpc-1936	88	7	had	have	VERB
dpc-1936	88	8	a	a	DET
dpc-1936	88	9	more	more	ADV
dpc-1936	88	10	rapid	rapid	ADJ
dpc-1936	88	11	mean	mean	NOUN
dpc-1936	88	12	reduction	reduction	NOUN
dpc-1936	88	13	in	in	ADP
dpc-1936	88	14	dlqi	dlqi	ADJ
dpc-1936	88	15	score	score	NOUN
dpc-1936	88	16	from	from	ADP
dpc-1936	88	17	baseline	baseline	NOUN
dpc-1936	88	18	.	.	PUNCT
dpc-1936	89	1	the	the	DET
dpc-1936	89	2	mean	mean	ADJ
dpc-1936	89	3	change	change	NOUN
dpc-1936	89	4	in	in	ADP
dpc-1936	89	5	dlqi	dlqi	PROPN
dpc-1936	89	6	was	be	AUX
dpc-1936	89	7	consistently	consistently	ADV
dpc-1936	89	8	greater	great	ADJ
dpc-1936	89	9	in	in	ADP
dpc-1936	89	10	the	the	DET
dpc-1936	89	11	ixeversus	ixeversus	PROPN
dpc-1936	89	12	ada	ada	PROPN
dpc-1936	89	13	-	-	PUNCT
dpc-1936	89	14	treated	treat	VERB
dpc-1936	89	15	patients	patient	NOUN
dpc-1936	89	16	and	and	CCONJ
dpc-1936	89	17	was	be	AUX
dpc-1936	89	18	statistically	statistically	ADV
dpc-1936	89	19	greater	great	ADJ
dpc-1936	89	20	at	at	ADP
dpc-1936	89	21	w4	w4	NOUN
dpc-1936	89	22	through	through	ADP
dpc-1936	89	23	w16	w16	NOUN
dpc-1936	89	24	(	(	PUNCT
dpc-1936	89	25	figure	figure	NOUN
dpc-1936	89	26	5b	5b	NUM
dpc-1936	89	27	)	)	PUNCT
dpc-1936	89	28	.	.	PUNCT
dpc-1936	90	1	the	the	DET
dpc-1936	90	2	mean	mean	ADJ
dpc-1936	90	3	change	change	NOUN
dpc-1936	90	4	in	in	ADP
dpc-1936	90	5	itch	itch	NOUN
dpc-1936	90	6	nrs	nrs	NOUN
dpc-1936	90	7	score	score	NOUN
dpc-1936	90	8	from	from	ADP
dpc-1936	90	9	baseline	baseline	ADJ
dpc-1936	90	10	and	and	CCONJ
dpc-1936	90	11	complete	complete	ADJ
dpc-1936	90	12	resolution	resolution	NOUN
dpc-1936	90	13	of	of	ADP
dpc-1936	90	14	itch	itch	NOUN
dpc-1936	90	15	(	(	PUNCT
dpc-1936	90	16	itch	itch	NOUN
dpc-1936	90	17	nrs	nrs	NOUN
dpc-1936	90	18	=	=	NOUN
dpc-1936	90	19	0	0	NUM
dpc-1936	90	20	)	)	PUNCT
dpc-1936	90	21	were	be	AUX
dpc-1936	90	22	numerically	numerically	ADV
dpc-1936	90	23	higher	high	ADJ
dpc-1936	90	24	(	(	PUNCT
dpc-1936	90	25	except	except	SCONJ
dpc-1936	90	26	for	for	ADP
dpc-1936	90	27	the	the	DET
dpc-1936	90	28	mean	mean	ADJ
dpc-1936	90	29	change	change	NOUN
dpc-1936	90	30	in	in	ADP
dpc-1936	90	31	itch	itch	NOUN
dpc-1936	90	32	nrs	nrs	NOUN
dpc-1936	90	33	score	score	NOUN
dpc-1936	90	34	from	from	ADP
dpc-1936	90	35	baseline	baseline	NOUN
dpc-1936	90	36	at	at	ADP
dpc-1936	90	37	w52	w52	NOUN
dpc-1936	90	38	,	,	PUNCT
dpc-1936	90	39	which	which	PRON
dpc-1936	90	40	was	be	AUX
dpc-1936	90	41	numerically	numerically	ADV
dpc-1936	90	42	equal	equal	ADJ
dpc-1936	90	43	)	)	PUNCT
dpc-1936	90	44	but	but	CCONJ
dpc-1936	90	45	not	not	PART
dpc-1936	90	46	significantly	significantly	ADV
dpc-1936	90	47	different	different	ADJ
dpc-1936	90	48	in	in	ADP
dpc-1936	90	49	the	the	DET
dpc-1936	90	50	ixe	ixe	PROPN
dpc-1936	90	51	versus	versus	ADP
dpc-1936	90	52	ada	ada	PROPN
dpc-1936	90	53	group	group	PROPN
dpc-1936	90	54	at	at	ADP
dpc-1936	90	55	all	all	DET
dpc-1936	90	56	timepoints	timepoint	NOUN
dpc-1936	90	57	through	through	ADP
dpc-1936	90	58	w52	w52	NOUN
dpc-1936	90	59	(	(	PUNCT
dpc-1936	90	60	figure	figure	VERB
dpc-1936	90	61	5c	5c	NOUN
dpc-1936	90	62	and	and	CCONJ
dpc-1936	90	63	d	d	NOUN
dpc-1936	90	64	)	)	PUNCT
dpc-1936	90	65	.	.	PUNCT
dpc-1936	91	1	safety	safety	NOUN
dpc-1936	91	2	the	the	DET
dpc-1936	91	3	frequency	frequency	NOUN
dpc-1936	91	4	of	of	ADP
dpc-1936	91	5	teaes	teaes	NOUN
dpc-1936	91	6	was	be	AUX
dpc-1936	91	7	similar	similar	ADJ
dpc-1936	91	8	in	in	ADP
dpc-1936	91	9	patients	patient	NOUN
dpc-1936	91	10	receiving	receive	VERB
dpc-1936	91	11	ixe	ixe	NOUN
dpc-1936	91	12	versus	versus	ADP
dpc-1936	91	13	ada	ada	PROPN
dpc-1936	91	14	(	(	PUNCT
dpc-1936	91	15	59.2	59.2	NUM
dpc-1936	91	16	%	%	NOUN
dpc-1936	91	17	versus	versus	ADP
dpc-1936	91	18	58.8	58.8	NUM
dpc-1936	91	19	%	%	NOUN
dpc-1936	91	20	)	)	PUNCT
dpc-1936	91	21	(	(	PUNCT
dpc-1936	91	22	table	table	NOUN
dpc-1936	91	23	3	3	NUM
dpc-1936	91	24	)	)	PUNCT
dpc-1936	91	25	;	;	PUNCT
dpc-1936	91	26	all	all	DET
dpc-1936	91	27	teaes	teaes	ADJ
dpc-1936	91	28	efficacy	efficacy	NOUN
dpc-1936	91	29	on	on	ADP
dpc-1936	91	30	skin	skin	NOUN
dpc-1936	91	31	,	,	PUNCT
dpc-1936	91	32	nails	nail	NOUN
dpc-1936	91	33	,	,	PUNCT
dpc-1936	91	34	and	and	CCONJ
dpc-1936	91	35	joints	joint	NOUN
dpc-1936	91	36	in	in	ADP
dpc-1936	91	37	the	the	DET
dpc-1936	91	38	subgroup	subgroup	NOUN
dpc-1936	91	39	of	of	ADP
dpc-1936	91	40	patients	patient	NOUN
dpc-1936	91	41	with	with	ADP
dpc-1936	91	42	active	active	ADJ
dpc-1936	91	43	psa	psa	NOUN
dpc-1936	91	44	and	and	CCONJ
dpc-1936	91	45	moderate	moderate	ADJ
dpc-1936	91	46	-	-	PUNCT
dpc-1936	91	47	to	to	ADP
dpc-1936	91	48	-	-	PUNCT
dpc-1936	91	49	severe	severe	ADJ
dpc-1936	91	50	pso	pso	NOUN
dpc-1936	91	51	at	at	ADP
dpc-1936	91	52	baseline	baseline	NOUN
dpc-1936	91	53	,	,	PUNCT
dpc-1936	91	54	a	a	DET
dpc-1936	91	55	significantly	significantly	ADV
dpc-1936	91	56	higher	high	ADJ
dpc-1936	91	57	proportion	proportion	NOUN
dpc-1936	91	58	of	of	ADP
dpc-1936	91	59	patients	patient	NOUN
dpc-1936	91	60	treated	treat	VERB
dpc-1936	91	61	with	with	ADP
dpc-1936	91	62	ixe	ixe	PROPN
dpc-1936	91	63	versus	versus	ADP
dpc-1936	91	64	ada	ada	PROPN
dpc-1936	91	65	simultaneously	simultaneously	ADV
dpc-1936	91	66	achieved	achieve	VERB
dpc-1936	91	67	the	the	DET
dpc-1936	91	68	primary	primary	ADJ
dpc-1936	91	69	endpoint	endpoint	NOUN
dpc-1936	91	70	,	,	PUNCT
dpc-1936	91	71	acr50	acr50	ADJ
dpc-1936	91	72	and	and	CCONJ
dpc-1936	91	73	pasi100	pasi100	PROPN
dpc-1936	91	74	,	,	PUNCT
dpc-1936	91	75	at	at	ADP
dpc-1936	91	76	w24	w24	PROPN
dpc-1936	91	77	(	(	PUNCT
dpc-1936	91	78	40.8	40.8	NUM
dpc-1936	91	79	%	%	NOUN
dpc-1936	91	80	versus	versus	ADP
dpc-1936	91	81	17.6	17.6	NUM
dpc-1936	91	82	%	%	NOUN
dpc-1936	91	83	,	,	PUNCT
dpc-1936	91	84	p	p	X
dpc-1936	91	85	=	=	NOUN
dpc-1936	91	86	0.015	0.015	NUM
dpc-1936	91	87	)	)	PUNCT
dpc-1936	91	88	and	and	CCONJ
dpc-1936	91	89	w52	w52	ADJ
dpc-1936	91	90	(	(	PUNCT
dpc-1936	91	91	38.8	38.8	NUM
dpc-1936	91	92	%	%	NOUN
dpc-1936	91	93	versus	versus	ADP
dpc-1936	91	94	17.6	17.6	NUM
dpc-1936	91	95	%	%	NOUN
dpc-1936	91	96	,	,	PUNCT
dpc-1936	91	97	p	p	X
dpc-1936	91	98	=	=	NOUN
dpc-1936	91	99	0.026	0.026	NUM
dpc-1936	91	100	)	)	PUNCT
dpc-1936	91	101	;	;	PUNCT
dpc-1936	91	102	statistically	statistically	ADV
dpc-1936	91	103	significant	significant	ADJ
dpc-1936	91	104	differences	difference	NOUN
dpc-1936	91	105	were	be	AUX
dpc-1936	91	106	observed	observe	VERB
dpc-1936	91	107	as	as	ADV
dpc-1936	91	108	early	early	ADV
dpc-1936	91	109	as	as	ADP
dpc-1936	91	110	w8	w8	NOUN
dpc-1936	91	111	(	(	PUNCT
dpc-1936	91	112	figure	figure	NOUN
dpc-1936	91	113	2	2	NUM
dpc-1936	91	114	)	)	PUNCT
dpc-1936	91	115	.	.	PUNCT
dpc-1936	92	1	complete	complete	ADJ
dpc-1936	92	2	skin	skin	NOUN
dpc-1936	92	3	clearance	clearance	NOUN
dpc-1936	92	4	(	(	PUNCT
dpc-1936	92	5	pasi100	pasi100	PROPN
dpc-1936	92	6	response	response	NOUN
dpc-1936	92	7	)	)	PUNCT
dpc-1936	92	8	was	be	AUX
dpc-1936	92	9	achieved	achieve	VERB
dpc-1936	92	10	by	by	ADP
dpc-1936	92	11	a	a	DET
dpc-1936	92	12	significantly	significantly	ADV
dpc-1936	92	13	higher	high	ADJ
dpc-1936	92	14	proportion	proportion	NOUN
dpc-1936	92	15	in	in	ADP
dpc-1936	92	16	the	the	DET
dpc-1936	92	17	ixe	ixe	PROPN
dpc-1936	92	18	versus	versus	ADP
dpc-1936	92	19	ada	ada	PROPN
dpc-1936	92	20	group	group	PROPN
dpc-1936	92	21	at	at	ADP
dpc-1936	92	22	w24	w24	PROPN
dpc-1936	92	23	(	(	PUNCT
dpc-1936	92	24	59.2	59.2	NUM
dpc-1936	92	25	%	%	NOUN
dpc-1936	92	26	versus	versus	ADP
dpc-1936	92	27	27.5	27.5	NUM
dpc-1936	92	28	%	%	NOUN
dpc-1936	92	29	,	,	PUNCT
dpc-1936	92	30	p	p	X
dpc-1936	92	31	=	=	NOUN
dpc-1936	92	32	0.002	0.002	NUM
dpc-1936	92	33	)	)	PUNCT
dpc-1936	92	34	and	and	CCONJ
dpc-1936	92	35	w52	w52	ADJ
dpc-1936	92	36	(	(	PUNCT
dpc-1936	92	37	59.2	59.2	NUM
dpc-1936	92	38	%	%	NOUN
dpc-1936	92	39	versus	versus	ADP
dpc-1936	92	40	25.5	25.5	NUM
dpc-1936	92	41	%	%	NOUN
dpc-1936	92	42	,	,	PUNCT
dpc-1936	92	43	p	p	NOUN
dpc-1936	92	44	=	=	NOUN
dpc-1936	92	45	0.001	0.001	NUM
dpc-1936	92	46	)	)	PUNCT
dpc-1936	92	47	;	;	PUNCT
dpc-1936	92	48	significant	significant	ADJ
dpc-1936	92	49	differences	difference	NOUN
dpc-1936	92	50	were	be	AUX
dpc-1936	92	51	observed	observe	VERB
dpc-1936	92	52	as	as	ADV
dpc-1936	92	53	early	early	ADV
dpc-1936	92	54	as	as	ADP
dpc-1936	92	55	w4	w4	NOUN
dpc-1936	92	56	(	(	PUNCT
dpc-1936	92	57	the	the	DET
dpc-1936	92	58	first	first	ADJ
dpc-1936	92	59	pasi	pasi	PROPN
dpc-1936	92	60	assessment	assessment	NOUN
dpc-1936	92	61	)	)	PUNCT
dpc-1936	92	62	and	and	CCONJ
dpc-1936	92	63	maintained	maintain	VERB
dpc-1936	92	64	throughout	throughout	ADP
dpc-1936	92	65	the	the	DET
dpc-1936	92	66	study	study	NOUN
dpc-1936	92	67	(	(	PUNCT
dpc-1936	92	68	figure	figure	NOUN
dpc-1936	92	69	  	  	SPACE
dpc-1936	92	70	3a	3a	NUM
dpc-1936	92	71	)	)	PUNCT
dpc-1936	92	72	.	.	PUNCT
dpc-1936	93	1	likewise	likewise	ADV
dpc-1936	93	2	,	,	PUNCT
dpc-1936	93	3	pasi90	pasi90	NOUN
dpc-1936	93	4	response	response	NOUN
dpc-1936	93	5	was	be	AUX
dpc-1936	93	6	significantly	significantly	ADV
dpc-1936	93	7	greater	great	ADJ
dpc-1936	93	8	in	in	ADP
dpc-1936	93	9	ixeversus	ixeversus	PROPN
dpc-1936	93	10	ada	ada	PROPN
dpc-1936	93	11	-	-	PUNCT
dpc-1936	93	12	treated	treat	VERB
dpc-1936	93	13	patients	patient	NOUN
dpc-1936	93	14	at	at	ADP
dpc-1936	93	15	all	all	DET
dpc-1936	93	16	time	time	NOUN
dpc-1936	93	17	points	point	NOUN
dpc-1936	93	18	starting	start	VERB
dpc-1936	93	19	at	at	ADP
dpc-1936	93	20	w4	w4	NOUN
dpc-1936	93	21	,	,	PUNCT
dpc-1936	93	22	except	except	SCONJ
dpc-1936	93	23	at	at	ADP
dpc-1936	93	24	w32	w32	NOUN
dpc-1936	93	25	(	(	PUNCT
dpc-1936	93	26	figure	figure	NOUN
dpc-1936	93	27	3b	3b	NUM
dpc-1936	93	28	)	)	PUNCT
dpc-1936	93	29	.	.	PUNCT
dpc-1936	94	1	ixeversus	ixeversus	PROPN
dpc-1936	94	2	adatreated	adatreate	VERB
dpc-1936	94	3	patients	patient	NOUN
dpc-1936	94	4	had	have	VERB
dpc-1936	94	5	more	more	ADV
dpc-1936	94	6	rapid	rapid	ADJ
dpc-1936	94	7	pasi75	pasi75	NOUN
dpc-1936	94	8	responses	response	NOUN
dpc-1936	94	9	with	with	ADP
dpc-1936	94	10	a	a	DET
dpc-1936	94	11	significantly	significantly	ADV
dpc-1936	94	12	higher	high	ADJ
dpc-1936	94	13	proportion	proportion	NOUN
dpc-1936	94	14	achieving	achieve	VERB
dpc-1936	94	15	pasi75	pasi75	NOUN
dpc-1936	94	16	from	from	ADP
dpc-1936	94	17	w4	w4	NOUN
dpc-1936	94	18	to	to	ADP
dpc-1936	94	19	w16	w16	NOUN
dpc-1936	94	20	,	,	PUNCT
dpc-1936	94	21	and	and	CCONJ
dpc-1936	94	22	numerically	numerically	ADV
dpc-1936	94	23	,	,	PUNCT
dpc-1936	94	24	but	but	CCONJ
dpc-1936	94	25	not	not	PART
dpc-1936	94	26	significantly	significantly	ADV
dpc-1936	94	27	(	(	PUNCT
dpc-1936	94	28	except	except	SCONJ
dpc-1936	94	29	for	for	ADP
dpc-1936	94	30	w40	w40	NOUN
dpc-1936	94	31	)	)	PUNCT
dpc-1936	94	32	,	,	PUNCT
dpc-1936	94	33	more	more	ADJ
dpc-1936	94	34	patients	patient	NOUN
dpc-1936	94	35	achieving	achieve	VERB
dpc-1936	94	36	pasi75	pasi75	NOUN
dpc-1936	94	37	through	through	ADP
dpc-1936	94	38	w52	w52	NOUN
dpc-1936	94	39	(	(	PUNCT
dpc-1936	94	40	figure	figure	NOUN
dpc-1936	94	41	3c	3c	NUM
dpc-1936	94	42	)	)	PUNCT
dpc-1936	94	43	.	.	PUNCT
dpc-1936	95	1	with	with	ADP
dpc-1936	95	2	regard	regard	NOUN
dpc-1936	95	3	to	to	ADP
dpc-1936	95	4	joint	joint	ADJ
dpc-1936	95	5	outcomes	outcome	NOUN
dpc-1936	95	6	,	,	PUNCT
dpc-1936	95	7	no	no	DET
dpc-1936	95	8	significant	significant	ADJ
dpc-1936	95	9	differences	difference	NOUN
dpc-1936	95	10	were	be	AUX
dpc-1936	95	11	observed	observe	VERB
dpc-1936	95	12	in	in	ADP
dpc-1936	95	13	acr50	acr50	VERB
dpc-1936	95	14	at	at	ADP
dpc-1936	95	15	w24	w24	PROPN
dpc-1936	95	16	and	and	CCONJ
dpc-1936	95	17	in	in	ADP
dpc-1936	95	18	acr20	acr20	NOUN
dpc-1936	95	19	,	,	PUNCT
dpc-1936	95	20	acr50	acr50	ADJ
dpc-1936	95	21	,	,	PUNCT
dpc-1936	95	22	or	or	CCONJ
dpc-1936	95	23	acr70	acr70	ADP
dpc-1936	95	24	responses	response	NOUN
dpc-1936	95	25	between	between	ADP
dpc-1936	95	26	ixeand	ixeand	PROPN
dpc-1936	95	27	ada	ada	PROPN
dpc-1936	95	28	-	-	PUNCT
dpc-1936	95	29	treated	treat	VERB
dpc-1936	95	30	patients	patient	NOUN
dpc-1936	95	31	through	through	ADP
dpc-1936	95	32	w52	w52	ADJ
dpc-1936	95	33	(	(	PUNCT
dpc-1936	95	34	table	table	NOUN
dpc-1936	95	35	2	2	NUM
dpc-1936	95	36	)	)	PUNCT
dpc-1936	95	37	.	.	PUNCT
dpc-1936	96	1	nail	nail	NOUN
dpc-1936	96	2	pso	pso	NOUN
dpc-1936	96	3	was	be	AUX
dpc-1936	96	4	prevalent	prevalent	ADJ
dpc-1936	96	5	in	in	ADP
dpc-1936	96	6	patients	patient	NOUN
dpc-1936	96	7	with	with	ADP
dpc-1936	96	8	active	active	ADJ
dpc-1936	96	9	psa	psa	NOUN
dpc-1936	96	10	and	and	CCONJ
dpc-1936	96	11	moderate	moderate	ADJ
dpc-1936	96	12	-	-	PUNCT
dpc-1936	96	13	to	to	ADP
dpc-1936	96	14	-	-	PUNCT
dpc-1936	96	15	severe	severe	ADJ
dpc-1936	96	16	pso	pso	NOUN
dpc-1936	96	17	,	,	PUNCT
dpc-1936	96	18	affecting	affect	VERB
dpc-1936	96	19	75.5	75.5	NUM
dpc-1936	96	20	%	%	NOUN
dpc-1936	96	21	(	(	PUNCT
dpc-1936	96	22	n	n	NOUN
dpc-1936	96	23	=	=	SYM
dpc-1936	96	24	37	37	NUM
dpc-1936	96	25	)	)	PUNCT
dpc-1936	96	26	and	and	CCONJ
dpc-1936	96	27	80.4	80.4	NUM
dpc-1936	96	28	%	%	NOUN
dpc-1936	96	29	(	(	PUNCT
dpc-1936	96	30	n	n	NOUN
dpc-1936	96	31	=	=	SYM
dpc-1936	96	32	41	41	NUM
dpc-1936	96	33	)	)	PUNCT
dpc-1936	96	34	of	of	ADP
dpc-1936	96	35	ixeand	ixeand	PROPN
dpc-1936	96	36	ada	ada	PROPN
dpc-1936	96	37	-	-	PUNCT
dpc-1936	96	38	treated	treat	VERB
dpc-1936	96	39	patients	patient	NOUN
dpc-1936	96	40	,	,	PUNCT
dpc-1936	96	41	respectively	respectively	ADV
dpc-1936	96	42	,	,	PUNCT
dpc-1936	96	43	at	at	ADP
dpc-1936	96	44	baseline	baseline	NOUN
dpc-1936	96	45	(	(	PUNCT
dpc-1936	96	46	fingernail	fingernail	NOUN
dpc-1936	96	47	napsi	napsi	NOUN
dpc-1936	96	48	≥	≥	NUM
dpc-1936	96	49	1	1	NUM
dpc-1936	96	50	)	)	PUNCT
dpc-1936	96	51	.	.	PUNCT
dpc-1936	97	1	baseline	baseline	PROPN
dpc-1936	97	2	demographics	demographic	NOUN
dpc-1936	97	3	and	and	CCONJ
dpc-1936	97	4	disease	disease	NOUN
dpc-1936	97	5	characteristics	characteristic	NOUN
dpc-1936	97	6	of	of	ADP
dpc-1936	97	7	patients	patient	NOUN
dpc-1936	97	8	with	with	ADP
dpc-1936	97	9	nail	nail	NOUN
dpc-1936	97	10	pso	pso	NOUN
dpc-1936	97	11	were	be	AUX
dpc-1936	97	12	balanced	balance	VERB
dpc-1936	97	13	between	between	ADP
dpc-1936	97	14	the	the	DET
dpc-1936	97	15	ixe	ixe	PROPN
dpc-1936	97	16	and	and	CCONJ
dpc-1936	97	17	ada	ada	PROPN
dpc-1936	97	18	groups	group	NOUN
dpc-1936	97	19	(	(	PUNCT
dpc-1936	97	20	data	datum	NOUN
dpc-1936	97	21	not	not	PART
dpc-1936	97	22	shown	show	VERB
dpc-1936	97	23	)	)	PUNCT
dpc-1936	97	24	.	.	PUNCT
dpc-1936	98	1	complete	complete	ADJ
dpc-1936	98	2	clearance	clearance	NOUN
dpc-1936	98	3	of	of	ADP
dpc-1936	98	4	fingernail	fingernail	NOUN
dpc-1936	98	5	pso	pso	NOUN
dpc-1936	98	6	occurred	occur	VERB
dpc-1936	98	7	in	in	ADP
dpc-1936	98	8	75.7	75.7	NUM
dpc-1936	98	9	%	%	NOUN
dpc-1936	98	10	of	of	ADP
dpc-1936	98	11	ixeversus	ixeversus	NOUN
dpc-1936	98	12	51.2	51.2	NUM
dpc-1936	98	13	%	%	NOUN
dpc-1936	98	14	of	of	ADP
dpc-1936	98	15	ada	ada	PROPN
dpc-1936	98	16	-	-	PUNCT
dpc-1936	98	17	treated	treat	VERB
dpc-1936	98	18	patients	patient	NOUN
dpc-1936	98	19	at	at	ADP
dpc-1936	98	20	w24	w24	PROPN
dpc-1936	98	21	(	(	PUNCT
dpc-1936	98	22	p	p	X
dpc-1936	98	23	=	=	NOUN
dpc-1936	98	24	0.035	0.035	NUM
dpc-1936	98	25	)	)	PUNCT
dpc-1936	98	26	,	,	PUNCT
dpc-1936	98	27	and	and	CCONJ
dpc-1936	98	28	a	a	DET
dpc-1936	98	29	numerically	numerically	ADV
dpc-1936	98	30	higher	high	ADJ
dpc-1936	98	31	proportion	proportion	NOUN
dpc-1936	98	32	of	of	ADP
dpc-1936	98	33	figure	figure	NOUN
dpc-1936	98	34	2	2	NUM
dpc-1936	98	35	.	.	NOUN
dpc-1936	98	36	percentage	percentage	NOUN
dpc-1936	98	37	of	of	ADP
dpc-1936	98	38	patients	patient	NOUN
dpc-1936	98	39	with	with	ADP
dpc-1936	98	40	psa	psa	NOUN
dpc-1936	98	41	and	and	CCONJ
dpc-1936	98	42	moderate	moderate	ADJ
dpc-1936	98	43	-	-	PUNCT
dpc-1936	98	44	to	to	ADP
dpc-1936	98	45	-	-	PUNCT
dpc-1936	98	46	severe	severe	ADJ
dpc-1936	98	47	pso	pso	NOUN
dpc-1936	98	48	simultaneously	simultaneously	ADV
dpc-1936	98	49	achieving	achieve	VERB
dpc-1936	98	50	acr50	acr50	ADJ
dpc-1936	98	51	and	and	CCONJ
dpc-1936	98	52	pasi100	pasi100	PROPN
dpc-1936	98	53	through	through	ADP
dpc-1936	98	54	week	week	NOUN
dpc-1936	98	55	52	52	NUM
dpc-1936	98	56	.	.	PUNCT
dpc-1936	99	1	ixe	ixe	PROPN
dpc-1936	99	2	versus	versus	ADP
dpc-1936	99	3	ada	ada	PROPN
dpc-1936	99	4	:	:	PUNCT
dpc-1936	100	1	*	*	PUNCT
dpc-1936	100	2	p	p	X
dpc-1936	100	3	≤	≤	NOUN
dpc-1936	100	4	0.05	0.05	NUM
dpc-1936	100	5	.	.	PUNCT
dpc-1936	101	1	acr	acr	PROPN
dpc-1936	101	2	=	=	PROPN
dpc-1936	101	3	american	american	PROPN
dpc-1936	101	4	college	college	PROPN
dpc-1936	101	5	of	of	ADP
dpc-1936	101	6	rheumatology	rheumatology	NOUN
dpc-1936	101	7	;	;	PUNCT
dpc-1936	101	8	ada	ada	PROPN
dpc-1936	101	9	=	=	PROPN
dpc-1936	101	10	adalimumab	adalimumab	PROPN
dpc-1936	101	11	;	;	PUNCT
dpc-1936	101	12	ixe	ixe	NOUN
dpc-1936	101	13	=	=	SYM
dpc-1936	101	14	ixekizumab	ixekizumab	NOUN
dpc-1936	101	15	;	;	PUNCT
dpc-1936	101	16	pasi	pasi	NOUN
dpc-1936	101	17	=	=	SYM
dpc-1936	101	18	psoriasis	psoriasis	NOUN
dpc-1936	101	19	area	area	NOUN
dpc-1936	101	20	and	and	CCONJ
dpc-1936	101	21	severity	severity	NOUN
dpc-1936	101	22	index	index	NOUN
dpc-1936	101	23	;	;	PUNCT
dpc-1936	101	24	psa	psa	VERB
dpc-1936	101	25	=	=	SYM
dpc-1936	101	26	psoriatic	psoriatic	ADJ
dpc-1936	101	27	arthritis	arthritis	NOUN
dpc-1936	101	28	;	;	PUNCT
dpc-1936	101	29	pso	pso	NOUN
dpc-1936	101	30	=	=	SYM
dpc-1936	101	31	plaque	plaque	NOUN
dpc-1936	101	32	psoriasis	psoriasis	NOUN
dpc-1936	101	33	.	.	PUNCT
dpc-1936	102	1	6	6	NUM
dpc-1936	102	2	original	original	ADJ
dpc-1936	102	3	article	article	NOUN
dpc-1936	102	4	|	|	ADV
dpc-1936	102	5	dermatol	dermatol	ADJ
dpc-1936	102	6	pract	pract	NOUN
dpc-1936	102	7	concept	concept	NOUN
dpc-1936	102	8	.	.	PUNCT
dpc-1936	103	1	2022;12(2):e2022104	2022;12(2):e2022104	NUM
dpc-1936	103	2	figure	figure	NOUN
dpc-1936	103	3	3	3	NUM
dpc-1936	103	4	.	.	PUNCT
dpc-1936	103	5	skin	skin	NOUN
dpc-1936	103	6	outcomes	outcome	NOUN
dpc-1936	103	7	through	through	ADP
dpc-1936	103	8	week	week	NOUN
dpc-1936	103	9	52	52	NUM
dpc-1936	103	10	.	.	PUNCT
dpc-1936	104	1	percentage	percentage	NOUN
dpc-1936	104	2	of	of	ADP
dpc-1936	104	3	patients	patient	NOUN
dpc-1936	104	4	with	with	ADP
dpc-1936	104	5	psa	psa	NOUN
dpc-1936	104	6	and	and	CCONJ
dpc-1936	104	7	moderate	moderate	ADJ
dpc-1936	104	8	-	-	PUNCT
dpc-1936	104	9	to	to	ADP
dpc-1936	104	10	-	-	PUNCT
dpc-1936	104	11	severe	severe	ADJ
dpc-1936	104	12	pso	pso	NOUN
dpc-1936	104	13	achieving	achieving	NOUN
dpc-1936	104	14	(	(	PUNCT
dpc-1936	104	15	a	a	X
dpc-1936	104	16	)	)	PUNCT
dpc-1936	104	17	pasi100	pasi100	PROPN
dpc-1936	104	18	,	,	PUNCT
dpc-1936	104	19	(	(	PUNCT
dpc-1936	104	20	b	b	X
dpc-1936	104	21	)	)	PUNCT
dpc-1936	104	22	pasi90	pasi90	NOUN
dpc-1936	104	23	,	,	PUNCT
dpc-1936	104	24	and	and	CCONJ
dpc-1936	104	25	(	(	PUNCT
dpc-1936	104	26	c	c	NOUN
dpc-1936	104	27	)	)	PUNCT
dpc-1936	104	28	pasi75	pasi75	NOUN
dpc-1936	104	29	.	.	PUNCT
dpc-1936	105	1	ixe	ixe	PROPN
dpc-1936	105	2	versus	versus	ADP
dpc-1936	105	3	ada	ada	PROPN
dpc-1936	105	4	:	:	PUNCT
dpc-1936	106	1	*	*	PUNCT
dpc-1936	106	2	p	p	X
dpc-1936	106	3	≤	≤	NOUN
dpc-1936	106	4	0.05	0.05	NUM
dpc-1936	106	5	,	,	PUNCT
dpc-1936	106	6	*	*	PUNCT
dpc-1936	106	7	*	*	PUNCT
dpc-1936	106	8	p	p	X
dpc-1936	106	9	≤	≤	NOUN
dpc-1936	106	10	0.01	0.01	NUM
dpc-1936	106	11	,	,	PUNCT
dpc-1936	106	12	*	*	PUNCT
dpc-1936	106	13	*	*	PUNCT
dpc-1936	106	14	*	*	PUNCT
dpc-1936	106	15	p	p	X
dpc-1936	106	16	≤	≤	NOUN
dpc-1936	106	17	0.001	0.001	NUM
dpc-1936	106	18	.	.	PUNCT
dpc-1936	107	1	ada	ada	PROPN
dpc-1936	107	2	=	=	PROPN
dpc-1936	107	3	adalimumab	adalimumab	PROPN
dpc-1936	107	4	;	;	PUNCT
dpc-1936	107	5	ixe	ixe	NOUN
dpc-1936	107	6	=	=	SYM
dpc-1936	107	7	ixekizumab	ixekizumab	NOUN
dpc-1936	107	8	;	;	PUNCT
dpc-1936	107	9	pasi	pasi	NOUN
dpc-1936	107	10	=	=	SYM
dpc-1936	107	11	psoriasis	psoriasis	NOUN
dpc-1936	107	12	area	area	NOUN
dpc-1936	107	13	and	and	CCONJ
dpc-1936	107	14	severity	severity	NOUN
dpc-1936	107	15	index	index	NOUN
dpc-1936	107	16	;	;	PUNCT
dpc-1936	107	17	psa	psa	VERB
dpc-1936	107	18	=	=	SYM
dpc-1936	107	19	psoriatic	psoriatic	ADJ
dpc-1936	107	20	arthritis	arthritis	NOUN
dpc-1936	107	21	;	;	PUNCT
dpc-1936	107	22	pso	pso	NOUN
dpc-1936	107	23	=	=	SYM
dpc-1936	107	24	plaque	plaque	NOUN
dpc-1936	107	25	psoriasis	psoriasis	NOUN
dpc-1936	107	26	.	.	PUNCT
dpc-1936	108	1	a	a	DET
dpc-1936	108	2	b	b	NOUN
dpc-1936	108	3	c	c	X
dpc-1936	108	4	original	original	ADJ
dpc-1936	108	5	article	article	NOUN
dpc-1936	108	6	|	|	ADV
dpc-1936	108	7	dermatol	dermatol	ADJ
dpc-1936	108	8	pract	pract	NOUN
dpc-1936	108	9	concept	concept	NOUN
dpc-1936	108	10	.	.	PUNCT
dpc-1936	109	1	2022;12(2):e2022104	2022;12(2):e2022104	PROPN
dpc-1936	109	2	7	7	NUM
dpc-1936	109	3	table	table	NOUN
dpc-1936	109	4	2	2	NUM
dpc-1936	109	5	.	.	PUNCT
dpc-1936	109	6	joint	joint	ADJ
dpc-1936	109	7	outcomes	outcome	NOUN
dpc-1936	109	8	at	at	ADP
dpc-1936	109	9	weeks	week	NOUN
dpc-1936	109	10	24	24	NUM
dpc-1936	109	11	and	and	CCONJ
dpc-1936	109	12	52	52	NUM
dpc-1936	109	13	week	week	NOUN
dpc-1936	109	14	24	24	NUM
dpc-1936	109	15	week	week	NOUN
dpc-1936	109	16	52	52	NUM
dpc-1936	109	17	ixe	ixe	NOUN
dpc-1936	109	18	(	(	PUNCT
dpc-1936	109	19	n	n	NOUN
dpc-1936	109	20	=	=	SYM
dpc-1936	109	21	49	49	NUM
dpc-1936	109	22	)	)	PUNCT
dpc-1936	109	23	ada	ada	PROPN
dpc-1936	109	24	(	(	PUNCT
dpc-1936	109	25	n	n	NOUN
dpc-1936	109	26	=	=	SYM
dpc-1936	109	27	51	51	NUM
dpc-1936	109	28	)	)	PUNCT
dpc-1936	109	29	treatment	treatment	NOUN
dpc-1936	109	30	difference	difference	NOUN
dpc-1936	109	31	ixe	ixe	NOUN
dpc-1936	109	32	versus	versus	ADP
dpc-1936	109	33	ada	ada	PROPN
dpc-1936	109	34	(	(	PUNCT
dpc-1936	109	35	95	95	NUM
dpc-1936	109	36	%	%	NOUN
dpc-1936	109	37	ci	ci	NOUN
dpc-1936	109	38	)	)	PUNCT
dpc-1936	109	39	pa	pa	PROPN
dpc-1936	109	40	ixe	ixe	PROPN
dpc-1936	109	41	(	(	PUNCT
dpc-1936	109	42	n	n	NOUN
dpc-1936	109	43	=	=	SYM
dpc-1936	109	44	49	49	NUM
dpc-1936	109	45	)	)	PUNCT
dpc-1936	109	46	ada	ada	PROPN
dpc-1936	109	47	(	(	PUNCT
dpc-1936	109	48	n	n	NOUN
dpc-1936	109	49	=	=	SYM
dpc-1936	109	50	51	51	NUM
dpc-1936	109	51	)	)	PUNCT
dpc-1936	109	52	treatment	treatment	NOUN
dpc-1936	109	53	difference	difference	NOUN
dpc-1936	109	54	ixe	ixe	NOUN
dpc-1936	109	55	versus	versus	ADP
dpc-1936	109	56	ada	ada	PROPN
dpc-1936	109	57	(	(	PUNCT
dpc-1936	109	58	95	95	NUM
dpc-1936	109	59	%	%	NOUN
dpc-1936	109	60	ci	ci	NOUN
dpc-1936	109	61	)	)	PUNCT
dpc-1936	109	62	pa	pa	PROPN
dpc-1936	109	63	acr70	acr70	ADV
dpc-1936	109	64	21	21	NUM
dpc-1936	109	65	(	(	PUNCT
dpc-1936	109	66	42.9	42.9	NUM
dpc-1936	109	67	)	)	PUNCT
dpc-1936	109	68	17	17	NUM
dpc-1936	109	69	(	(	PUNCT
dpc-1936	109	70	33.3	33.3	NUM
dpc-1936	109	71	)	)	PUNCT
dpc-1936	109	72	9.5	9.5	NUM
dpc-1936	109	73	(	(	PUNCT
dpc-1936	109	74	-9.4	-9.4	NOUN
dpc-1936	109	75	,	,	PUNCT
dpc-1936	109	76	28.5	28.5	NUM
dpc-1936	109	77	)	)	PUNCT
dpc-1936	109	78	0.411	0.411	NUM
dpc-1936	109	79	21	21	NUM
dpc-1936	109	80	(	(	PUNCT
dpc-1936	109	81	42.9	42.9	NUM
dpc-1936	109	82	)	)	PUNCT
dpc-1936	109	83	20	20	NUM
dpc-1936	109	84	(	(	PUNCT
dpc-1936	109	85	39.2	39.2	NUM
dpc-1936	109	86	)	)	PUNCT
dpc-1936	109	87	3.6	3.6	NUM
dpc-1936	109	88	(	(	PUNCT
dpc-1936	109	89	-15.6	-15.6	NUM
dpc-1936	109	90	,	,	PUNCT
dpc-1936	109	91	22.9	22.9	NUM
dpc-1936	109	92	)	)	PUNCT
dpc-1936	109	93	0.839	0.839	NUM
dpc-1936	109	94	acr50	acr50	ADJ
dpc-1936	109	95	29	29	NUM
dpc-1936	109	96	(	(	PUNCT
dpc-1936	109	97	59.2	59.2	NUM
dpc-1936	109	98	)	)	SYM
dpc-1936	109	99	28	28	NUM
dpc-1936	109	100	(	(	PUNCT
dpc-1936	109	101	54.9	54.9	NUM
dpc-1936	109	102	)	)	PUNCT
dpc-1936	109	103	4.3	4.3	NUM
dpc-1936	109	104	(	(	PUNCT
dpc-1936	109	105	-15.1	-15.1	PROPN
dpc-1936	109	106	,	,	PUNCT
dpc-1936	109	107	23.7	23.7	NUM
dpc-1936	109	108	)	)	PUNCT
dpc-1936	109	109	0.691	0.691	NUM
dpc-1936	109	110	27	27	NUM
dpc-1936	109	111	(	(	PUNCT
dpc-1936	109	112	55.1	55.1	NUM
dpc-1936	109	113	)	)	PUNCT
dpc-1936	109	114	32	32	NUM
dpc-1936	109	115	(	(	PUNCT
dpc-1936	109	116	62.7	62.7	NUM
dpc-1936	109	117	)	)	PUNCT
dpc-1936	109	118	-7.6	-7.6	NOUN
dpc-1936	109	119	(	(	PUNCT
dpc-1936	109	120	-26.9	-26.9	ADJ
dpc-1936	109	121	,	,	PUNCT
dpc-1936	109	122	11.6	11.6	NUM
dpc-1936	109	123	)	)	PUNCT
dpc-1936	109	124	0.542	0.542	NUM
dpc-1936	109	125	acr20	acr20	NOUN
dpc-1936	109	126	37	37	NUM
dpc-1936	109	127	(	(	PUNCT
dpc-1936	109	128	75.5	75.5	NUM
dpc-1936	109	129	)	)	PUNCT
dpc-1936	109	130	40	40	NUM
dpc-1936	109	131	(	(	PUNCT
dpc-1936	109	132	78.4	78.4	NUM
dpc-1936	109	133	)	)	PUNCT
dpc-1936	109	134	-2.9	-2.9	NOUN
dpc-1936	109	135	(	(	PUNCT
dpc-1936	109	136	-19.4	-19.4	PROPN
dpc-1936	109	137	,	,	PUNCT
dpc-1936	109	138	13.6	13.6	NUM
dpc-1936	109	139	)	)	PUNCT
dpc-1936	109	140	0.814	0.814	NUM
dpc-1936	109	141	36	36	NUM
dpc-1936	109	142	(	(	PUNCT
dpc-1936	109	143	73.5	73.5	NUM
dpc-1936	109	144	)	)	PUNCT
dpc-1936	109	145	41	41	NUM
dpc-1936	109	146	(	(	PUNCT
dpc-1936	109	147	80.4	80.4	NUM
dpc-1936	109	148	)	)	PUNCT
dpc-1936	109	149	-6.9	-6.9	PROPN
dpc-1936	109	150	(	(	PUNCT
dpc-1936	109	151	-23.4	-23.4	PROPN
dpc-1936	109	152	,	,	PUNCT
dpc-1936	109	153	9.6	9.6	NUM
dpc-1936	109	154	)	)	PUNCT
dpc-1936	109	155	0.480	0.480	NUM
dpc-1936	109	156	unless	unless	SCONJ
dpc-1936	109	157	otherwise	otherwise	ADV
dpc-1936	109	158	indicated	indicate	VERB
dpc-1936	109	159	,	,	PUNCT
dpc-1936	109	160	values	value	NOUN
dpc-1936	109	161	are	be	AUX
dpc-1936	109	162	presented	present	VERB
dpc-1936	109	163	as	as	ADP
dpc-1936	109	164	n	n	PROPN
dpc-1936	109	165	(	(	PUNCT
dpc-1936	109	166	%	%	NOUN
dpc-1936	109	167	)	)	PUNCT
dpc-1936	109	168	.	.	PUNCT
dpc-1936	110	1	ap	ap	PROPN
dpc-1936	110	2	value	value	NOUN
dpc-1936	110	3	:	:	PUNCT
dpc-1936	110	4	ixe	ixe	PROPN
dpc-1936	110	5	versus	versus	ADP
dpc-1936	110	6	ada	ada	PROPN
dpc-1936	110	7	acr	acr	PROPN
dpc-1936	110	8	=	=	PROPN
dpc-1936	110	9	american	american	PROPN
dpc-1936	110	10	college	college	PROPN
dpc-1936	110	11	of	of	ADP
dpc-1936	110	12	rheumatology	rheumatology	NOUN
dpc-1936	110	13	;	;	PUNCT
dpc-1936	110	14	ada	ada	PROPN
dpc-1936	110	15	=	=	PROPN
dpc-1936	110	16	adalimumab	adalimumab	PROPN
dpc-1936	110	17	;	;	PUNCT
dpc-1936	110	18	ci	ci	NOUN
dpc-1936	110	19	=	=	NOUN
dpc-1936	110	20	confidence	confidence	NOUN
dpc-1936	110	21	intervals	interval	NOUN
dpc-1936	110	22	;	;	PUNCT
dpc-1936	110	23	ixe	ixe	NOUN
dpc-1936	110	24	=	=	SYM
dpc-1936	110	25	ixekizumab	ixekizumab	NOUN
dpc-1936	110	26	.	.	PUNCT
dpc-1936	110	27	figure	figure	NOUN
dpc-1936	110	28	4	4	NUM
dpc-1936	110	29	.	.	PUNCT
dpc-1936	111	1	clinical	clinical	ADJ
dpc-1936	111	2	response	response	NOUN
dpc-1936	111	3	rate	rate	NOUN
dpc-1936	111	4	for	for	ADP
dpc-1936	111	5	fingernail	fingernail	NOUN
dpc-1936	111	6	pso	pso	NOUN
dpc-1936	111	7	endpoints	endpoint	NOUN
dpc-1936	111	8	through	through	ADP
dpc-1936	111	9	week	week	NOUN
dpc-1936	111	10	52	52	NUM
dpc-1936	111	11	.	.	PUNCT
dpc-1936	112	1	graphs	graph	NOUN
dpc-1936	112	2	depict	depict	NOUN
dpc-1936	112	3	results	result	NOUN
dpc-1936	112	4	for	for	ADP
dpc-1936	112	5	patients	patient	NOUN
dpc-1936	112	6	with	with	ADP
dpc-1936	112	7	moderate	moderate	ADJ
dpc-1936	112	8	-	-	PUNCT
dpc-1936	112	9	to	to	ADP
dpc-1936	112	10	-	-	PUNCT
dpc-1936	112	11	severe	severe	ADJ
dpc-1936	112	12	pso	pso	NOUN
dpc-1936	112	13	,	,	PUNCT
dpc-1936	112	14	psa	psa	VERB
dpc-1936	112	15	and	and	CCONJ
dpc-1936	112	16	a	a	DET
dpc-1936	112	17	fingernail	fingernail	NOUN
dpc-1936	112	18	napsi	napsi	NOUN
dpc-1936	112	19	≥	≥	NUM
dpc-1936	112	20	1	1	NUM
dpc-1936	112	21	score	score	NOUN
dpc-1936	112	22	at	at	ADP
dpc-1936	112	23	baseline	baseline	NOUN
dpc-1936	112	24	.	.	PUNCT
dpc-1936	113	1	(	(	PUNCT
dpc-1936	113	2	a	a	X
dpc-1936	113	3	)	)	PUNCT
dpc-1936	113	4	percentage	percentage	NOUN
dpc-1936	113	5	of	of	ADP
dpc-1936	113	6	patients	patient	NOUN
dpc-1936	113	7	achieving	achieve	VERB
dpc-1936	113	8	fingernail	fingernail	NOUN
dpc-1936	113	9	napsi	napsi	NOUN
dpc-1936	113	10	=	=	SYM
dpc-1936	113	11	0	0	NUM
dpc-1936	113	12	through	through	ADP
dpc-1936	113	13	week	week	NOUN
dpc-1936	113	14	52	52	NUM
dpc-1936	113	15	.	.	PUNCT
dpc-1936	114	1	(	(	PUNCT
dpc-1936	114	2	b	b	X
dpc-1936	114	3	)	)	PUNCT
dpc-1936	114	4	mean	mean	NOUN
dpc-1936	114	5	change	change	NOUN
dpc-1936	114	6	in	in	ADP
dpc-1936	114	7	fingernail	fingernail	NOUN
dpc-1936	114	8	napsi	napsi	NOUN
dpc-1936	114	9	score	score	NOUN
dpc-1936	114	10	from	from	ADP
dpc-1936	114	11	baseline	baseline	NOUN
dpc-1936	114	12	through	through	ADP
dpc-1936	114	13	week	week	NOUN
dpc-1936	114	14	52	52	NUM
dpc-1936	114	15	.	.	PUNCT
dpc-1936	115	1	ixe	ixe	PROPN
dpc-1936	115	2	versus	versus	ADP
dpc-1936	115	3	ada	ada	PROPN
dpc-1936	115	4	:	:	PUNCT
dpc-1936	116	1	*	*	PUNCT
dpc-1936	116	2	p	p	X
dpc-1936	116	3	≤	≤	NOUN
dpc-1936	116	4	0.05	0.05	NUM
dpc-1936	116	5	,	,	PUNCT
dpc-1936	116	6	*	*	PUNCT
dpc-1936	116	7	*	*	PUNCT
dpc-1936	116	8	p	p	X
dpc-1936	116	9	≤	≤	NOUN
dpc-1936	116	10	0.01	0.01	NUM
dpc-1936	116	11	.	.	PUNCT
dpc-1936	117	1	ada	ada	PROPN
dpc-1936	117	2	=	=	PROPN
dpc-1936	117	3	adalimumab	adalimumab	PROPN
dpc-1936	117	4	;	;	PUNCT
dpc-1936	117	5	ixe	ixe	NOUN
dpc-1936	117	6	=	=	SYM
dpc-1936	117	7	ixekizumab	ixekizumab	NOUN
dpc-1936	117	8	;	;	PUNCT
dpc-1936	117	9	napsi	napsi	NOUN
dpc-1936	117	10	=	=	SYM
dpc-1936	117	11	nail	nail	NOUN
dpc-1936	117	12	psoriasis	psoriasis	NOUN
dpc-1936	117	13	severity	severity	NOUN
dpc-1936	117	14	index	index	NOUN
dpc-1936	117	15	;	;	PUNCT
dpc-1936	117	16	psa	psa	VERB
dpc-1936	117	17	=	=	SYM
dpc-1936	117	18	psoriatic	psoriatic	ADJ
dpc-1936	117	19	arthritis	arthritis	NOUN
dpc-1936	117	20	;	;	PUNCT
dpc-1936	117	21	pso	pso	NOUN
dpc-1936	117	22	=	=	SYM
dpc-1936	117	23	plaque	plaque	NOUN
dpc-1936	117	24	psoriasis	psoriasis	NOUN
dpc-1936	117	25	.	.	PUNCT
dpc-1936	118	1	a	a	DET
dpc-1936	118	2	b	b	NUM
dpc-1936	118	3	8	8	NUM
dpc-1936	118	4	original	original	ADJ
dpc-1936	118	5	article	article	NOUN
dpc-1936	118	6	|	|	ADV
dpc-1936	118	7	dermatol	dermatol	ADJ
dpc-1936	118	8	pract	pract	NOUN
dpc-1936	118	9	concept	concept	NOUN
dpc-1936	118	10	.	.	PUNCT
dpc-1936	119	1	2022;12(2):e2022104	2022;12(2):e2022104	NUM
dpc-1936	119	2	figure	figure	NOUN
dpc-1936	119	3	5	5	NUM
dpc-1936	119	4	.	.	PUNCT
dpc-1936	119	5	clinical	clinical	ADJ
dpc-1936	119	6	response	response	NOUN
dpc-1936	119	7	rate	rate	NOUN
dpc-1936	119	8	for	for	ADP
dpc-1936	119	9	quality	quality	NOUN
dpc-1936	119	10	-	-	PUNCT
dpc-1936	119	11	of	of	ADP
dpc-1936	119	12	-	-	PUNCT
dpc-1936	119	13	life	life	NOUN
dpc-1936	119	14	endpoints	endpoint	NOUN
dpc-1936	119	15	through	through	ADP
dpc-1936	119	16	week	week	NOUN
dpc-1936	119	17	52	52	NUM
dpc-1936	119	18	.	.	PUNCT
dpc-1936	120	1	graphs	graph	NOUN
dpc-1936	120	2	depict	depict	NOUN
dpc-1936	120	3	results	result	NOUN
dpc-1936	120	4	for	for	ADP
dpc-1936	120	5	patients	patient	NOUN
dpc-1936	120	6	with	with	ADP
dpc-1936	120	7	psa	psa	NOUN
dpc-1936	120	8	and	and	CCONJ
dpc-1936	120	9	moderate	moderate	ADJ
dpc-1936	120	10	-	-	PUNCT
dpc-1936	120	11	to	to	ADP
dpc-1936	120	12	-	-	PUNCT
dpc-1936	120	13	severe	severe	ADJ
dpc-1936	120	14	pso	pso	NOUN
dpc-1936	120	15	at	at	ADP
dpc-1936	120	16	baseline	baseline	NOUN
dpc-1936	120	17	.	.	PUNCT
dpc-1936	121	1	(	(	PUNCT
dpc-1936	121	2	a	a	X
dpc-1936	121	3	)	)	PUNCT
dpc-1936	121	4	percentage	percentage	NOUN
dpc-1936	121	5	of	of	ADP
dpc-1936	121	6	patients	patient	NOUN
dpc-1936	121	7	achieving	achieve	VERB
dpc-1936	121	8	dlqi	dlqi	PROPN
dpc-1936	121	9	(	(	PUNCT
dpc-1936	121	10	0,1	0,1	NUM
dpc-1936	121	11	)	)	PUNCT
dpc-1936	121	12	through	through	ADP
dpc-1936	121	13	week	week	NOUN
dpc-1936	121	14	52	52	NUM
dpc-1936	121	15	.	.	PUNCT
dpc-1936	122	1	(	(	PUNCT
dpc-1936	122	2	b	b	X
dpc-1936	122	3	)	)	PUNCT
dpc-1936	122	4	mean	mean	NOUN
dpc-1936	122	5	change	change	NOUN
dpc-1936	122	6	from	from	ADP
dpc-1936	122	7	baseline	baseline	NOUN
dpc-1936	122	8	in	in	ADP
dpc-1936	122	9	dlqi	dlqi	ADJ
dpc-1936	122	10	score	score	NOUN
dpc-1936	122	11	through	through	ADP
dpc-1936	122	12	week	week	NOUN
dpc-1936	122	13	52	52	NUM
dpc-1936	122	14	.	.	PUNCT
dpc-1936	123	1	(	(	PUNCT
dpc-1936	123	2	c	c	X
dpc-1936	123	3	)	)	PUNCT
dpc-1936	123	4	percentage	percentage	NOUN
dpc-1936	123	5	of	of	ADP
dpc-1936	123	6	patients	patient	NOUN
dpc-1936	123	7	achieving	achieve	VERB
dpc-1936	123	8	itch	itch	NOUN
dpc-1936	123	9	nrs	nrs	NOUN
dpc-1936	123	10	=	=	NOUN
dpc-1936	123	11	0	0	NUM
dpc-1936	123	12	through	through	ADP
dpc-1936	123	13	week	week	NOUN
dpc-1936	123	14	52	52	NUM
dpc-1936	123	15	.	.	PUNCT
dpc-1936	124	1	(	(	PUNCT
dpc-1936	124	2	d	d	X
dpc-1936	124	3	)	)	PUNCT
dpc-1936	124	4	mean	mean	NOUN
dpc-1936	124	5	change	change	NOUN
dpc-1936	124	6	from	from	ADP
dpc-1936	124	7	baseline	baseline	NOUN
dpc-1936	124	8	in	in	ADP
dpc-1936	124	9	itch	itch	NOUN
dpc-1936	124	10	nrs	nrs	NOUN
dpc-1936	124	11	score	score	NOUN
dpc-1936	124	12	through	through	ADP
dpc-1936	124	13	week	week	NOUN
dpc-1936	124	14	52	52	NUM
dpc-1936	124	15	.	.	PUNCT
dpc-1936	125	1	ixe	ixe	PROPN
dpc-1936	125	2	versus	versus	ADP
dpc-1936	125	3	ada	ada	PROPN
dpc-1936	125	4	:	:	PUNCT
dpc-1936	126	1	*	*	PUNCT
dpc-1936	126	2	p	p	X
dpc-1936	126	3	≤	≤	NOUN
dpc-1936	126	4	0.05	0.05	NUM
dpc-1936	126	5	,	,	PUNCT
dpc-1936	126	6	*	*	PUNCT
dpc-1936	126	7	*	*	PUNCT
dpc-1936	126	8	p	p	X
dpc-1936	126	9	≤	≤	NOUN
dpc-1936	126	10	0.01	0.01	NUM
dpc-1936	126	11	.	.	PUNCT
dpc-1936	127	1	ada	ada	PROPN
dpc-1936	127	2	=	=	PROPN
dpc-1936	127	3	adalimumab	adalimumab	PROPN
dpc-1936	127	4	;	;	PUNCT
dpc-1936	127	5	dlqi	dlqi	ADJ
dpc-1936	127	6	=	=	PUNCT
dpc-1936	127	7	dermatology	dermatology	NOUN
dpc-1936	127	8	life	life	NOUN
dpc-1936	127	9	quality	quality	NOUN
dpc-1936	127	10	index	index	NOUN
dpc-1936	127	11	;	;	PUNCT
dpc-1936	127	12	ixe	ixe	NOUN
dpc-1936	127	13	=	=	SYM
dpc-1936	127	14	ixekizumab	ixekizumab	NOUN
dpc-1936	127	15	;	;	PUNCT
dpc-1936	127	16	nrs	nrs	PROPN
dpc-1936	127	17	=	=	PUNCT
dpc-1936	127	18	numeric	numeric	ADJ
dpc-1936	127	19	rating	rating	NOUN
dpc-1936	127	20	scale	scale	NOUN
dpc-1936	127	21	;	;	PUNCT
dpc-1936	127	22	psa	psa	VERB
dpc-1936	127	23	=	=	SYM
dpc-1936	127	24	psoriatic	psoriatic	ADJ
dpc-1936	127	25	arthritis	arthritis	NOUN
dpc-1936	127	26	;	;	PUNCT
dpc-1936	127	27	pso	pso	NOUN
dpc-1936	127	28	=	=	SYM
dpc-1936	127	29	plaque	plaque	NOUN
dpc-1936	127	30	psoriasis	psoriasis	NOUN
dpc-1936	127	31	.	.	PUNCT
dpc-1936	128	1	in	in	ADP
dpc-1936	128	2	the	the	DET
dpc-1936	128	3	ixe	ixe	PROPN
dpc-1936	128	4	group	group	NOUN
dpc-1936	128	5	and	and	CCONJ
dpc-1936	128	6	86.7	86.7	NUM
dpc-1936	128	7	%	%	NOUN
dpc-1936	128	8	in	in	ADP
dpc-1936	128	9	the	the	DET
dpc-1936	128	10	ada	ada	PROPN
dpc-1936	128	11	group	group	NOUN
dpc-1936	128	12	were	be	AUX
dpc-1936	128	13	mild	mild	ADJ
dpc-1936	128	14	or	or	CCONJ
dpc-1936	128	15	moderate	moderate	ADJ
dpc-1936	128	16	,	,	PUNCT
dpc-1936	128	17	while	while	SCONJ
dpc-1936	128	18	13.3	13.3	NUM
dpc-1936	128	19	%	%	NOUN
dpc-1936	128	20	in	in	ADP
dpc-1936	128	21	the	the	DET
dpc-1936	128	22	ada	ada	PROPN
dpc-1936	128	23	group	group	NOUN
dpc-1936	128	24	were	be	AUX
dpc-1936	128	25	severe	severe	ADJ
dpc-1936	128	26	.	.	PUNCT
dpc-1936	129	1	the	the	DET
dpc-1936	129	2	teaes	teaes	NOUN
dpc-1936	129	3	are	be	AUX
dpc-1936	129	4	consistent	consistent	ADJ
dpc-1936	129	5	with	with	ADP
dpc-1936	129	6	the	the	DET
dpc-1936	129	7	known	know	VERB
dpc-1936	129	8	safety	safety	NOUN
dpc-1936	129	9	profiles	profile	NOUN
dpc-1936	129	10	of	of	ADP
dpc-1936	129	11	both	both	DET
dpc-1936	129	12	drugs	drug	NOUN
dpc-1936	129	13	.	.	PUNCT
dpc-1936	130	1	the	the	DET
dpc-1936	130	2	frequency	frequency	NOUN
dpc-1936	130	3	of	of	ADP
dpc-1936	130	4	serious	serious	ADJ
dpc-1936	130	5	aes	aes	PROPN
dpc-1936	130	6	(	(	PUNCT
dpc-1936	130	7	saes	saes	PROPN
dpc-1936	130	8	)	)	PUNCT
dpc-1936	130	9	was	be	AUX
dpc-1936	130	10	lower	low	ADJ
dpc-1936	130	11	in	in	ADP
dpc-1936	130	12	ixeversus	ixeversus	PROPN
dpc-1936	130	13	ada	ada	PROPN
dpc-1936	130	14	-	-	PUNCT
dpc-1936	130	15	treated	treat	VERB
dpc-1936	130	16	patients	patient	NOUN
dpc-1936	130	17	(	(	PUNCT
dpc-1936	130	18	0.0	0.0	NUM
dpc-1936	130	19	%	%	NOUN
dpc-1936	130	20	versus	versus	ADP
dpc-1936	130	21	9.8	9.8	NUM
dpc-1936	130	22	%	%	NOUN
dpc-1936	130	23	)	)	PUNCT
dpc-1936	130	24	and	and	CCONJ
dpc-1936	130	25	a	a	DET
dpc-1936	130	26	lower	low	ADJ
dpc-1936	130	27	proportion	proportion	NOUN
dpc-1936	130	28	of	of	ADP
dpc-1936	130	29	patients	patient	NOUN
dpc-1936	130	30	in	in	ADP
dpc-1936	130	31	the	the	DET
dpc-1936	130	32	ixe	ixe	PROPN
dpc-1936	130	33	group	group	NOUN
dpc-1936	130	34	discontinued	discontinue	VERB
dpc-1936	130	35	due	due	ADP
dpc-1936	130	36	to	to	ADP
dpc-1936	130	37	an	an	DET
dpc-1936	130	38	ae	ae	PROPN
dpc-1936	130	39	compared	compare	VERB
dpc-1936	130	40	with	with	ADP
dpc-1936	130	41	ada	ada	PROPN
dpc-1936	130	42	group	group	PROPN
dpc-1936	130	43	(	(	PUNCT
dpc-1936	130	44	2.0	2.0	NUM
dpc-1936	130	45	%	%	NOUN
dpc-1936	130	46	versus	versus	ADP
dpc-1936	130	47	7.8	7.8	NUM
dpc-1936	130	48	%	%	NOUN
dpc-1936	130	49	)	)	PUNCT
dpc-1936	130	50	.	.	PUNCT
dpc-1936	131	1	no	no	DET
dpc-1936	131	2	deaths	death	NOUN
dpc-1936	131	3	occurred	occur	VERB
dpc-1936	131	4	during	during	ADP
dpc-1936	131	5	the	the	DET
dpc-1936	131	6	study	study	NOUN
dpc-1936	131	7	.	.	PUNCT
dpc-1936	132	1	conclusions	conclusion	NOUN
dpc-1936	132	2	this	this	DET
dpc-1936	132	3	subgroup	subgroup	ADJ
dpc-1936	132	4	analysis	analysis	NOUN
dpc-1936	132	5	focused	focus	VERB
dpc-1936	132	6	on	on	ADP
dpc-1936	132	7	the	the	DET
dpc-1936	132	8	biologic	biologic	NOUN
dpc-1936	132	9	-	-	PUNCT
dpc-1936	132	10	naïve	naïve	ADJ
dpc-1936	132	11	patients	patient	NOUN
dpc-1936	132	12	with	with	ADP
dpc-1936	132	13	active	active	ADJ
dpc-1936	132	14	psa	psa	NOUN
dpc-1936	132	15	and	and	CCONJ
dpc-1936	132	16	moderate	moderate	ADJ
dpc-1936	132	17	-	-	PUNCT
dpc-1936	132	18	to	to	ADP
dpc-1936	132	19	-	-	PUNCT
dpc-1936	132	20	severe	severe	ADJ
dpc-1936	132	21	pso	pso	NOUN
dpc-1936	132	22	at	at	ADP
dpc-1936	132	23	baseline	baseline	NOUN
dpc-1936	132	24	in	in	ADP
dpc-1936	132	25	the	the	DET
dpc-1936	132	26	spirit	spirit	PROPN
dpc-1936	132	27	-	-	PUNCT
dpc-1936	132	28	h2h	h2h	PROPN
dpc-1936	132	29	trial	trial	NOUN
dpc-1936	132	30	,	,	PUNCT
dpc-1936	132	31	which	which	PRON
dpc-1936	132	32	demonstrated	demonstrate	VERB
dpc-1936	132	33	higher	high	ADJ
dpc-1936	132	34	efficacy	efficacy	NOUN
dpc-1936	132	35	of	of	ADP
dpc-1936	132	36	ixe	ixe	PROPN
dpc-1936	132	37	versus	versus	ADP
dpc-1936	132	38	ada	ada	PROPN
dpc-1936	132	39	in	in	ADP
dpc-1936	132	40	patients	patient	NOUN
dpc-1936	132	41	with	with	ADP
dpc-1936	132	42	active	active	ADJ
dpc-1936	132	43	psa	psa	NOUN
dpc-1936	132	44	and	and	CCONJ
dpc-1936	132	45	pso	pso	NOUN
dpc-1936	132	46	,	,	PUNCT
dpc-1936	132	47	and	and	CCONJ
dpc-1936	132	48	determined	determine	VERB
dpc-1936	132	49	that	that	SCONJ
dpc-1936	132	50	ixe	ixe	NOUN
dpc-1936	132	51	is	be	AUX
dpc-1936	132	52	also	also	ADV
dpc-1936	132	53	more	more	ADV
dpc-1936	132	54	efficacious	efficacious	ADJ
dpc-1936	132	55	than	than	ADP
dpc-1936	132	56	ada	ada	PROPN
dpc-1936	132	57	for	for	ADP
dpc-1936	132	58	simultaneously	simultaneously	ADV
dpc-1936	132	59	achieving	achieve	VERB
dpc-1936	132	60	acr50	acr50	ADJ
dpc-1936	132	61	and	and	CCONJ
dpc-1936	132	62	pasi100	pasi100	PROPN
dpc-1936	132	63	at	at	ADP
dpc-1936	132	64	w24	w24	PROPN
dpc-1936	132	65	and	and	CCONJ
dpc-1936	132	66	w52	w52	NOUN
dpc-1936	132	67	in	in	ADP
dpc-1936	132	68	this	this	DET
dpc-1936	132	69	subgroup	subgroup	NOUN
dpc-1936	132	70	[	[	X
dpc-1936	132	71	18,19	18,19	NUM
dpc-1936	132	72	]	]	X
dpc-1936	132	73	.	.	PUNCT
dpc-1936	133	1	overall	overall	ADJ
dpc-1936	133	2	,	,	PUNCT
dpc-1936	133	3	ixe	ixe	ADV
dpc-1936	133	4	-	-	PUNCT
dpc-1936	133	5	treated	treat	VERB
dpc-1936	133	6	patients	patient	NOUN
dpc-1936	133	7	demonstrated	demonstrate	VERB
dpc-1936	133	8	higher	high	ADJ
dpc-1936	133	9	responses	response	NOUN
dpc-1936	133	10	for	for	ADP
dpc-1936	133	11	resolution	resolution	NOUN
dpc-1936	133	12	of	of	ADP
dpc-1936	133	13	skin	skin	NOUN
dpc-1936	133	14	and	and	CCONJ
dpc-1936	133	15	nail	nail	NOUN
dpc-1936	133	16	manifestations	manifestation	NOUN
dpc-1936	133	17	of	of	ADP
dpc-1936	133	18	pso	pso	PROPN
dpc-1936	133	19	versus	versus	ADP
dpc-1936	133	20	ada	ada	PROPN
dpc-1936	133	21	-	-	PUNCT
dpc-1936	133	22	treated	treat	VERB
dpc-1936	133	23	patients	patient	NOUN
dpc-1936	133	24	and	and	CCONJ
dpc-1936	133	25	comparable	comparable	ADJ
dpc-1936	133	26	response	response	NOUN
dpc-1936	133	27	rates	rate	NOUN
dpc-1936	133	28	regarding	regard	VERB
dpc-1936	133	29	improvement	improvement	NOUN
dpc-1936	133	30	in	in	ADP
dpc-1936	133	31	joint	joint	ADJ
dpc-1936	133	32	symptoms	symptom	NOUN
dpc-1936	133	33	.	.	PUNCT
dpc-1936	134	1	importantly	importantly	ADV
dpc-1936	134	2	,	,	PUNCT
dpc-1936	134	3	while	while	SCONJ
dpc-1936	134	4	anti	anti	ADJ
dpc-1936	134	5	-	-	ADJ
dpc-1936	134	6	tnf	tnf	ADJ
dpc-1936	134	7	biologics	biologic	NOUN
dpc-1936	134	8	have	have	AUX
dpc-1936	134	9	previously	previously	ADV
dpc-1936	134	10	been	be	AUX
dpc-1936	134	11	recommended	recommend	VERB
dpc-1936	134	12	as	as	ADP
dpc-1936	134	13	the	the	DET
dpc-1936	134	14	first	first	ADJ
dpc-1936	134	15	-	-	PUNCT
dpc-1936	134	16	line	line	NOUN
dpc-1936	134	17	biologic	biologic	NOUN
dpc-1936	134	18	to	to	PART
dpc-1936	134	19	treat	treat	VERB
dpc-1936	134	20	patients	patient	NOUN
dpc-1936	134	21	with	with	ADP
dpc-1936	134	22	psa	psa	NOUN
dpc-1936	134	23	and	and	CCONJ
dpc-1936	134	24	pso	pso	NOUN
dpc-1936	134	25	,	,	PUNCT
dpc-1936	134	26	these	these	DET
dpc-1936	134	27	results	result	NOUN
dpc-1936	134	28	indicate	indicate	VERB
dpc-1936	134	29	that	that	SCONJ
dpc-1936	134	30	ixe	ixe	NOUN
dpc-1936	134	31	is	be	AUX
dpc-1936	134	32	as	as	ADV
dpc-1936	134	33	good	good	ADJ
dpc-1936	134	34	as	as	ADP
dpc-1936	134	35	,	,	PUNCT
dpc-1936	134	36	if	if	SCONJ
dpc-1936	134	37	not	not	PART
dpc-1936	134	38	better	well	ADJ
dpc-1936	134	39	than	than	ADP
dpc-1936	134	40	,	,	PUNCT
dpc-1936	134	41	ada	ada	PROPN
dpc-1936	134	42	in	in	ADP
dpc-1936	134	43	treating	treat	VERB
dpc-1936	134	44	patients	patient	NOUN
dpc-1936	134	45	with	with	ADP
dpc-1936	134	46	active	active	ADJ
dpc-1936	134	47	psa	psa	NOUN
dpc-1936	134	48	and	and	CCONJ
dpc-1936	134	49	moderate	moderate	ADJ
dpc-1936	134	50	-	-	PUNCT
dpc-1936	134	51	to	to	ADP
dpc-1936	134	52	-	-	PUNCT
dpc-1936	134	53	severe	severe	ADJ
dpc-1936	134	54	pso	pso	NOUN
dpc-1936	135	1	[	[	X
dpc-1936	135	2	24	24	NUM
dpc-1936	135	3	]	]	PUNCT
dpc-1936	135	4	.	.	PUNCT
dpc-1936	135	5	moderate	moderate	ADJ
dpc-1936	135	6	-	-	PUNCT
dpc-1936	135	7	to	to	ADP
dpc-1936	135	8	-	-	PUNCT
dpc-1936	135	9	severe	severe	ADJ
dpc-1936	135	10	pso	pso	NOUN
dpc-1936	135	11	can	can	AUX
dpc-1936	135	12	have	have	VERB
dpc-1936	135	13	considerable	considerable	ADJ
dpc-1936	135	14	negative	negative	ADJ
dpc-1936	135	15	effects	effect	NOUN
dpc-1936	135	16	on	on	ADP
dpc-1936	135	17	patients	patient	NOUN
dpc-1936	135	18	qol	qol	PROPN
dpc-1936	135	19	,	,	PUNCT
dpc-1936	135	20	and	and	CCONJ
dpc-1936	135	21	the	the	DET
dpc-1936	135	22	burden	burden	NOUN
dpc-1936	135	23	of	of	ADP
dpc-1936	135	24	disease	disease	NOUN
dpc-1936	135	25	can	can	AUX
dpc-1936	135	26	be	be	AUX
dpc-1936	135	27	further	far	ADV
dpc-1936	135	28	compounded	compound	VERB
dpc-1936	135	29	by	by	ADP
dpc-1936	135	30	the	the	DET
dpc-1936	135	31	presence	presence	NOUN
dpc-1936	135	32	of	of	ADP
dpc-1936	135	33	nail	nail	NOUN
dpc-1936	135	34	pso	pso	NOUN
dpc-1936	135	35	and	and	CCONJ
dpc-1936	135	36	comorbid	comorbid	NOUN
dpc-1936	135	37	psa	psa	NOUN
dpc-1936	135	38	.	.	PUNCT
dpc-1936	136	1	the	the	DET
dpc-1936	136	2	ixe	ixe	PROPN
dpc-1936	136	3	group	group	NOUN
dpc-1936	136	4	had	have	VERB
dpc-1936	136	5	significantly	significantly	ADV
dpc-1936	136	6	more	more	ADJ
dpc-1936	136	7	patients	patient	NOUN
dpc-1936	136	8	achieving	achieve	VERB
dpc-1936	136	9	dlqi	dlqi	PROPN
dpc-1936	136	10	(	(	PUNCT
dpc-1936	136	11	0,1	0,1	NUM
dpc-1936	136	12	)	)	PUNCT
dpc-1936	136	13	at	at	ADP
dpc-1936	136	14	w24	w24	PROPN
dpc-1936	136	15	and	and	CCONJ
dpc-1936	136	16	numerically	numerically	ADV
dpc-1936	136	17	more	more	ADJ
dpc-1936	136	18	through	through	ADP
dpc-1936	136	19	w52	w52	NOUN
dpc-1936	136	20	compared	compare	VERB
dpc-1936	136	21	with	with	ADP
dpc-1936	136	22	the	the	DET
dpc-1936	136	23	ada	ada	PROPN
dpc-1936	136	24	group	group	NOUN
dpc-1936	136	25	,	,	PUNCT
dpc-1936	136	26	indicating	indicate	VERB
dpc-1936	136	27	that	that	SCONJ
dpc-1936	136	28	rapid	rapid	ADJ
dpc-1936	136	29	and	and	CCONJ
dpc-1936	136	30	sustained	sustained	ADJ
dpc-1936	136	31	skin	skin	NOUN
dpc-1936	136	32	clearance	clearance	NOUN
dpc-1936	136	33	had	have	VERB
dpc-1936	136	34	important	important	ADJ
dpc-1936	136	35	and	and	CCONJ
dpc-1936	136	36	clinically	clinically	ADV
dpc-1936	136	37	meaningful	meaningful	ADJ
dpc-1936	136	38	effects	effect	NOUN
dpc-1936	136	39	on	on	ADP
dpc-1936	136	40	qol	qol	NOUN
dpc-1936	136	41	for	for	ADP
dpc-1936	136	42	patients	patient	NOUN
dpc-1936	136	43	with	with	ADP
dpc-1936	136	44	active	active	ADJ
dpc-1936	136	45	psa	psa	NOUN
dpc-1936	136	46	and	and	CCONJ
dpc-1936	136	47	moderate	moderate	ADJ
dpc-1936	136	48	-	-	PUNCT
dpc-1936	136	49	to	to	ADP
dpc-1936	136	50	-	-	PUNCT
dpc-1936	136	51	severe	severe	ADJ
dpc-1936	136	52	pso	pso	NOUN
dpc-1936	136	53	.	.	PUNCT
dpc-1936	137	1	a	a	DET
dpc-1936	137	2	c	c	NOUN
dpc-1936	137	3	b	b	PROPN
dpc-1936	137	4	d	d	X
dpc-1936	137	5	original	original	ADJ
dpc-1936	137	6	article	article	NOUN
dpc-1936	137	7	|	|	ADV
dpc-1936	137	8	dermatol	dermatol	ADJ
dpc-1936	137	9	pract	pract	NOUN
dpc-1936	137	10	concept	concept	NOUN
dpc-1936	137	11	.	.	PUNCT
dpc-1936	138	1	2022;12(2):e2022104	2022;12(2):e2022104	PROPN
dpc-1936	138	2	9	9	NUM
dpc-1936	138	3	table	table	NOUN
dpc-1936	138	4	3	3	NUM
dpc-1936	138	5	.	.	PUNCT
dpc-1936	138	6	safety	safety	NOUN
dpc-1936	138	7	outcomes	outcome	NOUN
dpc-1936	138	8	category	category	PROPN
dpc-1936	138	9	ixe	ixe	NOUN
dpc-1936	138	10	(	(	PUNCT
dpc-1936	138	11	n	n	NOUN
dpc-1936	138	12	=	=	SYM
dpc-1936	138	13	49	49	NUM
dpc-1936	138	14	)	)	PUNCT
dpc-1936	138	15	ada	ada	PROPN
dpc-1936	138	16	(	(	PUNCT
dpc-1936	138	17	n	n	NOUN
dpc-1936	138	18	=	=	SYM
dpc-1936	138	19	51	51	NUM
dpc-1936	138	20	)	)	PUNCT
dpc-1936	138	21	teae	teae	ADP
dpc-1936	138	22	29	29	NUM
dpc-1936	138	23	(	(	PUNCT
dpc-1936	138	24	59.2	59.2	NUM
dpc-1936	138	25	)	)	PUNCT
dpc-1936	138	26	30	30	NUM
dpc-1936	138	27	(	(	PUNCT
dpc-1936	138	28	58.8	58.8	NUM
dpc-1936	138	29	)	)	PUNCT
dpc-1936	138	30	teae	teae	ADV
dpc-1936	138	31	by	by	ADP
dpc-1936	138	32	severity	severity	NOUN
dpc-1936	138	33	mild	mild	ADJ
dpc-1936	138	34	17	17	NUM
dpc-1936	138	35	(	(	PUNCT
dpc-1936	138	36	34.7	34.7	NUM
dpc-1936	138	37	)	)	SYM
dpc-1936	138	38	15	15	NUM
dpc-1936	138	39	(	(	PUNCT
dpc-1936	138	40	29.4	29.4	NUM
dpc-1936	138	41	)	)	PUNCT
dpc-1936	138	42	moderate	moderate	ADJ
dpc-1936	138	43	12	12	NUM
dpc-1936	138	44	(	(	PUNCT
dpc-1936	138	45	24.5	24.5	NUM
dpc-1936	138	46	)	)	PUNCT
dpc-1936	138	47	11	11	NUM
dpc-1936	138	48	(	(	PUNCT
dpc-1936	138	49	21.6	21.6	NUM
dpc-1936	138	50	)	)	PUNCT
dpc-1936	138	51	severe	severe	ADJ
dpc-1936	138	52	0	0	NUM
dpc-1936	138	53	4	4	NUM
dpc-1936	138	54	(	(	PUNCT
dpc-1936	138	55	7.8	7.8	NUM
dpc-1936	138	56	)	)	PUNCT
dpc-1936	138	57	death	death	NOUN
dpc-1936	138	58	0	0	SYM
dpc-1936	138	59	0	0	NUM
dpc-1936	138	60	saea	saea	NOUN
dpc-1936	138	61	0	0	NUM
dpc-1936	138	62	5	5	NUM
dpc-1936	138	63	(	(	PUNCT
dpc-1936	138	64	9.8	9.8	NUM
dpc-1936	138	65	)	)	PUNCT
dpc-1936	138	66	treatment	treatment	NOUN
dpc-1936	138	67	discontinuation	discontinuation	NOUN
dpc-1936	138	68	due	due	ADP
dpc-1936	138	69	to	to	ADP
dpc-1936	138	70	ae	ae	PROPN
dpc-1936	138	71	1	1	NUM
dpc-1936	138	72	(	(	PUNCT
dpc-1936	138	73	2.0	2.0	NUM
dpc-1936	138	74	)	)	PUNCT
dpc-1936	138	75	4	4	NUM
dpc-1936	138	76	(	(	PUNCT
dpc-1936	138	77	7.8	7.8	NUM
dpc-1936	138	78	)	)	PUNCT
dpc-1936	138	79	ae	ae	PROPN
dpc-1936	138	80	of	of	ADP
dpc-1936	138	81	special	special	ADJ
dpc-1936	138	82	interest	interest	NOUN
dpc-1936	138	83	infections	infection	NOUN
dpc-1936	138	84	13	13	NUM
dpc-1936	138	85	(	(	PUNCT
dpc-1936	138	86	26.5	26.5	NUM
dpc-1936	138	87	)	)	PUNCT
dpc-1936	138	88	18	18	NUM
dpc-1936	138	89	(	(	PUNCT
dpc-1936	138	90	35.3	35.3	NUM
dpc-1936	138	91	)	)	PUNCT
dpc-1936	138	92	serious	serious	ADJ
dpc-1936	138	93	infectionsb	infectionsb	NOUN
dpc-1936	138	94	0	0	NUM
dpc-1936	138	95	1	1	NUM
dpc-1936	138	96	(	(	PUNCT
dpc-1936	138	97	2.0	2.0	NUM
dpc-1936	138	98	)	)	PUNCT
dpc-1936	138	99	injection	injection	NOUN
dpc-1936	138	100	site	site	NOUN
dpc-1936	138	101	reactionsc	reactionsc	PROPN
dpc-1936	138	102	2	2	NUM
dpc-1936	138	103	(	(	PUNCT
dpc-1936	138	104	4.1	4.1	NUM
dpc-1936	138	105	)	)	PUNCT
dpc-1936	138	106	0	0	NUM
dpc-1936	138	107	allergic	allergic	ADJ
dpc-1936	138	108	/	/	SYM
dpc-1936	138	109	hypersensitivity	hypersensitivity	NOUN
dpc-1936	138	110	reactionsd	reactionsd	NOUN
dpc-1936	138	111	2	2	NUM
dpc-1936	138	112	(	(	PUNCT
dpc-1936	138	113	4.1	4.1	NUM
dpc-1936	138	114	)	)	SYM
dpc-1936	138	115	2	2	NUM
dpc-1936	138	116	(	(	PUNCT
dpc-1936	138	117	3.9	3.9	NUM
dpc-1936	138	118	)	)	PUNCT
dpc-1936	138	119	cerebrocardiovascular	cerebrocardiovascular	NOUN
dpc-1936	138	120	eventse	eventse	VERB
dpc-1936	138	121	0	0	NUM
dpc-1936	138	122	1	1	NUM
dpc-1936	138	123	(	(	PUNCT
dpc-1936	138	124	2.0	2.0	NUM
dpc-1936	138	125	)	)	PUNCT
dpc-1936	138	126	depression	depression	NOUN
dpc-1936	138	127	1	1	NUM
dpc-1936	138	128	(	(	PUNCT
dpc-1936	138	129	2.0	2.0	NUM
dpc-1936	138	130	)	)	PUNCT
dpc-1936	138	131	0	0	NUM
dpc-1936	139	1	data	datum	NOUN
dpc-1936	139	2	are	be	AUX
dpc-1936	139	3	presented	present	VERB
dpc-1936	139	4	as	as	ADP
dpc-1936	139	5	n	n	PROPN
dpc-1936	139	6	(	(	PUNCT
dpc-1936	139	7	%	%	NOUN
dpc-1936	139	8	)	)	PUNCT
dpc-1936	139	9	.	.	PUNCT
dpc-1936	140	1	asaes	asaes	PROPN
dpc-1936	140	2	were	be	AUX
dpc-1936	140	3	acute	acute	ADJ
dpc-1936	140	4	abdomen	abdomen	NOUN
dpc-1936	140	5	disorder	disorder	NOUN
dpc-1936	140	6	(	(	PUNCT
dpc-1936	140	7	n	n	NOUN
dpc-1936	140	8	=	=	SYM
dpc-1936	140	9	1	1	NUM
dpc-1936	140	10	)	)	PUNCT
dpc-1936	140	11	,	,	PUNCT
dpc-1936	140	12	pyrexia	pyrexia	NOUN
dpc-1936	140	13	(	(	PUNCT
dpc-1936	140	14	n	n	NOUN
dpc-1936	140	15	=	=	SYM
dpc-1936	140	16	1	1	NUM
dpc-1936	140	17	)	)	PUNCT
dpc-1936	140	18	,	,	PUNCT
dpc-1936	140	19	cellulitis	cellulitis	NOUN
dpc-1936	140	20	(	(	PUNCT
dpc-1936	140	21	n	n	NOUN
dpc-1936	140	22	=	=	SYM
dpc-1936	140	23	1	1	NUM
dpc-1936	140	24	)	)	PUNCT
dpc-1936	140	25	,	,	PUNCT
dpc-1936	140	26	polyneuropathy	polyneuropathy	ADJ
dpc-1936	140	27	(	(	PUNCT
dpc-1936	140	28	n	n	NOUN
dpc-1936	140	29	=	=	SYM
dpc-1936	140	30	1	1	NUM
dpc-1936	140	31	)	)	PUNCT
dpc-1936	140	32	,	,	PUNCT
dpc-1936	140	33	and	and	CCONJ
dpc-1936	140	34	peripheral	peripheral	ADJ
dpc-1936	140	35	artery	artery	NOUN
dpc-1936	140	36	occlusion	occlusion	NOUN
dpc-1936	140	37	and	and	CCONJ
dpc-1936	140	38	necrosis	necrosis	NOUN
dpc-1936	140	39	ischemic	ischemic	ADJ
dpc-1936	140	40	vascular	vascular	ADJ
dpc-1936	140	41	disorder	disorder	NOUN
dpc-1936	140	42	(	(	PUNCT
dpc-1936	140	43	n	n	NOUN
dpc-1936	140	44	=	=	SYM
dpc-1936	140	45	1	1	NUM
dpc-1936	140	46	)	)	PUNCT
dpc-1936	140	47	.	.	PUNCT
dpc-1936	141	1	bserious	bserious	ADJ
dpc-1936	141	2	infection	infection	NOUN
dpc-1936	141	3	was	be	AUX
dpc-1936	141	4	cellulitis	cellulitis	NOUN
dpc-1936	141	5	.	.	PUNCT
dpc-1936	142	1	cdefined	cdefine	VERB
dpc-1936	142	2	by	by	ADP
dpc-1936	142	3	high	high	ADJ
dpc-1936	142	4	level	level	NOUN
dpc-1936	142	5	term	term	NOUN
dpc-1936	142	6	(	(	PUNCT
dpc-1936	142	7	hlt	hlt	NOUN
dpc-1936	142	8	)	)	PUNCT
dpc-1936	142	9	.	.	PUNCT
dpc-1936	143	1	dno	dno	PROPN
dpc-1936	143	2	confirmed	confirm	VERB
dpc-1936	143	3	anaphylaxis	anaphylaxis	NOUN
dpc-1936	143	4	reported	report	VERB
dpc-1936	143	5	after	after	ADP
dpc-1936	143	6	medical	medical	ADJ
dpc-1936	143	7	review	review	PROPN
dpc-1936	143	8	.	.	PUNCT
dpc-1936	144	1	ecerebro	ecerebro	NOUN
dpc-1936	144	2	-	-	PUNCT
dpc-1936	144	3	cardiovascular	cardiovascular	ADJ
dpc-1936	144	4	events	event	NOUN
dpc-1936	144	5	are	be	AUX
dpc-1936	144	6	defined	define	VERB
dpc-1936	144	7	using	use	VERB
dpc-1936	144	8	terms	term	NOUN
dpc-1936	144	9	from	from	ADP
dpc-1936	144	10	the	the	DET
dpc-1936	144	11	following	following	ADJ
dpc-1936	144	12	subcategories	subcategorie	NOUN
dpc-1936	144	13	:	:	PUNCT
dpc-1936	144	14	cardiovascular	cardiovascular	ADJ
dpc-1936	144	15	death	death	NOUN
dpc-1936	144	16	,	,	PUNCT
dpc-1936	144	17	myocardial	myocardial	ADJ
dpc-1936	144	18	infarction	infarction	NOUN
dpc-1936	144	19	,	,	PUNCT
dpc-1936	144	20	hospitalization	hospitalization	NOUN
dpc-1936	144	21	for	for	ADP
dpc-1936	144	22	unstable	unstable	ADJ
dpc-1936	144	23	angina	angina	NOUN
dpc-1936	144	24	,	,	PUNCT
dpc-1936	144	25	hospitalization	hospitalization	NOUN
dpc-1936	144	26	for	for	ADP
dpc-1936	144	27	heart	heart	NOUN
dpc-1936	144	28	failure	failure	NOUN
dpc-1936	144	29	,	,	PUNCT
dpc-1936	144	30	hospitalization	hospitalization	NOUN
dpc-1936	144	31	for	for	ADP
dpc-1936	144	32	serious	serious	ADJ
dpc-1936	144	33	arrhythmia	arrhythmia	NOUN
dpc-1936	144	34	,	,	PUNCT
dpc-1936	144	35	hospitalization	hospitalization	NOUN
dpc-1936	144	36	for	for	ADP
dpc-1936	144	37	hypertension	hypertension	NOUN
dpc-1936	144	38	,	,	PUNCT
dpc-1936	144	39	resuscitated	resuscitate	VERB
dpc-1936	144	40	sudden	sudden	ADJ
dpc-1936	144	41	death	death	NOUN
dpc-1936	144	42	,	,	PUNCT
dpc-1936	144	43	cardiogenic	cardiogenic	ADJ
dpc-1936	144	44	shock	shock	NOUN
dpc-1936	144	45	due	due	ADP
dpc-1936	144	46	to	to	ADP
dpc-1936	144	47	myocardial	myocardial	ADJ
dpc-1936	144	48	infarction	infarction	NOUN
dpc-1936	144	49	,	,	PUNCT
dpc-1936	144	50	coronary	coronary	ADJ
dpc-1936	144	51	revascularization	revascularization	NOUN
dpc-1936	144	52	procedure	procedure	NOUN
dpc-1936	144	53	,	,	PUNCT
dpc-1936	144	54	neurologic	neurologic	NOUN
dpc-1936	144	55	-	-	PUNCT
dpc-1936	144	56	stroke	stroke	NOUN
dpc-1936	144	57	,	,	PUNCT
dpc-1936	144	58	and	and	CCONJ
dpc-1936	144	59	peripheral	peripheral	ADJ
dpc-1936	144	60	vascular	vascular	ADJ
dpc-1936	144	61	events	event	NOUN
dpc-1936	144	62	.	.	PUNCT
dpc-1936	145	1	ada	ada	PROPN
dpc-1936	145	2	=	=	PUNCT
dpc-1936	145	3	adalimumab	adalimumab	PROPN
dpc-1936	145	4	;	;	PUNCT
dpc-1936	145	5	ae	ae	PROPN
dpc-1936	145	6	=	=	PUNCT
dpc-1936	145	7	adverse	adverse	ADJ
dpc-1936	145	8	event	event	NOUN
dpc-1936	145	9	;	;	PUNCT
dpc-1936	145	10	ixe	ixe	NOUN
dpc-1936	145	11	=	=	SYM
dpc-1936	145	12	ixekizumab	ixekizumab	NOUN
dpc-1936	145	13	;	;	PUNCT
dpc-1936	146	1	sae	sae	PROPN
dpc-1936	146	2	=	=	PROPN
dpc-1936	146	3	serious	serious	ADJ
dpc-1936	146	4	adverse	adverse	ADJ
dpc-1936	146	5	event	event	NOUN
dpc-1936	146	6	;	;	PUNCT
dpc-1936	146	7	teae	teae	NOUN
dpc-1936	146	8	=	=	PUNCT
dpc-1936	146	9	treatment	treatment	NOUN
dpc-1936	146	10	-	-	PUNCT
dpc-1936	146	11	emergent	emergent	NOUN
dpc-1936	146	12	adverse	adverse	ADJ
dpc-1936	146	13	event	event	NOUN
dpc-1936	146	14	.	.	PUNCT
dpc-1936	147	1	nail	nail	NOUN
dpc-1936	147	2	pso	pso	NOUN
dpc-1936	147	3	can	can	AUX
dpc-1936	147	4	substantially	substantially	ADV
dpc-1936	147	5	compromise	compromise	VERB
dpc-1936	147	6	patients	patient	NOUN
dpc-1936	147	7	’	'	PUNCT
dpc-1936	147	8	daily	daily	ADJ
dpc-1936	147	9	activities	activity	NOUN
dpc-1936	147	10	by	by	ADP
dpc-1936	147	11	causing	cause	VERB
dpc-1936	147	12	pain	pain	NOUN
dpc-1936	147	13	and	and	CCONJ
dpc-1936	147	14	impairing	impair	VERB
dpc-1936	147	15	hand	hand	NOUN
dpc-1936	147	16	mobility	mobility	NOUN
dpc-1936	147	17	and	and	CCONJ
dpc-1936	147	18	is	be	AUX
dpc-1936	147	19	a	a	DET
dpc-1936	147	20	particularly	particularly	ADV
dpc-1936	147	21	difficult	difficult	ADJ
dpc-1936	147	22	to	to	PART
dpc-1936	147	23	treat	treat	VERB
dpc-1936	147	24	manifestation	manifestation	NOUN
dpc-1936	147	25	of	of	ADP
dpc-1936	147	26	pso	pso	NOUN
dpc-1936	147	27	[	[	X
dpc-1936	147	28	8	8	NUM
dpc-1936	147	29	]	]	PUNCT
dpc-1936	147	30	.	.	PUNCT
dpc-1936	148	1	improvement	improvement	NOUN
dpc-1936	148	2	and	and	CCONJ
dpc-1936	148	3	clearance	clearance	NOUN
dpc-1936	148	4	of	of	ADP
dpc-1936	148	5	nail	nail	NOUN
dpc-1936	148	6	pso	pso	NOUN
dpc-1936	148	7	is	be	AUX
dpc-1936	148	8	a	a	DET
dpc-1936	148	9	long	long	ADJ
dpc-1936	148	10	process	process	NOUN
dpc-1936	148	11	,	,	PUNCT
dpc-1936	148	12	partially	partially	ADV
dpc-1936	148	13	due	due	ADP
dpc-1936	148	14	to	to	ADP
dpc-1936	148	15	the	the	DET
dpc-1936	148	16	slow	slow	ADJ
dpc-1936	148	17	growth	growth	NOUN
dpc-1936	148	18	rate	rate	NOUN
dpc-1936	148	19	of	of	ADP
dpc-1936	148	20	nails	nail	NOUN
dpc-1936	148	21	,	,	PUNCT
dpc-1936	148	22	and	and	CCONJ
dpc-1936	148	23	consequently	consequently	ADV
dpc-1936	148	24	,	,	PUNCT
dpc-1936	148	25	efficacy	efficacy	NOUN
dpc-1936	148	26	can	can	AUX
dpc-1936	148	27	not	not	PART
dpc-1936	148	28	be	be	AUX
dpc-1936	148	29	evaluated	evaluate	VERB
dpc-1936	148	30	before	before	ADP
dpc-1936	148	31	12	12	NUM
dpc-1936	148	32	weeks	week	NOUN
dpc-1936	148	33	of	of	ADP
dpc-1936	148	34	treatment	treatment	NOUN
dpc-1936	148	35	[	[	X
dpc-1936	148	36	25	25	NUM
dpc-1936	148	37	]	]	PUNCT
dpc-1936	148	38	.	.	PUNCT
dpc-1936	149	1	in	in	ADP
dpc-1936	149	2	our	our	PRON
dpc-1936	149	3	subgroup	subgroup	NOUN
dpc-1936	149	4	analysis	analysis	NOUN
dpc-1936	149	5	,	,	PUNCT
dpc-1936	149	6	the	the	DET
dpc-1936	149	7	proportion	proportion	NOUN
dpc-1936	149	8	of	of	ADP
dpc-1936	149	9	patients	patient	NOUN
dpc-1936	149	10	experiencing	experience	VERB
dpc-1936	149	11	nail	nail	NOUN
dpc-1936	149	12	pso	pso	NOUN
dpc-1936	149	13	was	be	AUX
dpc-1936	149	14	higher	high	ADJ
dpc-1936	149	15	than	than	ADP
dpc-1936	149	16	in	in	ADP
dpc-1936	149	17	other	other	ADJ
dpc-1936	149	18	moderate	moderate	ADJ
dpc-1936	149	19	-	-	PUNCT
dpc-1936	149	20	to	to	ADP
dpc-1936	149	21	-	-	PUNCT
dpc-1936	149	22	severe	severe	ADJ
dpc-1936	149	23	pso	pso	NOUN
dpc-1936	149	24	clinical	clinical	ADJ
dpc-1936	149	25	trial	trial	NOUN
dpc-1936	149	26	populations	population	NOUN
dpc-1936	149	27	as	as	SCONJ
dpc-1936	149	28	all	all	DET
dpc-1936	149	29	patients	patient	NOUN
dpc-1936	149	30	had	have	VERB
dpc-1936	149	31	concomitant	concomitant	ADJ
dpc-1936	149	32	active	active	ADJ
dpc-1936	149	33	psa	psa	NOUN
dpc-1936	149	34	,	,	PUNCT
dpc-1936	149	35	which	which	PRON
dpc-1936	149	36	is	be	AUX
dpc-1936	149	37	associated	associate	VERB
dpc-1936	149	38	with	with	ADP
dpc-1936	149	39	higher	high	ADJ
dpc-1936	149	40	rates	rate	NOUN
dpc-1936	149	41	of	of	ADP
dpc-1936	149	42	nail	nail	NOUN
dpc-1936	149	43	pso	pso	NOUN
dpc-1936	149	44	than	than	ADP
dpc-1936	149	45	pso	pso	NOUN
dpc-1936	149	46	[	[	X
dpc-1936	149	47	26,27	26,27	NUM
dpc-1936	149	48	]	]	PUNCT
dpc-1936	149	49	.	.	PUNCT
dpc-1936	150	1	notably	notably	ADV
dpc-1936	150	2	,	,	PUNCT
dpc-1936	150	3	ixe	ixe	ADJ
dpc-1936	150	4	treatment	treatment	NOUN
dpc-1936	150	5	resulted	result	VERB
dpc-1936	150	6	in	in	ADP
dpc-1936	150	7	a	a	DET
dpc-1936	150	8	more	more	ADV
dpc-1936	150	9	rapid	rapid	ADJ
dpc-1936	150	10	increase	increase	NOUN
dpc-1936	150	11	overall	overall	ADV
dpc-1936	150	12	in	in	ADP
dpc-1936	150	13	clearance	clearance	NOUN
dpc-1936	150	14	of	of	ADP
dpc-1936	150	15	nail	nail	NOUN
dpc-1936	150	16	pso	pso	NOUN
dpc-1936	150	17	than	than	ADP
dpc-1936	150	18	ada	ada	PROPN
dpc-1936	150	19	,	,	PUNCT
dpc-1936	150	20	with	with	ADP
dpc-1936	150	21	significantly	significantly	ADV
dpc-1936	150	22	more	more	ADV
dpc-1936	150	23	ixeversus	ixeversus	PROPN
dpc-1936	150	24	ada	ada	PROPN
dpc-1936	150	25	-	-	PUNCT
dpc-1936	150	26	treated	treat	VERB
dpc-1936	150	27	patients	patient	NOUN
dpc-1936	150	28	demonstrating	demonstrate	VERB
dpc-1936	150	29	complete	complete	ADJ
dpc-1936	150	30	clearance	clearance	NOUN
dpc-1936	150	31	of	of	ADP
dpc-1936	150	32	nail	nail	NOUN
dpc-1936	150	33	pso	pso	NOUN
dpc-1936	150	34	at	at	ADP
dpc-1936	150	35	w24	w24	PROPN
dpc-1936	150	36	.	.	PUNCT
dpc-1936	151	1	previously	previously	ADV
dpc-1936	151	2	published	publish	VERB
dpc-1936	151	3	results	result	NOUN
dpc-1936	151	4	from	from	ADP
dpc-1936	151	5	the	the	DET
dpc-1936	151	6	ixora	ixora	PROPN
dpc-1936	151	7	-	-	PUNCT
dpc-1936	151	8	s	s	NOUN
dpc-1936	151	9	trial	trial	NOUN
dpc-1936	151	10	have	have	AUX
dpc-1936	151	11	demonstrated	demonstrate	VERB
dpc-1936	151	12	that	that	SCONJ
dpc-1936	151	13	ixe	ixe	NOUN
dpc-1936	151	14	is	be	AUX
dpc-1936	151	15	superior	superior	ADJ
dpc-1936	151	16	to	to	ADP
dpc-1936	151	17	ustekinumab	ustekinumab	NOUN
dpc-1936	151	18	,	,	PUNCT
dpc-1936	151	19	an	an	DET
dpc-1936	151	20	anti	anti	ADJ
dpc-1936	151	21	-	-	ADJ
dpc-1936	151	22	il-12/23	il-12/23	ADJ
dpc-1936	151	23	biologic	biologic	NOUN
dpc-1936	151	24	,	,	PUNCT
dpc-1936	151	25	in	in	ADP
dpc-1936	151	26	clearance	clearance	NOUN
dpc-1936	151	27	of	of	ADP
dpc-1936	151	28	nail	nail	NOUN
dpc-1936	151	29	pso	pso	NOUN
dpc-1936	151	30	at	at	ADP
dpc-1936	151	31	w24	w24	PROPN
dpc-1936	152	1	[	[	X
dpc-1936	152	2	26	26	NUM
dpc-1936	152	3	]	]	PUNCT
dpc-1936	152	4	.	.	PUNCT
dpc-1936	153	1	similarly	similarly	ADV
dpc-1936	153	2	,	,	PUNCT
dpc-1936	153	3	in	in	ADP
dpc-1936	153	4	the	the	DET
dpc-1936	153	5	ixora	ixora	ADJ
dpc-1936	153	6	-	-	PUNCT
dpc-1936	153	7	r	r	NOUN
dpc-1936	153	8	head	head	NOUN
dpc-1936	153	9	-	-	PUNCT
dpc-1936	153	10	to	to	ADP
dpc-1936	153	11	-	-	PUNCT
dpc-1936	153	12	head	head	NOUN
dpc-1936	153	13	trial	trial	NOUN
dpc-1936	153	14	comparing	compare	VERB
dpc-1936	153	15	ixe	ixe	NOUN
dpc-1936	153	16	with	with	ADP
dpc-1936	153	17	guselkumab	guselkumab	NOUN
dpc-1936	153	18	(	(	PUNCT
dpc-1936	153	19	gus	gus	PROPN
dpc-1936	153	20	)	)	PUNCT
dpc-1936	153	21	,	,	PUNCT
dpc-1936	153	22	an	an	DET
dpc-1936	153	23	anti	anti	ADJ
dpc-1936	153	24	-	-	ADJ
dpc-1936	153	25	il-23p19	il-23p19	ADJ
dpc-1936	153	26	biologic	biologic	NOUN
dpc-1936	153	27	,	,	PUNCT
dpc-1936	153	28	ixe	ixe	PROPN
dpc-1936	153	29	was	be	AUX
dpc-1936	153	30	superior	superior	ADJ
dpc-1936	153	31	to	to	ADP
dpc-1936	153	32	gus	gus	NOUN
dpc-1936	153	33	in	in	ADP
dpc-1936	153	34	clearance	clearance	NOUN
dpc-1936	153	35	of	of	ADP
dpc-1936	153	36	nail	nail	NOUN
dpc-1936	153	37	pso	pso	NOUN
dpc-1936	153	38	at	at	ADP
dpc-1936	153	39	w24	w24	PROPN
dpc-1936	153	40	[	[	X
dpc-1936	153	41	28	28	NUM
dpc-1936	153	42	]	]	PUNCT
dpc-1936	153	43	.	.	PUNCT
dpc-1936	154	1	the	the	DET
dpc-1936	154	2	voyage-1	voyage-1	NUM
dpc-1936	154	3	and	and	CCONJ
dpc-1936	154	4	-2	-2	NOUN
dpc-1936	154	5	trials	trial	NOUN
dpc-1936	154	6	demonstrated	demonstrate	VERB
dpc-1936	154	7	superiority	superiority	NOUN
dpc-1936	154	8	of	of	ADP
dpc-1936	154	9	gus	gus	NOUN
dpc-1936	154	10	to	to	ADP
dpc-1936	154	11	ada	ada	PROPN
dpc-1936	154	12	in	in	ADP
dpc-1936	154	13	achieving	achieve	VERB
dpc-1936	154	14	clear	clear	ADJ
dpc-1936	154	15	/	/	SYM
dpc-1936	154	16	almost	almost	ADV
dpc-1936	154	17	clear	clear	ADJ
dpc-1936	154	18	skin	skin	NOUN
dpc-1936	154	19	at	at	ADP
dpc-1936	154	20	w16	w16	NOUN
dpc-1936	154	21	;	;	PUNCT
dpc-1936	154	22	however	however	ADV
dpc-1936	154	23	,	,	PUNCT
dpc-1936	154	24	post	post	VERB
dpc-1936	154	25	hoc	hoc	X
dpc-1936	154	26	analysis	analysis	NOUN
dpc-1936	154	27	demonstrated	demonstrate	VERB
dpc-1936	154	28	that	that	SCONJ
dpc-1936	154	29	improvements	improvement	NOUN
dpc-1936	154	30	in	in	ADP
dpc-1936	154	31	nail	nail	NOUN
dpc-1936	154	32	pso	pso	NOUN
dpc-1936	154	33	from	from	ADP
dpc-1936	154	34	baseline	baseline	PROPN
dpc-1936	154	35	were	be	AUX
dpc-1936	154	36	higher	high	ADJ
dpc-1936	154	37	for	for	ADP
dpc-1936	154	38	ada	ada	PROPN
dpc-1936	154	39	versus	versus	ADP
dpc-1936	154	40	gus	gus	PROPN
dpc-1936	154	41	at	at	ADP
dpc-1936	154	42	w16	w16	NOUN
dpc-1936	154	43	,	,	PUNCT
dpc-1936	154	44	which	which	PRON
dpc-1936	154	45	suggests	suggest	VERB
dpc-1936	154	46	that	that	SCONJ
dpc-1936	154	47	the	the	DET
dpc-1936	154	48	different	different	ADJ
dpc-1936	154	49	methods	method	NOUN
dpc-1936	154	50	of	of	ADP
dpc-1936	154	51	action	action	NOUN
dpc-1936	154	52	of	of	ADP
dpc-1936	154	53	biologics	biologic	NOUN
dpc-1936	154	54	may	may	AUX
dpc-1936	154	55	result	result	VERB
dpc-1936	154	56	in	in	ADP
dpc-1936	154	57	differing	differ	VERB
dpc-1936	154	58	effects	effect	NOUN
dpc-1936	154	59	on	on	ADP
dpc-1936	154	60	specific	specific	ADJ
dpc-1936	154	61	pso	pso	NOUN
dpc-1936	154	62	disease	disease	NOUN
dpc-1936	154	63	domains	domain	NOUN
dpc-1936	154	64	,	,	PUNCT
dpc-1936	154	65	such	such	ADJ
dpc-1936	154	66	as	as	ADP
dpc-1936	154	67	nail	nail	NOUN
dpc-1936	154	68	pso	pso	NOUN
dpc-1936	155	1	[	[	X
dpc-1936	155	2	29–31	29–31	PROPN
dpc-1936	155	3	]	]	PUNCT
dpc-1936	155	4	.	.	PUNCT
dpc-1936	156	1	importantly	importantly	ADV
dpc-1936	156	2	,	,	PUNCT
dpc-1936	156	3	our	our	PRON
dpc-1936	156	4	analysis	analysis	NOUN
dpc-1936	156	5	of	of	ADP
dpc-1936	156	6	the	the	DET
dpc-1936	156	7	spirit	spirit	PROPN
dpc-1936	156	8	-	-	PUNCT
dpc-1936	156	9	h2h	h2h	PROPN
dpc-1936	156	10	subgroup	subgroup	NOUN
dpc-1936	156	11	with	with	ADP
dpc-1936	156	12	active	active	ADJ
dpc-1936	156	13	psa	psa	NOUN
dpc-1936	156	14	and	and	CCONJ
dpc-1936	156	15	moderate	moderate	ADJ
dpc-1936	156	16	-	-	PUNCT
dpc-1936	156	17	to	to	ADP
dpc-1936	156	18	-	-	PUNCT
dpc-1936	156	19	severe	severe	ADJ
dpc-1936	156	20	pso	pso	NOUN
dpc-1936	156	21	demonstrates	demonstrate	VERB
dpc-1936	156	22	that	that	SCONJ
dpc-1936	156	23	ixe	ixe	NOUN
dpc-1936	156	24	has	have	VERB
dpc-1936	156	25	higher	high	ADJ
dpc-1936	156	26	efficacy	efficacy	NOUN
dpc-1936	156	27	than	than	ADP
dpc-1936	156	28	ada	ada	PROPN
dpc-1936	156	29	in	in	ADP
dpc-1936	156	30	achieving	achieve	VERB
dpc-1936	156	31	complete	complete	ADJ
dpc-1936	156	32	clearance	clearance	NOUN
dpc-1936	156	33	of	of	ADP
dpc-1936	156	34	the	the	DET
dpc-1936	156	35	skin	skin	NOUN
dpc-1936	156	36	and	and	CCONJ
dpc-1936	156	37	nails	nail	NOUN
dpc-1936	156	38	at	at	ADP
dpc-1936	156	39	w24	w24	PROPN
dpc-1936	156	40	.	.	PUNCT
dpc-1936	157	1	overall	overall	ADV
dpc-1936	157	2	,	,	PUNCT
dpc-1936	157	3	these	these	PRON
dpc-1936	157	4	and	and	CCONJ
dpc-1936	157	5	previously	previously	ADV
dpc-1936	157	6	published	publish	VERB
dpc-1936	157	7	results	result	NOUN
dpc-1936	157	8	demonstrate	demonstrate	VERB
dpc-1936	157	9	the	the	DET
dpc-1936	157	10	consistent	consistent	ADJ
dpc-1936	157	11	high	high	ADJ
dpc-1936	157	12	efficacy	efficacy	NOUN
dpc-1936	157	13	of	of	ADP
dpc-1936	157	14	ixe	ixe	NOUN
dpc-1936	157	15	in	in	ADP
dpc-1936	157	16	achieving	achieve	VERB
dpc-1936	157	17	clearance	clearance	NOUN
dpc-1936	157	18	of	of	ADP
dpc-1936	157	19	nail	nail	NOUN
dpc-1936	157	20	pso	pso	NOUN
dpc-1936	157	21	.	.	PUNCT
dpc-1936	158	1	this	this	PRON
dpc-1936	158	2	is	be	AUX
dpc-1936	158	3	supported	support	VERB
dpc-1936	158	4	by	by	ADP
dpc-1936	158	5	multiple	multiple	ADJ
dpc-1936	158	6	recent	recent	ADJ
dpc-1936	158	7	network	network	NOUN
dpc-1936	158	8	meta	meta	NOUN
dpc-1936	158	9	-	-	PUNCT
dpc-1936	158	10	analyses	analysis	NOUN
dpc-1936	158	11	,	,	PUNCT
dpc-1936	158	12	which	which	PRON
dpc-1936	158	13	report	report	VERB
dpc-1936	158	14	that	that	SCONJ
dpc-1936	158	15	ixe	ixe	PROPN
dpc-1936	158	16	had	have	VERB
dpc-1936	158	17	the	the	DET
dpc-1936	158	18	highest	high	ADJ
dpc-1936	158	19	ranking	ranking	NOUN
dpc-1936	158	20	among	among	ADP
dpc-1936	158	21	approved	approve	VERB
dpc-1936	158	22	biologics	biologic	NOUN
dpc-1936	158	23	(	(	PUNCT
dpc-1936	158	24	and	and	CCONJ
dpc-1936	158	25	small	small	ADJ
dpc-1936	158	26	molecules	molecule	NOUN
dpc-1936	158	27	in	in	ADP
dpc-1936	158	28	one	one	NUM
dpc-1936	158	29	network	network	NOUN
dpc-1936	158	30	meta	meta	ADJ
dpc-1936	158	31	-	-	PUNCT
dpc-1936	158	32	analysis	analysis	NOUN
dpc-1936	158	33	)	)	PUNCT
dpc-1936	158	34	for	for	ADP
dpc-1936	158	35	the	the	DET
dpc-1936	158	36	treatment	treatment	NOUN
dpc-1936	158	37	and/or	and/or	CCONJ
dpc-1936	158	38	clearance	clearance	NOUN
dpc-1936	158	39	of	of	ADP
dpc-1936	158	40	nail	nail	NOUN
dpc-1936	158	41	pso	pso	NOUN
dpc-1936	159	1	[	[	X
dpc-1936	159	2	32–34	32–34	NUM
dpc-1936	159	3	]	]	PUNCT
dpc-1936	159	4	.	.	PUNCT
dpc-1936	160	1	of	of	ADP
dpc-1936	160	2	note	note	NOUN
dpc-1936	160	3	,	,	PUNCT
dpc-1936	160	4	>	>	X
dpc-1936	160	5	50	50	NUM
dpc-1936	160	6	%	%	NOUN
dpc-1936	160	7	of	of	ADP
dpc-1936	160	8	patients	patient	NOUN
dpc-1936	160	9	in	in	ADP
dpc-1936	160	10	our	our	PRON
dpc-1936	160	11	subgroup	subgroup	NOUN
dpc-1936	160	12	analysis	analysis	NOUN
dpc-1936	160	13	had	have	VERB
dpc-1936	160	14	concomitant	concomitant	ADJ
dpc-1936	160	15	mtx	mtx	NOUN
dpc-1936	160	16	use	use	NOUN
dpc-1936	160	17	at	at	ADP
dpc-1936	160	18	baseline	baseline	NOUN
dpc-1936	160	19	.	.	PUNCT
dpc-1936	161	1	previously	previously	ADV
dpc-1936	161	2	published	publish	VERB
dpc-1936	161	3	studies	study	NOUN
dpc-1936	161	4	have	have	AUX
dpc-1936	161	5	indicated	indicate	VERB
dpc-1936	161	6	that	that	SCONJ
dpc-1936	161	7	concomitant	concomitant	ADJ
dpc-1936	161	8	mtx	mtx	NOUN
dpc-1936	161	9	treatment	treatment	NOUN
dpc-1936	161	10	improves	improve	VERB
dpc-1936	161	11	the	the	DET
dpc-1936	161	12	efficacy	efficacy	NOUN
dpc-1936	161	13	of	of	ADP
dpc-1936	161	14	ada	ada	PROPN
dpc-1936	161	15	and	and	CCONJ
dpc-1936	161	16	other	other	ADJ
dpc-1936	161	17	anti	anti	ADJ
dpc-1936	161	18	-	-	ADJ
dpc-1936	161	19	tnf	tnf	ADJ
dpc-1936	161	20	biologics	biologic	NOUN
dpc-1936	161	21	in	in	ADP
dpc-1936	161	22	treating	treat	VERB
dpc-1936	161	23	rheumatoid	rheumatoid	NOUN
dpc-1936	161	24	arthritis	arthritis	NOUN
dpc-1936	161	25	,	,	PUNCT
dpc-1936	161	26	but	but	CCONJ
dpc-1936	161	27	the	the	DET
dpc-1936	161	28	results	result	NOUN
dpc-1936	161	29	regarding	regard	VERB
dpc-1936	161	30	the	the	DET
dpc-1936	161	31	effect	effect	NOUN
dpc-1936	161	32	of	of	ADP
dpc-1936	161	33	this	this	DET
dpc-1936	161	34	combined	combine	VERB
dpc-1936	161	35	therapy	therapy	NOUN
dpc-1936	161	36	for	for	ADP
dpc-1936	161	37	psa	psa	NOUN
dpc-1936	161	38	have	have	AUX
dpc-1936	161	39	been	be	AUX
dpc-1936	161	40	inconclusive	inconclusive	ADJ
dpc-1936	161	41	[	[	X
dpc-1936	161	42	35–38	35–38	NUM
dpc-1936	161	43	]	]	X
dpc-1936	161	44	.	.	PUNCT
dpc-1936	162	1	it	it	PRON
dpc-1936	162	2	has	have	AUX
dpc-1936	162	3	been	be	AUX
dpc-1936	162	4	suggested	suggest	VERB
dpc-1936	162	5	that	that	SCONJ
dpc-1936	162	6	in	in	ADP
dpc-1936	162	7	the	the	DET
dpc-1936	162	8	overall	overall	ADJ
dpc-1936	162	9	spirit	spirit	PROPN
dpc-1936	162	10	-	-	PUNCT
dpc-1936	162	11	h2h	h2h	PROPN
dpc-1936	162	12	study	study	NOUN
dpc-1936	162	13	population	population	NOUN
dpc-1936	162	14	,	,	PUNCT
dpc-1936	162	15	concomitant	concomitant	ADJ
dpc-1936	162	16	treatment	treatment	NOUN
dpc-1936	162	17	with	with	ADP
dpc-1936	162	18	mtx	mtx	NOUN
dpc-1936	162	19	increases	increase	VERB
dpc-1936	162	20	the	the	DET
dpc-1936	162	21	proportion	proportion	NOUN
dpc-1936	162	22	of	of	ADP
dpc-1936	162	23	ada	ada	PROPN
dpc-1936	162	24	-	-	PUNCT
dpc-1936	162	25	treated	treat	VERB
dpc-1936	162	26	patients	patient	NOUN
dpc-1936	162	27	achieving	achieve	VERB
dpc-1936	162	28	simultaneous	simultaneous	ADJ
dpc-1936	162	29	acr50	acr50	ADJ
dpc-1936	162	30	and	and	CCONJ
dpc-1936	162	31	pasi100	pasi100	PROPN
dpc-1936	162	32	,	,	PUNCT
dpc-1936	162	33	or	or	CCONJ
dpc-1936	162	34	napsi	napsi	NOUN
dpc-1936	162	35	=	=	SYM
dpc-1936	162	36	10	10	NUM
dpc-1936	162	37	original	original	ADJ
dpc-1936	162	38	article	article	NOUN
dpc-1936	162	39	|	|	ADV
dpc-1936	162	40	dermatol	dermatol	ADJ
dpc-1936	162	41	pract	pract	NOUN
dpc-1936	162	42	concept	concept	NOUN
dpc-1936	162	43	.	.	PUNCT
dpc-1936	163	1	2022;12(2):e2022104	2022;12(2):e2022104	PROPN
dpc-1936	163	2	4	4	X
dpc-1936	163	3	.	.	X
dpc-1936	163	4	gelfand	gelfand	PROPN
dpc-1936	163	5	jm	jm	PROPN
dpc-1936	163	6	,	,	PUNCT
dpc-1936	163	7	gladman	gladman	NOUN
dpc-1936	163	8	dd	dd	NOUN
dpc-1936	163	9	,	,	PUNCT
dpc-1936	163	10	mease	mease	PROPN
dpc-1936	163	11	pj	pj	PROPN
dpc-1936	163	12	,	,	PUNCT
dpc-1936	163	13	et	et	PROPN
dpc-1936	163	14	al	al	PROPN
dpc-1936	163	15	.	.	PUNCT
dpc-1936	164	1	epidemiology	epidemiology	NOUN
dpc-1936	164	2	of	of	ADP
dpc-1936	164	3	psoriatic	psoriatic	ADJ
dpc-1936	164	4	arthritis	arthritis	NOUN
dpc-1936	164	5	in	in	ADP
dpc-1936	164	6	the	the	DET
dpc-1936	164	7	population	population	NOUN
dpc-1936	164	8	of	of	ADP
dpc-1936	164	9	the	the	DET
dpc-1936	164	10	united	united	PROPN
dpc-1936	164	11	states	states	PROPN
dpc-1936	164	12	.	.	PUNCT
dpc-1936	165	1	j	j	PROPN
dpc-1936	165	2	am	be	AUX
dpc-1936	165	3	acad	acad	ADJ
dpc-1936	165	4	dermatol	dermatol	NOUN
dpc-1936	165	5	.	.	PUNCT
dpc-1936	166	1	2005;53(4):573.e571–573.e513	2005;53(4):573.e571–573.e513	NUM
dpc-1936	166	2	.	.	PUNCT
dpc-1936	167	1	doi	doi	NOUN
dpc-1936	167	2	:	:	PUNCT
dpc-1936	167	3	10.1016	10.1016	NUM
dpc-1936	167	4	/	/	SYM
dpc-1936	167	5	j.	j.	PROPN
dpc-1936	167	6	jaad.2005.03.046	jaad.2005.03.046	PROPN
dpc-1936	167	7	.	.	PUNCT
dpc-1936	168	1	pmid	pmid	NOUN
dpc-1936	168	2	:	:	PUNCT
dpc-1936	168	3	16198775	16198775	NUM
dpc-1936	168	4	.	.	PUNCT
dpc-1936	169	1	5	5	X
dpc-1936	169	2	.	.	X
dpc-1936	169	3	reich	reich	PROPN
dpc-1936	169	4	k	k	PROPN
dpc-1936	169	5	,	,	PUNCT
dpc-1936	169	6	krüger	krüger	PROPN
dpc-1936	169	7	k	k	NOUN
dpc-1936	169	8	,	,	PUNCT
dpc-1936	169	9	mössner	mössner	X
dpc-1936	169	10	r	r	PROPN
dpc-1936	169	11	,	,	PUNCT
dpc-1936	169	12	augustin	augustin	PROPN
dpc-1936	169	13	m.	m.	PROPN
dpc-1936	169	14	epidemiology	epidemiology	NOUN
dpc-1936	169	15	and	and	CCONJ
dpc-1936	169	16	clinical	clinical	ADJ
dpc-1936	169	17	pattern	pattern	NOUN
dpc-1936	169	18	of	of	ADP
dpc-1936	169	19	psoriatic	psoriatic	ADJ
dpc-1936	169	20	arthritis	arthritis	NOUN
dpc-1936	169	21	in	in	ADP
dpc-1936	169	22	germany	germany	PROPN
dpc-1936	169	23	:	:	PUNCT
dpc-1936	169	24	a	a	DET
dpc-1936	169	25	prospective	prospective	ADJ
dpc-1936	169	26	interdisciplinary	interdisciplinary	ADJ
dpc-1936	169	27	epidemiological	epidemiological	ADJ
dpc-1936	169	28	study	study	NOUN
dpc-1936	169	29	of	of	ADP
dpc-1936	169	30	1511	1511	NUM
dpc-1936	169	31	patients	patient	NOUN
dpc-1936	169	32	with	with	ADP
dpc-1936	169	33	plaque	plaque	NOUN
dpc-1936	169	34	-	-	PUNCT
dpc-1936	169	35	type	type	NOUN
dpc-1936	169	36	psoriasis	psoriasis	NOUN
dpc-1936	169	37	.	.	PUNCT
dpc-1936	170	1	br	br	PROPN
dpc-1936	170	2	j	j	PROPN
dpc-1936	170	3	dermatol	dermatol	NOUN
dpc-1936	170	4	.	.	PUNCT
dpc-1936	171	1	2009;160(5):1040	2009;160(5):1040	NUM
dpc-1936	171	2	–	–	PUNCT
dpc-1936	171	3	1047	1047	NUM
dpc-1936	171	4	.	.	PUNCT
dpc-1936	172	1	doi	doi	NOUN
dpc-1936	172	2	:	:	PUNCT
dpc-1936	172	3	10.1111	10.1111	NUM
dpc-1936	172	4	/	/	SYM
dpc-1936	172	5	j.1365	j.1365	NOUN
dpc-1936	172	6	-	-	PUNCT
dpc-1936	172	7	2133.2008.09023.x	2133.2008.09023.x	NUM
dpc-1936	172	8	.	.	PUNCT
dpc-1936	173	1	pmid	pmid	NOUN
dpc-1936	173	2	:	:	PUNCT
dpc-1936	173	3	19210498	19210498	NUM
dpc-1936	173	4	.	.	PUNCT
dpc-1936	174	1	6	6	X
dpc-1936	174	2	.	.	X
dpc-1936	174	3	rigopoulos	rigopoulos	PROPN
dpc-1936	174	4	d	d	PROPN
dpc-1936	174	5	,	,	PUNCT
dpc-1936	174	6	baran	baran	NOUN
dpc-1936	174	7	r	r	NOUN
dpc-1936	174	8	,	,	PUNCT
dpc-1936	174	9	chiheb	chiheb	NOUN
dpc-1936	174	10	s	s	PROPN
dpc-1936	174	11	,	,	PUNCT
dpc-1936	174	12	et	et	PROPN
dpc-1936	174	13	al	al	PROPN
dpc-1936	174	14	.	.	PUNCT
dpc-1936	175	1	recommendations	recommendation	NOUN
dpc-1936	175	2	for	for	ADP
dpc-1936	175	3	the	the	DET
dpc-1936	175	4	definition	definition	NOUN
dpc-1936	175	5	,	,	PUNCT
dpc-1936	175	6	evaluation	evaluation	NOUN
dpc-1936	175	7	,	,	PUNCT
dpc-1936	175	8	and	and	CCONJ
dpc-1936	175	9	treatment	treatment	NOUN
dpc-1936	175	10	of	of	ADP
dpc-1936	175	11	nail	nail	NOUN
dpc-1936	175	12	psoriasis	psoriasis	NOUN
dpc-1936	175	13	in	in	ADP
dpc-1936	175	14	adult	adult	NOUN
dpc-1936	175	15	patients	patient	NOUN
dpc-1936	175	16	with	with	ADP
dpc-1936	175	17	no	no	PRON
dpc-1936	175	18	or	or	CCONJ
dpc-1936	175	19	mild	mild	ADJ
dpc-1936	175	20	skin	skin	NOUN
dpc-1936	175	21	psoriasis	psoriasis	NOUN
dpc-1936	175	22	:	:	PUNCT
dpc-1936	175	23	a	a	DET
dpc-1936	175	24	dermatologist	dermatologist	NOUN
dpc-1936	175	25	and	and	CCONJ
dpc-1936	175	26	nail	nail	NOUN
dpc-1936	175	27	expert	expert	NOUN
dpc-1936	175	28	group	group	NOUN
dpc-1936	175	29	consensus	consensus	NOUN
dpc-1936	175	30	.	.	PUNCT
dpc-1936	176	1	j	j	PROPN
dpc-1936	176	2	am	be	AUX
dpc-1936	176	3	acad	acad	ADJ
dpc-1936	176	4	dermatol	dermatol	NOUN
dpc-1936	176	5	.	.	PUNCT
dpc-1936	177	1	2019;81(1):228	2019;81(1):228	NUM
dpc-1936	177	2	–	–	PUNCT
dpc-1936	177	3	240	240	NUM
dpc-1936	177	4	.	.	PUNCT
dpc-1936	178	1	doi	doi	NOUN
dpc-1936	178	2	:	:	PUNCT
dpc-1936	178	3	10.1016	10.1016	NUM
dpc-1936	178	4	/	/	SYM
dpc-1936	178	5	j.jaad.2019.01.072	j.jaad.2019.01.072	NOUN
dpc-1936	178	6	.	.	PUNCT
dpc-1936	179	1	pmid	pmid	NOUN
dpc-1936	179	2	:	:	PUNCT
dpc-1936	179	3	30731172	30731172	NUM
dpc-1936	179	4	.	.	PUNCT
dpc-1936	180	1	7	7	X
dpc-1936	180	2	.	.	X
dpc-1936	180	3	mcgonagle	mcgonagle	NOUN
dpc-1936	180	4	d	d	NOUN
dpc-1936	180	5	,	,	PUNCT
dpc-1936	180	6	tan	tan	PROPN
dpc-1936	180	7	al	al	PROPN
dpc-1936	180	8	,	,	PUNCT
dpc-1936	180	9	benjamin	benjamin	PROPN
dpc-1936	180	10	m.	m.	PROPN
dpc-1936	180	11	the	the	DET
dpc-1936	180	12	nail	nail	NOUN
dpc-1936	180	13	as	as	ADP
dpc-1936	180	14	a	a	DET
dpc-1936	180	15	musculoskeletal	musculoskeletal	ADJ
dpc-1936	180	16	appendage	appendage	NOUN
dpc-1936	180	17	--	--	PUNCT
dpc-1936	180	18	implications	implication	NOUN
dpc-1936	180	19	for	for	ADP
dpc-1936	180	20	an	an	DET
dpc-1936	180	21	improved	improved	ADJ
dpc-1936	180	22	understanding	understanding	NOUN
dpc-1936	180	23	of	of	ADP
dpc-1936	180	24	the	the	DET
dpc-1936	180	25	link	link	NOUN
dpc-1936	180	26	between	between	ADP
dpc-1936	180	27	psoriasis	psoriasis	NOUN
dpc-1936	180	28	and	and	CCONJ
dpc-1936	180	29	arthritis	arthritis	NOUN
dpc-1936	180	30	.	.	PUNCT
dpc-1936	181	1	dermatology	dermatology	NOUN
dpc-1936	181	2	.	.	PUNCT
dpc-1936	182	1	2009;218(2):97–102	2009;218(2):97–102	NUM
dpc-1936	182	2	.	.	PUNCT
dpc-1936	183	1	doi	doi	NOUN
dpc-1936	183	2	:	:	PUNCT
dpc-1936	183	3	10.1159/000182250	10.1159/000182250	NUM
dpc-1936	183	4	.	.	PUNCT
dpc-1936	184	1	pmid	pmid	NOUN
dpc-1936	184	2	:	:	PUNCT
dpc-1936	184	3	19060455	19060455	NUM
dpc-1936	184	4	.	.	PUNCT
dpc-1936	185	1	8	8	X
dpc-1936	185	2	.	.	X
dpc-1936	186	1	jiaravuthisan	jiaravuthisan	PROPN
dpc-1936	186	2	mm	mm	PROPN
dpc-1936	186	3	,	,	PUNCT
dpc-1936	186	4	sasseville	sasseville	NOUN
dpc-1936	186	5	d	d	NOUN
dpc-1936	186	6	,	,	PUNCT
dpc-1936	186	7	vender	vender	NOUN
dpc-1936	186	8	rb	rb	PROPN
dpc-1936	186	9	,	,	PUNCT
dpc-1936	186	10	murphy	murphy	PROPN
dpc-1936	186	11	f	f	PROPN
dpc-1936	186	12	,	,	PUNCT
dpc-1936	186	13	muhn	muhn	PROPN
dpc-1936	186	14	cy	cy	PROPN
dpc-1936	186	15	.	.	NOUN
dpc-1936	186	16	psoriasis	psoriasis	NOUN
dpc-1936	186	17	of	of	ADP
dpc-1936	186	18	the	the	DET
dpc-1936	186	19	nail	nail	NOUN
dpc-1936	186	20	:	:	PUNCT
dpc-1936	186	21	anatomy	anatomy	NOUN
dpc-1936	186	22	,	,	PUNCT
dpc-1936	186	23	pathology	pathology	NOUN
dpc-1936	186	24	,	,	PUNCT
dpc-1936	186	25	clinical	clinical	ADJ
dpc-1936	186	26	presentation	presentation	NOUN
dpc-1936	186	27	,	,	PUNCT
dpc-1936	186	28	and	and	CCONJ
dpc-1936	186	29	a	a	DET
dpc-1936	186	30	review	review	NOUN
dpc-1936	186	31	of	of	ADP
dpc-1936	186	32	the	the	DET
dpc-1936	186	33	literature	literature	NOUN
dpc-1936	186	34	on	on	ADP
dpc-1936	186	35	therapy	therapy	NOUN
dpc-1936	186	36	.	.	PUNCT
dpc-1936	187	1	j	j	PROPN
dpc-1936	187	2	am	be	AUX
dpc-1936	187	3	acad	acad	ADJ
dpc-1936	187	4	dermatol	dermatol	NOUN
dpc-1936	187	5	.	.	PUNCT
dpc-1936	188	1	2007;57(1):1–27	2007;57(1):1–27	NUM
dpc-1936	188	2	.	.	PUNCT
dpc-1936	189	1	doi	doi	NOUN
dpc-1936	189	2	:	:	PUNCT
dpc-1936	189	3	10.1016	10.1016	NUM
dpc-1936	189	4	/	/	SYM
dpc-1936	189	5	j.jaad.2005.07.073	j.jaad.2005.07.073	PROPN
dpc-1936	189	6	.	.	PUNCT
dpc-1936	190	1	pmid	pmid	NOUN
dpc-1936	190	2	:	:	PUNCT
dpc-1936	190	3	17572277	17572277	NUM
dpc-1936	190	4	.	.	PUNCT
dpc-1936	191	1	9	9	X
dpc-1936	191	2	.	.	X
dpc-1936	192	1	nast	nast	PROPN
dpc-1936	192	2	a	a	PROPN
dpc-1936	192	3	,	,	PUNCT
dpc-1936	192	4	smith	smith	PROPN
dpc-1936	192	5	c	c	PROPN
dpc-1936	192	6	,	,	PUNCT
dpc-1936	192	7	spuls	spuls	PROPN
dpc-1936	192	8	p	p	X
dpc-1936	192	9	,	,	PUNCT
dpc-1936	192	10	et	et	PROPN
dpc-1936	192	11	al	al	PROPN
dpc-1936	192	12	.	.	PROPN
dpc-1936	193	1	euroguiderm	euroguiderm	PROPN
dpc-1936	193	2	guideline	guideline	NOUN
dpc-1936	193	3	for	for	ADP
dpc-1936	193	4	the	the	DET
dpc-1936	193	5	systemic	systemic	ADJ
dpc-1936	193	6	treatment	treatment	NOUN
dpc-1936	193	7	of	of	ADP
dpc-1936	193	8	psoriasis	psoriasis	NOUN
dpc-1936	193	9	vulgaris	vulgaris	NOUN
dpc-1936	193	10	.	.	PUNCT
dpc-1936	194	1	available	available	ADJ
dpc-1936	194	2	from	from	ADP
dpc-1936	194	3	:	:	PUNCT
dpc-1936	194	4	https://www.edf.one/home/guidelines/euroguiderm-psoriasis	https://www.edf.one/home/guidelines/euroguiderm-psoriasis	PROPN
dpc-1936	194	5	vulgaris.html	vulgaris.html	PROPN
dpc-1936	194	6	:	:	PUNCT
dpc-1936	194	7	european	european	ADJ
dpc-1936	194	8	dermatology	dermatology	NOUN
dpc-1936	194	9	forum;2020	forum;2020	PROPN
dpc-1936	194	10	.	.	PUNCT
dpc-1936	195	1	accessed	access	VERB
dpc-1936	195	2	12	12	NUM
dpc-1936	195	3	dec	dec	PROPN
dpc-1936	195	4	.	.	PROPN
dpc-1936	195	5	2020	2020	NUM
dpc-1936	195	6	.	.	PUNCT
dpc-1936	196	1	10	10	NUM
dpc-1936	196	2	.	.	PUNCT
dpc-1936	196	3	gossec	gossec	PROPN
dpc-1936	196	4	l	l	PROPN
dpc-1936	196	5	,	,	PUNCT
dpc-1936	196	6	baraliakos	baraliakos	ADJ
dpc-1936	196	7	x	x	NOUN
dpc-1936	196	8	,	,	PUNCT
dpc-1936	196	9	kerschbaumer	kerschbaumer	PROPN
dpc-1936	196	10	a	a	PROPN
dpc-1936	196	11	,	,	PUNCT
dpc-1936	196	12	et	et	PROPN
dpc-1936	196	13	al	al	PROPN
dpc-1936	196	14	.	.	PROPN
dpc-1936	197	1	eular	eular	ADJ
dpc-1936	197	2	recommendations	recommendation	NOUN
dpc-1936	197	3	for	for	ADP
dpc-1936	197	4	the	the	DET
dpc-1936	197	5	management	management	NOUN
dpc-1936	197	6	of	of	ADP
dpc-1936	197	7	psoriatic	psoriatic	ADJ
dpc-1936	197	8	arthritis	arthritis	NOUN
dpc-1936	197	9	with	with	ADP
dpc-1936	197	10	pharmacological	pharmacological	ADJ
dpc-1936	197	11	therapies	therapy	NOUN
dpc-1936	197	12	:	:	PUNCT
dpc-1936	197	13	2019	2019	NUM
dpc-1936	197	14	update	update	NOUN
dpc-1936	197	15	.	.	PUNCT
dpc-1936	198	1	ann	ann	PROPN
dpc-1936	198	2	rheum	rheum	PROPN
dpc-1936	198	3	dis	dis	PROPN
dpc-1936	198	4	.	.	PUNCT
dpc-1936	199	1	2020;79(6):700–712	2020;79(6):700–712	X
dpc-1936	199	2	.	.	PUNCT
dpc-1936	199	3	doi	doi	NOUN
dpc-1936	199	4	:	:	PUNCT
dpc-1936	199	5	10.1136	10.1136	NUM
dpc-1936	199	6	/	/	SYM
dpc-1936	199	7	annrheumdis-2020	annrheumdis-2020	NOUN
dpc-1936	199	8	-	-	PUNCT
dpc-1936	199	9	217159	217159	NUM
dpc-1936	199	10	.	.	PUNCT
dpc-1936	200	1	pmid	pmid	NOUN
dpc-1936	200	2	:	:	PUNCT
dpc-1936	200	3	32434812	32434812	NUM
dpc-1936	200	4	;	;	PUNCT
dpc-1936	200	5	pmcid	pmcid	ADJ
dpc-1936	200	6	:	:	PUNCT
dpc-1936	200	7	pmc7286048	pmc7286048	NOUN
dpc-1936	200	8	.	.	PUNCT
dpc-1936	201	1	11	11	NUM
dpc-1936	201	2	.	.	X
dpc-1936	202	1	mease	mease	PROPN
dpc-1936	202	2	pj	pj	PROPN
dpc-1936	202	3	,	,	PUNCT
dpc-1936	202	4	goffe	goffe	PROPN
dpc-1936	202	5	bs	bs	PROPN
dpc-1936	202	6	,	,	PUNCT
dpc-1936	202	7	metz	metz	PROPN
dpc-1936	202	8	j	j	PROPN
dpc-1936	202	9	,	,	PUNCT
dpc-1936	202	10	vanderstoep	vanderstoep	VERB
dpc-1936	202	11	a	a	DET
dpc-1936	202	12	,	,	PUNCT
dpc-1936	202	13	finck	finck	ADJ
dpc-1936	202	14	b	b	NOUN
dpc-1936	202	15	,	,	PUNCT
dpc-1936	202	16	burge	burge	NOUN
dpc-1936	202	17	dj	dj	NOUN
dpc-1936	202	18	.	.	PUNCT
dpc-1936	203	1	etanercept	etanercept	NOUN
dpc-1936	203	2	in	in	ADP
dpc-1936	203	3	the	the	DET
dpc-1936	203	4	treatment	treatment	NOUN
dpc-1936	203	5	of	of	ADP
dpc-1936	203	6	psoriatic	psoriatic	ADJ
dpc-1936	203	7	arthritis	arthritis	NOUN
dpc-1936	203	8	and	and	CCONJ
dpc-1936	203	9	psoriasis	psoriasis	NOUN
dpc-1936	203	10	:	:	PUNCT
dpc-1936	203	11	a	a	DET
dpc-1936	203	12	randomised	randomised	ADJ
dpc-1936	203	13	trial	trial	NOUN
dpc-1936	203	14	.	.	PUNCT
dpc-1936	204	1	lancet	lancet	NOUN
dpc-1936	204	2	.	.	PUNCT
dpc-1936	205	1	2000;356(9227):385–390	2000;356(9227):385–390	X
dpc-1936	205	2	.	.	PUNCT
dpc-1936	206	1	doi	doi	NOUN
dpc-1936	206	2	:	:	PUNCT
dpc-1936	206	3	10.1016	10.1016	NUM
dpc-1936	206	4	/	/	SYM
dpc-1936	206	5	s0140	s0140	PROPN
dpc-1936	206	6	-	-	PUNCT
dpc-1936	206	7	6736(00)02530	6736(00)02530	NUM
dpc-1936	206	8	-	-	PUNCT
dpc-1936	206	9	7	7	NUM
dpc-1936	206	10	.	.	PUNCT
dpc-1936	207	1	pmid	pmid	NOUN
dpc-1936	207	2	:	:	PUNCT
dpc-1936	207	3	10972371	10972371	NUM
dpc-1936	207	4	.	.	PUNCT
dpc-1936	208	1	12	12	NUM
dpc-1936	208	2	.	.	PUNCT
dpc-1936	209	1	kavanaugh	kavanaugh	PROPN
dpc-1936	209	2	a	a	PROPN
dpc-1936	209	3	,	,	PUNCT
dpc-1936	209	4	mcinnes	mcinnes	PROPN
dpc-1936	209	5	i	i	PRON
dpc-1936	209	6	,	,	PUNCT
dpc-1936	209	7	mease	mease	ADJ
dpc-1936	209	8	p	p	X
dpc-1936	209	9	,	,	PUNCT
dpc-1936	209	10	et	et	PROPN
dpc-1936	209	11	al	al	PROPN
dpc-1936	209	12	.	.	PROPN
dpc-1936	209	13	golimumab	golimumab	PROPN
dpc-1936	209	14	,	,	PUNCT
dpc-1936	209	15	a	a	DET
dpc-1936	209	16	new	new	ADJ
dpc-1936	209	17	human	human	ADJ
dpc-1936	209	18	tumor	tumor	NOUN
dpc-1936	209	19	necrosis	necrosis	NOUN
dpc-1936	209	20	factor	factor	NOUN
dpc-1936	209	21	alpha	alpha	NOUN
dpc-1936	209	22	antibody	antibody	NOUN
dpc-1936	209	23	,	,	PUNCT
dpc-1936	209	24	administered	administer	VERB
dpc-1936	209	25	every	every	DET
dpc-1936	209	26	four	four	NUM
dpc-1936	209	27	weeks	week	NOUN
dpc-1936	209	28	as	as	ADP
dpc-1936	209	29	a	a	DET
dpc-1936	209	30	subcutaneous	subcutaneous	ADJ
dpc-1936	209	31	injection	injection	NOUN
dpc-1936	209	32	in	in	ADP
dpc-1936	209	33	psoriatic	psoriatic	ADJ
dpc-1936	209	34	arthritis	arthritis	NOUN
dpc-1936	209	35	:	:	PUNCT
dpc-1936	209	36	twenty	twenty	NUM
dpc-1936	209	37	-	-	PUNCT
dpc-1936	209	38	four	four	NUM
dpc-1936	209	39	-	-	PUNCT
dpc-1936	209	40	week	week	NOUN
dpc-1936	209	41	efficacy	efficacy	NOUN
dpc-1936	209	42	and	and	CCONJ
dpc-1936	209	43	safety	safety	NOUN
dpc-1936	209	44	results	result	NOUN
dpc-1936	209	45	of	of	ADP
dpc-1936	209	46	a	a	DET
dpc-1936	209	47	randomized	randomized	ADJ
dpc-1936	209	48	,	,	PUNCT
dpc-1936	209	49	placebo	placebo	NOUN
dpc-1936	209	50	-	-	PUNCT
dpc-1936	209	51	controlled	control	VERB
dpc-1936	209	52	study	study	NOUN
dpc-1936	209	53	.	.	PUNCT
dpc-1936	210	1	arthritis	arthritis	NOUN
dpc-1936	210	2	rheum	rheum	NOUN
dpc-1936	210	3	.	.	PUNCT
dpc-1936	211	1	2009;60(4):976–986	2009;60(4):976–986	NUM
dpc-1936	211	2	.	.	X
dpc-1936	212	1	doi	doi	NOUN
dpc-1936	212	2	:	:	PUNCT
dpc-1936	212	3	10.1002	10.1002	NUM
dpc-1936	212	4	/	/	SYM
dpc-1936	212	5	art.24403	art.24403	PROPN
dpc-1936	212	6	.	.	PUNCT
dpc-1936	213	1	pmid	pmid	NOUN
dpc-1936	213	2	:	:	PUNCT
dpc-1936	213	3	19333944	19333944	NUM
dpc-1936	213	4	.	.	PUNCT
dpc-1936	214	1	13	13	NUM
dpc-1936	214	2	.	.	X
dpc-1936	215	1	mease	mease	PROPN
dpc-1936	215	2	pj	pj	PROPN
dpc-1936	215	3	,	,	PUNCT
dpc-1936	215	4	gladman	gladman	NOUN
dpc-1936	215	5	dd	dd	PROPN
dpc-1936	215	6	,	,	PUNCT
dpc-1936	215	7	ritchlin	ritchlin	PROPN
dpc-1936	215	8	ct	ct	PROPN
dpc-1936	215	9	,	,	PUNCT
dpc-1936	215	10	et	et	PROPN
dpc-1936	215	11	al	al	PROPN
dpc-1936	215	12	.	.	PROPN
dpc-1936	215	13	adalimumab	adalimumab	PROPN
dpc-1936	215	14	for	for	ADP
dpc-1936	215	15	the	the	DET
dpc-1936	215	16	treatment	treatment	NOUN
dpc-1936	215	17	of	of	ADP
dpc-1936	215	18	patients	patient	NOUN
dpc-1936	215	19	with	with	ADP
dpc-1936	215	20	moderately	moderately	ADV
dpc-1936	215	21	to	to	PART
dpc-1936	215	22	severely	severely	ADV
dpc-1936	215	23	active	active	ADJ
dpc-1936	215	24	psoriatic	psoriatic	ADJ
dpc-1936	215	25	arthritis	arthritis	NOUN
dpc-1936	215	26	:	:	PUNCT
dpc-1936	215	27	results	result	NOUN
dpc-1936	215	28	of	of	ADP
dpc-1936	215	29	a	a	DET
dpc-1936	215	30	double	double	ADJ
dpc-1936	215	31	-	-	PUNCT
dpc-1936	215	32	blind	blind	ADJ
dpc-1936	215	33	,	,	PUNCT
dpc-1936	215	34	randomized	randomize	VERB
dpc-1936	215	35	,	,	PUNCT
dpc-1936	215	36	placebo	placebo	NOUN
dpc-1936	215	37	-	-	PUNCT
dpc-1936	215	38	controlled	control	VERB
dpc-1936	215	39	trial	trial	NOUN
dpc-1936	215	40	.	.	PUNCT
dpc-1936	216	1	arthritis	arthritis	NOUN
dpc-1936	216	2	rheum	rheum	NOUN
dpc-1936	216	3	.	.	PUNCT
dpc-1936	217	1	2005;52(10):3279–3289	2005;52(10):3279–3289	NUM
dpc-1936	217	2	.	.	PUNCT
dpc-1936	218	1	doi	doi	NOUN
dpc-1936	218	2	:	:	PUNCT
dpc-1936	218	3	10.1002	10.1002	NUM
dpc-1936	218	4	/	/	SYM
dpc-1936	218	5	art.21306	art.21306	NOUN
dpc-1936	218	6	.	.	PUNCT
dpc-1936	219	1	pmid	pmid	NOUN
dpc-1936	219	2	:	:	PUNCT
dpc-1936	219	3	16200601	16200601	NUM
dpc-1936	219	4	.	.	PUNCT
dpc-1936	220	1	14	14	NUM
dpc-1936	220	2	.	.	PUNCT
dpc-1936	221	1	mease	mease	PROPN
dpc-1936	221	2	pj	pj	PROPN
dpc-1936	221	3	,	,	PUNCT
dpc-1936	221	4	genovese	genovese	PROPN
dpc-1936	221	5	mc	mc	PROPN
dpc-1936	221	6	,	,	PUNCT
dpc-1936	221	7	greenwald	greenwald	PROPN
dpc-1936	221	8	mw	mw	PROPN
dpc-1936	221	9	,	,	PUNCT
dpc-1936	221	10	et	et	PROPN
dpc-1936	221	11	al	al	PROPN
dpc-1936	221	12	.	.	PROPN
dpc-1936	221	13	brodalumab	brodalumab	PROPN
dpc-1936	221	14	,	,	PUNCT
dpc-1936	221	15	an	an	DET
dpc-1936	221	16	anti	anti	ADJ
dpc-1936	221	17	-	-	ADJ
dpc-1936	221	18	il17ra	il17ra	NOUN
dpc-1936	221	19	monoclonal	monoclonal	NOUN
dpc-1936	221	20	antibody	antibody	NOUN
dpc-1936	221	21	,	,	PUNCT
dpc-1936	221	22	in	in	ADP
dpc-1936	221	23	psoriatic	psoriatic	ADJ
dpc-1936	221	24	arthritis	arthritis	NOUN
dpc-1936	221	25	.	.	PUNCT
dpc-1936	222	1	n	n	PROPN
dpc-1936	222	2	engl	engl	PROPN
dpc-1936	222	3	j	j	PROPN
dpc-1936	222	4	med	med	PROPN
dpc-1936	222	5	.	.	PUNCT
dpc-1936	223	1	2014;370(24):2295–2306	2014;370(24):2295–2306	NUM
dpc-1936	223	2	.	.	PUNCT
dpc-1936	224	1	doi	doi	NOUN
dpc-1936	224	2	:	:	PUNCT
dpc-1936	224	3	10.1056	10.1056	NUM
dpc-1936	224	4	/	/	SYM
dpc-1936	224	5	nejmoa1315231	nejmoa1315231	PROPN
dpc-1936	224	6	.	.	PUNCT
dpc-1936	225	1	pmid	pmid	NOUN
dpc-1936	225	2	:	:	PUNCT
dpc-1936	225	3	24918373	24918373	NUM
dpc-1936	225	4	.	.	PUNCT
dpc-1936	226	1	15	15	NUM
dpc-1936	226	2	.	.	X
dpc-1936	227	1	mease	mease	PROPN
dpc-1936	227	2	pj	pj	PROPN
dpc-1936	227	3	,	,	PUNCT
dpc-1936	227	4	van	van	PROPN
dpc-1936	227	5	der	der	PROPN
dpc-1936	227	6	heijde	heijde	NOUN
dpc-1936	227	7	d	d	PROPN
dpc-1936	227	8	,	,	PUNCT
dpc-1936	227	9	ritchlin	ritchlin	PROPN
dpc-1936	227	10	ct	ct	PROPN
dpc-1936	227	11	,	,	PUNCT
dpc-1936	227	12	et	et	PROPN
dpc-1936	227	13	al	al	PROPN
dpc-1936	227	14	.	.	PROPN
dpc-1936	227	15	ixekizumab	ixekizumab	PROPN
dpc-1936	227	16	,	,	PUNCT
dpc-1936	227	17	an	an	DET
dpc-1936	227	18	interleukin-17a	interleukin-17a	PROPN
dpc-1936	227	19	specific	specific	ADJ
dpc-1936	227	20	monoclonal	monoclonal	NOUN
dpc-1936	227	21	antibody	antibody	NOUN
dpc-1936	227	22	,	,	PUNCT
dpc-1936	227	23	for	for	ADP
dpc-1936	227	24	the	the	DET
dpc-1936	227	25	treatment	treatment	NOUN
dpc-1936	227	26	of	of	ADP
dpc-1936	227	27	biologic	biologic	NOUN
dpc-1936	227	28	-	-	PUNCT
dpc-1936	227	29	naive	naive	ADJ
dpc-1936	227	30	patients	patient	NOUN
dpc-1936	227	31	with	with	ADP
dpc-1936	227	32	active	active	ADJ
dpc-1936	227	33	psoriatic	psoriatic	ADJ
dpc-1936	227	34	arthritis	arthritis	NOUN
dpc-1936	227	35	:	:	PUNCT
dpc-1936	227	36	results	result	NOUN
dpc-1936	227	37	from	from	ADP
dpc-1936	227	38	the	the	DET
dpc-1936	227	39	24	24	NUM
dpc-1936	227	40	-	-	PUNCT
dpc-1936	227	41	week	week	NOUN
dpc-1936	227	42	randomised	randomise	VERB
dpc-1936	227	43	,	,	PUNCT
dpc-1936	227	44	double	double	ADJ
dpc-1936	227	45	-	-	PUNCT
dpc-1936	227	46	blind	blind	ADJ
dpc-1936	227	47	,	,	PUNCT
dpc-1936	227	48	placebo	placebo	NOUN
dpc-1936	227	49	-	-	PUNCT
dpc-1936	227	50	controlled	control	VERB
dpc-1936	227	51	and	and	CCONJ
dpc-1936	227	52	active	active	ADJ
dpc-1936	227	53	(	(	PUNCT
dpc-1936	227	54	adalimumab)-controlled	adalimumab)-controlle	VERB
dpc-1936	227	55	period	period	NOUN
dpc-1936	227	56	of	of	ADP
dpc-1936	227	57	the	the	DET
dpc-1936	227	58	phase	phase	NOUN
dpc-1936	227	59	iii	iii	NUM
dpc-1936	227	60	trial	trial	NOUN
dpc-1936	227	61	spirit	spirit	NOUN
dpc-1936	227	62	-	-	PUNCT
dpc-1936	227	63	p1	p1	PROPN
dpc-1936	227	64	.	.	PUNCT
dpc-1936	228	1	ann	ann	PROPN
dpc-1936	228	2	rheum	rheum	PROPN
dpc-1936	228	3	dis	dis	PROPN
dpc-1936	228	4	.	.	PUNCT
dpc-1936	229	1	2017;76(1):79–87	2017;76(1):79–87	X
dpc-1936	229	2	.	.	PUNCT
dpc-1936	229	3	doi	doi	NOUN
dpc-1936	229	4	:	:	PUNCT
dpc-1936	229	5	10.1136/	10.1136/	NUM
dpc-1936	229	6	0	0	NUM
dpc-1936	229	7	at	at	ADP
dpc-1936	229	8	w52	w52	NOUN
dpc-1936	229	9	but	but	CCONJ
dpc-1936	229	10	does	do	AUX
dpc-1936	229	11	not	not	PART
dpc-1936	229	12	have	have	VERB
dpc-1936	229	13	a	a	DET
dpc-1936	229	14	response	response	NOUN
dpc-1936	229	15	-	-	PUNCT
dpc-1936	229	16	modifying	modify	VERB
dpc-1936	229	17	effect	effect	NOUN
dpc-1936	229	18	in	in	ADP
dpc-1936	229	19	ixe	ixe	NOUN
dpc-1936	229	20	-	-	PUNCT
dpc-1936	229	21	treated	treat	VERB
dpc-1936	229	22	patients	patient	NOUN
dpc-1936	229	23	[	[	X
dpc-1936	229	24	39	39	NUM
dpc-1936	229	25	]	]	PUNCT
dpc-1936	229	26	.	.	PUNCT
dpc-1936	230	1	therefore	therefore	ADV
dpc-1936	230	2	,	,	PUNCT
dpc-1936	230	3	it	it	PRON
dpc-1936	230	4	is	be	AUX
dpc-1936	230	5	possible	possible	ADJ
dpc-1936	230	6	that	that	SCONJ
dpc-1936	230	7	the	the	DET
dpc-1936	230	8	proportion	proportion	NOUN
dpc-1936	230	9	of	of	ADP
dpc-1936	230	10	ada	ada	PROPN
dpc-1936	230	11	-	-	PUNCT
dpc-1936	230	12	treated	treat	VERB
dpc-1936	230	13	patients	patient	NOUN
dpc-1936	230	14	achieving	achieve	VERB
dpc-1936	230	15	simultaneous	simultaneous	ADJ
dpc-1936	230	16	acr50	acr50	ADJ
dpc-1936	230	17	and	and	CCONJ
dpc-1936	230	18	pasi100	pasi100	PROPN
dpc-1936	230	19	,	,	PUNCT
dpc-1936	230	20	or	or	CCONJ
dpc-1936	230	21	clearance	clearance	NOUN
dpc-1936	230	22	of	of	ADP
dpc-1936	230	23	nail	nail	NOUN
dpc-1936	230	24	pso	pso	NOUN
dpc-1936	230	25	in	in	ADP
dpc-1936	230	26	our	our	PRON
dpc-1936	230	27	subgroup	subgroup	NOUN
dpc-1936	230	28	analysis	analysis	NOUN
dpc-1936	230	29	is	be	AUX
dpc-1936	230	30	higher	high	ADJ
dpc-1936	230	31	than	than	SCONJ
dpc-1936	230	32	would	would	AUX
dpc-1936	230	33	be	be	AUX
dpc-1936	230	34	observed	observe	VERB
dpc-1936	230	35	in	in	ADP
dpc-1936	230	36	patients	patient	NOUN
dpc-1936	230	37	receiving	receive	VERB
dpc-1936	230	38	ada	ada	PROPN
dpc-1936	230	39	monotherapy	monotherapy	NOUN
dpc-1936	230	40	.	.	PUNCT
dpc-1936	231	1	the	the	DET
dpc-1936	231	2	safety	safety	NOUN
dpc-1936	231	3	profiles	profile	NOUN
dpc-1936	231	4	of	of	ADP
dpc-1936	231	5	both	both	CCONJ
dpc-1936	231	6	ixe	ixe	NOUN
dpc-1936	231	7	and	and	CCONJ
dpc-1936	231	8	ada	ada	PROPN
dpc-1936	231	9	were	be	AUX
dpc-1936	231	10	consistent	consistent	ADJ
dpc-1936	231	11	with	with	ADP
dpc-1936	231	12	previous	previous	ADJ
dpc-1936	231	13	clinical	clinical	ADJ
dpc-1936	231	14	trials	trial	NOUN
dpc-1936	231	15	and	and	CCONJ
dpc-1936	231	16	the	the	DET
dpc-1936	231	17	prescriber	prescriber	NOUN
dpc-1936	231	18	information	information	NOUN
dpc-1936	231	19	for	for	ADP
dpc-1936	231	20	both	both	DET
dpc-1936	231	21	drugs	drug	NOUN
dpc-1936	231	22	.	.	PUNCT
dpc-1936	232	1	the	the	DET
dpc-1936	232	2	ada	ada	PROPN
dpc-1936	232	3	group	group	PROPN
dpc-1936	232	4	had	have	VERB
dpc-1936	232	5	numerically	numerically	ADV
dpc-1936	232	6	more	more	ADJ
dpc-1936	232	7	saes	sae	NOUN
dpc-1936	232	8	(	(	PUNCT
dpc-1936	232	9	there	there	PRON
dpc-1936	232	10	were	be	VERB
dpc-1936	232	11	no	no	DET
dpc-1936	232	12	saes	saes	PROPN
dpc-1936	232	13	in	in	ADP
dpc-1936	232	14	the	the	DET
dpc-1936	232	15	ixe	ixe	PROPN
dpc-1936	232	16	group	group	NOUN
dpc-1936	232	17	)	)	PUNCT
dpc-1936	232	18	and	and	CCONJ
dpc-1936	232	19	treatment	treatment	NOUN
dpc-1936	232	20	discontinuations	discontinuation	NOUN
dpc-1936	232	21	due	due	ADJ
dpc-1936	232	22	to	to	ADP
dpc-1936	232	23	aes	aes	PROPN
dpc-1936	232	24	,	,	PUNCT
dpc-1936	232	25	which	which	PRON
dpc-1936	232	26	is	be	AUX
dpc-1936	232	27	consistent	consistent	ADJ
dpc-1936	232	28	with	with	ADP
dpc-1936	232	29	previously	previously	ADV
dpc-1936	232	30	published	publish	VERB
dpc-1936	232	31	safety	safety	NOUN
dpc-1936	232	32	data	datum	NOUN
dpc-1936	232	33	from	from	ADP
dpc-1936	232	34	the	the	DET
dpc-1936	232	35	overall	overall	ADJ
dpc-1936	232	36	spirit	spirit	NOUN
dpc-1936	232	37	-	-	PUNCT
dpc-1936	232	38	h2h	h2h	PROPN
dpc-1936	232	39	trial	trial	NOUN
dpc-1936	232	40	[	[	X
dpc-1936	232	41	18,19	18,19	NUM
dpc-1936	232	42	]	]	PUNCT
dpc-1936	232	43	.	.	PUNCT
dpc-1936	233	1	the	the	DET
dpc-1936	233	2	limitations	limitation	NOUN
dpc-1936	233	3	of	of	ADP
dpc-1936	233	4	this	this	DET
dpc-1936	233	5	study	study	NOUN
dpc-1936	233	6	include	include	VERB
dpc-1936	233	7	the	the	DET
dpc-1936	233	8	open	open	ADJ
dpc-1936	233	9	-	-	PUNCT
dpc-1936	233	10	label	label	NOUN
dpc-1936	233	11	design	design	NOUN
dpc-1936	233	12	,	,	PUNCT
dpc-1936	233	13	which	which	PRON
dpc-1936	233	14	may	may	AUX
dpc-1936	233	15	have	have	AUX
dpc-1936	233	16	biased	bias	VERB
dpc-1936	233	17	the	the	DET
dpc-1936	233	18	outcome	outcome	NOUN
dpc-1936	233	19	assessments	assessment	NOUN
dpc-1936	233	20	.	.	PUNCT
dpc-1936	234	1	another	another	DET
dpc-1936	234	2	limitation	limitation	NOUN
dpc-1936	234	3	is	be	AUX
dpc-1936	234	4	that	that	SCONJ
dpc-1936	234	5	while	while	SCONJ
dpc-1936	234	6	the	the	DET
dpc-1936	234	7	data	datum	NOUN
dpc-1936	234	8	show	show	VERB
dpc-1936	234	9	clinically	clinically	ADV
dpc-1936	234	10	meaningful	meaningful	ADJ
dpc-1936	234	11	differences	difference	NOUN
dpc-1936	234	12	,	,	PUNCT
dpc-1936	234	13	the	the	DET
dpc-1936	234	14	sample	sample	NOUN
dpc-1936	234	15	size	size	NOUN
dpc-1936	234	16	was	be	AUX
dpc-1936	234	17	small	small	ADJ
dpc-1936	234	18	and	and	CCONJ
dpc-1936	234	19	this	this	DET
dpc-1936	234	20	post	post	X
dpc-1936	234	21	hoc	hoc	X
dpc-1936	234	22	analysis	analysis	NOUN
dpc-1936	234	23	was	be	AUX
dpc-1936	234	24	not	not	PART
dpc-1936	234	25	powered	power	VERB
dpc-1936	234	26	to	to	PART
dpc-1936	234	27	demonstrate	demonstrate	VERB
dpc-1936	234	28	statistical	statistical	ADJ
dpc-1936	234	29	differences	difference	NOUN
dpc-1936	234	30	between	between	ADP
dpc-1936	234	31	these	these	DET
dpc-1936	234	32	subgroups	subgroup	NOUN
dpc-1936	234	33	.	.	PUNCT
dpc-1936	235	1	in	in	ADP
dpc-1936	235	2	conclusion	conclusion	NOUN
dpc-1936	235	3	,	,	PUNCT
dpc-1936	235	4	this	this	DET
dpc-1936	235	5	subgroup	subgroup	NOUN
dpc-1936	235	6	analysis	analysis	NOUN
dpc-1936	235	7	demonstrated	demonstrate	VERB
dpc-1936	235	8	that	that	SCONJ
dpc-1936	235	9	ixeversus	ixeversus	PROPN
dpc-1936	235	10	ada	ada	PROPN
dpc-1936	235	11	-	-	PUNCT
dpc-1936	235	12	treated	treat	VERB
dpc-1936	235	13	patients	patient	NOUN
dpc-1936	235	14	achieved	achieve	VERB
dpc-1936	235	15	significantly	significantly	ADV
dpc-1936	235	16	greater	greater	ADV
dpc-1936	235	17	simultaneous	simultaneous	ADJ
dpc-1936	235	18	pasi100	pasi100	PROPN
dpc-1936	235	19	and	and	CCONJ
dpc-1936	235	20	acr50	acr50	ADJ
dpc-1936	235	21	responses	response	NOUN
dpc-1936	235	22	through	through	ADP
dpc-1936	235	23	w52	w52	NOUN
dpc-1936	235	24	and	and	CCONJ
dpc-1936	235	25	confirmed	confirm	VERB
dpc-1936	235	26	ixe	ixe	NOUN
dpc-1936	235	27	as	as	ADP
dpc-1936	235	28	an	an	DET
dpc-1936	235	29	efficacious	efficacious	ADJ
dpc-1936	235	30	and	and	CCONJ
dpc-1936	235	31	safe	safe	ADJ
dpc-1936	235	32	treatment	treatment	NOUN
dpc-1936	235	33	for	for	ADP
dpc-1936	235	34	patients	patient	NOUN
dpc-1936	235	35	with	with	ADP
dpc-1936	235	36	active	active	ADJ
dpc-1936	235	37	psa	psa	NOUN
dpc-1936	235	38	and	and	CCONJ
dpc-1936	235	39	moderate	moderate	ADJ
dpc-1936	235	40	-	-	PUNCT
dpc-1936	235	41	to	to	ADP
dpc-1936	235	42	severe	severe	ADJ
dpc-1936	235	43	pso	pso	NOUN
dpc-1936	235	44	.	.	PUNCT
dpc-1936	236	1	additionally	additionally	ADV
dpc-1936	236	2	,	,	PUNCT
dpc-1936	236	3	comparison	comparison	NOUN
dpc-1936	236	4	of	of	ADP
dpc-1936	236	5	the	the	DET
dpc-1936	236	6	results	result	NOUN
dpc-1936	236	7	of	of	ADP
dpc-1936	236	8	this	this	DET
dpc-1936	236	9	analysis	analysis	NOUN
dpc-1936	236	10	with	with	ADP
dpc-1936	236	11	those	those	PRON
dpc-1936	236	12	of	of	ADP
dpc-1936	236	13	other	other	ADJ
dpc-1936	236	14	studies	study	NOUN
dpc-1936	236	15	confirms	confirm	VERB
dpc-1936	236	16	the	the	DET
dpc-1936	236	17	efficacy	efficacy	NOUN
dpc-1936	236	18	of	of	ADP
dpc-1936	236	19	ixe	ixe	NOUN
dpc-1936	236	20	in	in	ADP
dpc-1936	236	21	treating	treat	VERB
dpc-1936	236	22	nail	nail	NOUN
dpc-1936	236	23	pso	pso	NOUN
dpc-1936	236	24	in	in	ADP
dpc-1936	236	25	patients	patient	NOUN
dpc-1936	236	26	with	with	ADP
dpc-1936	236	27	moderate	moderate	ADJ
dpc-1936	236	28	-	-	PUNCT
dpc-1936	236	29	to	to	ADP
dpc-1936	236	30	-	-	PUNCT
dpc-1936	236	31	severe	severe	ADJ
dpc-1936	236	32	pso	pso	NOUN
dpc-1936	236	33	,	,	PUNCT
dpc-1936	236	34	irrespective	irrespective	ADV
dpc-1936	236	35	of	of	ADP
dpc-1936	236	36	concomitant	concomitant	ADJ
dpc-1936	236	37	active	active	ADJ
dpc-1936	236	38	psa	psa	NOUN
dpc-1936	237	1	[	[	PUNCT
dpc-1936	237	2	26	26	NUM
dpc-1936	237	3	-	-	SYM
dpc-1936	237	4	28	28	NUM
dpc-1936	237	5	]	]	PUNCT
dpc-1936	237	6	.	.	PUNCT
dpc-1936	238	1	these	these	DET
dpc-1936	238	2	results	result	NOUN
dpc-1936	238	3	increase	increase	VERB
dpc-1936	238	4	awareness	awareness	NOUN
dpc-1936	238	5	of	of	ADP
dpc-1936	238	6	available	available	ADJ
dpc-1936	238	7	treatment	treatment	NOUN
dpc-1936	238	8	options	option	NOUN
dpc-1936	238	9	and	and	CCONJ
dpc-1936	238	10	inform	inform	VERB
dpc-1936	238	11	evidence	evidence	NOUN
dpc-1936	238	12	-	-	PUNCT
dpc-1936	238	13	based	base	VERB
dpc-1936	238	14	clinical	clinical	ADJ
dpc-1936	238	15	decisions	decision	NOUN
dpc-1936	238	16	for	for	ADP
dpc-1936	238	17	patients	patient	NOUN
dpc-1936	238	18	with	with	ADP
dpc-1936	238	19	active	active	ADJ
dpc-1936	238	20	psa	psa	NOUN
dpc-1936	238	21	and	and	CCONJ
dpc-1936	238	22	moderate	moderate	ADJ
dpc-1936	238	23	-	-	PUNCT
dpc-1936	238	24	to	to	ADP
dpc-1936	238	25	-	-	PUNCT
dpc-1936	238	26	severe	severe	ADJ
dpc-1936	238	27	pso	pso	NOUN
dpc-1936	238	28	.	.	PUNCT
dpc-1936	239	1	acknowledgements	acknowledgement	NOUN
dpc-1936	239	2	the	the	DET
dpc-1936	239	3	authors	author	NOUN
dpc-1936	239	4	would	would	AUX
dpc-1936	239	5	like	like	VERB
dpc-1936	239	6	to	to	PART
dpc-1936	239	7	thank	thank	VERB
dpc-1936	239	8	gabrielle	gabrielle	PROPN
dpc-1936	239	9	stack	stack	NOUN
dpc-1936	239	10	,	,	PUNCT
dpc-1936	239	11	phd	phd	NOUN
dpc-1936	239	12	,	,	PUNCT
dpc-1936	239	13	a	a	DET
dpc-1936	239	14	medical	medical	ADJ
dpc-1936	239	15	writer	writer	NOUN
dpc-1936	239	16	and	and	CCONJ
dpc-1936	239	17	employee	employee	NOUN
dpc-1936	239	18	of	of	ADP
dpc-1936	239	19	eli	eli	PROPN
dpc-1936	239	20	lilly	lilly	PROPN
dpc-1936	239	21	and	and	CCONJ
dpc-1936	239	22	company	company	NOUN
dpc-1936	239	23	,	,	PUNCT
dpc-1936	239	24	for	for	ADP
dpc-1936	239	25	writing	writing	NOUN
dpc-1936	239	26	and	and	CCONJ
dpc-1936	239	27	editorial	editorial	ADJ
dpc-1936	239	28	support	support	NOUN
dpc-1936	239	29	.	.	PUNCT
dpc-1936	240	1	references	reference	NOUN
dpc-1936	240	2	1	1	NUM
dpc-1936	240	3	.	.	PUNCT
dpc-1936	240	4	de	de	PROPN
dpc-1936	240	5	vlam	vlam	PROPN
dpc-1936	240	6	k	k	PROPN
dpc-1936	240	7	,	,	PUNCT
dpc-1936	240	8	gottlieb	gottlieb	PROPN
dpc-1936	240	9	ab	ab	PROPN
dpc-1936	240	10	,	,	PUNCT
dpc-1936	240	11	mease	mease	PROPN
dpc-1936	240	12	pj	pj	PROPN
dpc-1936	240	13	.	.	PUNCT
dpc-1936	241	1	current	current	ADJ
dpc-1936	241	2	concepts	concept	NOUN
dpc-1936	241	3	in	in	ADP
dpc-1936	241	4	psoriatic	psoriatic	ADJ
dpc-1936	241	5	arthritis	arthritis	NOUN
dpc-1936	241	6	:	:	PUNCT
dpc-1936	241	7	pathogenesis	pathogenesis	NOUN
dpc-1936	241	8	and	and	CCONJ
dpc-1936	241	9	management	management	NOUN
dpc-1936	241	10	.	.	PUNCT
dpc-1936	242	1	acta	acta	PROPN
dpc-1936	242	2	derm	derm	PROPN
dpc-1936	242	3	venereol	venereol	NOUN
dpc-1936	242	4	.	.	PUNCT
dpc-1936	243	1	2014;94(6):627–634	2014;94(6):627–634	X
dpc-1936	243	2	.	.	PUNCT
dpc-1936	243	3	doi	doi	PROPN
dpc-1936	243	4	:	:	PUNCT
dpc-1936	243	5	10.2340/00015555	10.2340/00015555	NUM
dpc-1936	243	6	-	-	SYM
dpc-1936	243	7	1833	1833	NUM
dpc-1936	243	8	.	.	PUNCT
dpc-1936	244	1	pmid	pmid	NOUN
dpc-1936	244	2	:	:	PUNCT
dpc-1936	244	3	24573106	24573106	NUM
dpc-1936	244	4	.	.	PUNCT
dpc-1936	245	1	2	2	X
dpc-1936	245	2	.	.	X
dpc-1936	245	3	kavanaugh	kavanaugh	PROPN
dpc-1936	245	4	a	a	PRON
dpc-1936	245	5	,	,	PUNCT
dpc-1936	245	6	helliwell	helliwell	NOUN
dpc-1936	245	7	p	p	X
dpc-1936	245	8	,	,	PUNCT
dpc-1936	245	9	ritchlin	ritchlin	PROPN
dpc-1936	245	10	ct	ct	PROPN
dpc-1936	245	11	.	.	PUNCT
dpc-1936	246	1	psoriatic	psoriatic	ADJ
dpc-1936	246	2	arthritis	arthritis	NOUN
dpc-1936	246	3	and	and	CCONJ
dpc-1936	246	4	burden	burden	NOUN
dpc-1936	246	5	of	of	ADP
dpc-1936	246	6	disease	disease	NOUN
dpc-1936	246	7	:	:	PUNCT
dpc-1936	246	8	patient	patient	ADJ
dpc-1936	246	9	perspectives	perspective	NOUN
dpc-1936	246	10	from	from	ADP
dpc-1936	246	11	the	the	DET
dpc-1936	246	12	population	population	NOUN
dpc-1936	246	13	-	-	PUNCT
dpc-1936	246	14	based	base	VERB
dpc-1936	246	15	multinational	multinational	ADJ
dpc-1936	246	16	assessment	assessment	NOUN
dpc-1936	246	17	of	of	ADP
dpc-1936	246	18	psoriasis	psoriasis	NOUN
dpc-1936	246	19	and	and	CCONJ
dpc-1936	246	20	psoriatic	psoriatic	ADJ
dpc-1936	246	21	arthritis	arthritis	NOUN
dpc-1936	246	22	(	(	PUNCT
dpc-1936	246	23	mapp	mapp	NOUN
dpc-1936	246	24	)	)	PUNCT
dpc-1936	246	25	survey	survey	NOUN
dpc-1936	246	26	.	.	PUNCT
dpc-1936	247	1	rheumatol	rheumatol	VERB
dpc-1936	247	2	ther	ther	ADV
dpc-1936	247	3	.	.	PUNCT
dpc-1936	248	1	2016;3(1):91–102	2016;3(1):91–102	NUM
dpc-1936	248	2	.	.	PUNCT
dpc-1936	249	1	doi	doi	NOUN
dpc-1936	249	2	:	:	PUNCT
dpc-1936	249	3	10.1007	10.1007	NUM
dpc-1936	249	4	/	/	SYM
dpc-1936	249	5	s40744	s40744	NOUN
dpc-1936	249	6	-	-	PUNCT
dpc-1936	249	7	016	016	NUM
dpc-1936	249	8	-	-	PUNCT
dpc-1936	249	9	0029	0029	NUM
dpc-1936	249	10	-	-	PUNCT
dpc-1936	249	11	z.	z.	PROPN
dpc-1936	249	12	pmid	pmid	PROPN
dpc-1936	249	13	:	:	PUNCT
dpc-1936	249	14	27747516	27747516	NUM
dpc-1936	249	15	.	.	PUNCT
dpc-1936	250	1	pmcid	pmcid	ADJ
dpc-1936	250	2	:	:	PUNCT
dpc-1936	250	3	pmc4999579	pmc4999579	NOUN
dpc-1936	250	4	.	.	PUNCT
dpc-1936	251	1	3	3	X
dpc-1936	251	2	.	.	X
dpc-1936	251	3	boehncke	boehncke	PROPN
dpc-1936	251	4	wh	wh	PROPN
dpc-1936	251	5	,	,	PUNCT
dpc-1936	251	6	menter	menter	NOUN
dpc-1936	251	7	a.	a.	NOUN
dpc-1936	251	8	burden	burden	NOUN
dpc-1936	251	9	of	of	ADP
dpc-1936	251	10	disease	disease	NOUN
dpc-1936	251	11	:	:	PUNCT
dpc-1936	251	12	psoriasis	psoriasis	NOUN
dpc-1936	251	13	and	and	CCONJ
dpc-1936	251	14	psoriatic	psoriatic	ADJ
dpc-1936	251	15	arthritis	arthritis	NOUN
dpc-1936	251	16	.	.	PUNCT
dpc-1936	252	1	am	be	AUX
dpc-1936	252	2	j	j	PROPN
dpc-1936	252	3	clin	clin	PROPN
dpc-1936	252	4	dermatol	dermatol	NOUN
dpc-1936	252	5	.	.	PUNCT
dpc-1936	253	1	2013;14(5):377–388	2013;14(5):377–388	X
dpc-1936	253	2	.	.	PUNCT
dpc-1936	253	3	doi	doi	NOUN
dpc-1936	253	4	:	:	PUNCT
dpc-1936	253	5	10.1007	10.1007	NUM
dpc-1936	253	6	/	/	SYM
dpc-1936	253	7	s40257	s40257	NOUN
dpc-1936	253	8	-	-	PUNCT
dpc-1936	253	9	013	013	NUM
dpc-1936	253	10	-	-	PUNCT
dpc-1936	253	11	0032	0032	NUM
dpc-1936	253	12	-	-	PUNCT
dpc-1936	253	13	x.	x.	NOUN
dpc-1936	253	14	pmid	pmid	PROPN
dpc-1936	253	15	:	:	PUNCT
dpc-1936	253	16	23771648	23771648	NUM
dpc-1936	253	17	.	.	PUNCT
dpc-1936	254	1	original	original	ADJ
dpc-1936	254	2	article	article	NOUN
dpc-1936	254	3	|	|	ADV
dpc-1936	254	4	dermatol	dermatol	ADJ
dpc-1936	254	5	pract	pract	NOUN
dpc-1936	254	6	concept	concept	NOUN
dpc-1936	254	7	.	.	PUNCT
dpc-1936	255	1	2022;12(2):e2022104	2022;12(2):e2022104	PROPN
dpc-1936	255	2	11	11	NUM
dpc-1936	255	3	28	28	NUM
dpc-1936	255	4	.	.	PUNCT
dpc-1936	256	1	blauvelt	blauvelt	VERB
dpc-1936	256	2	a	a	PRON
dpc-1936	256	3	,	,	PUNCT
dpc-1936	256	4	leonardi	leonardi	PROPN
dpc-1936	256	5	c	c	PROPN
dpc-1936	256	6	,	,	PUNCT
dpc-1936	256	7	elewski	elewski	NOUN
dpc-1936	256	8	b	b	PROPN
dpc-1936	256	9	,	,	PUNCT
dpc-1936	256	10	et	et	PROPN
dpc-1936	256	11	al	al	PROPN
dpc-1936	256	12	.	.	PUNCT
dpc-1936	257	1	a	a	DET
dpc-1936	257	2	head	head	NOUN
dpc-1936	257	3	-	-	PUNCT
dpc-1936	257	4	to	to	ADP
dpc-1936	257	5	-	-	PUNCT
dpc-1936	257	6	head	head	NOUN
dpc-1936	257	7	comparison	comparison	NOUN
dpc-1936	257	8	of	of	ADP
dpc-1936	257	9	ixekizumab	ixekizumab	NOUN
dpc-1936	257	10	vs.	vs.	ADP
dpc-1936	257	11	guselkumab	guselkumab	NOUN
dpc-1936	257	12	in	in	ADP
dpc-1936	257	13	patients	patient	NOUN
dpc-1936	257	14	with	with	ADP
dpc-1936	257	15	moderate	moderate	ADJ
dpc-1936	257	16	-	-	PUNCT
dpc-1936	257	17	to	to	ADP
dpc-1936	257	18	-	-	PUNCT
dpc-1936	257	19	severe	severe	ADJ
dpc-1936	257	20	plaque	plaque	NOUN
dpc-1936	257	21	psoriasis	psoriasis	NOUN
dpc-1936	257	22	:	:	PUNCT
dpc-1936	257	23	24	24	NUM
dpc-1936	257	24	-	-	PUNCT
dpc-1936	257	25	week	week	NOUN
dpc-1936	257	26	efficacy	efficacy	NOUN
dpc-1936	257	27	and	and	CCONJ
dpc-1936	257	28	safety	safety	NOUN
dpc-1936	257	29	results	result	NOUN
dpc-1936	257	30	from	from	ADP
dpc-1936	257	31	a	a	DET
dpc-1936	257	32	randomized	randomized	ADJ
dpc-1936	257	33	,	,	PUNCT
dpc-1936	257	34	double	double	ADJ
dpc-1936	257	35	-	-	PUNCT
dpc-1936	257	36	blinded	blind	VERB
dpc-1936	257	37	trial	trial	NOUN
dpc-1936	257	38	.	.	PUNCT
dpc-1936	258	1	br	br	PROPN
dpc-1936	258	2	j	j	PROPN
dpc-1936	258	3	dermatol	dermatol	NOUN
dpc-1936	258	4	.	.	PUNCT
dpc-1936	259	1	2020	2020	NUM
dpc-1936	259	2	.	.	PUNCT
dpc-1936	260	1	doi	doi	NOUN
dpc-1936	260	2	:	:	PUNCT
dpc-1936	260	3	10.1111	10.1111	NUM
dpc-1936	260	4	/	/	SYM
dpc-1936	260	5	bjd.19509	bjd.19509	NOUN
dpc-1936	260	6	.	.	PUNCT
dpc-1936	261	1	pmid	pmid	NOUN
dpc-1936	261	2	:	:	PUNCT
dpc-1936	261	3	32880909	32880909	NUM
dpc-1936	261	4	.	.	PUNCT
dpc-1936	262	1	pmcid	pmcid	NOUN
dpc-1936	262	2	:	:	PUNCT
dpc-1936	262	3	pmc8246960	pmc8246960	PROPN
dpc-1936	262	4	.	.	PUNCT
dpc-1936	263	1	29	29	NUM
dpc-1936	263	2	.	.	PUNCT
dpc-1936	263	3	blauvelt	blauvelt	VERB
dpc-1936	263	4	a	a	PRON
dpc-1936	263	5	,	,	PUNCT
dpc-1936	263	6	papp	papp	PROPN
dpc-1936	263	7	ka	ka	PROPN
dpc-1936	263	8	,	,	PUNCT
dpc-1936	263	9	griffiths	griffiths	PROPN
dpc-1936	263	10	ce	ce	PROPN
dpc-1936	263	11	,	,	PUNCT
dpc-1936	263	12	et	et	PROPN
dpc-1936	263	13	al	al	PROPN
dpc-1936	263	14	.	.	PROPN
dpc-1936	263	15	efficacy	efficacy	NOUN
dpc-1936	263	16	and	and	CCONJ
dpc-1936	263	17	safety	safety	NOUN
dpc-1936	263	18	of	of	ADP
dpc-1936	263	19	guselkumab	guselkumab	NOUN
dpc-1936	263	20	,	,	PUNCT
dpc-1936	263	21	an	an	DET
dpc-1936	263	22	anti	anti	ADJ
dpc-1936	263	23	-	-	ADJ
dpc-1936	263	24	interleukin-23	interleukin-23	ADJ
dpc-1936	263	25	monoclonal	monoclonal	NOUN
dpc-1936	263	26	antibody	antibody	NOUN
dpc-1936	263	27	,	,	PUNCT
dpc-1936	263	28	compared	compare	VERB
dpc-1936	263	29	with	with	ADP
dpc-1936	263	30	adalimumab	adalimumab	NOUN
dpc-1936	263	31	for	for	ADP
dpc-1936	263	32	the	the	DET
dpc-1936	263	33	continuous	continuous	ADJ
dpc-1936	263	34	treatment	treatment	NOUN
dpc-1936	263	35	of	of	ADP
dpc-1936	263	36	patients	patient	NOUN
dpc-1936	263	37	with	with	ADP
dpc-1936	263	38	moderate	moderate	ADJ
dpc-1936	263	39	to	to	ADP
dpc-1936	263	40	severe	severe	ADJ
dpc-1936	263	41	psoriasis	psoriasis	NOUN
dpc-1936	263	42	:	:	PUNCT
dpc-1936	263	43	results	result	VERB
dpc-1936	263	44	from	from	ADP
dpc-1936	263	45	the	the	DET
dpc-1936	263	46	phase	phase	NOUN
dpc-1936	263	47	iii	iii	NOUN
dpc-1936	263	48	,	,	PUNCT
dpc-1936	263	49	double	double	ADJ
dpc-1936	263	50	-	-	PUNCT
dpc-1936	263	51	blinded	blind	VERB
dpc-1936	263	52	,	,	PUNCT
dpc-1936	263	53	placeboand	placeboand	VERB
dpc-1936	263	54	active	active	ADJ
dpc-1936	263	55	comparator	comparator	NOUN
dpc-1936	263	56	-	-	PUNCT
dpc-1936	263	57	controlled	control	VERB
dpc-1936	263	58	voyage	voyage	NOUN
dpc-1936	263	59	1	1	NUM
dpc-1936	263	60	trial	trial	NOUN
dpc-1936	263	61	.	.	PUNCT
dpc-1936	264	1	j	j	PROPN
dpc-1936	264	2	am	be	AUX
dpc-1936	264	3	acad	acad	ADJ
dpc-1936	264	4	dermatol	dermatol	NOUN
dpc-1936	264	5	.	.	PUNCT
dpc-1936	265	1	2017;76(3):405–417	2017;76(3):405–417	NUM
dpc-1936	265	2	.	.	PUNCT
dpc-1936	265	3	doi	doi	NOUN
dpc-1936	265	4	:	:	PUNCT
dpc-1936	265	5	10.1016	10.1016	NUM
dpc-1936	265	6	/	/	SYM
dpc-1936	265	7	j.jaad.2016.11.041	j.jaad.2016.11.041	PROPN
dpc-1936	265	8	.	.	PUNCT
dpc-1936	266	1	pmid	pmid	NOUN
dpc-1936	266	2	:	:	PUNCT
dpc-1936	266	3	28057360	28057360	NUM
dpc-1936	266	4	.	.	PUNCT
dpc-1936	267	1	30	30	NUM
dpc-1936	267	2	.	.	PUNCT
dpc-1936	268	1	reich	reich	PROPN
dpc-1936	268	2	k	k	PROPN
dpc-1936	268	3	,	,	PUNCT
dpc-1936	268	4	armstrong	armstrong	PROPN
dpc-1936	268	5	aw	aw	PROPN
dpc-1936	268	6	,	,	PUNCT
dpc-1936	268	7	foley	foley	PROPN
dpc-1936	268	8	p	p	X
dpc-1936	268	9	,	,	PUNCT
dpc-1936	268	10	et	et	PROPN
dpc-1936	268	11	al	al	PROPN
dpc-1936	268	12	.	.	PROPN
dpc-1936	268	13	efficacy	efficacy	NOUN
dpc-1936	268	14	and	and	CCONJ
dpc-1936	268	15	safety	safety	NOUN
dpc-1936	268	16	of	of	ADP
dpc-1936	268	17	guselkumab	guselkumab	NOUN
dpc-1936	268	18	,	,	PUNCT
dpc-1936	268	19	an	an	DET
dpc-1936	268	20	anti	anti	ADJ
dpc-1936	268	21	-	-	ADJ
dpc-1936	268	22	interleukin-23	interleukin-23	ADJ
dpc-1936	268	23	monoclonal	monoclonal	NOUN
dpc-1936	268	24	antibody	antibody	NOUN
dpc-1936	268	25	,	,	PUNCT
dpc-1936	268	26	compared	compare	VERB
dpc-1936	268	27	with	with	ADP
dpc-1936	268	28	adalimumab	adalimumab	NOUN
dpc-1936	268	29	for	for	ADP
dpc-1936	268	30	the	the	DET
dpc-1936	268	31	treatment	treatment	NOUN
dpc-1936	268	32	of	of	ADP
dpc-1936	268	33	patients	patient	NOUN
dpc-1936	268	34	with	with	ADP
dpc-1936	268	35	moderate	moderate	ADJ
dpc-1936	268	36	to	to	ADP
dpc-1936	268	37	severe	severe	ADJ
dpc-1936	268	38	psoriasis	psoriasis	NOUN
dpc-1936	268	39	with	with	ADP
dpc-1936	268	40	randomized	randomized	ADJ
dpc-1936	268	41	withdrawal	withdrawal	NOUN
dpc-1936	268	42	and	and	CCONJ
dpc-1936	268	43	retreatment	retreatment	NOUN
dpc-1936	268	44	:	:	PUNCT
dpc-1936	268	45	results	result	NOUN
dpc-1936	268	46	from	from	ADP
dpc-1936	268	47	the	the	DET
dpc-1936	268	48	phase	phase	NOUN
dpc-1936	268	49	iii	iii	NOUN
dpc-1936	268	50	,	,	PUNCT
dpc-1936	268	51	double	double	ADJ
dpc-1936	268	52	-	-	PUNCT
dpc-1936	268	53	blind	blind	ADJ
dpc-1936	268	54	,	,	PUNCT
dpc-1936	268	55	placeboand	placeboand	VERB
dpc-1936	268	56	active	active	ADJ
dpc-1936	268	57	comparator	comparator	NOUN
dpc-1936	268	58	-	-	PUNCT
dpc-1936	268	59	controlled	control	VERB
dpc-1936	268	60	voyage	voyage	NOUN
dpc-1936	268	61	2	2	NUM
dpc-1936	268	62	trial	trial	NOUN
dpc-1936	268	63	.	.	PUNCT
dpc-1936	269	1	j	j	PROPN
dpc-1936	269	2	am	be	AUX
dpc-1936	269	3	acad	acad	ADJ
dpc-1936	269	4	dermatol	dermatol	NOUN
dpc-1936	269	5	.	.	PUNCT
dpc-1936	270	1	2017;76(3):418–431	2017;76(3):418–431	X
dpc-1936	270	2	.	.	PUNCT
dpc-1936	271	1	doi	doi	NOUN
dpc-1936	271	2	:	:	PUNCT
dpc-1936	271	3	10.1016	10.1016	NUM
dpc-1936	271	4	/	/	SYM
dpc-1936	271	5	j.jaad.2016.11.042	j.jaad.2016.11.042	PROPN
dpc-1936	271	6	.	.	PUNCT
dpc-1936	272	1	pmid	pmid	NOUN
dpc-1936	272	2	:	:	PUNCT
dpc-1936	272	3	28057361	28057361	NUM
dpc-1936	272	4	.	.	PUNCT
dpc-1936	273	1	31	31	NUM
dpc-1936	273	2	.	.	PUNCT
dpc-1936	274	1	foley	foley	PROPN
dpc-1936	274	2	p	p	PROPN
dpc-1936	274	3	,	,	PUNCT
dpc-1936	274	4	gordon	gordon	PROPN
dpc-1936	274	5	k	k	PROPN
dpc-1936	274	6	,	,	PUNCT
dpc-1936	274	7	griffiths	griffiths	PROPN
dpc-1936	274	8	cem	cem	PROPN
dpc-1936	274	9	,	,	PUNCT
dpc-1936	274	10	et	et	PROPN
dpc-1936	274	11	al	al	PROPN
dpc-1936	274	12	.	.	PROPN
dpc-1936	274	13	efficacy	efficacy	PROPN
dpc-1936	274	14	of	of	ADP
dpc-1936	274	15	guselkumab	guselkumab	NOUN
dpc-1936	274	16	compared	compare	VERB
dpc-1936	274	17	with	with	ADP
dpc-1936	274	18	adalimumab	adalimumab	NOUN
dpc-1936	274	19	and	and	CCONJ
dpc-1936	274	20	placebo	placebo	NOUN
dpc-1936	274	21	for	for	ADP
dpc-1936	274	22	psoriasis	psoriasis	NOUN
dpc-1936	274	23	in	in	ADP
dpc-1936	274	24	specific	specific	ADJ
dpc-1936	274	25	body	body	NOUN
dpc-1936	274	26	regions	region	NOUN
dpc-1936	274	27	:	:	PUNCT
dpc-1936	274	28	a	a	DET
dpc-1936	274	29	secondary	secondary	ADJ
dpc-1936	274	30	analysis	analysis	NOUN
dpc-1936	274	31	of	of	ADP
dpc-1936	274	32	2	2	NUM
dpc-1936	274	33	randomized	randomize	VERB
dpc-1936	274	34	clinical	clinical	ADJ
dpc-1936	274	35	trials	trial	NOUN
dpc-1936	274	36	.	.	PUNCT
dpc-1936	275	1	jama	jama	PROPN
dpc-1936	275	2	dermatol	dermatol	NOUN
dpc-1936	275	3	.	.	PUNCT
dpc-1936	276	1	2018;154(6):676–683	2018;154(6):676–683	NUM
dpc-1936	276	2	.	.	PUNCT
dpc-1936	277	1	doi	doi	NOUN
dpc-1936	277	2	:	:	PUNCT
dpc-1936	277	3	10.1001	10.1001	NUM
dpc-1936	277	4	/	/	SYM
dpc-1936	277	5	jamadermatol.2018.0793	jamadermatol.2018.0793	ADJ
dpc-1936	277	6	.	.	PUNCT
dpc-1936	278	1	pmid	pmid	NOUN
dpc-1936	278	2	:	:	PUNCT
dpc-1936	278	3	29799960	29799960	NUM
dpc-1936	278	4	.	.	PUNCT
dpc-1936	279	1	pmcid	pmcid	NOUN
dpc-1936	279	2	:	:	PUNCT
dpc-1936	279	3	pmc6145649	pmc6145649	NOUN
dpc-1936	279	4	.	.	PUNCT
dpc-1936	280	1	32	32	NUM
dpc-1936	280	2	.	.	PUNCT
dpc-1936	281	1	huang	huang	PROPN
dpc-1936	281	2	ih	ih	PROPN
dpc-1936	281	3	,	,	PUNCT
dpc-1936	281	4	wu	wu	PROPN
dpc-1936	281	5	pc	pc	PROPN
dpc-1936	281	6	,	,	PUNCT
dpc-1936	281	7	yang	yang	PROPN
dpc-1936	281	8	th	th	PROPN
dpc-1936	281	9	,	,	PUNCT
dpc-1936	281	10	et	et	PROPN
dpc-1936	281	11	al	al	PROPN
dpc-1936	281	12	.	.	PUNCT
dpc-1936	281	13	small	small	ADJ
dpc-1936	281	14	molecule	molecule	NOUN
dpc-1936	281	15	inhibitors	inhibitor	NOUN
dpc-1936	281	16	and	and	CCONJ
dpc-1936	281	17	biologics	biologic	NOUN
dpc-1936	281	18	in	in	ADP
dpc-1936	281	19	treating	treat	VERB
dpc-1936	281	20	nail	nail	NOUN
dpc-1936	281	21	psoriasis	psoriasis	NOUN
dpc-1936	281	22	:	:	PUNCT
dpc-1936	281	23	a	a	DET
dpc-1936	281	24	systematic	systematic	ADJ
dpc-1936	281	25	review	review	NOUN
dpc-1936	281	26	and	and	CCONJ
dpc-1936	281	27	network	network	NOUN
dpc-1936	281	28	meta	meta	ADJ
dpc-1936	281	29	-	-	PUNCT
dpc-1936	281	30	analysis	analysis	NOUN
dpc-1936	281	31	.	.	PUNCT
dpc-1936	282	1	j	j	PROPN
dpc-1936	282	2	am	be	AUX
dpc-1936	282	3	acad	acad	ADJ
dpc-1936	282	4	dermatol	dermatol	NOUN
dpc-1936	282	5	.	.	PUNCT
dpc-1936	283	1	2021	2021	NUM
dpc-1936	283	2	;	;	PUNCT
dpc-1936	283	3	85(1):135	85(1):135	NOUN
dpc-1936	283	4	-	-	SYM
dpc-1936	283	5	143	143	NUM
dpc-1936	283	6	.	.	PUNCT
dpc-1936	284	1	doi	doi	NOUN
dpc-1936	284	2	:	:	PUNCT
dpc-1936	284	3	10.1016	10.1016	NUM
dpc-1936	284	4	/	/	SYM
dpc-1936	284	5	j.jaad.2021.01.024	j.jaad.2021.01.024	PROPN
dpc-1936	284	6	.	.	PUNCT
dpc-1936	285	1	pmid	pmid	NOUN
dpc-1936	285	2	:	:	PUNCT
dpc-1936	285	3	33482253	33482253	NUM
dpc-1936	285	4	.	.	PUNCT
dpc-1936	286	1	33	33	NUM
dpc-1936	286	2	.	.	PUNCT
dpc-1936	287	1	szebényi	szebényi	PROPN
dpc-1936	287	2	j	j	PROPN
dpc-1936	287	3	,	,	PUNCT
dpc-1936	287	4	gede	gede	PROPN
dpc-1936	287	5	n	n	CCONJ
dpc-1936	287	6	,	,	PUNCT
dpc-1936	287	7	hegyi	hegyi	PROPN
dpc-1936	287	8	p	p	NOUN
dpc-1936	287	9	,	,	PUNCT
dpc-1936	287	10	et	et	PROPN
dpc-1936	287	11	al	al	PROPN
dpc-1936	287	12	.	.	PROPN
dpc-1936	287	13	efficacy	efficacy	NOUN
dpc-1936	287	14	of	of	ADP
dpc-1936	287	15	biologics	biologic	NOUN
dpc-1936	287	16	targeting	target	VERB
dpc-1936	287	17	tumour	tumour	NOUN
dpc-1936	287	18	necrosis	necrosis	NOUN
dpc-1936	287	19	factor	factor	NOUN
dpc-1936	287	20	-	-	PUNCT
dpc-1936	287	21	alpha	alpha	NOUN
dpc-1936	287	22	,	,	PUNCT
dpc-1936	287	23	interleukin-17	interleukin-17	PROPN
dpc-1936	287	24	-12/23	-12/23	PUNCT
dpc-1936	287	25	,	,	PUNCT
dpc-1936	287	26	-23	-23	PUNCT
dpc-1936	287	27	and	and	CCONJ
dpc-1936	287	28	small	small	ADJ
dpc-1936	287	29	molecules	molecule	NOUN
dpc-1936	287	30	targeting	target	VERB
dpc-1936	287	31	jak	jak	PROPN
dpc-1936	287	32	and	and	CCONJ
dpc-1936	287	33	pde4	pde4	NOUN
dpc-1936	287	34	in	in	ADP
dpc-1936	287	35	the	the	DET
dpc-1936	287	36	treatment	treatment	NOUN
dpc-1936	287	37	of	of	ADP
dpc-1936	287	38	nail	nail	NOUN
dpc-1936	287	39	psoriasis	psoriasis	NOUN
dpc-1936	287	40	:	:	PUNCT
dpc-1936	287	41	a	a	DET
dpc-1936	287	42	network	network	NOUN
dpc-1936	287	43	meta	meta	NOUN
dpc-1936	287	44	-	-	PUNCT
dpc-1936	287	45	analysis	analysis	NOUN
dpc-1936	287	46	.	.	PUNCT
dpc-1936	288	1	acta	acta	PROPN
dpc-1936	288	2	derm	derm	PROPN
dpc-1936	288	3	venereol	venereol	NOUN
dpc-1936	288	4	.	.	PUNCT
dpc-1936	289	1	2020;100(18):adv00318	2020;100(18):adv00318	X
dpc-1936	289	2	.	.	PUNCT
dpc-1936	290	1	doi	doi	NOUN
dpc-1936	290	2	:	:	PUNCT
dpc-1936	290	3	10.2340/00015555	10.2340/00015555	NUM
dpc-1936	290	4	-	-	SYM
dpc-1936	290	5	3640	3640	NUM
dpc-1936	290	6	.	.	PUNCT
dpc-1936	291	1	pmid	pmid	NOUN
dpc-1936	291	2	:	:	PUNCT
dpc-1936	291	3	32965504	32965504	NUM
dpc-1936	291	4	.	.	PUNCT
dpc-1936	292	1	34	34	NUM
dpc-1936	292	2	.	.	PUNCT
dpc-1936	292	3	reich	reich	PROPN
dpc-1936	292	4	k	k	PROPN
dpc-1936	292	5	,	,	PUNCT
dpc-1936	292	6	conrad	conrad	PROPN
dpc-1936	292	7	c	c	PROPN
dpc-1936	292	8	,	,	PUNCT
dpc-1936	292	9	kristensen	kristensen	PROPN
dpc-1936	292	10	le	le	PROPN
dpc-1936	292	11	,	,	PUNCT
dpc-1936	292	12	et	et	PROPN
dpc-1936	292	13	al	al	PROPN
dpc-1936	292	14	.	.	PUNCT
dpc-1936	293	1	network	network	PROPN
dpc-1936	293	2	meta	meta	ADJ
dpc-1936	293	3	-	-	PUNCT
dpc-1936	293	4	analysis	analysis	NOUN
dpc-1936	293	5	comparing	compare	VERB
dpc-1936	293	6	the	the	DET
dpc-1936	293	7	efficacy	efficacy	NOUN
dpc-1936	293	8	of	of	ADP
dpc-1936	293	9	biologic	biologic	NOUN
dpc-1936	293	10	treatments	treatment	NOUN
dpc-1936	293	11	for	for	ADP
dpc-1936	293	12	achieving	achieve	VERB
dpc-1936	293	13	complete	complete	ADJ
dpc-1936	293	14	resolution	resolution	NOUN
dpc-1936	293	15	of	of	ADP
dpc-1936	293	16	nail	nail	NOUN
dpc-1936	293	17	psoriasis	psoriasis	NOUN
dpc-1936	293	18	.	.	PUNCT
dpc-1936	294	1	j	j	PROPN
dpc-1936	294	2	dermatolog	dermatolog	PROPN
dpc-1936	294	3	treat	treat	NOUN
dpc-1936	294	4	.	.	PUNCT
dpc-1936	295	1	2021:1	2021:1	NUM
dpc-1936	295	2	-	-	SYM
dpc-1936	295	3	9	9	NUM
dpc-1936	295	4	.	.	PUNCT
dpc-1936	295	5	doi	doi	NOUN
dpc-1936	295	6	:	:	PUNCT
dpc-1936	295	7	10.1080/09546634.2021.1892024	10.1080/09546634.2021.1892024	NUM
dpc-1936	295	8	.	.	PUNCT
dpc-1936	296	1	pmid	pmid	NOUN
dpc-1936	296	2	:	:	PUNCT
dpc-1936	296	3	33641593	33641593	NUM
dpc-1936	296	4	.	.	PUNCT
dpc-1936	297	1	35	35	NUM
dpc-1936	297	2	.	.	PUNCT
dpc-1936	297	3	breedveld	breedveld	PROPN
dpc-1936	297	4	fc	fc	PROPN
dpc-1936	297	5	,	,	PUNCT
dpc-1936	297	6	weisman	weisman	PROPN
dpc-1936	297	7	mh	mh	PROPN
dpc-1936	297	8	,	,	PUNCT
dpc-1936	297	9	kavanaugh	kavanaugh	PROPN
dpc-1936	297	10	af	af	PROPN
dpc-1936	297	11	,	,	PUNCT
dpc-1936	297	12	et	et	PROPN
dpc-1936	297	13	al	al	PROPN
dpc-1936	297	14	.	.	PUNCT
dpc-1936	298	1	the	the	DET
dpc-1936	298	2	premier	premier	PROPN
dpc-1936	298	3	study	study	NOUN
dpc-1936	298	4	:	:	PUNCT
dpc-1936	298	5	a	a	DET
dpc-1936	298	6	multicenter	multicenter	NOUN
dpc-1936	298	7	,	,	PUNCT
dpc-1936	298	8	randomized	randomize	VERB
dpc-1936	298	9	,	,	PUNCT
dpc-1936	298	10	double	double	ADJ
dpc-1936	298	11	-	-	PUNCT
dpc-1936	298	12	blind	blind	ADJ
dpc-1936	298	13	clinical	clinical	ADJ
dpc-1936	298	14	trial	trial	NOUN
dpc-1936	298	15	of	of	ADP
dpc-1936	298	16	combination	combination	NOUN
dpc-1936	298	17	therapy	therapy	NOUN
dpc-1936	298	18	with	with	ADP
dpc-1936	298	19	adalimumab	adalimumab	NOUN
dpc-1936	298	20	plus	plus	CCONJ
dpc-1936	298	21	methotrexate	methotrexate	NOUN
dpc-1936	298	22	versus	versus	ADP
dpc-1936	298	23	methotrexate	methotrexate	NOUN
dpc-1936	298	24	alone	alone	ADV
dpc-1936	298	25	or	or	CCONJ
dpc-1936	298	26	adalimumab	adalimumab	NOUN
dpc-1936	298	27	alone	alone	ADV
dpc-1936	298	28	in	in	ADP
dpc-1936	298	29	patients	patient	NOUN
dpc-1936	298	30	with	with	ADP
dpc-1936	298	31	early	early	ADJ
dpc-1936	298	32	,	,	PUNCT
dpc-1936	298	33	aggressive	aggressive	ADJ
dpc-1936	298	34	rheumatoid	rheumatoid	NOUN
dpc-1936	298	35	arthritis	arthritis	NOUN
dpc-1936	298	36	who	who	PRON
dpc-1936	298	37	had	have	AUX
dpc-1936	298	38	not	not	PART
dpc-1936	298	39	had	have	VERB
dpc-1936	298	40	previous	previous	ADJ
dpc-1936	298	41	methotrexate	methotrexate	NOUN
dpc-1936	298	42	treatment	treatment	NOUN
dpc-1936	298	43	.	.	PUNCT
dpc-1936	299	1	arthritis	arthritis	NOUN
dpc-1936	299	2	rheum	rheum	NOUN
dpc-1936	299	3	.	.	PUNCT
dpc-1936	300	1	2006;54(1	2006;54(1	NUM
dpc-1936	300	2	):	):	PUNCT
dpc-1936	301	1	26–37	26–37	NOUN
dpc-1936	301	2	.	.	PUNCT
dpc-1936	302	1	doi	doi	NOUN
dpc-1936	302	2	:	:	PUNCT
dpc-1936	302	3	10.1002	10.1002	NUM
dpc-1936	302	4	/	/	SYM
dpc-1936	302	5	art.21519	art.21519	PROPN
dpc-1936	302	6	.	.	PUNCT
dpc-1936	303	1	pmid	pmid	NOUN
dpc-1936	303	2	:	:	PUNCT
dpc-1936	303	3	16385520	16385520	NUM
dpc-1936	303	4	.	.	PUNCT
dpc-1936	304	1	36	36	NUM
dpc-1936	304	2	.	.	PUNCT
dpc-1936	305	1	van	van	PROPN
dpc-1936	305	2	der	der	PROPN
dpc-1936	305	3	heijde	heijde	NOUN
dpc-1936	305	4	d	d	PROPN
dpc-1936	305	5	,	,	PUNCT
dpc-1936	305	6	klareskog	klareskog	PROPN
dpc-1936	305	7	l	l	NOUN
dpc-1936	305	8	,	,	PUNCT
dpc-1936	305	9	rodriguez	rodriguez	NOUN
dpc-1936	305	10	-	-	PUNCT
dpc-1936	305	11	valverde	valverde	PROPN
dpc-1936	305	12	v	v	PROPN
dpc-1936	305	13	,	,	PUNCT
dpc-1936	305	14	et	et	PROPN
dpc-1936	305	15	al	al	PROPN
dpc-1936	305	16	.	.	PROPN
dpc-1936	305	17	comparison	comparison	NOUN
dpc-1936	305	18	of	of	ADP
dpc-1936	305	19	etanercept	etanercept	NOUN
dpc-1936	305	20	and	and	CCONJ
dpc-1936	305	21	methotrexate	methotrexate	VERB
dpc-1936	305	22	,	,	PUNCT
dpc-1936	305	23	alone	alone	ADJ
dpc-1936	305	24	and	and	CCONJ
dpc-1936	305	25	combined	combine	VERB
dpc-1936	305	26	,	,	PUNCT
dpc-1936	305	27	in	in	ADP
dpc-1936	305	28	the	the	DET
dpc-1936	305	29	treatment	treatment	NOUN
dpc-1936	305	30	of	of	ADP
dpc-1936	305	31	rheumatoid	rheumatoid	NOUN
dpc-1936	305	32	arthritis	arthritis	NOUN
dpc-1936	305	33	:	:	PUNCT
dpc-1936	305	34	two	two	NUM
dpc-1936	305	35	-	-	PUNCT
dpc-1936	305	36	year	year	NOUN
dpc-1936	305	37	clinical	clinical	ADJ
dpc-1936	305	38	and	and	CCONJ
dpc-1936	305	39	radiographic	radiographic	ADJ
dpc-1936	305	40	results	result	NOUN
dpc-1936	305	41	from	from	ADP
dpc-1936	305	42	the	the	DET
dpc-1936	305	43	tempo	tempo	NOUN
dpc-1936	305	44	study	study	NOUN
dpc-1936	305	45	,	,	PUNCT
dpc-1936	305	46	a	a	DET
dpc-1936	305	47	double	double	ADJ
dpc-1936	305	48	-	-	PUNCT
dpc-1936	305	49	blind	blind	ADJ
dpc-1936	305	50	,	,	PUNCT
dpc-1936	305	51	randomized	randomize	VERB
dpc-1936	305	52	trial	trial	NOUN
dpc-1936	305	53	.	.	PUNCT
dpc-1936	306	1	arthritis	arthritis	NOUN
dpc-1936	306	2	rheum	rheum	NOUN
dpc-1936	306	3	.	.	PUNCT
dpc-1936	307	1	2006;54(4):1063–1074	2006;54(4):1063–1074	PROPN
dpc-1936	307	2	.	.	PUNCT
dpc-1936	308	1	doi	doi	PROPN
dpc-1936	308	2	10.1002	10.1002	NUM
dpc-1936	308	3	/	/	SYM
dpc-1936	308	4	art.21655	art.21655	PROPN
dpc-1936	308	5	.	.	PUNCT
dpc-1936	309	1	pmid	pmid	NOUN
dpc-1936	309	2	:	:	PUNCT
dpc-1936	309	3	16572441	16572441	NUM
dpc-1936	309	4	.	.	PUNCT
dpc-1936	310	1	37	37	NUM
dpc-1936	310	2	.	.	PUNCT
dpc-1936	311	1	smolen	smolen	PROPN
dpc-1936	311	2	js	js	PROPN
dpc-1936	311	3	,	,	PUNCT
dpc-1936	311	4	kay	kay	PROPN
dpc-1936	311	5	j	j	PROPN
dpc-1936	311	6	,	,	PUNCT
dpc-1936	311	7	doyle	doyle	PROPN
dpc-1936	311	8	mk	mk	PROPN
dpc-1936	311	9	,	,	PUNCT
dpc-1936	311	10	et	et	PROPN
dpc-1936	311	11	al	al	PROPN
dpc-1936	311	12	.	.	PROPN
dpc-1936	311	13	golimumab	golimumab	NOUN
dpc-1936	311	14	in	in	ADP
dpc-1936	311	15	patients	patient	NOUN
dpc-1936	311	16	with	with	ADP
dpc-1936	311	17	active	active	ADJ
dpc-1936	311	18	rheumatoid	rheumatoid	NOUN
dpc-1936	311	19	arthritis	arthritis	NOUN
dpc-1936	311	20	after	after	ADP
dpc-1936	311	21	treatment	treatment	NOUN
dpc-1936	311	22	with	with	ADP
dpc-1936	311	23	tumour	tumour	NOUN
dpc-1936	311	24	necrosis	necrosis	NOUN
dpc-1936	311	25	factor	factor	NOUN
dpc-1936	311	26	alpha	alpha	NOUN
dpc-1936	311	27	inhibitors	inhibitor	NOUN
dpc-1936	311	28	(	(	PUNCT
dpc-1936	311	29	go	go	VERB
dpc-1936	311	30	-	-	PUNCT
dpc-1936	311	31	after	after	ADP
dpc-1936	311	32	study	study	NOUN
dpc-1936	311	33	):	):	PUNCT
dpc-1936	311	34	a	a	DET
dpc-1936	311	35	multicentre	multicentre	NOUN
dpc-1936	311	36	,	,	PUNCT
dpc-1936	311	37	randomised	randomise	VERB
dpc-1936	311	38	,	,	PUNCT
dpc-1936	311	39	double	double	ADJ
dpc-1936	311	40	-	-	PUNCT
dpc-1936	311	41	blind	blind	ADJ
dpc-1936	311	42	,	,	PUNCT
dpc-1936	311	43	placebo	placebo	NOUN
dpc-1936	311	44	-	-	PUNCT
dpc-1936	311	45	controlled	control	VERB
dpc-1936	311	46	,	,	PUNCT
dpc-1936	311	47	phase	phase	NOUN
dpc-1936	311	48	iii	iii	NUM
dpc-1936	311	49	trial	trial	NOUN
dpc-1936	311	50	.	.	PUNCT
dpc-1936	312	1	lancet	lancet	PROPN
dpc-1936	312	2	.	.	PUNCT
dpc-1936	313	1	2009;374(9685):210–221	2009;374(9685):210–221	PROPN
dpc-1936	313	2	.	.	PUNCT
dpc-1936	313	3	doi	doi	NOUN
dpc-1936	313	4	:	:	PUNCT
dpc-1936	313	5	10.1016	10.1016	NUM
dpc-1936	313	6	/	/	SYM
dpc-1936	313	7	s01406736(09)60506	s01406736(09)60506	NOUN
dpc-1936	313	8	-	-	PUNCT
dpc-1936	313	9	7	7	NUM
dpc-1936	313	10	.	.	PUNCT
dpc-1936	314	1	pmid	pmid	NOUN
dpc-1936	314	2	:	:	PUNCT
dpc-1936	314	3	19560810	19560810	NUM
dpc-1936	314	4	.	.	PUNCT
dpc-1936	315	1	annrheumdis-2016	annrheumdis-2016	PROPN
dpc-1936	315	2	-	-	PUNCT
dpc-1936	315	3	209709	209709	NUM
dpc-1936	315	4	.	.	PUNCT
dpc-1936	316	1	pmid	pmid	NOUN
dpc-1936	316	2	:	:	PUNCT
dpc-1936	316	3	27553214	27553214	NUM
dpc-1936	316	4	.	.	PUNCT
dpc-1936	317	1	pmcid	pmcid	ADJ
dpc-1936	317	2	:	:	PUNCT
dpc-1936	317	3	pmc5264219	pmc5264219	ADJ
dpc-1936	317	4	.	.	PUNCT
dpc-1936	318	1	16	16	NUM
dpc-1936	318	2	.	.	PUNCT
dpc-1936	319	1	mease	mease	PROPN
dpc-1936	319	2	pj	pj	PROPN
dpc-1936	319	3	,	,	PUNCT
dpc-1936	319	4	mcinnes	mcinnes	PROPN
dpc-1936	319	5	ib	ib	PROPN
dpc-1936	319	6	,	,	PUNCT
dpc-1936	319	7	kirkham	kirkham	PROPN
dpc-1936	319	8	b	b	PROPN
dpc-1936	319	9	,	,	PUNCT
dpc-1936	319	10	et	et	PROPN
dpc-1936	319	11	al	al	PROPN
dpc-1936	319	12	.	.	PROPN
dpc-1936	319	13	secukinumab	secukinumab	NOUN
dpc-1936	319	14	inhibition	inhibition	NOUN
dpc-1936	319	15	of	of	ADP
dpc-1936	319	16	interleukin-17a	interleukin-17a	PROPN
dpc-1936	319	17	in	in	ADP
dpc-1936	319	18	patients	patient	NOUN
dpc-1936	319	19	with	with	ADP
dpc-1936	319	20	psoriatic	psoriatic	ADJ
dpc-1936	319	21	arthritis	arthritis	NOUN
dpc-1936	319	22	.	.	PUNCT
dpc-1936	320	1	n	n	PROPN
dpc-1936	320	2	engl	engl	PROPN
dpc-1936	320	3	j	j	PROPN
dpc-1936	320	4	med	med	PROPN
dpc-1936	320	5	.	.	PUNCT
dpc-1936	321	1	2015;373(14):1329–1339	2015;373(14):1329–1339	NUM
dpc-1936	321	2	.	.	PUNCT
dpc-1936	322	1	doi	doi	NOUN
dpc-1936	322	2	:	:	PUNCT
dpc-1936	322	3	10.1056	10.1056	NUM
dpc-1936	322	4	/	/	SYM
dpc-1936	322	5	nejmoa1412679	nejmoa1412679	PROPN
dpc-1936	322	6	.	.	PUNCT
dpc-1936	323	1	pmid	pmid	NOUN
dpc-1936	323	2	:	:	PUNCT
dpc-1936	323	3	26422723	26422723	NUM
dpc-1936	323	4	.	.	PUNCT
dpc-1936	324	1	17	17	NUM
dpc-1936	324	2	.	.	X
dpc-1936	325	1	nash	nash	PROPN
dpc-1936	325	2	p	p	PROPN
dpc-1936	325	3	,	,	PUNCT
dpc-1936	325	4	kirkham	kirkham	PROPN
dpc-1936	325	5	b	b	PROPN
dpc-1936	325	6	,	,	PUNCT
dpc-1936	325	7	okada	okada	PROPN
dpc-1936	325	8	m	m	PROPN
dpc-1936	325	9	,	,	PUNCT
dpc-1936	325	10	et	et	PROPN
dpc-1936	325	11	al	al	PROPN
dpc-1936	325	12	.	.	PROPN
dpc-1936	325	13	ixekizumab	ixekizumab	NOUN
dpc-1936	325	14	for	for	ADP
dpc-1936	325	15	the	the	DET
dpc-1936	325	16	treatment	treatment	NOUN
dpc-1936	325	17	of	of	ADP
dpc-1936	325	18	patients	patient	NOUN
dpc-1936	325	19	with	with	ADP
dpc-1936	325	20	active	active	ADJ
dpc-1936	325	21	psoriatic	psoriatic	ADJ
dpc-1936	325	22	arthritis	arthritis	NOUN
dpc-1936	325	23	and	and	CCONJ
dpc-1936	325	24	an	an	DET
dpc-1936	325	25	inadequate	inadequate	ADJ
dpc-1936	325	26	response	response	NOUN
dpc-1936	325	27	to	to	ADP
dpc-1936	325	28	tumour	tumour	NOUN
dpc-1936	325	29	necrosis	necrosis	NOUN
dpc-1936	325	30	factor	factor	NOUN
dpc-1936	325	31	inhibitors	inhibitor	NOUN
dpc-1936	325	32	:	:	PUNCT
dpc-1936	325	33	results	result	NOUN
dpc-1936	325	34	from	from	ADP
dpc-1936	325	35	the	the	DET
dpc-1936	325	36	24	24	NUM
dpc-1936	325	37	-	-	PUNCT
dpc-1936	325	38	week	week	NOUN
dpc-1936	325	39	randomised	randomise	VERB
dpc-1936	325	40	,	,	PUNCT
dpc-1936	325	41	double	double	ADJ
dpc-1936	325	42	-	-	PUNCT
dpc-1936	325	43	blind	blind	ADJ
dpc-1936	325	44	,	,	PUNCT
dpc-1936	325	45	placebo	placebo	NOUN
dpc-1936	325	46	-	-	PUNCT
dpc-1936	325	47	controlled	control	VERB
dpc-1936	325	48	period	period	NOUN
dpc-1936	325	49	of	of	ADP
dpc-1936	325	50	the	the	DET
dpc-1936	325	51	spirit	spirit	NOUN
dpc-1936	325	52	-	-	PUNCT
dpc-1936	325	53	p2	p2	NOUN
dpc-1936	325	54	phase	phase	NOUN
dpc-1936	325	55	3	3	NUM
dpc-1936	325	56	trial	trial	NOUN
dpc-1936	325	57	.	.	PUNCT
dpc-1936	326	1	lancet	lancet	NOUN
dpc-1936	326	2	.	.	PUNCT
dpc-1936	327	1	2017;389(10086):2317	2017;389(10086):2317	NUM
dpc-1936	327	2	–	–	PUNCT
dpc-1936	327	3	2327	2327	NUM
dpc-1936	327	4	.	.	PUNCT
dpc-1936	328	1	doi	doi	NOUN
dpc-1936	328	2	:	:	PUNCT
dpc-1936	328	3	10.1016	10.1016	NUM
dpc-1936	328	4	/	/	SYM
dpc-1936	328	5	s0140	s0140	PROPN
dpc-1936	328	6	-	-	PUNCT
dpc-1936	328	7	6736(17)31429	6736(17)31429	NUM
dpc-1936	328	8	-	-	PUNCT
dpc-1936	328	9	0	0	NUM
dpc-1936	328	10	.	.	PUNCT
dpc-1936	329	1	pmid	pmid	NOUN
dpc-1936	329	2	:	:	PUNCT
dpc-1936	329	3	26422723	26422723	NUM
dpc-1936	329	4	.	.	PUNCT
dpc-1936	330	1	18	18	NUM
dpc-1936	330	2	.	.	X
dpc-1936	331	1	mease	mease	PROPN
dpc-1936	331	2	pj	pj	PROPN
dpc-1936	331	3	,	,	PUNCT
dpc-1936	331	4	smolen	smolen	ADJ
dpc-1936	331	5	js	js	PROPN
dpc-1936	331	6	,	,	PUNCT
dpc-1936	331	7	behrens	behrens	PROPN
dpc-1936	331	8	f	f	PROPN
dpc-1936	331	9	,	,	PUNCT
dpc-1936	331	10	et	et	PROPN
dpc-1936	331	11	al	al	PROPN
dpc-1936	331	12	.	.	PUNCT
dpc-1936	332	1	a	a	DET
dpc-1936	332	2	head	head	NOUN
dpc-1936	332	3	-	-	PUNCT
dpc-1936	332	4	to	to	ADP
dpc-1936	332	5	-	-	PUNCT
dpc-1936	332	6	head	head	NOUN
dpc-1936	332	7	comparison	comparison	NOUN
dpc-1936	332	8	of	of	ADP
dpc-1936	332	9	the	the	DET
dpc-1936	332	10	efficacy	efficacy	NOUN
dpc-1936	332	11	and	and	CCONJ
dpc-1936	332	12	safety	safety	NOUN
dpc-1936	332	13	of	of	ADP
dpc-1936	332	14	ixekizumab	ixekizumab	NOUN
dpc-1936	332	15	and	and	CCONJ
dpc-1936	332	16	adalimumab	adalimumab	NOUN
dpc-1936	332	17	in	in	ADP
dpc-1936	332	18	biological	biological	ADJ
dpc-1936	332	19	-	-	PUNCT
dpc-1936	332	20	naïve	naïve	ADJ
dpc-1936	332	21	patients	patient	NOUN
dpc-1936	332	22	with	with	ADP
dpc-1936	332	23	active	active	ADJ
dpc-1936	332	24	psoriatic	psoriatic	ADJ
dpc-1936	332	25	arthritis	arthritis	NOUN
dpc-1936	332	26	:	:	PUNCT
dpc-1936	332	27	24	24	NUM
dpc-1936	332	28	-	-	PUNCT
dpc-1936	332	29	week	week	NOUN
dpc-1936	332	30	results	result	NOUN
dpc-1936	332	31	of	of	ADP
dpc-1936	332	32	a	a	DET
dpc-1936	332	33	randomised	randomise	VERB
dpc-1936	332	34	,	,	PUNCT
dpc-1936	332	35	open	open	ADJ
dpc-1936	332	36	-	-	PUNCT
dpc-1936	332	37	label	label	NOUN
dpc-1936	332	38	,	,	PUNCT
dpc-1936	332	39	blinded	blind	VERB
dpc-1936	332	40	-	-	PUNCT
dpc-1936	332	41	assessor	assessor	NOUN
dpc-1936	332	42	trial	trial	NOUN
dpc-1936	332	43	.	.	PUNCT
dpc-1936	333	1	ann	ann	PROPN
dpc-1936	333	2	rheum	rheum	PROPN
dpc-1936	333	3	dis	dis	PROPN
dpc-1936	333	4	.	.	PUNCT
dpc-1936	334	1	2020;79(1):123–131	2020;79(1):123–131	X
dpc-1936	334	2	.	.	PUNCT
dpc-1936	335	1	doi	doi	NOUN
dpc-1936	335	2	:	:	PUNCT
dpc-1936	335	3	10.1136	10.1136	NUM
dpc-1936	335	4	/	/	SYM
dpc-1936	335	5	annrheumdis-2019	annrheumdis-2019	NOUN
dpc-1936	335	6	-	-	PUNCT
dpc-1936	335	7	215386	215386	NUM
dpc-1936	335	8	.	.	PUNCT
dpc-1936	336	1	pmid	pmid	NOUN
dpc-1936	336	2	:	:	PUNCT
dpc-1936	336	3	31563894	31563894	NUM
dpc-1936	336	4	.	.	PUNCT
dpc-1936	337	1	pmcid	pmcid	NOUN
dpc-1936	337	2	:	:	PUNCT
dpc-1936	337	3	pmc6937408	pmc6937408	VERB
dpc-1936	337	4	.	.	PUNCT
dpc-1936	338	1	19	19	NUM
dpc-1936	338	2	.	.	PUNCT
dpc-1936	339	1	smolen	smolen	VERB
dpc-1936	339	2	js	js	PROPN
dpc-1936	339	3	,	,	PUNCT
dpc-1936	339	4	mease	mease	NOUN
dpc-1936	339	5	p	p	NOUN
dpc-1936	339	6	,	,	PUNCT
dpc-1936	339	7	tahir	tahir	PROPN
dpc-1936	339	8	h	h	PROPN
dpc-1936	339	9	,	,	PUNCT
dpc-1936	339	10	et	et	PROPN
dpc-1936	339	11	al	al	PROPN
dpc-1936	339	12	.	.	PROPN
dpc-1936	339	13	multicentre	multicentre	PROPN
dpc-1936	339	14	,	,	PUNCT
dpc-1936	339	15	randomised	randomise	VERB
dpc-1936	339	16	,	,	PUNCT
dpc-1936	339	17	open	open	ADJ
dpc-1936	339	18	-	-	PUNCT
dpc-1936	339	19	label	label	NOUN
dpc-1936	339	20	,	,	PUNCT
dpc-1936	339	21	parallel	parallel	NOUN
dpc-1936	339	22	-	-	PUNCT
dpc-1936	339	23	group	group	NOUN
dpc-1936	339	24	study	study	NOUN
dpc-1936	339	25	evaluating	evaluate	VERB
dpc-1936	339	26	the	the	DET
dpc-1936	339	27	efficacy	efficacy	NOUN
dpc-1936	339	28	and	and	CCONJ
dpc-1936	339	29	safety	safety	NOUN
dpc-1936	339	30	of	of	ADP
dpc-1936	339	31	ixekizumab	ixekizumab	NOUN
dpc-1936	339	32	versus	versus	ADP
dpc-1936	339	33	adalimumab	adalimumab	NOUN
dpc-1936	339	34	in	in	ADP
dpc-1936	339	35	patients	patient	NOUN
dpc-1936	339	36	with	with	ADP
dpc-1936	339	37	psoriatic	psoriatic	ADJ
dpc-1936	339	38	arthritis	arthritis	NOUN
dpc-1936	339	39	naïve	naïve	ADJ
dpc-1936	339	40	to	to	ADP
dpc-1936	339	41	biological	biological	ADJ
dpc-1936	339	42	disease	disease	NOUN
dpc-1936	339	43	-	-	PUNCT
dpc-1936	339	44	modifying	modify	VERB
dpc-1936	339	45	antirheumatic	antirheumatic	ADJ
dpc-1936	339	46	drug	drug	NOUN
dpc-1936	339	47	:	:	PUNCT
dpc-1936	339	48	final	final	ADJ
dpc-1936	339	49	results	result	NOUN
dpc-1936	339	50	by	by	ADP
dpc-1936	339	51	week	week	NOUN
dpc-1936	339	52	52	52	NUM
dpc-1936	339	53	.	.	PUNCT
dpc-1936	340	1	ann	ann	PROPN
dpc-1936	340	2	rheum	rheum	PROPN
dpc-1936	340	3	dis	dis	PROPN
dpc-1936	340	4	.	.	PUNCT
dpc-1936	341	1	2020;79:1310–1319	2020;79:1310–1319	PROPN
dpc-1936	341	2	.	.	PUNCT
dpc-1936	341	3	doi	doi	NOUN
dpc-1936	341	4	:	:	PUNCT
dpc-1936	341	5	10.1136	10.1136	NUM
dpc-1936	341	6	/	/	SYM
dpc-1936	341	7	annrheumdis-2020	annrheumdis-2020	NOUN
dpc-1936	341	8	-	-	PUNCT
dpc-1936	341	9	217372	217372	NUM
dpc-1936	341	10	.	.	PUNCT
dpc-1936	342	1	pmid	pmid	NOUN
dpc-1936	342	2	:	:	PUNCT
dpc-1936	342	3	32660977	32660977	NUM
dpc-1936	342	4	.	.	PUNCT
dpc-1936	343	1	pmcid	pmcid	NOUN
dpc-1936	343	2	:	:	PUNCT
dpc-1936	343	3	pmc7509529	pmc7509529	PROPN
dpc-1936	343	4	.	.	PUNCT
dpc-1936	344	1	20	20	NUM
dpc-1936	344	2	.	.	PUNCT
dpc-1936	345	1	furue	furue	PROPN
dpc-1936	345	2	k	k	PROPN
dpc-1936	345	3	,	,	PUNCT
dpc-1936	345	4	ito	ito	PROPN
dpc-1936	345	5	t	t	PROPN
dpc-1936	345	6	,	,	PUNCT
dpc-1936	345	7	furue	furue	ADJ
dpc-1936	345	8	m.	m.	NOUN
dpc-1936	345	9	differential	differential	PROPN
dpc-1936	345	10	efficacy	efficacy	NOUN
dpc-1936	345	11	of	of	ADP
dpc-1936	345	12	biologic	biologic	NOUN
dpc-1936	345	13	treatments	treatment	NOUN
dpc-1936	345	14	targeting	target	VERB
dpc-1936	345	15	the	the	DET
dpc-1936	345	16	tnf	tnf	PROPN
dpc-1936	345	17	-	-	PUNCT
dpc-1936	345	18	α	α	NOUN
dpc-1936	345	19	/	/	SYM
dpc-1936	345	20	il-23	il-23	NOUN
dpc-1936	345	21	/	/	SYM
dpc-1936	345	22	il-17	il-17	NUM
dpc-1936	345	23	axis	axis	NOUN
dpc-1936	345	24	in	in	ADP
dpc-1936	345	25	psoriasis	psoriasis	NOUN
dpc-1936	345	26	and	and	CCONJ
dpc-1936	345	27	psoriatic	psoriatic	ADJ
dpc-1936	345	28	arthritis	arthritis	NOUN
dpc-1936	345	29	.	.	PUNCT
dpc-1936	346	1	cytokine	cytokine	NOUN
dpc-1936	346	2	.	.	PUNCT
dpc-1936	347	1	2018;111:182–188	2018;111:182–188	NUM
dpc-1936	347	2	.	.	PUNCT
dpc-1936	348	1	doi	doi	NOUN
dpc-1936	348	2	:	:	PUNCT
dpc-1936	348	3	10.1016	10.1016	NUM
dpc-1936	348	4	/	/	SYM
dpc-1936	348	5	j.	j.	PROPN
dpc-1936	348	6	cyto.2018.08.025	cyto.2018.08.025	PROPN
dpc-1936	348	7	.	.	PUNCT
dpc-1936	349	1	pmid	pmid	NOUN
dpc-1936	349	2	:	:	PUNCT
dpc-1936	349	3	30172115	30172115	NUM
dpc-1936	349	4	.	.	PUNCT
dpc-1936	350	1	21	21	NUM
dpc-1936	350	2	.	.	PUNCT
dpc-1936	350	3	griffiths	griffiths	PROPN
dpc-1936	350	4	ce	ce	PROPN
dpc-1936	350	5	,	,	PUNCT
dpc-1936	350	6	reich	reich	PROPN
dpc-1936	350	7	k	k	PROPN
dpc-1936	350	8	,	,	PUNCT
dpc-1936	350	9	lebwohl	lebwohl	PROPN
dpc-1936	350	10	m	m	PROPN
dpc-1936	350	11	,	,	PUNCT
dpc-1936	350	12	et	et	PROPN
dpc-1936	350	13	al	al	PROPN
dpc-1936	350	14	.	.	PROPN
dpc-1936	350	15	comparison	comparison	NOUN
dpc-1936	350	16	of	of	ADP
dpc-1936	350	17	ixekizumab	ixekizumab	NOUN
dpc-1936	350	18	with	with	ADP
dpc-1936	350	19	etanercept	etanercept	NOUN
dpc-1936	350	20	or	or	CCONJ
dpc-1936	350	21	placebo	placebo	NOUN
dpc-1936	350	22	in	in	ADP
dpc-1936	350	23	moderate	moderate	ADJ
dpc-1936	350	24	-	-	PUNCT
dpc-1936	350	25	to	to	ADP
dpc-1936	350	26	-	-	PUNCT
dpc-1936	350	27	severe	severe	ADJ
dpc-1936	350	28	psoriasis	psoriasis	NOUN
dpc-1936	350	29	(	(	PUNCT
dpc-1936	350	30	uncover-2	uncover-2	NUM
dpc-1936	350	31	and	and	CCONJ
dpc-1936	350	32	uncover-3	uncover-3	NUM
dpc-1936	350	33	):	):	PUNCT
dpc-1936	350	34	results	result	NOUN
dpc-1936	350	35	from	from	ADP
dpc-1936	350	36	two	two	NUM
dpc-1936	350	37	phase	phase	NOUN
dpc-1936	350	38	3	3	NUM
dpc-1936	350	39	randomised	randomise	VERB
dpc-1936	350	40	trials	trial	NOUN
dpc-1936	350	41	.	.	PUNCT
dpc-1936	351	1	lancet	lancet	VERB
dpc-1936	351	2	.	.	PUNCT
dpc-1936	352	1	2015;386(9993):541–551	2015;386(9993):541–551	NUM
dpc-1936	352	2	.	.	PUNCT
dpc-1936	353	1	doi	doi	NOUN
dpc-1936	353	2	:	:	PUNCT
dpc-1936	353	3	10.1016	10.1016	NUM
dpc-1936	353	4	/	/	SYM
dpc-1936	353	5	s0140	s0140	PROPN
dpc-1936	353	6	-	-	PUNCT
dpc-1936	353	7	6736(15)60125	6736(15)60125	NUM
dpc-1936	353	8	-	-	PUNCT
dpc-1936	353	9	8	8	NUM
dpc-1936	353	10	.	.	PUNCT
dpc-1936	354	1	pmid	pmid	NOUN
dpc-1936	354	2	:	:	PUNCT
dpc-1936	354	3	26072109	26072109	NUM
dpc-1936	354	4	.	.	PUNCT
dpc-1936	355	1	22	22	NUM
dpc-1936	355	2	.	.	PUNCT
dpc-1936	356	1	langley	langley	PROPN
dpc-1936	356	2	rg	rg	PROPN
dpc-1936	356	3	,	,	PUNCT
dpc-1936	356	4	elewski	elewski	PROPN
dpc-1936	356	5	be	be	AUX
dpc-1936	356	6	,	,	PUNCT
dpc-1936	356	7	lebwohl	lebwohl	PROPN
dpc-1936	356	8	m	m	PROPN
dpc-1936	356	9	,	,	PUNCT
dpc-1936	356	10	et	et	PROPN
dpc-1936	356	11	al	al	PROPN
dpc-1936	356	12	.	.	PROPN
dpc-1936	356	13	secukinumab	secukinumab	PROPN
dpc-1936	356	14	in	in	ADP
dpc-1936	356	15	plaque	plaque	NOUN
dpc-1936	356	16	psoriasis	psoriasis	NOUN
dpc-1936	356	17	--	--	PUNCT
dpc-1936	356	18	results	result	NOUN
dpc-1936	356	19	of	of	ADP
dpc-1936	356	20	two	two	NUM
dpc-1936	356	21	phase	phase	NOUN
dpc-1936	356	22	3	3	NUM
dpc-1936	356	23	trials	trial	NOUN
dpc-1936	356	24	.	.	PUNCT
dpc-1936	357	1	n	n	PROPN
dpc-1936	357	2	engl	engl	PROPN
dpc-1936	357	3	j	j	PROPN
dpc-1936	357	4	med	med	PROPN
dpc-1936	357	5	.	.	PUNCT
dpc-1936	358	1	2014;371(4):326–338	2014;371(4):326–338	NUM
dpc-1936	358	2	.	.	PUNCT
dpc-1936	358	3	doi	doi	NOUN
dpc-1936	358	4	:	:	PUNCT
dpc-1936	358	5	10.1056	10.1056	NUM
dpc-1936	358	6	/	/	SYM
dpc-1936	358	7	nejmoa1314258	nejmoa1314258	PROPN
dpc-1936	358	8	.	.	PUNCT
dpc-1936	359	1	pmid	pmid	NOUN
dpc-1936	359	2	:	:	PUNCT
dpc-1936	359	3	25007392	25007392	NUM
dpc-1936	359	4	.	.	PUNCT
dpc-1936	360	1	23	23	NUM
dpc-1936	360	2	.	.	PUNCT
dpc-1936	361	1	gordon	gordon	PROPN
dpc-1936	361	2	kb	kb	PROPN
dpc-1936	361	3	,	,	PUNCT
dpc-1936	361	4	blauvelt	blauvelt	VERB
dpc-1936	361	5	a	a	DET
dpc-1936	361	6	,	,	PUNCT
dpc-1936	361	7	papp	papp	PROPN
dpc-1936	361	8	ka	ka	PROPN
dpc-1936	361	9	,	,	PUNCT
dpc-1936	361	10	et	et	PROPN
dpc-1936	361	11	al	al	PROPN
dpc-1936	361	12	.	.	PROPN
dpc-1936	361	13	phase	phase	NOUN
dpc-1936	361	14	3	3	NUM
dpc-1936	361	15	trials	trial	NOUN
dpc-1936	361	16	of	of	ADP
dpc-1936	361	17	ixekizumab	ixekizumab	NOUN
dpc-1936	361	18	in	in	ADP
dpc-1936	361	19	moderate	moderate	ADJ
dpc-1936	361	20	-	-	PUNCT
dpc-1936	361	21	to	to	ADP
dpc-1936	361	22	-	-	PUNCT
dpc-1936	361	23	severe	severe	ADJ
dpc-1936	361	24	plaque	plaque	NOUN
dpc-1936	361	25	psoriasis	psoriasis	NOUN
dpc-1936	361	26	.	.	PUNCT
dpc-1936	362	1	n	n	PROPN
dpc-1936	362	2	engl	engl	PROPN
dpc-1936	362	3	j	j	PROPN
dpc-1936	362	4	med	med	PROPN
dpc-1936	362	5	.	.	PUNCT
dpc-1936	363	1	2016;375(4):345–356	2016;375(4):345–356	X
dpc-1936	363	2	.	.	X
dpc-1936	363	3	doi	doi	NOUN
dpc-1936	363	4	:	:	PUNCT
dpc-1936	363	5	10.1056	10.1056	NUM
dpc-1936	363	6	/	/	SYM
dpc-1936	363	7	nejmoa1512711	nejmoa1512711	NOUN
dpc-1936	363	8	.	.	PUNCT
dpc-1936	364	1	pmid	pmid	NOUN
dpc-1936	364	2	:	:	PUNCT
dpc-1936	364	3	27299809	27299809	NUM
dpc-1936	364	4	.	.	PUNCT
dpc-1936	365	1	24	24	NUM
dpc-1936	365	2	.	.	X
dpc-1936	366	1	amin	amin	PROPN
dpc-1936	366	2	m	m	PROPN
dpc-1936	366	3	,	,	PUNCT
dpc-1936	366	4	no	no	DET
dpc-1936	366	5	dj	dj	NOUN
dpc-1936	366	6	,	,	PUNCT
dpc-1936	366	7	egeberg	egeberg	PROPN
dpc-1936	366	8	a	a	PROPN
dpc-1936	366	9	,	,	PUNCT
dpc-1936	366	10	wu	wu	PROPN
dpc-1936	366	11	jj	jj	PROPN
dpc-1936	366	12	.	.	PROPN
dpc-1936	366	13	choosing	choose	VERB
dpc-1936	366	14	first	first	ADJ
dpc-1936	366	15	-	-	PUNCT
dpc-1936	366	16	line	line	NOUN
dpc-1936	366	17	biologic	biologic	NOUN
dpc-1936	366	18	treatment	treatment	NOUN
dpc-1936	366	19	for	for	ADP
dpc-1936	366	20	moderate	moderate	ADJ
dpc-1936	366	21	-	-	PUNCT
dpc-1936	366	22	to	to	ADP
dpc-1936	366	23	-	-	PUNCT
dpc-1936	366	24	severe	severe	ADJ
dpc-1936	366	25	psoriasis	psoriasis	NOUN
dpc-1936	366	26	:	:	PUNCT
dpc-1936	366	27	what	what	PRON
dpc-1936	366	28	does	do	AUX
dpc-1936	366	29	the	the	DET
dpc-1936	366	30	evidence	evidence	NOUN
dpc-1936	366	31	say	say	VERB
dpc-1936	366	32	?	?	PUNCT
dpc-1936	366	33	am	be	AUX
dpc-1936	366	34	j	j	PROPN
dpc-1936	366	35	clin	clin	PROPN
dpc-1936	366	36	dermatol	dermatol	NOUN
dpc-1936	366	37	.	.	PUNCT
dpc-1936	367	1	2018;19(1):1–13	2018;19(1):1–13	NUM
dpc-1936	367	2	.	.	PUNCT
dpc-1936	368	1	doi	doi	NOUN
dpc-1936	368	2	:	:	PUNCT
dpc-1936	368	3	10.1007	10.1007	NUM
dpc-1936	368	4	/	/	SYM
dpc-1936	368	5	s40257	s40257	NOUN
dpc-1936	368	6	-	-	PUNCT
dpc-1936	368	7	017	017	NUM
dpc-1936	368	8	-	-	PUNCT
dpc-1936	368	9	0328	0328	NUM
dpc-1936	368	10	-	-	PUNCT
dpc-1936	368	11	3	3	NUM
dpc-1936	368	12	.	.	PUNCT
dpc-1936	369	1	pmid	pmid	NOUN
dpc-1936	369	2	:	:	PUNCT
dpc-1936	369	3	29080066	29080066	NUM
dpc-1936	369	4	.	.	PUNCT
dpc-1936	370	1	25	25	NUM
dpc-1936	370	2	.	.	PUNCT
dpc-1936	371	1	pasch	pasch	PROPN
dpc-1936	371	2	mc	mc	PROPN
dpc-1936	371	3	.	.	PROPN
dpc-1936	371	4	nail	nail	NOUN
dpc-1936	371	5	psoriasis	psoriasis	NOUN
dpc-1936	371	6	:	:	PUNCT
dpc-1936	371	7	a	a	DET
dpc-1936	371	8	review	review	NOUN
dpc-1936	371	9	of	of	ADP
dpc-1936	371	10	treatment	treatment	NOUN
dpc-1936	371	11	options	option	NOUN
dpc-1936	371	12	.	.	PUNCT
dpc-1936	372	1	drugs	drug	NOUN
dpc-1936	372	2	.	.	PUNCT
dpc-1936	373	1	2016;76(6):675–705	2016;76(6):675–705	NUM
dpc-1936	373	2	.	.	PUNCT
dpc-1936	373	3	doi	doi	NOUN
dpc-1936	373	4	:	:	PUNCT
dpc-1936	373	5	10.1007	10.1007	NUM
dpc-1936	373	6	/	/	SYM
dpc-1936	373	7	s40265	s40265	NOUN
dpc-1936	373	8	-	-	PUNCT
dpc-1936	373	9	016	016	NUM
dpc-1936	373	10	-	-	PUNCT
dpc-1936	373	11	05645	05645	NUM
dpc-1936	373	12	.	.	PUNCT
dpc-1936	374	1	pmid	pmid	NOUN
dpc-1936	374	2	:	:	PUNCT
dpc-1936	374	3	27041288	27041288	NUM
dpc-1936	374	4	.	.	PUNCT
dpc-1936	375	1	pmcid	pmcid	NOUN
dpc-1936	375	2	:	:	PUNCT
dpc-1936	375	3	pmc4833799	pmc4833799	ADV
dpc-1936	375	4	.	.	PUNCT
dpc-1936	376	1	26	26	NUM
dpc-1936	376	2	.	.	PUNCT
dpc-1936	376	3	wasel	wasel	PROPN
dpc-1936	376	4	n	n	CCONJ
dpc-1936	376	5	,	,	PUNCT
dpc-1936	376	6	thaçi	thaçi	NOUN
dpc-1936	376	7	d	d	PROPN
dpc-1936	376	8	,	,	PUNCT
dpc-1936	376	9	french	french	ADJ
dpc-1936	376	10	le	le	X
dpc-1936	376	11	,	,	PUNCT
dpc-1936	376	12	et	et	PROPN
dpc-1936	376	13	al	al	PROPN
dpc-1936	376	14	.	.	PROPN
dpc-1936	376	15	ixekizumab	ixekizumab	PROPN
dpc-1936	376	16	and	and	CCONJ
dpc-1936	376	17	ustekinumab	ustekinumab	NOUN
dpc-1936	376	18	efficacy	efficacy	NOUN
dpc-1936	376	19	in	in	ADP
dpc-1936	376	20	nail	nail	NOUN
dpc-1936	376	21	psoriasis	psoriasis	NOUN
dpc-1936	376	22	in	in	ADP
dpc-1936	376	23	patients	patient	NOUN
dpc-1936	376	24	with	with	ADP
dpc-1936	376	25	moderate	moderate	ADJ
dpc-1936	376	26	-	-	PUNCT
dpc-1936	376	27	to	to	ADP
dpc-1936	376	28	-	-	PUNCT
dpc-1936	376	29	severe	severe	ADJ
dpc-1936	376	30	psoriasis	psoriasis	NOUN
dpc-1936	376	31	:	:	PUNCT
dpc-1936	376	32	52	52	NUM
dpc-1936	376	33	-	-	PUNCT
dpc-1936	376	34	week	week	NOUN
dpc-1936	376	35	results	result	NOUN
dpc-1936	376	36	from	from	ADP
dpc-1936	376	37	a	a	DET
dpc-1936	376	38	phase	phase	NOUN
dpc-1936	376	39	3	3	NUM
dpc-1936	376	40	,	,	PUNCT
dpc-1936	376	41	head	head	NOUN
dpc-1936	376	42	-	-	PUNCT
dpc-1936	376	43	to	to	ADP
dpc-1936	376	44	-	-	PUNCT
dpc-1936	376	45	head	head	NOUN
dpc-1936	376	46	study	study	NOUN
dpc-1936	376	47	(	(	PUNCT
dpc-1936	376	48	ixora	ixora	PROPN
dpc-1936	376	49	-	-	PUNCT
dpc-1936	376	50	s	s	NOUN
dpc-1936	376	51	)	)	PUNCT
dpc-1936	376	52	.	.	PUNCT
dpc-1936	377	1	dermatol	dermatol	NOUN
dpc-1936	377	2	ther	ther	ADV
dpc-1936	377	3	(	(	PUNCT
dpc-1936	377	4	heidelb	heidelb	NOUN
dpc-1936	377	5	)	)	PUNCT
dpc-1936	377	6	.	.	PUNCT
dpc-1936	378	1	2020;10:663–670	2020;10:663–670	NOUN
dpc-1936	378	2	.	.	PUNCT
dpc-1936	379	1	doi	doi	NOUN
dpc-1936	379	2	:	:	PUNCT
dpc-1936	379	3	10.1007	10.1007	NUM
dpc-1936	379	4	/	/	SYM
dpc-1936	379	5	s13555	s13555	PROPN
dpc-1936	379	6	-	-	PUNCT
dpc-1936	379	7	020	020	NUM
dpc-1936	379	8	-	-	PUNCT
dpc-1936	379	9	00383	00383	NUM
dpc-1936	379	10	-	-	PUNCT
dpc-1936	379	11	x.	x.	NOUN
dpc-1936	379	12	pmid	pmid	PROPN
dpc-1936	379	13	:	:	PUNCT
dpc-1936	379	14	32415575	32415575	NUM
dpc-1936	379	15	.	.	PUNCT
dpc-1936	380	1	pmcid	pmcid	NOUN
dpc-1936	380	2	:	:	PUNCT
dpc-1936	380	3	pmc7367982	pmc7367982	NOUN
dpc-1936	380	4	.	.	PUNCT
dpc-1936	381	1	27	27	NUM
dpc-1936	381	2	.	.	PUNCT
dpc-1936	382	1	van	van	PROPN
dpc-1936	382	2	de	de	X
dpc-1936	382	3	kerkhof	kerkhof	PROPN
dpc-1936	382	4	p	p	PROPN
dpc-1936	382	5	,	,	PUNCT
dpc-1936	382	6	guenther	guenther	PROPN
dpc-1936	382	7	l	l	PROPN
dpc-1936	382	8	,	,	PUNCT
dpc-1936	382	9	gottlieb	gottlieb	PROPN
dpc-1936	382	10	ab	ab	PROPN
dpc-1936	382	11	,	,	PUNCT
dpc-1936	382	12	et	et	PROPN
dpc-1936	382	13	al	al	PROPN
dpc-1936	382	14	.	.	PROPN
dpc-1936	382	15	ixekizumab	ixekizumab	NOUN
dpc-1936	382	16	treatment	treatment	NOUN
dpc-1936	382	17	improves	improve	VERB
dpc-1936	382	18	fingernail	fingernail	NOUN
dpc-1936	382	19	psoriasis	psoriasis	NOUN
dpc-1936	382	20	in	in	ADP
dpc-1936	382	21	patients	patient	NOUN
dpc-1936	382	22	with	with	ADP
dpc-1936	382	23	moderate	moderate	ADJ
dpc-1936	382	24	-	-	PUNCT
dpc-1936	382	25	to	to	ADP
dpc-1936	382	26	-	-	PUNCT
dpc-1936	382	27	severe	severe	ADJ
dpc-1936	382	28	psoriasis	psoriasis	NOUN
dpc-1936	382	29	:	:	PUNCT
dpc-1936	382	30	results	result	VERB
dpc-1936	382	31	from	from	ADP
dpc-1936	382	32	the	the	DET
dpc-1936	382	33	randomized	randomized	ADJ
dpc-1936	382	34	,	,	PUNCT
dpc-1936	382	35	controlled	controlled	ADJ
dpc-1936	382	36	and	and	CCONJ
dpc-1936	382	37	open	open	ADJ
dpc-1936	382	38	-	-	PUNCT
dpc-1936	382	39	label	label	NOUN
dpc-1936	382	40	phases	phase	NOUN
dpc-1936	382	41	of	of	ADP
dpc-1936	382	42	uncover-3	uncover-3	PROPN
dpc-1936	382	43	.	.	PUNCT
dpc-1936	383	1	j	j	PROPN
dpc-1936	383	2	eur	eur	PROPN
dpc-1936	383	3	acad	acad	PROPN
dpc-1936	383	4	dermatol	dermatol	NOUN
dpc-1936	383	5	venereol	venereol	NOUN
dpc-1936	383	6	.	.	PUNCT
dpc-1936	384	1	2017;31(3):477–482	2017;31(3):477–482	X
dpc-1936	384	2	.	.	PUNCT
dpc-1936	384	3	doi	doi	NOUN
dpc-1936	384	4	:	:	PUNCT
dpc-1936	384	5	10.1111	10.1111	NUM
dpc-1936	384	6	/	/	SYM
dpc-1936	384	7	jdv.14033	jdv.14033	PROPN
dpc-1936	384	8	.	.	PUNCT
dpc-1936	385	1	pmid	pmid	NOUN
dpc-1936	385	2	:	:	PUNCT
dpc-1936	385	3	27910156	27910156	NUM
dpc-1936	385	4	.	.	PUNCT
dpc-1936	386	1	12	12	NUM
dpc-1936	386	2	original	original	ADJ
dpc-1936	386	3	article	article	NOUN
dpc-1936	386	4	|	|	ADV
dpc-1936	386	5	dermatol	dermatol	ADJ
dpc-1936	386	6	pract	pract	NOUN
dpc-1936	386	7	concept	concept	NOUN
dpc-1936	386	8	.	.	PUNCT
dpc-1936	387	1	2022;12(2):e2022104	2022;12(2):e2022104	PROPN
dpc-1936	387	2	39	39	NUM
dpc-1936	387	3	.	.	PUNCT
dpc-1936	388	1	smolen	smolen	VERB
dpc-1936	388	2	js	js	PROPN
dpc-1936	388	3	,	,	PUNCT
dpc-1936	388	4	sebba	sebba	VERB
dpc-1936	388	5	a	a	DET
dpc-1936	388	6	,	,	PUNCT
dpc-1936	388	7	ruderman	ruderman	NOUN
dpc-1936	388	8	em	em	PRON
dpc-1936	388	9	,	,	PUNCT
dpc-1936	388	10	et	et	PROPN
dpc-1936	388	11	al	al	PROPN
dpc-1936	388	12	.	.	PROPN
dpc-1936	388	13	efficacy	efficacy	NOUN
dpc-1936	388	14	and	and	CCONJ
dpc-1936	388	15	safety	safety	NOUN
dpc-1936	388	16	of	of	ADP
dpc-1936	388	17	ixekizumab	ixekizumab	NOUN
dpc-1936	388	18	with	with	ADP
dpc-1936	388	19	or	or	CCONJ
dpc-1936	388	20	without	without	ADP
dpc-1936	388	21	methotrexate	methotrexate	NOUN
dpc-1936	388	22	in	in	ADP
dpc-1936	388	23	biologic	biologic	ADJ
dpc-1936	388	24	-	-	PUNCT
dpc-1936	388	25	naïve	naïve	ADJ
dpc-1936	388	26	patients	patient	NOUN
dpc-1936	388	27	with	with	ADP
dpc-1936	388	28	psoriatic	psoriatic	ADJ
dpc-1936	388	29	arthritis	arthritis	NOUN
dpc-1936	388	30	:	:	PUNCT
dpc-1936	388	31	52	52	NUM
dpc-1936	388	32	-	-	PUNCT
dpc-1936	388	33	week	week	NOUN
dpc-1936	388	34	results	result	NOUN
dpc-1936	388	35	from	from	ADP
dpc-1936	388	36	spirit	spirit	PROPN
dpc-1936	388	37	-	-	PUNCT
dpc-1936	388	38	h2h	h2h	PROPN
dpc-1936	388	39	study	study	NOUN
dpc-1936	388	40	.	.	PUNCT
dpc-1936	389	1	rheumatol	rheumatol	VERB
dpc-1936	389	2	ther	ther	ADV
dpc-1936	389	3	.	.	PUNCT
dpc-1936	390	1	2020;7:1021–1035	2020;7:1021–1035	X
dpc-1936	390	2	.	.	PUNCT
dpc-1936	390	3	doi	doi	NOUN
dpc-1936	390	4	:	:	PUNCT
dpc-1936	390	5	10.1007	10.1007	NUM
dpc-1936	390	6	/	/	SYM
dpc-1936	390	7	s40744	s40744	NOUN
dpc-1936	390	8	-	-	PUNCT
dpc-1936	390	9	020	020	NUM
dpc-1936	390	10	-	-	PUNCT
dpc-1936	390	11	00250	00250	NUM
dpc-1936	390	12	-	-	PUNCT
dpc-1936	390	13	3	3	NUM
dpc-1936	390	14	.	.	PUNCT
dpc-1936	391	1	pmid	pmid	NOUN
dpc-1936	391	2	:	:	PUNCT
dpc-1936	391	3	33200394	33200394	NUM
dpc-1936	391	4	.	.	PUNCT
dpc-1936	392	1	pmcid	pmcid	NOUN
dpc-1936	392	2	:	:	PUNCT
dpc-1936	392	3	pmc7695764	pmc7695764	NOUN
dpc-1936	392	4	.	.	PUNCT
dpc-1936	393	1	38	38	NUM
dpc-1936	393	2	.	.	PUNCT
dpc-1936	394	1	behrens	behrens	PROPN
dpc-1936	394	2	f	f	PROPN
dpc-1936	394	3	,	,	PUNCT
dpc-1936	394	4	cañete	cañete	PROPN
dpc-1936	394	5	jd	jd	PROPN
dpc-1936	394	6	,	,	PUNCT
dpc-1936	394	7	olivieri	olivieri	PROPN
dpc-1936	394	8	i	i	PROPN
dpc-1936	394	9	,	,	PUNCT
dpc-1936	394	10	van	van	PROPN
dpc-1936	394	11	kuijk	kuijk	PROPN
dpc-1936	394	12	aw	aw	INTJ
dpc-1936	394	13	,	,	PUNCT
dpc-1936	394	14	mchugh	mchugh	PROPN
dpc-1936	394	15	n	n	PROPN
dpc-1936	394	16	,	,	PUNCT
dpc-1936	394	17	combe	combe	PROPN
dpc-1936	394	18	b.	b.	PROPN
dpc-1936	394	19	tumour	tumour	NOUN
dpc-1936	394	20	necrosis	necrosis	NOUN
dpc-1936	394	21	factor	factor	NOUN
dpc-1936	394	22	inhibitor	inhibitor	NOUN
dpc-1936	394	23	monotherapy	monotherapy	NOUN
dpc-1936	394	24	vs	vs	ADP
dpc-1936	394	25	combination	combination	NOUN
dpc-1936	394	26	with	with	ADP
dpc-1936	394	27	mtx	mtx	NOUN
dpc-1936	394	28	in	in	ADP
dpc-1936	394	29	the	the	DET
dpc-1936	394	30	treatment	treatment	NOUN
dpc-1936	394	31	of	of	ADP
dpc-1936	394	32	psa	psa	NOUN
dpc-1936	394	33	:	:	PUNCT
dpc-1936	394	34	a	a	DET
dpc-1936	394	35	systematic	systematic	ADJ
dpc-1936	394	36	review	review	NOUN
dpc-1936	394	37	of	of	ADP
dpc-1936	394	38	the	the	DET
dpc-1936	394	39	literature	literature	NOUN
dpc-1936	394	40	.	.	PUNCT
dpc-1936	395	1	rheumatology	rheumatology	NOUN
dpc-1936	395	2	(	(	PUNCT
dpc-1936	395	3	oxford	oxford	PROPN
dpc-1936	395	4	)	)	PUNCT
dpc-1936	395	5	.	.	PUNCT
dpc-1936	396	1	2015;54(5):915–926	2015;54(5):915–926	X
dpc-1936	396	2	.	.	PUNCT
dpc-1936	397	1	doi	doi	NOUN
dpc-1936	397	2	:	:	PUNCT
dpc-1936	397	3	10.1093	10.1093	NUM
dpc-1936	397	4	/	/	SYM
dpc-1936	397	5	rheumatology	rheumatology	NOUN
dpc-1936	397	6	/	/	SYM
dpc-1936	397	7	keu415	keu415	PROPN
dpc-1936	397	8	.	.	PUNCT
dpc-1936	398	1	pmid	pmid	NOUN
dpc-1936	398	2	:	:	PUNCT
dpc-1936	398	3	25349441	25349441	NUM
dpc-1936	398	4	.	.	PUNCT